VAERS Reports AS7143C

VAERS 2661292

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7143C

kritisch

Staat: -
Alter: 82,0
Geschlecht: M
Eingang: 26.07.2023
Impfdatum: 07.09.2022
Beginn: 11.09.2022
Tage bis Beginn: 4,0
Dosis: 5
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt

Acute respiratory failure Hypoxia Obstructive sleep apnoea syndrome

Symptomtext

ADULT OBSTRUCTIVE SLEEP APNEA ACUTE HYPOXEMIC RESPIRATORY FAILURE HYPOXIA

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute respiratory failure
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2660902

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7143C

kritisch

Staat: -
Alter: 60,0
Geschlecht: F
Eingang: 26.07.2023
Impfdatum: 14.09.2022
Beginn: 15.10.2022
Tage bis Beginn: 31,0
Dosis: 5
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt

Acute myocardial infarction

Symptomtext

ACUTE NON ST ELEVATION MI

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute myocardial infarction
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2618532

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7143C

kritisch

Staat: CA
Alter: 67,0
Geschlecht: F
Eingang: 20.04.2023
Impfdatum: 14.09.2022
Beginn: 27.12.2022
Tage bis Beginn: 104,0
Dosis: 5
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein

Bell's palsy Blood test COVID-19 Cerebrovascular accident Computerised tomogram head abnormal Condition aggravated Fatigue Feeling abnormal Gait disturbance Headache Hypertension Hypoaesthesia Magnetic resonance imaging head abnormal Neuritis Neurological symptom Paraesthesia SARS-CoV-2 test positive Sinus disorder

Symptomtext

On 12/27/2022, I tested myself for COVID-19 because I felt funny. When it was positive, I didn't feel too bad. Over the course of the next few days, the left side of my face felt slight tingling and numbness and I felt like I was favoring my left side when walking. I called 911 on 12/30/2023, after thinking it was sinus issues for a few days. They took me to a nearby hospital. They confirmed my positive COVID-19 results. That night, the doctor told me I had a mild stroke. They recommended that I see a neurologist. It was a holiday weekend, so I was unable to be seen. They ultimately air lifted me on 01/01/2023, to another hospital. They didn't think it was too severe, but I had very high blood pressure as well. I saw two neurologists as well as the head neurologist. They all concurred that I had a mild stroke and my blood pressure was just getting worse. I don't remember what all kind of medications they gave me. I also developed a really bad COVID-19 headache. As soon as I was diagnosed, I called my primary doctor, who recommended I take PAXLOVID. I was only able to take 9 of the 10 doses, which my doctor said was alright. I was only in that hospital for 2 days. They always considered it a mild case. Eventually the head neurologist came in and informed me that I actually did not have a stroke. His conclusion was that I had Bell's Palsy. He believed that the COVID-19 cause inflammation that affected the nerves in my brain which gave me stroke like symptoms. The morning of 01/02/2023 or 01/03/2023, they discharged me, and I've been ok since. Even today, I feel lucky because the only remaining symptom has been occasional fatigue. About every 2 weeks or so, I get extremely fatigued. Sunday, I took multiple 2-hour naps and then went to bed at 09:00PM.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Cerebrovascular accident
Hospital-Tage: 4,0
Labordaten: 27DEC2023 at home COVID-19 test positive; 30DEC2023 COVID-19 test positive, MRI Stroke diagnosis; Cat Scan, Stroke Diagnosis; Blood work, results unknown
Aktuelle Erkrankungen: None
Vorgeschichte: High Blood Pressure; Pre Diabetes
Andere Medikamente: Losartan-HCTZ; atenolol; fluticasone; pantoprazole; airborne; multivitamin; FOCUS FACTOR; biotin
Allergien: None
Vorherige Impfungen: First and Second Moderna dose, 2021, fatigue and body aches

VAERS 2613148

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7143C

kritisch

Staat: WI
Alter: 99,0
Geschlecht: F
Eingang: 11.04.2023
Impfdatum: 26.09.2022
Beginn: 26.02.2023
Tage bis Beginn: 153,0
Dosis: 5
Route/Site: UN / UN

Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: nein

Asthenia COVID-19 Chest X-ray normal Death Dyspnoea exertional Electrocardiogram normal Full blood count normal Hypoxia Metabolic function test normal Oxygen saturation decreased Respiratory failure SARS-CoV-2 test positive Urine analysis normal

Symptomtext

On 2/26/2023, patient presented to the emergency department via ambulance from her assisted living facility for evaluation of weakness and a positive COVID-19 antigen test at her facility. In the emergency department, patient was given a COVID-19 NAA test which resulted positive; Her chest x-ray showed no acute cardiopulmonary findings; Her CMP and CBC labs were unremarkable, UA was negative, and EKG was normal sinus rhythm. Patient become hypoxic with ambulation and desaturated to 84% on room air; She was treated with oxygen supplementation and IV Decadron. She was diagnosed with hypoxia secondary to COVID-19 infection and weakness. Patient was admitted to the hospital for further evaluation and treatment. Hospital discharge date is unknown. At some point, the patient was transferred to where she died on 3/10/2023. Her death abstract listed immediate cause of death as respiratory failure due to COVID-19 infection. Submitter does not have access to further medical information on this case. If more information is needed, please contact the admitting hospital.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: 2/26/2023 - Positive COVID-19 antigen test at patient's assisted living facility. 2/26/2023 - In the emergency department - Positive COVID-19 test; Chest x-ray showed no acute cardiopulmonary findings; CMP and CBC labs were unremarkable, UA was negative, and EKG was normal sinus rhythm.
Aktuelle Erkrankungen: Unknown
Vorgeschichte: Degenerative joint disease, gastroesophageal reflux disease, heart murmur, nephrolithiasis, sarcoidosis, hyperlipidemia, primary open-angle glaucoma of the left eye, and dementia.
Andere Medikamente: Unknown
Allergien: Allergies: Codeine ? shakey; Diphenhydramine ? hypotension; Iron Dextran - hypotensive and swelling; Penicillins ? hives; Sulfa (Sulfonamide Antibiotics).
Vorherige Impfungen: -

VAERS 2595047

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7143C

kritisch

Staat: WA
Alter: 55,0
Geschlecht: M
Eingang: 10.03.2023
Impfdatum: 07.09.2022
Beginn: 25.02.2023
Tage bis Beginn: 171,0
Dosis: 5
Route/Site: IM / UN

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: ja

Computerised tomogram Fibrin D dimer increased Pulmonary embolism

Symptomtext

Diagnosised Bilateral Pulmonary embih

Weitere VAERSDATA-Felder

Praegender Schweregrund: Pulmonary embolism
Hospital-Tage: -
Labordaten: Elevated Ddmier test - 25Feb2023 CT Scan -25Feb2023
Aktuelle Erkrankungen: N?A
Vorgeschichte: N/A
Andere Medikamente: N/A
Allergien: N/A
Vorherige Impfungen: -

VAERS 2594676

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7143C

kritisch

Staat: CT
Alter: 71,0
Geschlecht: F
Eingang: 10.03.2023
Impfdatum: 07.09.2022
Beginn: 13.10.2022
Tage bis Beginn: 36,0
Dosis: 5
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: ja

Arteriovenous malformation Cerebral haemorrhage Computerised tomogram head abnormal Diplopia Headache Intensive care Magnetic resonance imaging head abnormal Radiotherapy to brain SARS-CoV-2 test negative

Symptomtext

On 10/13/2022, about 10:00PM, I got a very bad headache. I went to urgent care Wednesday and Friday. They said it wasn't COVID-19, it was a virus. Then on Saturday, I woke and for about ten minutes I had double vision. I had the same thing on Sunday. On Monday, I called my Primary Care Physician. The nurse called me back early afternoon. She said go to the emergency room. There, they did a CT Scan and said it was a brain bleed. I was hospitalized and in the ICU for five days. Then in January, I had radiological surgery. They determined an Arteriovenous Malformation. I am fine.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Cerebral haemorrhage
Hospital-Tage: 5,0
Labordaten: 17OCT2022 COVID-19 test negative; 19OCT2022 COVID-19 test negative; 24OCT2022 COVID-19 test negative; 24OCT2022 CT Scan and MRI Brain Bleed; 23NOV2022 CT Scan and MRI, Blood was dissipating
Aktuelle Erkrankungen: N/A
Vorgeschichte: Mild Emphysema; Allergy Induced Asthma
Andere Medikamente: Vitamin B complex; vitamin D; ZYRTEC; bupropion XL
Allergien: Codeine; pollen; dander; mold
Vorherige Impfungen: -

VAERS 2591854

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7143C

kritisch

Staat: AR
Alter: 74,0
Geschlecht: M
Eingang: 06.03.2023
Impfdatum: 03.09.2022
Beginn: 01.01.2023
Tage bis Beginn: 120,0
Dosis: 5
Route/Site: SYR / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Blood pressure systolic increased Death of relative Hypertension Stress

Symptomtext

I began monitoring my blood pressure in early January 2023. I encountered some high systolic readings. The readings were in 140s and 150s. Previous systolic readings had been in the 120s. I was experiencing a high level of stress due to a family illness. My family member died at the end of January. I continued to monitor my blood pressure through February 2023. The high readings persisted. I sought medical attention on March 01, 2023. I was prescribed valsartan, 1 dose daily, to control high blood pressure. I've continued to monitor my blood pressure daily since the prescription was filled. I'm seeing moderate results in lowering blood pressure to date. I'm continuing to exercise most days when weather permits. I walk two miles daily.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death of relative
Hospital-Tage: -
Labordaten: 03/01/2023 Blood Pressure 162/92
Aktuelle Erkrankungen: None
Vorgeschichte: Heart Disease; Darier Disease
Andere Medikamente: Cetirizine; magnesium; zinc; CENTRUM SILVER; ELIQUIS; famotidine; valacyclovir; simvastatin
Allergien: Penicillin; BACTRIM; erythromycin
Vorherige Impfungen: -

VAERS 2440710

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7143C

kritisch

Staat: NV
Alter: 87,0
Geschlecht: F
Eingang: 23.09.2022
Impfdatum: 08.09.2022
Beginn: 01.09.2022
Tage bis Beginn: -
Dosis: 3
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein

Asthenia Chills Dizziness Fall Headache COVID-19 immunisation Feeling hot Hyperhidrosis Interchange of vaccine products Near death experience Pelvic fracture Pelvic pain SARS-CoV-2 test Joint injury Malaise Nausea Walking aid user Syncope

Symptomtext

This spontaneous case was reported by a patient and describes the occurrence of NEAR DEATH EXPERIENCE (almost died), SYNCOPE (next thing I know, I was on the ground must have fainted), PELVIC FRACTURE (Cracked the bone with 2 balls, Cracked Pelvis in 1 spot per CAT Scan or MRI, Broke the other ball clean through), HYPERHIDROSIS (Sweats, woke up wringing wet), PELVIC PAIN (Broke my pelvis because of this shot, Knocked me for a loop, a lot of pain), FEELING HOT (Body was on fire), DIZZINESS (felt really, terribly dizzy) and CHILLS (Chills so bad teeth chattered) in an 87-year-old female patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. The patient's past medical history included COVID-19 in September 2021. Previously administered products included for Drug use for unknown indication: JANSSEN COVID-19 VACCINE (Dose 1). Past adverse reactions to the above products included No adverse event with JANSSEN COVID-19 VACCINE. Concurrent medical conditions included Blood pressure management and Allergy (Allergies: long time ago but can't recall). Concomitant products included LOSARTAN for Blood pressure high. On 08-Sep-2022, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. In September 2022, the patient experienced NEAR DEATH EXPERIENCE (almost died) (seriousness criteria hospitalization and medically significant), SYNCOPE (next thing I know, I was on the ground must have fainted) (seriousness criteria hospitalization and medically significant), PELVIC FRACTURE (Cracked the bone with 2 balls, Cracked Pelvis in 1 spot per CAT Scan or MRI, Broke the other ball clean through.) (seriousness criteria hospitalization and medically significant), HYPERHIDROSIS (Sweats, woke up wringing wet) (seriousness criterion hospitalization), PELVIC PAIN (Broke my pelvis because of this shot , Knocked me for a loop, a lot of pain) (seriousness criterion hospitalization), FEELING HOT (Body was on fire) (seriousness criterion hospitalization), DIZZINESS (felt really, terribly dizzy) (seriousness criterion hospitalization) and CHILLS (Chills so bad teeth chattered) (seriousness criterion hospitalization). On an unknown date, the patient experienced COVID-19 IMMUNISATION (Revaccination with different COVID-19 vaccine) and INTERCHANGE OF VACCINE PRODUCTS (Interchange of vaccine products). The patient was hospitalized from 12-Sep-2022 to 14-Sep-2022 due to CHILLS, DIZZINESS, FEELING HOT, HYPERHIDROSIS, NEAR DEATH EXPERIENCE, PELVIC FRACTURE and PELVIC PAIN. The patient was treated with IBUPROFEN at an unspecified dose and frequency and PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, NEAR DEATH EXPERIENCE (almost died), SYNCOPE (next thing I know, I was on the ground must have fainted), PELVIC FRACTURE (Cracked the bone with 2 balls, Cracked Pelvis in 1 spot per CAT Scan or MRI, Broke the other ball clean through.), HYPERHIDROSIS (Sweats, woke up wringing wet), PELVIC PAIN (Broke my pelvis because of this shot , Knocked me for a loop, a lot of pain), FEELING HOT (Body was on fire), DIZZINESS (felt really, terribly dizzy) and CHILLS (Chills so bad teeth chattered) had not resolved and COVID-19 IMMUNISATION (Revaccination with different COVID-19 vaccine) and INTERCHANGE OF VACCINE PRODUCTS (Interchange of vaccine products) outcome was unknown. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In September 2021, SARS-CoV-2 test: (Positive) had symptoms but no hospitalization. For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter did not provide any causality assessments. Patient had chills so bad her teeth chattered, sweats, broke her pelvis because of this shot, knocked for a loop, patient went to bed that night woke up wringing wet, her body was on fire, got water and turned, she felt terribly dizzy, next thing she know she was on ground, must have fainted. Patient was hospitalized from 12-Sep-2022 through Wednesday afternoon, 14-Sep-2022. She was crippled, cracked the bone with 2 balls, cracked pelvis in one spot per CAT scan or MRI, broke the other ball clean through. Patient suffered until Monday. Doctors said it will take 6 weeks to 2 months to heal. Doctor's can not do surgery now. Company comment: This spontaneous case concerns an 87-year-old female patient, with relevant medical history of allergy and had symptomatic COVID-19 with positive SARS-CoV-2 test (same month of vaccination), who experienced the unexpected serious (hospitalization and medically significant) events of Near death experienced (reported as almost died) and Pelvic fracture, and unexpected serious (hospitalization) Hyperhidrosis, Pelvic pain, Feeling hot, Dizziness, and Chills, and expected serious (medically significant and hospitalization) event of Syncope (reported as I was on the ground, must have fainted) after receiving a dose of mRNA-1273 bivalent BA.4/BA.5. The events occurred within the same month of vaccination. Patient reported that she was almost died, felt dizzy and must had fainted and broke her pelvis because of the shot and got crippled. Took Paracetamol and Ibuprofen. Patient was hospitalized 4th day post vaccination and was discharged after two days. Computerized tomography or magnetic resonance imaging showed pelvic fracture. The outcome of events was reported as not resolved. On an unknown date, patient received COVID-19 VACCINE NRVV AD26 (JNJ 78436735) as 1st dose prior to mRNA-1273 bivalent BA.4/BA.5 (Revaccination with different COVID-19 vaccine and Interchange of vaccine products). It was reported that patient was in good health prior to vaccination. The benefit-risk relationship of mRNA-1273 is not affected by this report. This case was linked to US-MODERNATX, INC.-MOD-2022-647572, US-MODERNATX, INC.-MOD-2022-647578 (E2B Linked Report). Sender's Comments: This spontaneous case concerns an 87-year-old female patient, with relevant medical history of allergy and had symptomatic COVID-19 with positive SARS-CoV-2 test (same month of vaccination), who experienced the unexpected serious (hospitalization and medically significant) events of Near death experienced (reported as almost died) and Pelvic fracture, and unexpected serious (hospitalization) Hyperhidrosis, Pelvic pain, Feeling hot, Dizziness, and Chills, and expected serious (medically significant and hospitalization) event of Syncope (reported as I was on the ground, must have fainted) after receiving a dose of mRNA-1273 bivalent BA.4/BA.5. The events occurred within the same month of vaccination. Patient reported that she was almost died, felt dizzy and must had fainted and broke her pelvis because of the shot and got crippled. Took Paracetamol and Ibuprofen. Patient was hospitalized 4th day post vaccination and was discharged after two days. Computerized tomography or magnetic resonance imaging showed pelvic fracture. The outcome of events was reported as not resolved. On an unknown date, patient received COVID-19 VACCINE NRVV AD26 (JNJ 78436735) as 1st dose prior to mRNA-1273 bivalent BA.4/BA.5 (Revaccination with different COVID-19 vaccine and Interchange of vaccine products). It was reported that patient was in good health prior to vaccination. The benefit-risk relationship of mRNA-1273 is not affected by this report. US-MODERNATX, INC.-MOD-2022-647572:Patient No 1 case; US-MODERNATX, INC.-MOD-2022-647578: Patient No 2 case.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Near death experience
Hospital-Tage: -
Labordaten: Test Date: 202109; Test Name: Covid-19; Test Result: Positive; Result Unstructured Data: had symptoms but no hospitalization.
Aktuelle Erkrankungen: Blood pressure management
Vorgeschichte: Medical History/Concurrent Conditions: Allergy (Allergies: long time ago but can't recall); COVID-19
Andere Medikamente: LOSARTAN
Allergien: -
Vorherige Impfungen: -

VAERS 2686242

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7143C

schwer

Staat: MD
Alter: 74,0
Geschlecht: F
Eingang: 26.09.2023
Impfdatum: 08.09.2022
Beginn: 01.05.2023
Tage bis Beginn: 235,0
Dosis: 5
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

COVID-19 Venous thrombosis limb

Symptomtext

covid 19; The patient states she was also diagnosed with a chronic minor blood clot in the left femoral vein during the time she got COVID.; This spontaneous case was reported by a patient and describes the occurrence of VENOUS THROMBOSIS LIMB (The patient states she was also diagnosed with a chronic minor blood clot in the left femoral vein during the time she got COVID.) in a 74-year-old female patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. AS7143C) for COVID-19 prophylaxis. The occurrence of additional non-serious events is detailed below. Previously administered products included for COVID-19 prophylaxis: Moderna COVID-19 Vaccine (Batch number-031M20A, Dose 1) on 13-Feb-2021, Moderna COVID-19 Vaccine (Batch number-061A21A, Dose 2) on 13-Mar-2021, Moderna COVID-19 Vaccine (Batch number-026D21A, Dose 3) on 22-Oct-2021, Moderna COVID-19 Vaccine (Batch number-002M21A and Dose 4) on 08-Apr-2022. Past adverse reactions to the above products included No adverse event with Moderna COVID-19 Vaccine, Moderna COVID-19 Vaccine, Moderna COVID-19 Vaccine and Moderna COVID-19 Vaccine. On 08-Sep-2022, the patient received fifth dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. In May 2023, the patient experienced COVID-19 (covid 19). In 2023, the patient experienced VENOUS THROMBOSIS LIMB (The patient states she was also diagnosed with a chronic minor blood clot in the left femoral vein during the time she got COVID.) (seriousness criterion medically significant). The patient was treated with DABIGATRAN ETEXILATE MESILATE (PRADAXA) for Clot blood, at an unspecified dose and frequency. At the time of the report, VENOUS THROMBOSIS LIMB (The patient states she was also diagnosed with a chronic minor blood clot in the left femoral vein during the time she got COVID.) had not resolved and COVID-19 (covid 19) had resolved. For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter did not provide any causality assessments. It was reported that the patient had COVID in May 2023. The patient stated that she was also diagnosed with a chronic minor blood clot in the left femoral vein during the time she got COVID. They told her she might have had it prior to developing COVID. They said it looked like it was not resulting from COVID. Patient was using the blood thinner at the time of reporting because it was stable but still there. Patient stated she confirmed from COVID within a week. She had some fatigue afterwards. She did not had any other treatment. Company Comment: This is a Spontaneous case concerning a 74-year-old female patient with no medical history reported, who experienced the serious (per medically significant) unexpected AESI of thrombosis. A non-serious event of COVID-19 was also reported. The events occurred approximately 8 months after the fifth dose of mRNA-1273 received for COVID-19 Vaccination. It was reported that the patient was diagnosed with a chronic minor blood clot in the left femoral vein during the time she got COVID. They told her she might have had it prior to developing COVID. She was treated with PRADAXA for thrombosis and did not receive any other treatment. Concurrent COVID-19 infection and patient's advanced age may remain as confounders for thrombosis. The benefit-risk relationship of mRNA-1273 is not affected by this report.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Venous thrombosis limb
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2642207

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7143C

schwer

Staat: -
Alter: 81,0
Geschlecht: M
Eingang: 07.06.2023
Impfdatum: 13.09.2022
Beginn: 13.11.2022
Tage bis Beginn: 61,0
Dosis: 5
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt

Infection Shock

Symptomtext

PYOGENIC SHOCK

Weitere VAERSDATA-Felder

Praegender Schweregrund: Shock
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2635379

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7143C

schwer

Staat: -
Alter: 71,0
Geschlecht: F
Eingang: 23.05.2023
Impfdatum: 07.09.2022
Beginn: 19.09.2022
Tage bis Beginn: 12,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt

Ischaemic stroke

Symptomtext

PATIENT RECEIVED VACCINE FROM OUTSIDE SOURCE ACUTE STROKE DUE TO ISCHEMIA, UNSPECIFIED TYPE AND ARTERY

Weitere VAERSDATA-Felder

Praegender Schweregrund: Ischaemic stroke
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2619104

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7143C

schwer

Staat: OR
Alter: 76,0
Geschlecht: F
Eingang: 21.04.2023
Impfdatum: 10.09.2022
Beginn: 09.12.2022
Tage bis Beginn: 90,0
Dosis: 4
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: ja Hospital: ja Disable: ja ER: ja Erholt: nein

Anticoagulant therapy Blood test Compression garment application Computerised tomogram abnormal Dysstasia Joint swelling Limb discomfort Magnetic resonance imaging Pain in extremity Peripheral swelling Pulmonary thrombosis Skin discolouration Skin warm Thrombosis Ultrasound Doppler abnormal Vena cava thrombosis

Symptomtext

When I first got out of bed and put my legs on the floor, I couldn't stand up, because my left leg felt like lead and hurt. I then noticed that my left leg was swollen about three times the size of the right leg and discolored. I didn't know what was going on, so I researched my symptoms on the Internet, which advised me to go to the ER as soon as possible. I then called the ambulance, who then transported me to the ER. At the ER, the attending doctor saw my leg and immediately knew what the problem was. I underwent bloodwork and an MRI or CT scan. I was admitted to the hospital in the medical-surgical wing and hooked up to an IV. I was given intravenous blood thinners. I was in the hospital for four or five days. The attending doctor told me that I had a "massive blood clot" that had started in my left ankle and then extended all the way up my leg and into my torso to an unknown location. The doctor also told me that it would probably be at least a year before the clot dissipates. At the time, I thought the blood thinner would be the cause of the dissipation, but I later learned from my hematologist that the purpose of the blood thinner is not to dissipate the clot, but to keep new clots from forming. Ultimately, the body dissipates the clot on its own. I was released from the hospital after four or five days, and prescribed XARELTO. I was also given an anti-nausea drug, which constipated me, so I promptly stopped taking it. I was advised to take various precautionary measures. I was advised to not sit with my legs bent, but to have them elevated. I was also told to make sure that I kept walking; I have had to learn to pace myself to walk enough, but not too much. I also bought a wedge, which I use to keep my legs elevated as I sleep. I've also been doing some yoga exercises that are designed to help circulation and to maintain my upper body strength. On 12/17/2022, I went back to the ER, because my left leg and hip became extremely swollen and hot to the touch. The ER staff told me that I needed to use an ACE bandage for compression. Later in January 2023, I saw my hematologist for the first time, and he said that the ACE bandage was useless and that I should use compression socks. I have been doing this ever since on a daily basis. I've noticed that since I've been wearing the compression socks, I have had no more swelling or pain flare-ups. I underwent more bloodwork to see if I had an underlying illness or genetic factor that could be the cause of the issue, and those were ruled out when the results came back. He also took an inventory of my medical history. I was advised to continue taking the XARELTO, wear the compression socks, and continue elevating my legs and exercising in moderation. I was also advised to take every precaution against bumping my head or cutting myself, because those things could cause a brain bleed. My daughter has basically childproofed my home and given me a first aid kit with equipment to use in case I cut myself or bump my head. On 3/20/2023, I saw my hematologist again. During this visit, he showed me the images from the CT scan or ultrasound I had undergone at the ER in December 2022. He showed me that the blood clot extended from my left ankle all the way to my inferior vena cava and that there were clots in the lungs. He said that the clots in the lungs sometimes happen, especially if a blood clot elsewhere in the body is dissipating, and that I should not be alarmed. I am due to see the hematologist again in June 2023. He basically told me during the March appointment that I should resume my normal activities but do them carefully. I feel like I live in the land of ambiguity. I'm sleeping well and feel fine, but I have to take so many precautions against bumping my head, cutting myself, catching COVID-19, or catching any other contagion.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Pulmonary thrombosis
Hospital-Tage: 5,0
Labordaten: DEC2022 Ultrasound or CT Scan, blood clot extending from left ankle to inferior Vena Cava detected
Aktuelle Erkrankungen: None
Vorgeschichte: Hypothyroidism; Hypertension
Andere Medikamente: ARMOUR THYROID; lisinopril
Allergien: Beta blockers; penicillin; codeine; opiates; seasonal allergies
Vorherige Impfungen: -

VAERS 2604893

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7143C

schwer

Staat: IL
Alter: 64,0
Geschlecht: F
Eingang: 28.03.2023
Impfdatum: 25.09.2022
Beginn: 14.10.2022
Tage bis Beginn: 19,0
Dosis: 5
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: ja

Blood test abnormal COVID-19 Dehydration Electrocardiogram abnormal Headache Oropharyngeal pain Pain SARS-CoV-2 test positive Syncope

Symptomtext

Started having a sore throat, headache; and felt achy. Work place gave me a PCR COVID-19 test and was positive. Contacted doctor and was prescribed Paxlovid. A week after taking Paxlovid, I fainted and was taken to the hospital by ambulance. Had blood panel ran, and was told that I was severely dehydrated. Was given an EKG and it was abnormal. Doctor thought that it was due to both dehydration and COVID-19. Finally tested negative for COVID-19 on 12/28/2022. Tested positive for COVID-19 again on 03/18/2023. Doctor prescribed Paxlovid again.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Syncope
Hospital-Tage: -
Labordaten: 10OCT2022 PCR COVID-19 test - Positive; 25OCT2022 Blood Panel - Dehydration; 18MAR2023 COVID-19 test - Positive.
Aktuelle Erkrankungen: N/A
Vorgeschichte: Juvenile Rheumatoid Arthritis; Reynauld Syndrome.
Andere Medikamente: Simvastatin; Plaquenil; Folic Acid; Methotrexate; Voltarin Gel; Tylenol; Calcium.
Allergien: Darvoncet; Nnasid; Diclofenac; Bay Leaf; Blue dye; Bee stings.
Vorherige Impfungen: -

VAERS 2597718

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7143C

schwer

Staat: WA
Alter: 69,0
Geschlecht: F
Eingang: 16.03.2023
Impfdatum: 13.09.2022
Beginn: 08.03.2023
Tage bis Beginn: 176,0
Dosis: 5
Route/Site: IM / AR

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: ja

Asthenia Chest X-ray abnormal Cough Fatigue Pneumonia bacterial Pulmonary oedema Pyrexia Rales SARS-CoV-2 test negative Viral test negative

Symptomtext

I had coughing, fatigue, weakness, a fever, some crackling in my lungs. My husband and I were on vacation, we had packed home COVID-19 test, it came back negative. The next morning, I went to the local emergency room. The did a PCR rapid COVID-19 that came back negative, I had a chest x-ray that showed that I did have fluid in my lungs, I had a nasal swab that came back negative for viral pneumonia. It was determined I had bacterial pneumonia I was given an antibiotic that has helped me to recover. I am still tired but feeling better.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Pulmonary oedema
Hospital-Tage: -
Labordaten: 8MAR2023 home COVID-19 positive; 9MAR2023 PCR rapid COVID-19 negative; 9MAR2023 Chest X-ray positive; 9MAR2023 nasal swab pneumonia, negative for viral pneumonia
Aktuelle Erkrankungen: No
Vorgeschichte: Insomnia
Andere Medikamente: ONE A DAY vitamins; escitalopram; amitriptyline; CRESTOR; prednisolone eye drops; RHOPRESSA
Allergien: Erythromycin; shellfish sensitivity; lactose intolerance
Vorherige Impfungen: -

VAERS 2591269

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7143C

schwer

Staat: CO
Alter: 74,0
Geschlecht: F
Eingang: 03.03.2023
Impfdatum: 06.09.2022
Beginn: 01.11.2022
Tage bis Beginn: 56,0
Dosis: 5
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Arrhythmia Cardiac stress test abnormal Catheterisation cardiac normal Chest pain Dyspnoea Dyspnoea exertional Echocardiogram normal Electrocardiogram ambulatory Exercise test abnormal Myocarditis Ventricular tachycardia

Symptomtext

About two months after the COVID-19 vaccine, I started to have chest pain and shortness of breath with exercise. It was intermitted with exercise. I went to see my primary physician who referred me to have an exercise stress test, which indicated I had arrythmias, V tachycardia. When I received the cardiac catheterization, it showed normal coronary arteries and normal heart function. My doctors think my arrythmias is due to myocarditis. I'm currently having a Holter monitor done.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Myocarditis
Hospital-Tage: -
Labordaten: 01FEB2023 - Echocardiogram - Normal heart; 27JAN2023 - Exercise Stress Test - Arrythmias; 09FEB2023 - Cardiac Catheterization - Normal heart
Aktuelle Erkrankungen: N/A
Vorgeschichte: Diabetes
Andere Medikamente: Metformin; Glimepiride; Levothyroxine; Aleve; MiraLAX; Biotin; Triple Flex; Fish Oil
Allergien: Sulfa; Statins
Vorherige Impfungen: -

VAERS 2584696

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7143C

schwer

Staat: -
Alter: 55,0
Geschlecht: M
Eingang: 27.02.2023
Impfdatum: 08.09.2022
Beginn: 14.09.2022
Tage bis Beginn: 6,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Anxiety Burning sensation COVID-19 immunisation Disturbance in attention Dizziness Blood test Electromyogram Feeling abnormal Insomnia Interchange of vaccine products Nerve conduction studies Neuropathy peripheral Feeling hot Hyperaesthesia Laboratory test Magnetic resonance imaging head Oral discomfort Paraesthesia

Symptomtext

states that something has been off regarding heat and cold sensitivity in his hands and feet/Cold water feels too cold and hot water feels too hot/sensitivity to temperature has enhanced a lot; cannot sleep due to this; cannot focus on anything; scared that something is going to happen/states that something has been off regarding heat and cold sensitivity in his hands and feet/Cold water feels too cold and hot water feels too hot/; feels lightheaded and like he is going to faint; Interchange of vaccine products; Revaccination with different COVID-19 vaccine; it seems like some type of neuropathy is going on; anxious/gets uneasiness spells every now/scared that something is going to happen; having burning sensations in his hands and feet; This spontaneous case was reported by a consumer and describes the occurrence of NEUROPATHY PERIPHERAL (it seems like some type of neuropathy is going on) in a 55-year-old male patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. AS7143C) for COVID-19 prophylaxis. The occurrence of additional non-serious events is detailed below. Previously administered products included for Product used for unknown indication: PFIZER BIONTECH COVID-19 VACCINE (Second dose) in March 2021, PFIZER BIONTECH COVID-19 VACCINE (First dose) in March 2021 and PFIZER BIONTECH COVID-19 VACCINE (1st booster) in April 2022. Past adverse reactions to the above products included No adverse event with PFIZER BIONTECH COVID-19 VACCINE, PFIZER BIONTECH COVID-19 VACCINE and PFIZER BIONTECH COVID-19 VACCINE. On 08-Sep-2022, the patient received fourth dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On 14-Sep-2022, the patient experienced BURNING SENSATION (having burning sensations in his hands and feet). On an unknown date, the patient experienced NEUROPATHY PERIPHERAL (it seems like some type of neuropathy is going on) (seriousness criterion medically significant), ANXIETY (anxious/gets uneasiness spells every now/scared that something is going to happen), TEMPERATURE INTOLERANCE (states that something has been off regarding heat and cold sensitivity in his hands and feet/Cold water feels too cold and hot water feels too hot/sensitivity to temperature has enhanced a lot), INSOMNIA (cannot sleep due to this), DISTURBANCE IN ATTENTION (cannot focus on anything), FEELING ABNORMAL (scared that something is going to happen/states that something has been off regarding heat and cold sensitivity in his hands and feet/Cold water feels too cold and hot water feels too hot/), DIZZINESS (feels lightheaded and like he is going to faint), INTERCHANGE OF VACCINE PRODUCTS (Interchange of vaccine products) and COVID-19 IMMUNISATION (Revaccination with different COVID-19 vaccine). At the time of the report, NEUROPATHY PERIPHERAL (it seems like some type of neuropathy is going on), TEMPERATURE INTOLERANCE (states that something has been off regarding heat and cold sensitivity in his hands and feet/Cold water feels too cold and hot water feels too hot/sensitivity to temperature has enhanced a lot), INSOMNIA (cannot sleep due to this), DISTURBANCE IN ATTENTION (cannot focus on anything), FEELING ABNORMAL (scared that something is going to happen/states that something has been off regarding heat and cold sensitivity in his hands and feet/Cold water feels too cold and hot water feels too hot/), INTERCHANGE OF VACCINE PRODUCTS (Interchange of vaccine products) and COVID-19 IMMUNISATION (Revaccination with different COVID-19 vaccine) outcome was unknown and ANXIETY (anxious/gets uneasiness spells every now/scared that something is going to happen), BURNING SENSATION (having burning sensations in his hands and feet) and DIZZINESS (feels lightheaded and like he is going to faint) had not resolved. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Nerve conduction studies: Nerve conduction study: Normal, Sensory neuropathy test is pending. On an unknown date, Weight: lost about 40 lbs. For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter did not provide any causality assessments. No concomitant medications were reported. Patient reported that even with normal cold water, he feels too cold.He reported that he gets uneasiness spells every now and then where he feels lightheaded and like he is going to faint, but that feeling eventually passes through. He is seeing a neurologist. He says he had been healthy all his life, but now he had been suffering for almost 4 months. No treatment medications were reported. Company comment: This is a Spontaneous case concerns a 55 years old male patient, with no relevant medical history, who experienced unexpected serious (medically significant) event of neuropathy peripheral, which occurred in context with booster dose of mRNA-1273 vaccination BA.4/BA.5. About a week after vaccination patient experienced burning sensation and cold insensitivity in the hand and the feet, patient says some type of neuropathy is going on. Patent experienced some light lightheaded and like he is going to faint, anxious and insomnia. Last week he went to emergency, consulted neurologist nerve conduction study was normal. Lost 40 lbs after vaccination. Patient received three doses of TOZINAMERNAN prior to the mRNA-1273 bivalent BA.1 vaccination BA.4/BA.5 (Interchange of vaccine products). The benefit-risk relationship of mRNA-1273 bivalent BA.4/BA.5 vaccination is not affected by this report. This case was linked to US-MODERNATX, INC.-MOD-2023-712074 (E2B Linked Report). Most recent FOLLOW-UP information incorporated above includes: On 21-Feb-2023: Significant live Follow-up information received - Relevant Past Drug History, Events and Results of tests and procedures relevant to the investigation of the patient and Narrative has been updated.; Sender's Comments: US-MODERNATX, INC.-MOD-2023-712074:other people case

Weitere VAERSDATA-Felder

Praegender Schweregrund: Syncope
Hospital-Tage: -
Labordaten: Test Name: nerve conduction studies; Result Unstructured Data: Nerve conduction study: Normal, Sensory neuropathy test is pending; Test Name: weight; Result Unstructured Data: lost about 40 lbs
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2584696

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7143C

schwer

Staat: -
Alter: 55,0
Geschlecht: M
Eingang: 27.02.2023
Impfdatum: 08.09.2022
Beginn: 14.09.2022
Tage bis Beginn: 6,0
Dosis: 4
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Anxiety Burning sensation COVID-19 immunisation Disturbance in attention Dizziness Blood test Electromyogram Feeling abnormal Insomnia Interchange of vaccine products Nerve conduction studies Neuropathy peripheral Feeling hot Hyperaesthesia Laboratory test Magnetic resonance imaging head Oral discomfort Paraesthesia

Symptomtext

states that something has been off regarding heat and cold sensitivity in his hands and feet/Cold water feels too cold and hot water feels too hot/sensitivity to temperature has enhanced a lot; cannot sleep due to this; cannot focus on anything; scared that something is going to happen/states that something has been off regarding heat and cold sensitivity in his hands and feet/Cold water feels too cold and hot water feels too hot/; feels lightheaded and like he is going to faint; Interchange of vaccine products; Revaccination with different COVID-19 vaccine; it seems like some type of neuropathy is going on; anxious/gets uneasiness spells every now/scared that something is going to happen; having burning sensations in his hands and feet; This spontaneous case was reported by a consumer and describes the occurrence of NEUROPATHY PERIPHERAL (it seems like some type of neuropathy is going on) in a 55-year-old male patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. AS7143C) for COVID-19 prophylaxis. The occurrence of additional non-serious events is detailed below. Previously administered products included for Product used for unknown indication: PFIZER BIONTECH COVID-19 VACCINE (Second dose) in March 2021, PFIZER BIONTECH COVID-19 VACCINE (First dose) in March 2021 and PFIZER BIONTECH COVID-19 VACCINE (1st booster) in April 2022. Past adverse reactions to the above products included No adverse event with PFIZER BIONTECH COVID-19 VACCINE, PFIZER BIONTECH COVID-19 VACCINE and PFIZER BIONTECH COVID-19 VACCINE. On 08-Sep-2022, the patient received fourth dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On 14-Sep-2022, the patient experienced BURNING SENSATION (having burning sensations in his hands and feet). On an unknown date, the patient experienced NEUROPATHY PERIPHERAL (it seems like some type of neuropathy is going on) (seriousness criterion medically significant), ANXIETY (anxious/gets uneasiness spells every now/scared that something is going to happen), TEMPERATURE INTOLERANCE (states that something has been off regarding heat and cold sensitivity in his hands and feet/Cold water feels too cold and hot water feels too hot/sensitivity to temperature has enhanced a lot), INSOMNIA (cannot sleep due to this), DISTURBANCE IN ATTENTION (cannot focus on anything), FEELING ABNORMAL (scared that something is going to happen/states that something has been off regarding heat and cold sensitivity in his hands and feet/Cold water feels too cold and hot water feels too hot/), DIZZINESS (feels lightheaded and like he is going to faint), INTERCHANGE OF VACCINE PRODUCTS (Interchange of vaccine products) and COVID-19 IMMUNISATION (Revaccination with different COVID-19 vaccine). At the time of the report, NEUROPATHY PERIPHERAL (it seems like some type of neuropathy is going on), TEMPERATURE INTOLERANCE (states that something has been off regarding heat and cold sensitivity in his hands and feet/Cold water feels too cold and hot water feels too hot/sensitivity to temperature has enhanced a lot), INSOMNIA (cannot sleep due to this), DISTURBANCE IN ATTENTION (cannot focus on anything), FEELING ABNORMAL (scared that something is going to happen/states that something has been off regarding heat and cold sensitivity in his hands and feet/Cold water feels too cold and hot water feels too hot/), INTERCHANGE OF VACCINE PRODUCTS (Interchange of vaccine products) and COVID-19 IMMUNISATION (Revaccination with different COVID-19 vaccine) outcome was unknown and ANXIETY (anxious/gets uneasiness spells every now/scared that something is going to happen), BURNING SENSATION (having burning sensations in his hands and feet) and DIZZINESS (feels lightheaded and like he is going to faint) had not resolved. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Nerve conduction studies: Nerve conduction study: Normal, Sensory neuropathy test is pending. On an unknown date, Weight: lost about 40 lbs. For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter did not provide any causality assessments. No concomitant medications were reported. Patient reported that even with normal cold water, he feels too cold.He reported that he gets uneasiness spells every now and then where he feels lightheaded and like he is going to faint, but that feeling eventually passes through. He is seeing a neurologist. He says he had been healthy all his life, but now he had been suffering for almost 4 months. No treatment medications were reported. Company comment: This is a Spontaneous case concerns a 55 years old male patient, with no relevant medical history, who experienced unexpected serious (medically significant) event of neuropathy peripheral, which occurred in context with booster dose of mRNA-1273 vaccination BA.4/BA.5. About a week after vaccination patient experienced burning sensation and cold insensitivity in the hand and the feet, patient says some type of neuropathy is going on. Patent experienced some light lightheaded and like he is going to faint, anxious and insomnia. Last week he went to emergency, consulted neurologist nerve conduction study was normal. Lost 40 lbs after vaccination. Patient received three doses of TOZINAMERNAN prior to the mRNA-1273 bivalent BA.1 vaccination BA.4/BA.5 (Interchange of vaccine products). The benefit-risk relationship of mRNA-1273 bivalent BA.4/BA.5 vaccination is not affected by this report. This case was linked to US-MODERNATX, INC.-MOD-2023-712074 (E2B Linked Report). Most recent FOLLOW-UP information incorporated above includes: On 21-Feb-2023: Significant live Follow-up information received - Relevant Past Drug History, Events and Results of tests and procedures relevant to the investigation of the patient and Narrative has been updated.; Sender's Comments: US-MODERNATX, INC.-MOD-2023-712074:other people case

Weitere VAERSDATA-Felder

Praegender Schweregrund: Syncope
Hospital-Tage: -
Labordaten: Test Name: nerve conduction studies; Result Unstructured Data: Nerve conduction study: Normal, Sensory neuropathy test is pending; Test Name: weight; Result Unstructured Data: lost about 40 lbs
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2542803

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7143C

schwer

Staat: AZ
Alter: 64,0
Geschlecht: M
Eingang: 24.12.2022
Impfdatum: 16.09.2022
Beginn: 19.09.2022
Tage bis Beginn: 3,0
Dosis: 1
Route/Site: IM / AR

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: ja

Coagulation test normal Magnetic resonance imaging spinal abnormal Pathology test Sciatica Spinal cord injury Spinal epidural haematoma Spinal laminectomy Thrombosis

Symptomtext

9/16/22 Received Flu shot and COVID19 Bivalent booster 9/19/22 Sciatica symptoms started in right calf (I have never had sciatica symptoms in the past) 10/1/22 Sciatica symptoms became more severe in the right calf and right hamstring. 11/22/22 Went to ER, due to severe sciatica symptoms. MRI revealed lesion on spine. Emergency laminectomy surgery to remove spontaneous spinal epidural hematoma. Hematoma contained blood clots.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Thrombosis
Hospital-Tage: 4,0
Labordaten: Pathology on lesion was negative for cancer and clotting-factor issues. Doctors confused as to why this occurred.
Aktuelle Erkrankungen: None
Vorgeschichte: Very healthy, no chronic health conditions besides hypothyroidism
Andere Medikamente: Levothyxine, baby aspirin
Allergien: NKA
Vorherige Impfungen: -

VAERS 2459764

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7143C

schwer

Staat: WA
Alter: 72,0
Geschlecht: F
Eingang: 01.11.2022
Impfdatum: 09.09.2022
Beginn: 01.09.2022
Tage bis Beginn: -
Dosis: UNK
Route/Site: IM / UN

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Chest X-ray normal Fibrin D dimer normal Pericarditis

Symptomtext

Per doctor's note, based on recent vaccination, she suspects pericarditis.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Pericarditis
Hospital-Tage: -
Labordaten: unknown
Aktuelle Erkrankungen: unknown
Vorgeschichte: unknown
Andere Medikamente: unknown
Allergien: Keflex and Codeine
Vorherige Impfungen: -

VAERS 2487324

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7143C

schwer

Staat: CA
Alter: 76,0
Geschlecht: M
Eingang: 24.10.2022
Impfdatum: 26.09.2022
Beginn: 30.09.2022
Tage bis Beginn: 4,0
Dosis: 5
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: ja

Angiogram normal Echocardiogram normal Fatigue Feeling abnormal Heart rate increased Ischaemic stroke Magnetic resonance imaging head normal Speech disorder

Symptomtext

Four days after the booster I took my dog on a walk. I began to have fast heart rate. The next several days I had the same feeling even without exercise. I started to not feel good and very tired over the next few days. On October 14, 2022, my sons called the ambulance because I was unable to speak. I was also struggling with my words and recognition. I went to the hospital and was diagnosed with ischemic stroke. Although the tests did not indicate a stroke, they treated me as if I had one. They gave me Tenecteplase and then I was able to speak after that.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Ischaemic stroke
Hospital-Tage: 4,0
Labordaten: CT angiogram, normal; MRI Brain, normal; Echo Cardiogram, normal;
Aktuelle Erkrankungen: -
Vorgeschichte: Arthritis; Gout; High Blood Pressure; Ruptured discs in back
Andere Medikamente: Allopurinol; Simvastatin; Amlodipine; Lisinopril; Multi Vitamin; Vitamin B Complex; Vitamin C
Allergien: -
Vorherige Impfungen: -

VAERS 2481872

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge AS7143C

schwer

Staat: OH
Alter: 54,0
Geschlecht: F
Eingang: 18.10.2022
Impfdatum: 10.09.2022
Beginn: 09.10.2022
Tage bis Beginn: 29,0
Dosis: 4
Route/Site: SYR / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Deep vein thrombosis Pain in extremity Ultrasound Doppler abnormal

Symptomtext

I had a DVT in my left leg in the vein confirmed by ultrasound. I started with a pain in my leg and went to be seen and they found a blood cot. They placed me on Zorolto for 3 months and to follow up with Hematology.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Deep vein thrombosis
Hospital-Tage: -
Labordaten: Ultrasound - DVT in left leg
Aktuelle Erkrankungen: No
Vorgeschichte: Hypothyroidism
Andere Medikamente: Lisinopril; Aspirin; Euthyox; Corlanor
Allergien: Augmentin
Vorherige Impfungen: After the 3rd COVID-19 vaccine 9/17/21 I started having syncope and had an episode at work and they took me to the ER. This was

VAERS 2475526

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7143C

schwer

Staat: CO
Alter: 59,0
Geschlecht: M
Eingang: 11.10.2022
Impfdatum: 15.09.2022
Beginn: 17.09.2022
Tage bis Beginn: 2,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: ja

Brain natriuretic peptide increased C-reactive protein increased Chest discomfort Decreased appetite Dyskinesia Echocardiogram abnormal Electrocardiogram abnormal Fatigue Hyperhidrosis Hypokinesia Pericarditis Syncope Troponin increased

Symptomtext

09/15/22 Received vaccine 09/16/22 Throughout the day on 9/16/2022 he felt extremely tired with poor appetite, but no myalgias, chest pain, palpitations, or shortness of breath. he had an episode of syncope lasting up to 5 minutes and accompanied by extensive diaphoresis, and some brief jerking but without post-ictal symptoms, He came by ambulance to the ED, where he had a troponin elevated to 0.25, BNP elevated above 5000, CRP at 190, and an EKG consistent with pericarditis. Repeat troponin was up to 0.29 then dropped to 0.1. He denied any chest pain initially 09/17/22 discussed the case with the cardiologist on-call, Dr., who suggested admission for a heparin drip, metoprolol, aspirin, atorvastatin, and close monitoring of labs and telemetry. He advised an echocardiogram anytime in the first 48 hours. 09/19/22 9/19 he mentioned having a minor discomfort in the upper chest only with deep breathing on 9/17 and 9/18. None on 9/19. An echo on 9/19 showed inferior hypokinesis. Transferred to higher level of care.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Pericarditis
Hospital-Tage: 2,0
Labordaten: see above
Aktuelle Erkrankungen: none
Vorgeschichte: Hypothyroidism Transaminitis Polycythemia Asthma Chronic hypoxemic respiratory failure Sleep apnea
Andere Medikamente: Advair, BID Albuterol, PRN Aspirin, QD Atorvastatin, QD Oxygen, 2L Levothyroxine, QD Zolpidem, PRN
Allergien: Penicillins
Vorherige Impfungen: -

VAERS 2450941

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge AS7143C

schwer

Staat: ME
Alter: 69,0
Geschlecht: M
Eingang: 19.09.2022
Impfdatum: 12.09.2022
Beginn: 13.09.2022
Tage bis Beginn: 1,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Bell's palsy Eyelid ptosis Facial asymmetry Gait disturbance Grip strength decreased

Symptomtext

Minor Bells palsy on left (injection side); asymmetrical smile and gait, and left eyelid drooping, and a marked difference in hand grip strength.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Bell's palsy
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: Asthma, food and drug and pollen allergies
Andere Medikamente: Theophylline, spironolactone, Treleg Ellipta, zinc, phenytoin sodium, albuterol aerosol inhaler, montelukast sodium, amlodpine, fish oil, glucosamine, vitamin D
Allergien: Beef, lamb, shellfish, crustaceans,
Vorherige Impfungen: -

VAERS 2441063

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7143C

schwer

Staat: WV
Alter: 68,0
Geschlecht: F
Eingang: 12.09.2022
Impfdatum: 12.09.2022
Beginn: 12.09.2022
Tage bis Beginn: 0,0
Dosis: 5
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Blood glucose normal Dizziness Fall Seizure

Symptomtext

Patient received vaccine and was impatient to get to front of store to shop for puzzle books. Approximately 15 minutes, as she was leaving the store, she got dizzy and fell. Her companion said she was having a seizure. EMS was called and responded approximately 5 minutes later and checked blood sugar and pulse ox-reported normal. Patient said she no longer felt dizzy and did not want to be transported.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Seizure
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: none reported
Vorgeschichte: Seizures
Andere Medikamente: Keppra, Paxil, Protonix, Atenolol, Calcitriol, Mesalamine, Mirtazapine, Requip
Allergien: n/a
Vorherige Impfungen: -

VAERS 2431066

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7143C

schwer

Staat: MI
Alter: 47,0
Geschlecht: M
Eingang: 07.09.2022
Impfdatum: 07.09.2022
Beginn: 07.09.2022
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Loss of consciousness

Symptomtext

Patient Passed out shortly after being vaccinated, was standing at pharmacy counter and collapsed, staff called 911 and the patient was taken to hospital Medical Center emergency room in ambulance

Weitere VAERSDATA-Felder

Praegender Schweregrund: Loss of consciousness
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: Bipolar Disorder
Andere Medikamente: Methylphenidate 18mg ER, Lithium Carbonate 300mg, Sertraline 25mg
Allergien: No Known Allergies
Vorherige Impfungen: -

VAERS 2428197

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge as7143c

schwer

Staat: WI
Alter: 59,0
Geschlecht: F
Eingang: 02.09.2022
Impfdatum: 02.09.2022
Beginn: 02.09.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Chest pain Condition aggravated Confusional state Loss of consciousness Pain in extremity Pain in jaw Seizure Unresponsive to stimuli

Symptomtext

The patient filled out their paperwork and included a history of seizures but was said they did not have known history of seizures related to vaccines. The patient was advised to wait in our waiting room for 15 minutes after the administration. As they were standing up to leave after 15 minutes she started seizing. As I, the pharmacist, ran out to help, her friend and an observer assisted in slowly lowering her to the floor. She was lowered without injury and turned onto her side. As this was occurring a pharmacy team member called 911, even though the friend denied service as "she has had seizures for over 20 years". I informed them we had to call 911 but they had the right to deny transport. The seizure lasted maybe less than 1 minute, stopped for about 30 seconds but patient was unresponsive but with pulse and then another seizure occurred lasting maybe less than 1 minute. The patient then regained consciousness but was confused. I directed her to remain laying down, but she slowly sat into a sitting position. She almost immediately grabbed her chest and complained of severe chest pain. She then also complained of jaw pain and shook her arm and complained of right sided arm pain when asked. I asked a pharmacy team member to get 4 chewable baby aspirin (81mg x4) as these are signs of a heart attack. The friend stated she has a long history of heart issues but in the adrenaline of the moment I do not remember what issues she stated. As the staff member was getting the Aspirin EMS arrived and agreed to administer the 325 mg total of chewable aspirin. The EMS assisted the patient in taking the aspirin and helped her off the floor onto their gurney. I gave as much detail in my report to EMS as possible and they took the patient out of the store to the hospital. At the time of transport she was alert and still complaining of chest pain.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Loss of consciousness
Hospital-Tage: -
Labordaten: n/a
Aktuelle Erkrankungen: unknown
Vorgeschichte: seizures and friend reported long history of heart issues but unaware of what
Andere Medikamente: Pantoprazole 40 mg Alprazolam 0.5 mg Alprazolam 1 mg Trazodone 50 mg Tizanidine 4 mg Dilantin 100 mg Meclinizine 12.5 mg Phenobarbital 97.2 mg Amitriptyline 25 mg Ipratropium/Albuterol 0.5/3mg Any other aren't filled with us and we aren't
Allergien: DEpakote, Penicillin, Toradol
Vorherige Impfungen: -

VAERS 2713207

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7143C

moderat

Staat: MI
Alter: 74,0
Geschlecht: M
Eingang: 13.11.2023
Impfdatum: 14.09.2022
Beginn: 29.08.2023
Tage bis Beginn: 349,0
Dosis: 5
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: ja

Asthenia Blood culture negative COVID-19 Chest X-ray abnormal Culture negative Endocarditis Fatigue Legionella test Pneumonia Pyrexia SARS-CoV-2 test positive Sepsis Sputum culture Staphylococcal bacteraemia Streptococcus test negative

Symptomtext

BRIEF OVERVIEW: Admission Date: 8/29/2023 Discharge Date: Sep 2, 2023 Discharge Disposition: home health care svc DETAILS OF HOSPITAL STAY: PRESENTING PROBLEM: History of bacteremia [Z87.898] Community acquired pneumonia of left lower lobe of lung [J18.9] Sepsis, due to unspecified organism, unspecified whether acute organ dysfunction present (HCC) [A41.9] COVID [U07.1] COVID-19 [U07.1] HOSPITAL COURSE: Patient is a 75 y.o. male with chronic combined CHF (LVEF 23%), NICM, hx endocarditis in setting of MRSA bacteremia treated in March 2023 on suppressive doxycycline, and chronic back pain. Patient presented after 7 days weakness, fatigue, fever. He was septic, COVID-19 positive, and CXR with questionable subtle pneumonia in LLL. Patient remained on room air during his hospitalization. He was treated with Remdesivir (ends on 9/3/23) and supportive care. With concern for possible pneumonia the patient received Ceftriaxone IV and was continued on his home suppressive doxycycline. The patient was febrile overnight on 8/30. Infectious work up included negative legionella antigen, negative strep pneumoniae antigen, blood cultures remained negative and sputum cultures remained negative. PT/OT assessed the patient and recommended home with home health/PT/OT. Patient was discharged in stable condition on 9/2/23

Weitere VAERSDATA-Felder

Praegender Schweregrund: Pneumonia
Hospital-Tage: 4,0
Labordaten: -
Aktuelle Erkrankungen: None
Vorgeschichte: History of MRSA infection Chronic combined systolic and diastolic heart failure (HCC) History of endocarditis Cardiomyopathy, nonischemic (HCC) Hypertension Osteoarthritis Headache Chronic low back pain Colon polyps FH: colon cancer Bronchiectasis (HCC) Glaucoma Medication overuse headache Chronic migraine Gout Opioid dependence (HCC) Decreased responsiveness Dehydration Community acquired pneumonia of left lower lobe of lung Other dysphagia History of septic arthritis of right shoulder Weakness Chronic back pain Chronic pain of both shoulders Implantable cardioverter-defibrillator (ICD) in situ
Andere Medikamente: butalbital-aspirin-caffeine-codeine (FIORINAL WITH CODEINE) per Capsule carboxymethylcellulose sod PF (REFRESH PLUS) ophthalmic solution Cobalamin Combinations (NEURIVA PLUS) CAPS cyclobenzaprine (FLEXERIL) 10 mg tablet dapagliflozin (FARXI
Allergien: Entex LaAnxiety Shellfish AllergySwelling MorphineItching, Rash Shellfish Topamax [Topiramate]
Vorherige Impfungen: -

VAERS 2661286

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7143C

moderat

Staat: -
Alter: 85,0
Geschlecht: M
Eingang: 26.07.2023
Impfdatum: 07.09.2022
Beginn: 10.03.2023
Tage bis Beginn: 184,0
Dosis: 5
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt

Hypotension

Symptomtext

HYPOTENSION

Weitere VAERSDATA-Felder

Praegender Schweregrund: Hypotension
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2634828

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge AS7143C

moderat

Staat: IL
Alter: 84,0
Geschlecht: F
Eingang: 22.05.2023
Impfdatum: 01.09.2022
Beginn: 04.05.2023
Tage bis Beginn: 245,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: ja

COVID-19 Chills Dyspnoea Hypersomnia Mobility decreased Muscular weakness Pain in extremity Pneumonia viral SARS-CoV-2 test positive Viral test positive

Symptomtext

I had a sore arm and a lazy day after receiving the vaccine. I had severe chills and difficulty staying awake for a few days prior to testing positive for COVID-19. I tested positive for COVID-19 and viral pneumonia on 05/04/2023 in the emergency room. I had difficulty breathing. I was admitted to the hospital for five days on the COVID floor. Got home and self-isolated. My breathing is better, and my muscles are very weak.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Dyspnoea
Hospital-Tage: 5,0
Labordaten: 04MAY2023 COVID-19 Test - Positive; 04MAY2023 Viral Pneumonia Test - Positive
Aktuelle Erkrankungen: N/A
Vorgeschichte: Irregular Heartbeat; CHF
Andere Medikamente: Amiodaron; Amlodipine; Eliquis; Furosemide; Vitamin A; Vitamin B Complex; Magnesium; Potassium; Baby Aspirin; Alprazolam
Allergien: Penicillin; Sulfa
Vorherige Impfungen: -

VAERS 2631957

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7143C

moderat

Staat: AZ
Alter: 73,0
Geschlecht: F
Eingang: 15.05.2023
Impfdatum: 09.09.2022
Beginn: 17.11.2022
Tage bis Beginn: 69,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: ja ER: ja Erholt: nein

COVID-19 Ejection fraction decreased Exposure to SARS-CoV-2 Malaise Pneumonia SARS-CoV-2 test positive

Symptomtext

On 11/17/2022, I tested positive for COVID-19. I was exposed by a friend of mine who was ill at the time. I had real light symptoms. I just went to bed immediately and stayed away from people. I recovered really quickly, but on 12/19/2022, I got pneumonia. I went to the emergency room and was admitted until 12/22/2022. My heart injection fraction is now 20%, while it was fine before. My doctor believes it to be related to the COVID-19.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Pneumonia
Hospital-Tage: 4,0
Labordaten: 17NOV2022 at home COVID-19 test positive
Aktuelle Erkrankungen: None
Vorgeschichte: None
Andere Medikamente: Vitamin A; calcium; vitamin D; glucosamine; super B complex; vitamin E; vitamin C; fish oil
Allergien: None
Vorherige Impfungen: -

VAERS 2614157

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7143C

moderat

Staat: WA
Alter: 58,0
Geschlecht: F
Eingang: 12.04.2023
Impfdatum: 06.09.2022
Beginn: 21.02.2023
Tage bis Beginn: 168,0
Dosis: 5
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

COVID-19 Cough Diarrhoea Dyspnoea Headache Nausea Pain Productive cough Pyrexia SARS-CoV-2 test positive

Symptomtext

In late February 2023 I began feeling symptoms that began as a high fever of 103.7. I was nauseous and had diarrhea with a headache and body aches. My cough was so bad I would vomit. It tested positive for COVID-19 on February 24, 2023. I took Paxlovid. Within a day or so I began to feel better. As of today, I still have a cough and my lungs are heavy with "muck". I have trouble breathing for a little while in the morning.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Dyspnoea
Hospital-Tage: -
Labordaten: COVID-19 home, positive, 02242023
Aktuelle Erkrankungen: N/A
Vorgeschichte: Immune Compromised
Andere Medikamente: Vitamin D; Vitamin B
Allergien: N/a
Vorherige Impfungen: -

VAERS 2613819

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7143C

moderat

Staat: WA
Alter: 63,0
Geschlecht: M
Eingang: 12.04.2023
Impfdatum: 08.09.2022
Beginn: 20.11.2022
Tage bis Beginn: 73,0
Dosis: 5
Route/Site: IM / UN

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Blood test COVID-19 Chest X-ray Cough Electrocardiogram Fatigue Lung disorder Pneumonia Vaccine breakthrough infection

Symptomtext

I had a breakthrough case of Covid-19 around November 24th, started having lung issues coughing and fatigue, I went to urgent care originally then sent to a doctors office and was advised it was pneumonia, was placed on multiple antibiotics.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Pneumonia
Hospital-Tage: -
Labordaten: Chest X-Ray, EKG, Bloodwork
Aktuelle Erkrankungen: None
Vorgeschichte: Multiple Sclerosis
Andere Medikamente: Losartan; potassium; nortriptyline
Allergien: Mercurochrome
Vorherige Impfungen: -

VAERS 2611419

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7143C

moderat

Staat: SC
Alter: 81,0
Geschlecht: F
Eingang: 07.04.2023
Impfdatum: 08.09.2022
Beginn: 24.01.2023
Tage bis Beginn: 138,0
Dosis: 5
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Asthenia Chest X-ray abnormal Cough Dyspnoea Feeling abnormal Influenza virus test negative Myalgia Pneumonia Pyrexia SARS-CoV-2 test negative

Symptomtext

I had shortness of breath, a cough, a fever, body weakness and muscle aches. I felt like garbage.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Dyspnoea
Hospital-Tage: -
Labordaten: Flu test negative 1/24/2023; CPR COVID-19 test negative 1/24/2023; Chest X-ray confirmed pneumonia
Aktuelle Erkrankungen: No
Vorgeschichte: Asthma; High blood pressure
Andere Medikamente: SYNTHROID; PROTONIX; CELEXA; FLONASE; TOPROL XL; SYMBICORT; olmesartan; torsemide calcium w/ vitamin D
Allergien: Penicillin
Vorherige Impfungen: Shingles- 2018

VAERS 2611412

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7143C

moderat

Staat: PA
Alter: 83,0
Geschlecht: F
Eingang: 07.04.2023
Impfdatum: 22.09.2022
Beginn: 01.01.2023
Tage bis Beginn: 101,0
Dosis: 5
Route/Site: IM / AR

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: ja

Back pain Cardiac stress test normal Chest X-ray abnormal Chest pain Computerised tomogram abnormal Cough Inflammation

Symptomtext

In January 2023 I started having a persistent cough that not only lingered it would not abate. It was causing my chest and back to hurt I was coughing so much. With having COPD, I have been advised by my health care team to go into the emergency room if they are not available to get evaluated. Upon arriving at the emergency room, they did a chest x-ray and CAT scan that came back positive for inflammation. I stayed overnight for a stress test that came back fine.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Chest pain
Hospital-Tage: 1,0
Labordaten: 00JAN2023 Chest X-ray positive for inflammation; 00JAN2023CAT scan positive for inflammation; 00JAN2023 Stress test normal
Aktuelle Erkrankungen: No
Vorgeschichte: COPD; High Cholesterol; Heart Condition; Atrial Fibrillation
Andere Medikamente: TRELEGY inhaler; metoprolol; XARELTO; COSOPT eye drops; simvastatin; ramipril; ropinirole; baby aspirin; VENTOLIN inhaler; PROLIA inject every; ipratropium bromide nasal spray; calcium; multivitamin
Allergien: Penicillin; BACTRIM; LEVAQUIN; blueberries
Vorherige Impfungen: -

VAERS 2604011

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7143C

moderat

Staat: IN
Alter: 57,0
Geschlecht: F
Eingang: 27.03.2023
Impfdatum: 22.09.2022
Beginn: 01.09.2022
Tage bis Beginn: -
Dosis: 4
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: ja

COVID-19 Dyspnoea Headache Heart rate increased Pain Pain in extremity SARS-CoV-2 test positive

Symptomtext

I had a sore arm and I felt achy for about a day. I tested positive for COVID-19 on 09/2021. Second time tested positive for COVID-19 on 1/19/2023. I had a really bad headache and elevated heart rate with COVID-19 in 09/2021. Recently I had shortness of breath in 02/2023 and I went to the emergency room. I was given a breathing treatment and I was told that the treatment did help me. I was tested again for COVID-19, but it was negative. I have been advised to continue to use the inhaler.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Dyspnoea
Hospital-Tage: -
Labordaten: FEB2023 COVID-19 test negative; 09JAN2023 COVID-19 test positive; SEPT2021 COVID-19 test positive
Aktuelle Erkrankungen: N/A
Vorgeschichte: Celiac Disease
Andere Medikamente: Cranberry; CLARITIN; tramadol
Allergien: Wheat; gluten
Vorherige Impfungen: -

VAERS 2601881

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7143C

moderat

Staat: NV
Alter: 76,0
Geschlecht: F
Eingang: 22.03.2023
Impfdatum: 11.09.2022
Beginn: 12.03.2023
Tage bis Beginn: 182,0
Dosis: 5
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein

Acute cardiac event Brain scan abnormal Cardiac monitoring abnormal Electrocardiogram Headache Intracranial aneurysm Scan Supraventricular tachycardia Tachyphrenia Vomiting

Symptomtext

I had a cardiac health event and I had to go to the hospital. I had a headache, blood pressure 189, and heart racing. They did test on me. They EKG, scan, and monitoring to me. They said it was some glitching but nothing serious. They prescribed me medication. I woke up with headache and vomiting a couples days later. I went back to the hospital, and they did a brain scan. They found an aneurism and because of the placement they decided not to remove it. I am doing treatment.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Supraventricular tachycardia
Hospital-Tage: 4,0
Labordaten: EKG, 03/09/2023 Mentoring SVT Brain Scan, Aneurism, 03/14/2023
Aktuelle Erkrankungen: N/A
Vorgeschichte: Rheumatoid Arthritis
Andere Medikamente: Baby Aspirin; Multivitamin; Levothyroxine; Simvastatin; Olmesartan
Allergien: N/A
Vorherige Impfungen: -

VAERS 2600314

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7143C

moderat

Staat: CO
Alter: 81,0
Geschlecht: M
Eingang: 21.03.2023
Impfdatum: 17.09.2022
Beginn: 08.12.2022
Tage bis Beginn: 82,0
Dosis: 5
Route/Site: - / RA

Tod: unbekannt Lebensbedrohlich: ja Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Anaemia Anticoagulant therapy Atrial fibrillation Blood sodium decreased Blood test abnormal Dehydration Dizziness Endoscopy abnormal Internal haemorrhage Left atrial appendage closure implant

Symptomtext

Three months after the COVID-19 vaccine had a dizzy spell. Went to the emergency room and after testing they found that my sodium levels were low and I was probably dehydrated. About 6 weeks later had another similar dizzy spell and went to the emergency room again, testing showed that I had Anemia as well as low sodium levels. Had an Endoscopy test and testing showed that I had internal bleeding, probably due to taking blood thinners. Also started having Afib, doctor put in a Left Atrial Appendage Closure in an outpatient clinic. Still has Afib.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Dehydration
Hospital-Tage: -
Labordaten: 08DEC2022 Blood testing, Anemia and sodium levels were low.
Aktuelle Erkrankungen: N/A
Vorgeschichte: High Blood Pressure, Heart Calcifications; past Stroke; Afib.
Andere Medikamente: Valsartan HCTZ; carvedilol; ELIQUIS; baby aspirin; atorvastatin; vitamin D3; calcium citrate; coQ10, METAMUCIL.
Allergien: Meloxicam; baclofen
Vorherige Impfungen: -

VAERS 2598676

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7143C

moderat

Staat: MO
Alter: 43,0
Geschlecht: F
Eingang: 17.03.2023
Impfdatum: 15.09.2022
Beginn: 19.02.2023
Tage bis Beginn: 157,0
Dosis: 4
Route/Site: SYR / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

COVID-19 Cough Dyspnoea Fatigue Headache Lymphadenopathy Malaise Oropharyngeal pain Pain Pyrexia Respiratory tract congestion SARS-CoV-2 test positive Sinusitis Upper-airway cough syndrome

Symptomtext

My COVID-19 infection started on 02/19/2023 at night around 10:00PM. I had a post nasal drip. I started feeling congestions. I took the home COVID-19 test on 02/21/2023 which was positive. I had cough was dry, fever of 99.08-99.09, body aches, lymph nodes were swollen, fatigue, headaches and shortness of breath. The same day I did a telehealth with clinic where they prescribed PAXLOVID for 5 days and inhaler. I took the complete course of the medication but I stopped using the inhaler immediately. I wasn't feeling well with the inhaler. I test negative for COVID-19 on 02/25/2023. On 02/28/2023 I had severe congestions in the morning along with post nasal drip, fatigue, and sore throat. On 03/02/2023 I took another COVID-19 which was positive. I did another telehealth on the same day they prescribe me with antibiotics and cough syrup. On 03/08/2023 I tested negative for COVID-19 infection. I was quarantined for at least 5 days or so. I do have sinus infection so am not sure if it's from COVID-19 infection.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Dyspnoea
Hospital-Tage: -
Labordaten: 21FEB2023 COVID-19 test positive; 25FEB2023 COVID-19 test negative; 02MAR2023 COVID-19 test positive; 08MAR2023 COVID-19 test negative
Aktuelle Erkrankungen: N/A
Vorgeschichte: Anemia; Severe Dry Eye Syndrome
Andere Medikamente: Prenatal vitamin (PND; DHA)
Allergien: Gluten; codeine; ibuprofen; amoxicillin
Vorherige Impfungen: COVID-19 I was knocked out for 3 days straight.

VAERS 2598639

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7143C

moderat

Staat: MI
Alter: 74,0
Geschlecht: M
Eingang: 17.03.2023
Impfdatum: 06.09.2022
Beginn: 15.11.2022
Tage bis Beginn: 70,0
Dosis: UNK
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Cardiac stress test Chest pain Exercise tolerance decreased Pulmonary function test

Symptomtext

11/15/2023 I started to get pains in the center of my chest while I was walking. I rested and it resolved. It happened again the next day and continued. I had to stop my cardiovascular exercising. I contacted my doctor and he set me up for a pulmonary function test. I also had a stress test. I have not seen the cardiologist yet to get the results. I have not started my exercise program again, so it has not happened.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Chest pain
Hospital-Tage: -
Labordaten: Stress test, unknown; results; Pulmonary function test, unknown results.
Aktuelle Erkrankungen: None
Vorgeschichte: Cardiovascular disease; High Blood Pressure; High Cholesterol
Andere Medikamente: Pantoprazole sod; PLAVIX; rosuvastatin; metoprolol
Allergien: None
Vorherige Impfungen: -

VAERS 2597647

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7143C

moderat

Staat: AZ
Alter: 75,0
Geschlecht: M
Eingang: 16.03.2023
Impfdatum: 13.09.2022
Beginn: 08.01.2023
Tage bis Beginn: 117,0
Dosis: 5
Route/Site: SYR / AR

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: ja

Atypical pneumonia COVID-19 Chest X-ray abnormal Cough Feeling abnormal Malaise Pyrexia Retching SARS-CoV-2 test positive Sinusitis

Symptomtext

What led me to the COVID-19 test was feeling feverish, not quite right. At that point I was heaving. At some point, I took the test on 01/08 and I had COVID-19. In one of my visits to my PCP, during these episodes, it was determined I had a sinus infection along with COVID-19. I was prescribed an antibiotic. It helped with my sinuses and it felt great and the symptoms of COVID-19 went away over time. I had this hack that I couldn't get rid of and my heart rate was elevated at 130 BPM. I went to the ER 02/17/2023 and I had tests done and it was determined I had walking pneumonia. I was prescribed erythromycin and penicillin. I was done with those meds by 02/28/2023. I'm not sure what the real order was of these events, but I was sick for about 2 months and finally recovered by the end of February. I would say that was the sickest I had ever felt in my life.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Atypical pneumonia
Hospital-Tage: -
Labordaten: 08JAN2023 at home COVID-19 test positive; 17FEB2023 Chest X-ray, indicated pneumonia
Aktuelle Erkrankungen: None
Vorgeschichte: CKD Stage 3; Arthritis
Andere Medikamente: Tamsulosin; ARMOUR THYROID; amlodipine besylate; ramipril; furosemide; vitamin B complex; iron
Allergien: Statins
Vorherige Impfungen: -

VAERS 2597108

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7143C

moderat

Staat: NE
Alter: 31,0
Geschlecht: M
Eingang: 15.03.2023
Impfdatum: 09.09.2022
Beginn: 20.01.2023
Tage bis Beginn: 133,0
Dosis: 4
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Asthma COVID-19 Condition aggravated Cough Dizziness Dyspnoea Nasal congestion Oropharyngeal pain Pain Pyrexia SARS-CoV-2 test positive

Symptomtext

After my vaccine I was feverish and achy, it was about 7-8 hours after my vaccine was administered and it lasted about 24 hours. By the 48 hour mark everything was back to normal. In January I started off with a sore throat and then after that I woke up on the morning of January 22nd, I started to have my asthma flare up and having shortness of breath and coughing. I started to have a stuffy nose and it picked up as time continued. Shortness of breath lasted three weeks after my positive test for COVID-19. I had a fever for about 1-2 days and about 4-5 days after my test I felt very dizzy. My oxygen levels got as low as 97 and I felt dizzy for about a week long. As of now I feel normal past week my throat has been sore but I am feeling well however the shortness of breath lasted a long time but is gone. After my telemedicine visit I was prescribed prednisone 10 mg twice a day, I was using my albuterol nebulizer every 4 hours, and I was also taking a cough syrup as well that had guaifenesin and dextromethorphan. I also would take TYLENOL or ibuprofen for body aches and BENADRYL for stuffiness.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Condition aggravated
Hospital-Tage: -
Labordaten: 20JAN2023 COVID-19 negative; 22JAN2023 COVID-19 test positive
Aktuelle Erkrankungen: N/A
Vorgeschichte: Asthma; Eczema
Andere Medikamente: ZYRTEC; montelukast; ALLEGRA
Allergien: Sulfa drugs; peanuts; eggs; soy
Vorherige Impfungen: Previous COVID-19 vaccines and Flu vaccines tend to leave my arm sore and cause me to experience the same symptoms.

VAERS 2597016

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7143C

moderat

Staat: VA
Alter: 78,0
Geschlecht: F
Eingang: 15.03.2023
Impfdatum: 09.09.2022
Beginn: 19.01.2023
Tage bis Beginn: 132,0
Dosis: 5
Route/Site: IM / UN

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Chest pain Laboratory test Scan normal

Symptomtext

Nothing happened after the vaccine. But January 19, 2023, I was having hurting on my chest, I went to the ER, they did scan test because they thought I had Pulmonary embolism, but the test came fine; at the same time, I had severe pain on my chest, in the meantime Pulmonary is treating me, I had a test done yesterday and doctor is waiting to see if I need any treatment. I have a FU appointment next week after he read the lab work and the scan.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Chest pain
Hospital-Tage: -
Labordaten: 19JAN2023 Scan Test - Normal; 14March2023 - Scan Test - waiting for the results; 13March2023 - Lab Work - Waiting
Aktuelle Erkrankungen: N/A
Vorgeschichte: N/A
Andere Medikamente: N/A
Allergien: N/A
Vorherige Impfungen: -

VAERS 2597000

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7143C

moderat

Staat: PR
Alter: 78,0
Geschlecht: F
Eingang: 15.03.2023
Impfdatum: 10.09.2022
Beginn: 28.02.2023
Tage bis Beginn: 171,0
Dosis: 5
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: ja

Full blood count normal Furuncle Malaise Mobility decreased Pain Pyrexia Rash

Symptomtext

On 02/28/2023 I started feeling unwell and noticed that I had developed a boil that was painful to the point where I couldn't sit down.On 02/29/2023 I noticed that more boils had developed in the same area and was feeling sick.On 03/01/2023 I had a fever off and on and was able to see the Dermatologist. He prescribed a topical pain cream and referred me to the ER. I went to the ER and was put on a 24 hour antibiotic IV. I went home feeling better Saturday but was progressively feeling sick again. I went to the ER and again was put on a course of antibiotics and I developed a rash throughout my entire body. I stopped taking antibiotics and was put agin on Benadryl and prescribed Cefdinir 300 mgs.I am feeling better now however I will need to follow up with my Doctor.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Mobility decreased
Hospital-Tage: 1,0
Labordaten: 03/01/2023 - CBC normal
Aktuelle Erkrankungen: None
Vorgeschichte: Hypertension; Hyperthyroid; Glaucoma
Andere Medikamente: Megared; B12; Baby Aspirin; Vitamin C; Synthroid; Losartan; Alopurinol; Escitapolan
Allergien: Clindamycin Phosphate
Vorherige Impfungen: -

VAERS 2596227

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7143C

moderat

Staat: CA
Alter: 76,0
Geschlecht: M
Eingang: 14.03.2023
Impfdatum: 10.09.2022
Beginn: 09.02.2023
Tage bis Beginn: 152,0
Dosis: 5
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Ageusia Anosmia Body temperature decreased COVID-19 Ear discomfort Ear infection Headache Malaise Myalgia Night sweats Paraesthesia Productive cough Pyrexia SARS-CoV-2 test positive Sinus disorder Sinusitis

Symptomtext

My symptoms included fever with night sweats, pain in my head, sinus infection, productive phlegm, tingling in my hands and legs and muscle pains. My temperature went from 98 to 92 one day. I tested negative for the first two days at home for COVID-19. At the doctor I took a PCR, and it was negative. The next day I tested positive. I began to take Paxlovid and began to feel better. When the Paxlovid ended, two days later I got a rebound case. This time I could not smell, or taste and I was sick for another 4-five days. My temperature did the same thing. I had sinus issues, and my ear was clogged. I still have an ear infection and will see an ENT later this week.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Paraesthesia
Hospital-Tage: -
Labordaten: COVID-19 home, positive, 02142023; COVID-19 home, positive, 02182023; COVID-19, positive, 02232023
Aktuelle Erkrankungen: N/A
Vorgeschichte: Psoriatic Arthritis
Andere Medikamente: Spivera; Prolulant; Toperole XL; Singular; Vitamin D; Synthroid;
Allergien: Scallops
Vorherige Impfungen: -

VAERS 2596064

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7143C

moderat

Staat: NC
Alter: 64,0
Geschlecht: M
Eingang: 14.03.2023
Impfdatum: 09.09.2022
Beginn: 01.10.2022
Tage bis Beginn: 22,0
Dosis: 5
Route/Site: IM / AR

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Feeling cold Hypoaesthesia Paraesthesia Pyrexia

Symptomtext

I had little chill and fever after receiving the vaccine for about two days. I developed numbness and tingling in my right foot the end of 10/2022. I went to my doctor, and I was referred to a neurologist. I don't have an appointment yet but hopefully soon. It is very annoying and nothing really helps to relieve the symptoms.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Paraesthesia
Hospital-Tage: -
Labordaten: N/A
Aktuelle Erkrankungen: N/A
Vorgeschichte: N/A
Andere Medikamente: N/A
Allergien: N/A
Vorherige Impfungen: -

VAERS 2595575

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7143C

moderat

Staat: FL
Alter: 47,0
Geschlecht: F
Eingang: 13.03.2023
Impfdatum: 11.09.2022
Beginn: 18.01.2023
Tage bis Beginn: 129,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

COVID-19 Diplopia Dizziness Dry skin Eye pain Headache Laboratory test Pyrexia Respiratory tract congestion SARS-CoV-2 test positive Tachycardia Vertigo

Symptomtext

I had a terrible fever for about 36 hours, tachycardia, horrendous head and eye pain, congestion, really bad vertigo, and headache. My skin was also extremely dry. I decided to take an at-home COVID-19 which came back positive. It took 13 days before I got a negative test. Afterwards, I contacted my endocrinologist about my leftover symptoms. She was concerned about myocardia from rebounding COVID-19. A couple of days later, I started experiencing double vision so I went to the emergency room. They performed examinations including hand-eye coordination, pupil check, and other tests to ensure the clotting and headache wasn't extreme and that I wasn't suffering from a stroke. I opted in to stay for more hours for further monitoring. Eventually, I was discharged and was able to go home with a prescription for Ibuprofen. As of now, I still have episodes of dizziness. I have an appointment with a PCP on 03/16/2023 for further diagnosis.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Tachycardia
Hospital-Tage: -
Labordaten: 19JAN2023 -- COVID-19 Test - Positive
Aktuelle Erkrankungen: N/A
Vorgeschichte: Diabetes
Andere Medikamente: Vitamin D; Atorvastatin; Baby Aspirin; Humalog; Dexatone
Allergien: N/A
Vorherige Impfungen: -

VAERS 2594745

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7143C

moderat

Staat: WA
Alter: 64,0
Geschlecht: M
Eingang: 10.03.2023
Impfdatum: 08.09.2022
Beginn: 01.12.2022
Tage bis Beginn: 84,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Chest X-ray Cough Immunosuppressant drug therapy Musculoskeletal chest pain Sinusitis Systemic scleroderma

Symptomtext

Cough leading to left sided chest wall pain; Persistent sign of sinus respiratory tract infection; Systemic sclerosis with immunosuppressant drug therapy.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Musculoskeletal chest pain
Hospital-Tage: -
Labordaten: Chest X-Ray 25Jan2023
Aktuelle Erkrankungen: Scleroderma lung disease; pulmonary disease chronic right sided heart failure ; severe tricuspid valve inconsistency.
Vorgeschichte: Immunosuppressed due to chemo
Andere Medikamente: Apixaban; empagliflozin; esomeprazole; flecainide; metolazone; metoprolol succinate; mycophenolate mofetil; ondansetron; oxygen; potassium chloride; prednisone; sertraline; spironolactone; tadalafil; torsemide; acetaminophen; vitamin D3; ir
Allergien: N/A
Vorherige Impfungen: -

VAERS 2593968

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7143C

moderat

Staat: MD
Alter: 78,0
Geschlecht: M
Eingang: 09.03.2023
Impfdatum: 07.09.2022
Beginn: 01.03.2023
Tage bis Beginn: 175,0
Dosis: 5
Route/Site: IM / AR

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Dyspnoea

Symptomtext

I did not have an adverse reaction to the vaccine. In 03/2023, I have become short of breath during normal activity that my doctor associates with my low blood pressure. I have an appointment with my cardiologist tomorrow to discuss.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Dyspnoea
Hospital-Tage: -
Labordaten: N/A
Aktuelle Erkrankungen: N/A
Vorgeschichte: Osteoarthritis; High Blood Pressure; Heart Disease; Anemic; Kidney Disease
Andere Medikamente: PLAVIX; probiotic capsules; famotidine; albuterol; CELEBREX; amlodipine; PRALUENT; VIAGRA; loperamide; ranolazine
Allergien: N/A
Vorherige Impfungen: -

VAERS 2593878

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7143C

moderat

Staat: WI
Alter: 67,0
Geschlecht: F
Eingang: 09.03.2023
Impfdatum: 07.09.2022
Beginn: 02.01.2023
Tage bis Beginn: 117,0
Dosis: 5
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

COVID-19 Dyspnoea Exposure to SARS-CoV-2 Malaise Pyrexia SARS-CoV-2 test positive

Symptomtext

After the vaccine everything was fine. Taking precautions. On January, I was exposed to my grandson, at Christmas time, he got sick, my daughter took it for urgent care, and then she was negative. We were going north to my daughter's place, my daughter on Dec 31st she tested positive. I went home on Jan 1st and on Jan 2nd, I woke with fever (102.1), I called my primary doctor and she transferred to the COVID clinic unit, and because of my medications and did give me PAXLOVID, they gave me another similar medication. I remain sick, after my days of medication, I called my doctor (Jan 11) because I had a shortness of breath, they gave me steroids and the last dose was on Jan 16th.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Dyspnoea
Hospital-Tage: -
Labordaten: 02JAN2023 COVID-19 test positive
Aktuelle Erkrankungen: N/A
Vorgeschichte: Dyskinesia; Post thrombotic Syndrome; Restless Leg Syndrome; Sleep Apnea
Andere Medikamente: Dyskinesia; post thrombotic syndrome; restless leg syndrome; sleep apnea
Allergien: Sulfa; Z-PAK; coumadin; thimerosal; statins; reequip; clonazepam
Vorherige Impfungen: Zoster; GlaxoSmithKline Biologicals; 2019; Numbness/tingling to fingers, burning sensation in palm of hand in arm injection was

VAERS 2593820

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7143C

moderat

Staat: KY
Alter: 69,0
Geschlecht: M
Eingang: 09.03.2023
Impfdatum: 07.09.2022
Beginn: 23.12.2022
Tage bis Beginn: 107,0
Dosis: 5
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Cardiac monitoring Condition aggravated Cough Dyspnoea Electrocardiogram abnormal Pulmonary congestion Ventricular extrasystoles

Symptomtext

On 12/23/2022 I had a hard time breathing, short of breath. I also had lung congestion and coughing. I went to the emergency room and they stated I had some PVC but I had PVC since 2016. I went to feeling better and I went home. Then event occurred on 01/22/2023 and I went to the emergency room again for the same symptoms and they referred me to a cardiologist. They also provided me with medications anthramycin and inhaler. I am following up with the cardiologist. I'm now on a heart monitor for 30 day.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Condition aggravated
Hospital-Tage: -
Labordaten: 23DEC2022 EKG test abnormal, 22JAN2023 EKG test abnormal
Aktuelle Erkrankungen: N/A
Vorgeschichte: Arthritis; Long Standing Allergies
Andere Medikamente: Tramadol; multivitamin; vitamin D3; vitamin B-12; SINGULAIR; probiotic
Allergien: Pollen; BACTRIM
Vorherige Impfungen: -

VAERS 2593162

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7143C

moderat

Staat: TX
Alter: 77,0
Geschlecht: F
Eingang: 08.03.2023
Impfdatum: 06.09.2022
Beginn: 17.12.2022
Tage bis Beginn: 102,0
Dosis: 5
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Back pain COVID-19 Cough Feeling abnormal Headache Malaise Mobility decreased Respiratory tract congestion Rhinorrhoea SARS-CoV-2 test positive

Symptomtext

I did not have an adverse reaction to the vaccine. I began not feeling well on 12/17/2022 with a runny nose, cough, congestion, headache and just not feeling good. I tested positive for COVID-19 on 12/18/2022. I contacted my doctor and got a prescription for PAXLOVID. I tolerated the medication, but it had a terrible taste. It took a while for all the symptoms to go away. I had a pain in my back that made sitting comfortably was difficult. That lasted for about two months. As of today, I feel better with no lingering symptoms.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Mobility decreased
Hospital-Tage: -
Labordaten: 18DEC2022 COVID-19 test positive
Aktuelle Erkrankungen: N/A
Vorgeschichte: Acid Reflux
Andere Medikamente: ZYRTEC
Allergien: Environmental allergies
Vorherige Impfungen: -

VAERS 2566859

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7143C

moderat

Staat: WA
Alter: 39,0
Geschlecht: M
Eingang: 24.01.2023
Impfdatum: 09.09.2022
Beginn: 20.09.2022
Tage bis Beginn: 11,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: nein

Angiogram cerebral normal Anti-NMDA antibody negative Anti-thyroid antibody Anti-thyroid antibody negative Antibody test negative Antinuclear antibody negative Bacterial test negative Blood glucose decreased Blood immunoglobulin G Blood thyroid stimulating hormone normal CD4 lymphocytes decreased CD4/CD8 ratio decreased CSF glucose decreased CSF protein increased CSF red blood cell count Computerised tomogram thorax abnormal Confusional state Culture negative

Symptomtext

10 days after vaccinations (9/19) he started experiencing a new headache and sensitivity to light along with nausea. He went to emergency room and was treated for migraine. His headache continued and on 9/27 (18 days after vaccinations) he went to primary care MD who ordered MRI of brain with and without contrast as well as CT angiogram of brain. Imaging showed no significant abnormalities. On 10/6/22 (27 days after vaccinations) he went to emergency room again for same symptoms as well as left arm numbness and memory issues as well as worsening drowsiness. CT angiography was normal and he was discharged. On 10/11/2022 (32 days after vaccinations) he become significantly more confused and sister insisted he go to emergency room again. Repeat MRI brain showed significant bilateral (right > left) medial temporal enhancing lesions. Workup negative for infections and serologic autoimmune/paraneoplastic disease. He did not get any steroids or treatments aside from very briefly being on acyclovir for initial concern for HSV encephalitis. Subsequent imaging as shown improvement in brain lesions but discovered a cervical spine lesion (unknown if this was present before. FDG PET showed small area of avidity in thoracic spine so now getting thoracic spine MRI. He is slowly improving in terms of his cognition and left-sided weakness. He has high cognitive reserve so is able to function despite slowly recovering encephalopathy.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Migraine
Hospital-Tage: 10,0
Labordaten: Labs: 12/6/22: - Anti-MOG Ab negative by FACS - T cell subset low CD4 count (0.551, LLN 0.730) with lower CD4/CD8 being 0.81 (LLN 1.00) - Ig G/A/M nl Urine: Tox negative (10/12/2022) Serum: QuantiFERON negative COVID PCR negative West Nile virus IgG and IgM negative Carcinoembryonic antigen negative AFB culture w/stain negative Respiratory TB PCR negative Paraneoplastic panel negative Anti-NMDA receptor negative ANA negative 10/19/2022: TSH 8.978, free T4 0.8 Anti-TPO negative Antithyroglobulin negative CSF: 10/12/2022: RBC 0 WBC 606 (91% lymphocytes) Glucose 36 Protein 100 Enterovirus PCR negative Parechovirus PCR negative Bacterial culture negative Fungal culture negative Negative bacterial DNA detection Mycoplasma DNA detection negative T. Whipplei DNA PCR negative 10/17/2022: RBC 1000 WBC 321 (95% lymphocytes) Glucose 42 Protein 76 OCB 1 IgG synthesis rate IgG index normal ACE 3.0 (ULN 2.5) VZV PCR negative HSV 1/2 PCR negative UCSF Pathogen Dx (UCSF Test P710) negative for DNA viruses, RNA viruses, Bacteria, Fungi, parasites Calif(LaCrosse) Enceph Ab, IgG, CSF: <1:1 Calif(LaCrosse) Enceph Ab, IgM, CSF: <1:1 East Equine Enceph Ab, IgG, CSF: <1:1 East Equine Enceph Ab, IgM, CSF: <1:1 St. Louis Enceph Ab, IgG, CSF: <1:1 St. Louis Enceph Ab, IgM, CSF: <1:1 West Equine Enceph Ab, IgG, CSF: <1:1 West Equine Enceph Ab, IgM, CSF: <1:1 Flow cytometry normal TB PCR West Nile virus PCR negative Urine: Histoplasma antigen negative Imaging: MRI Brain w/wo contrast 1/12/2023: Compared to brain MR from 10/17/2022, there has been interval resolution of diffusion restriction and enhancement in the right greater than left hippocampi and adjacent parenchyma with significant improvement in T2/FLAIR hyperintensity involving these regions. Mild FLAIR signal abnormality remains in the right temporal stem and parahippocampal region favoring gliosis, with development of interval encephalomalacia in the right parahippocampal mesial temporal lobe. MRI C-spine w/wo contrast 1/12/2023: Per my read, T2/STIR L non-enhancing, well-demarcated lesion from lower C3 - lower C5. 3.0 cm long T2 hyperintense nonenhancing cord signal abnormality in the left cervical hemicord with small edematous rim extending from C3-4 to C5-6. This finding is nonspecific and favors presumed infectious/inflammatory etiologies, and is also favored to represent the same supratentorial process. PET CT Whole Body 1/4/2023: Small, focal region of T-spine avidity. CT C/A/P 10/13/22: No acute intra-abdominal findings or suspicious for neoplasm.. Calcified granulomas within the right lung with calcified right hilar lymph nodes, compatible with Ranke complex, most likely sequela from prior granulomatous infection. US Scrotum Normal testes. No mass seen. Otherwise unremarkable scrotal ultrasound. MRI Brain w/wo contrast 10/17/2022: Compared to brain MR from 10/11/2022, overall slightly decreased diffusion restriction, T2/FLAIR hyperintensity, and enhancement of the right greater than left hippocampi and adjacent parenchyma, which as noted before is consistent with encephalitis which may be autoimmune, paraneoplastic, or viral. MRI Brain w/wo contrast 10/12/2022: Right greater than left bilateral asymmetric involvement of the hippocampi, adjacent white matter and basal ganglia region on the right with associated restricted diffusion, patchy contrast enhancement, without findings of hemorrhage is most concerning for autoimmune encephalitis which could be paraneoplastic or not. However, viral encephalitis, including herpes encephalitis, is also in the differential since there is usually a considerable overlap of the imaging findings between these two entities. MRI brain w/wo contrast 9/29/2022 1. No acute intracranial process. 2. There are 3 punctate T2/FLAIR intracranial white matter lesions identified, nonspecific in patient of this age group. Differential includes chronic ischemic disease, migraines, or demyelinating disease. No abnormal enhancement.
Aktuelle Erkrankungen: none
Vorgeschichte: none
Andere Medikamente: multivitamin
Allergien: none
Vorherige Impfungen: -

VAERS 2548056

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge AS7143C

moderat

Staat: IN
Alter: 72,0
Geschlecht: M
Eingang: 02.01.2023
Impfdatum: 01.09.2022
Beginn: 01.09.2022
Tage bis Beginn: 0,0
Dosis: 5
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Electrocardiogram ambulatory abnormal Heart rate irregular Palpitations Ventricular extrasystoles

Symptomtext

Heart Pounding. Irregular heartbeat. Holter monitor showed 34% PVC's.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Palpitations
Hospital-Tage: -
Labordaten: Holter Monitor 10/1/2022 showed 34% PVC's
Aktuelle Erkrankungen: None
Vorgeschichte: None
Andere Medikamente: 100 mg Allopurinol 10 mg Lipitor 88 micrograms Synthroid 200 mg Magnesium Daily vitamin
Allergien: None
Vorherige Impfungen: -

VAERS 2542748

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7143C

moderat

Staat: NV
Alter: 59,0
Geschlecht: F
Eingang: 24.12.2022
Impfdatum: 16.09.2022
Beginn: 26.11.2022
Tage bis Beginn: 71,0
Dosis: 5
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: ja Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Asthma Bronchial hyperreactivity Bronchitis COVID-19 Chest X-ray Condition aggravated SARS-CoV-2 test positive

Symptomtext

COVID, Paxlovid, COVID rebound, exacerbated asthma and reactive airway infection (bronchitis) followed by more asthma

Weitere VAERSDATA-Felder

Praegender Schweregrund: Condition aggravated
Hospital-Tage: -
Labordaten: COVID tests, chest x-ray
Aktuelle Erkrankungen: -
Vorgeschichte: Asthma
Andere Medikamente: Albuterol, Flovent, Premarin
Allergien: None
Vorherige Impfungen: -

VAERS 2537764

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7143C

moderat

Staat: MD
Alter: 71,0
Geschlecht: M
Eingang: 20.12.2022
Impfdatum: 09.09.2022
Beginn: 11.09.2022
Tage bis Beginn: 2,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Condition aggravated Electrocardiogram Influenza like illness Ventricular extrasystoles Ventricular tachycardia

Symptomtext

15 sec episode of V-tach and additional PVCs (recorded by implanted pacemaker) 2 days after injection. Experienced flu-like symptoms 2 days after injection. All issues resolved within a few days without treatment.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Condition aggravated
Hospital-Tage: -
Labordaten: EKG (recorded by pacemaker and transmitted 9/12/2022)
Aktuelle Erkrankungen: n/a
Vorgeschichte: hypertension (stabile) vasovagal syncope (demand pacemaker with recording ability) paroxysmal A fib (aproximately1 week post suspected Covid event in Feb 2020.) V-tach (1 week post suspected Covid event in Feb 2020.)
Andere Medikamente: lisinopril 2.5mg 1x tadalafil 5mg 1x Eliquis 5mg 2x metoprolol 50mg 1x multivitamin 1x received seasonal flu vaccine at same time as Moderna Omicron booster
Allergien: no food or meds only cats, mice, dust mites
Vorherige Impfungen: -

VAERS 2537714

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7143C

moderat

Staat: NC
Alter: 60,0
Geschlecht: M
Eingang: 20.12.2022
Impfdatum: 16.09.2022
Beginn: 03.12.2022
Tage bis Beginn: 78,0
Dosis: 4
Route/Site: SYR / AR

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Abnormal dreams Arthralgia COVID-19 Cough Dyspnoea Fatigue Middle insomnia Mucosal discolouration Mucosal hypertrophy Nasopharyngitis Oropharyngeal pain Respiratory tract congestion Rhinorrhoea SARS-CoV-2 test positive

Symptomtext

12/3/2022 About mid-day, I had a sore throat. I drank tea with honey and a shot of brandy and it did not help. In the evening I took NYQUIL when I went to bed. The next day, I had more of a sore throat that went away that evening. I was very fatigued and stayed in bed pretty much all day. It felt like I had a head cold. That night I had really strange dreams, it was very weird. On 12/5/22, I took a home COVID test and it was positive. I called my doctor's office and was prescribed PAXLOVID. I began taking it that afternoon. I took NYQUIL that night and had trouble breathing. I began having a runny nose. Around 2 in the morning, I was not having that much trouble breathing. I felt I was in a better place by 2 or 3 in the morning and was able to sleep for a while. On 12/6/22 I worked from home. That night, I slept better, but in the middle of the night I woke with real pain in the joints in my elbows. It felt like the worse arthritis. The next morning, they were still tender, but the pain had passed. 12/7/22, I was coughing, congestion and a runny nose with thick green mucous. By 12/8/22 I was feeling better and was a lot better by 12/9/22. 12/11/22 I took a home COVID test and it was negative. I was still coughing a little with thick mucous. I spoke to my doctor again and he put me on antibiotics which I have been taking and am now symptom free.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Dyspnoea
Hospital-Tage: -
Labordaten: At home COVID test, positive and negative
Aktuelle Erkrankungen: None
Vorgeschichte: None
Andere Medikamente: Acyclovir
Allergien: Intolerance to MALARONE
Vorherige Impfungen: -

VAERS 2535582

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7143C

moderat

Staat: WA
Alter: 67,0
Geschlecht: F
Eingang: 16.12.2022
Impfdatum: 14.09.2022
Beginn: 06.12.2022
Tage bis Beginn: 83,0
Dosis: 6
Route/Site: SYR / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Arthropathy Blood potassium decreased Blood test Differential white blood cell count Electrocardiogram Fall Fatigue Feeling abnormal Full blood count abnormal Hypertension Loss of personal independence in daily activities Mean platelet volume increased Memory impairment Metabolic function test abnormal Platelet count decreased

Symptomtext

On December 6, I was walking with my husband and suddenly slumped over to the left side into him. My left knee buckled and I felt like I had blanked out. I couldn't remember what happened. I didn't fall to the ground and I was supported by him. I was able to stand straight again after a few seconds had passed and continued to walk. I walked about 15 more minutes to get home and I just remember feeling dazed and very tired. I phoned my doctor's office who suggested I get checked out at the ER. I went to the ER and they did blood work and an EKG. Upon coming into the ER, I had very high blood pressure which was 196/102. Discharge was 150/90. They suggested I take my blood pressure and see my doctor within a few days. It was 10 days before I could see her. In that time, I took my blood pressure about 5 times and it was all okay except for one which was 147/93. The others were within a few points of 120/80. I've been tired but I've been able to function normally. At the time of the event, I felt like I couldn't function normally that evening. Besides being fatigued, I carry on with normal activities of daily life. My doctor today recommended doing more labs for typhoid and she has checked my potassium which was slightly low coming out of the ER. There's also been an order for a Holter monitor. Whenever that is put on me, I'll get the data for that. I have an appointment with an electrophysiologist in early January. Before this incident, I did not have any symptoms that I'm aware of. For example, I did not feel heart palpitations. I didn't have any symptoms, it just came as a surprise. I was feeling somewhat more fatigued than normal in the weeks before the event.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Hypertension
Hospital-Tage: -
Labordaten: Blood work, EKG, Blood pressure taken; CBC with differential, platelets were flagged low at 147k per mcl, MPV were flagged high at 12.1 fl; Basic Metabolic panel, potassium was flagged slightly below standard range at 3.4 mmol/l
Aktuelle Erkrankungen: None
Vorgeschichte: A-Flutter; Glaucoma; Osteoporosis
Andere Medikamente: ELIQUIS; PROLIA; latanoprost; vitamin B12; calcium with magnesium and boron; vitamin D3; blink for contacts eyedrops; REFRESH OPTIVE advance eyedrops; REFRESH RELIEVA eyedrops; BIOTRUE hydration boost eyedrops; vitamin C; zinc
Allergien: Dust mites
Vorherige Impfungen: 10/7/2021 3rd COVID-19 Pfizer vaccine, on 10/28/2021, I had an A-flutter event. This was the first time I found out I had A-flut

VAERS 2533530

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7143C

moderat

Staat: OR
Alter: 72,0
Geschlecht: F
Eingang: 15.12.2022
Impfdatum: 09.09.2022
Beginn: 27.10.2022
Tage bis Beginn: 48,0
Dosis: 5
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: ja

Arthralgia COVID-19 Chills Condition aggravated Discomfort Feeling abnormal Feeling cold Headache SARS-CoV-2 test positive

Symptomtext

In October of 2022, I was traveling on an airplane. I was feeling completely fine on the flight. In the airport I was starting to feel bad, then from the next flight I started to come down with chills and could not get warm. The next day I started to feel a headache come on, and feeling very uncomfortable. I had chills that continued and I never came down with a fever. On 10/28/2022 I took an at home COVID-19 test that came out positive. I tried to get in touch with my doctor however was unsuccessful. I was not short of breath or any lung issues. I contacted 911 to ask what I should do and I was then taken to the ER. I was given PAXLOVID and started it on the 29th of October. After that I was in bed for a very long time. I was isolated for about 5 days from my husband. Around six days I was starting to feel better and after 10 days I was back to normal. At this point my health is good and I am only having continuous hip pain from before.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Condition aggravated
Hospital-Tage: -
Labordaten: 18OCT2022 COVID-19 at home test positive
Aktuelle Erkrankungen: N/A
Vorgeschichte: N/A
Andere Medikamente: KIRKLAND multivitamin; coQ10; vitamin D3; fish oil
Allergien: Thimerosal
Vorherige Impfungen: Flu vaccine with thimerosal had given me an allergic reaction that caused a very intense burning sensation.

VAERS 2533429

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7143C

moderat

Staat: MO
Alter: 62,0
Geschlecht: F
Eingang: 15.12.2022
Impfdatum: 08.09.2022
Beginn: 23.09.2022
Tage bis Beginn: 15,0
Dosis: 5
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: nein

Breath sounds abnormal Chest X-ray abnormal Computerised tomogram normal Dyspnoea Laboratory test normal Liver function test normal Oxygen saturation decreased Pneumonia Renal function test normal Respiratory syncytial virus infection Total lung capacity decreased

Symptomtext

I have been experiencing a slow decline in my lung capacity. The rattling in my lungs has just gotten worse and worse. My O2 saturation readings have been getting lower. Around the 30th of November, I couldn't breathe at all. I went to the emergency room that night and at first, they thought it was pneumonia and they gave me LEVAQUIN. They confirmed pneumonia with a chest x-ray. They performed a CT scan with contrast to rule out blood clots. They performed other tests and stated it was not bacterial pneumonia, but an RSV virus with pneumonia. I spent 5 days in the hospital on fluids, breathing treatments, and oxygen. I returned home with oxygen, and they are hoping to ween me off within the next two weeks. I was also prescribed prednisone, albuterol, and coughing pearls.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Dyspnoea
Hospital-Tage: 5,0
Labordaten: 30NOV2022 chest X-ray, diagnosed Pneumonia; CT scan, nothing found; Pancreatic/Kidney/Liver panel normal
Aktuelle Erkrankungen: Breathing issues
Vorgeschichte: Asthma; Diabetes; High Blood Pressure; High Cholesterol
Andere Medikamente: Metoprolol; SINGULAIR; hydrochlorothiazide; PRILOSEC; vitamin C; albuterol inhaler; LEVEMIR; NOVOLOG
Allergien: Penicillin; ACE inhibitors; beta blockers; enalapril; amoxicillin
Vorherige Impfungen: -

VAERS 2530090

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7143C

moderat

Staat: CA
Alter: 49,0
Geschlecht: F
Eingang: 13.12.2022
Impfdatum: 10.09.2022
Beginn: 30.11.2022
Tage bis Beginn: 81,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Headache Oral discomfort Paraesthesia Paraesthesia oral Tongue discomfort

Symptomtext

On 9/10/2022, I received the Moderna Bivalent booster for COVID-19, plus a flu vaccine. On 11/30/2022, I noticed a tingling sensation mainly on the left side of my face. The tingling continued in the days that followed, and I saw my PCP on 12/2/2022. She told me that the tingling could have been due to shingles or to palsy, except I didn't have the lesions that accompany shingles or the facial drooping that accompanies palsy. I have a history of migraines, so my doctor suspected that I could be experiencing a prodromal migraine. However, this was different from my prior migraines. Normally, my migraines are ocular and have an aura. The flashing lights will often occur just before the pain comes, and as long as I take IMITREX during the aura stage, the pain doesn't come. On 12/3/2022, I began to have a headache that affected mainly the forehead area. I tried several doses of IMITREX, but it was no avail. The pain didn't go away until 12/11/2022. I don't know if my Moderna Bivalent booster and/or my flu shot were in any way connected to the migraine. However, I am reporting this, since this is the first time I have ever experienced the pre-pain tingling and lack of aura with a migraine. At the time of this writing, I am about 95% better. I still have intermittent tingling on smaller patches of my face. My lips and tongue also feel kind of weird, because there is a section of the lips and tongue that also experienced the tingling during the early stages of the migraine. They are no longer tingling, but they still don't feel quite right. The sensation I currently have is similar to the one you get at the end stage of when you're coming off of NOVOCAINE after a dentist's visit.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Paraesthesia
Hospital-Tage: -
Labordaten: None.
Aktuelle Erkrankungen: None.
Vorgeschichte: Depression; Hyperthyroidism; Hypertension; Gastroesophageal Reflux Disease.
Andere Medikamente: WELLBUTRIN XR; levothyroxine; PROTONIX; lisinopril; super B complex vitamins; iron; vitamin D.
Allergien: Phenol; tree nuts.
Vorherige Impfungen: -

VAERS 2527695

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7143C

moderat

Staat: IN
Alter: 33,0
Geschlecht: M
Eingang: 09.12.2022
Impfdatum: 07.09.2022
Beginn: 09.09.2022
Tage bis Beginn: 2,0
Dosis: 4
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Condition aggravated Exercise tolerance decreased Tendonitis

Symptomtext

I was training for a half marathon at time of the vaccination. I was likely *over*-training as I had increased my distance and speed too quickly. I had run 21 miles in the week leading up to my vaccination and been running higher mileages and faster paces than my previous baseline for about 2 months prior. Two days after the vaccination, I began to feel what has now been diagnosed as tendinitis in my left posterior tibialis. I have been unable to run since the injury. I am still experiencing symptoms 3 months later after attempting to conservatively manage and treat it myself and am now starting physical therapy. The injury was very likely just an over-use injury from all the running I was doing without proper cross training and too quick of a ramp-up. However, my sports medicine doctor in December mentioned the timing of the vaccination could have worsened the tendinitis by creating some additional temporary inflammation in my body.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Condition aggravated
Hospital-Tage: -
Labordaten: -Sports Medicine doctor physical examination (November 29)
Aktuelle Erkrankungen: -NA
Vorgeschichte: -GERD -Mild Asthma
Andere Medikamente: -Omeprazole 20 mg 1x daily -"Relevate" brain health vitamin supplement website -CBD Oil, small doses taken sporadically -Melatonin 3mg
Allergien: -Penicillin -Sulfa Drugs
Vorherige Impfungen: -

VAERS 2527679

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7143C

moderat

Staat: NY
Alter: 37,0
Geschlecht: F
Eingang: 09.12.2022
Impfdatum: 08.09.2022
Beginn: 15.11.2022
Tage bis Beginn: 68,0
Dosis: 3
Route/Site: SYR / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Alopecia Aphonia Dyspnoea Insomnia Paranasal sinus discomfort Polymerase chain reaction Respiratory tract congestion Throat irritation Vaccine breakthrough infection

Symptomtext

I had a breakthrough case, tickle in throat, shortness of breath, congestion insomnia, hair loss. Lost my voice, sinus pressure.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Dyspnoea
Hospital-Tage: -
Labordaten: PCR test
Aktuelle Erkrankungen: Lyme disease
Vorgeschichte: Slightly high Cholesterol
Andere Medikamente: KARIVA; vitamin B12; women's ONE A DAY multivitamin; loratadine
Allergien: Seasonal allergies
Vorherige Impfungen: -

VAERS 2527077

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7143C

moderat

Staat: IL
Alter: 54,0
Geschlecht: F
Eingang: 08.12.2022
Impfdatum: 07.09.2022
Beginn: 24.10.2022
Tage bis Beginn: 47,0
Dosis: 5
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Condition aggravated Ear discomfort Ear pain Fatigue Hypoacusis Impaired work ability Influenza virus test negative Malaise Nasal congestion Oropharyngeal pain Productive cough Pyrexia Respiratory symptom SARS-CoV-2 test negative Sleep disorder Tinnitus

Symptomtext

I received the Moderna COVID-19 booster on 9/7/2022. On 10/24/2022, I woke up at night with a sore throat. I felt a wave of fatigue and had a slight fever. On 10/25/2022, I developed respiratory symptoms that included stuffy nose, phlegm in the throat, clogged ears, an earache in the right ear. I had difficulty hearing, and listening is a key necessity for my job, as I am a psychologist. Not only that, but I also have pre-existing tinnitus, and it was exacerbated by the symptoms I developed. I took a home antigen test on 10/27/2022 and got a negative result. I was also given a flu test by my doctor, which also yielded a negative result. The doctor then prescribed me an antibiotic cough suppressant, which I ended up not taking. Instead, on the10/28/2022, I contacted my PCP, who prescribed ciprofloxacin. From then on, I took the ciprofloxacin with MUCINEX to treat my symptoms. Altogether, I was sick for 3 1/2 weeks. It was 4 weeks before I got my hearing back and felt fine again. Thankfully, I have the option of working remotely, so I didn't miss too much work during my illness.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Condition aggravated
Hospital-Tage: -
Labordaten: 10/27/2022 home antigen test negative result; 10/27/2022 clinical flu test negative result.
Aktuelle Erkrankungen: None.
Vorgeschichte: Acid Reflux Disease.
Andere Medikamente: SINGULAIR; famotidine; LINZESS.
Allergien: Penicillin; Z-PAK; erythromycin.
Vorherige Impfungen: I always experience drowsiness, arm pain, body aches, and a slight fever whenever I get Moderna COVID-19 injections.

VAERS 2525351

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7143C

moderat

Staat: MI
Alter: 78,0
Geschlecht: M
Eingang: 07.12.2022
Impfdatum: 12.09.2022
Beginn: 02.12.2022
Tage bis Beginn: 81,0
Dosis: 5
Route/Site: IM / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: ja

COVID-19 COVID-19 pneumonia Chest X-ray abnormal Dyspnoea Gastric ulcer Haematemesis Haemoglobin decreased Hiatus hernia Hypoxia Nausea Oesophagitis Oesophagogastroduodenoscopy abnormal Pneumonia Pneumonia bacterial Productive cough Pyrexia SARS-CoV-2 test positive

Symptomtext

COVID+ 12/2/2022. Vaccination status - moderna x4 + Moderna BIVALENT BRIEF OVERVIEW: Admission Date: 12/2/2022 Discharge Date: Dec 5, 2022 Discharge Disposition: home or self care Active Issues Requiring Follow-up: COVID pneumonia Bacterial pneumonia - Ceftin for 1 more day - isolate as able - Mask in public for next 5 days - Can discuss Paxlovid with PCP if desired - f/u blood cultures Esophagitis Superficial gastric ulcers Hiatal hernia - PPI BID x8 weeks then daily - f/u PRN with GI - Limit NSAIDs - GERD lifestyle precautions - f/u biopsies - negative HTN - Home meds resumed - Consider increasing doses if needed DETAILS OF HOSPITAL STAY: PRESENTING PROBLEM: Hypoxia Coffee ground emesis Community acquired pneumonia, unspecified laterality COVID-19 virus infection Pneumonia due to COVID-19 virus HOSPITAL COURSE: The patient is a 78 y.o. male with PMHx of HTN, hearing loss with cochlear implant, CKD3, HLD, anxiety, prostate cancer, insomnia who presented to the ED with complaints of fever, cough and coffee ground emesis. He developed a fever and tested positive for COVID-19. He subsequently developed nausea with some coffee ground emesis along with productive cough and dyspnea. In the ER CXR with patchy airspace disease suggesting right basilar pneumonia. He was started on abx and admitted to medicine for pneumonia. He was quickly weaned off supplemental oxygen. He continued on abx for bacterial pneumonia and was discharged with 1 more dose of Ceftin. When he presented he had significant coffee ground emesis and requested GI consult. Hemoglobin with drastic decrease from 14 to 10 and GI evaluated. EGD done on 12/4 with esophagitis, gastric ulcers, and hiatal hernia. Hemoglobin remained stable. Given his clinical stability he was discharged home on 12/5/22. CONSULTS / RECOMMENDATION: GI - EGD done, see above for other findings/recs

Weitere VAERSDATA-Felder

Praegender Schweregrund: COVID-19 pneumonia
Hospital-Tage: 3,0
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: Anxiety Benign essential HTN Lipidemia Meniere's disease Mixed stress and urge urinary incontinence Psychophysiological insomnia Pure hypercholesterolemia RBBB (right bundle branch block) Tinnitus Allergic rhinitis Personal history of kidney cancer Primary insomnia Edema Stage 3a chronic kidney disease Sensorineural hearing loss, bilateral
Andere Medikamente: amLODIPine Besylate 5 mg Oral Daily Fesoterodine Fumarate 4 MG 2 tablets Oral Daily hydrALAZINE HCl 25 mg Oral 3 times daily Losartan Potassium 25 MG No dose, route, or frequency recorded. Melatonin 10 MG 1 tablet Oral Nightly Omega-3 Fatty
Allergien: No known allergies
Vorherige Impfungen: -

VAERS 2509622

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7143C

moderat

Staat: FL
Alter: 63,0
Geschlecht: F
Eingang: 16.11.2022
Impfdatum: 09.09.2022
Beginn: 29.10.2022
Tage bis Beginn: 50,0
Dosis: 1
Route/Site: SYR / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

COVID-19 Dyspnoea Fatigue Nasal congestion Pain Parosmia Pyrexia Respiratory tract congestion SARS-CoV-2 test positive Taste disorder

Symptomtext

I started having shortness of breath, my chest got congested, really bad nose congestion, extremely tired with body ache, I had trouble tasting and smelling, and started running a fever. I called the DR and was prescribed the antiviral drug and other medication. I took the antiviral and probably within 48 hours I started feeling much better. And by Thursday of that week I started feeling like I was over that hill and much better.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Dyspnoea
Hospital-Tage: -
Labordaten: COVID-19 on 10/31 positive.
Aktuelle Erkrankungen: No
Vorgeschichte: Asthma
Andere Medikamente: ARMOUR thyroid; ALLEGRA; ZYRTEC
Allergien: Sulfur drugs; trees; grass
Vorherige Impfungen: Pfizer vaccine in 2020 and I went into anaphylaxis.

VAERS 2508918

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7143C

moderat

Staat: MA
Alter: 50,0
Geschlecht: F
Eingang: 15.11.2022
Impfdatum: 02.10.2022
Beginn: 01.10.2022
Tage bis Beginn: -
Dosis: 4
Route/Site: IM / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Angular cheilitis Condition aggravated Rash Rash erythematous Rash pruritic

Symptomtext

10/29/22 spouse noticed red rash on lower half of scalp, which continues to the day I am reporting this on 11/15/22. In retrospect, I think the rash appeared at least by 10/22/22 and maybe earlier based on memories of periodic itching. I saw a primary care nurse practitioner on 11/10/22 who prescribed ketoconazole shampoo which I started using daily on 11/11/22. On 11/10 or 11/11/22 I developed angular cheilitis which I've treated with ketoconazole ointment that I had on hand. I got a flu shot on the same day as the COVID booster, but I don't know what flu shot it was so I can't add it to this form.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Condition aggravated
Hospital-Tage: -
Labordaten: None.
Aktuelle Erkrankungen: None
Vorgeschichte: Rosacea; Angular Cheilitis
Andere Medikamente: Sertraline; Vit B Complex; Zyrtec; Calcium supplement; Turmeric Curcumin supplement daily D3 supplement.
Allergien: Sensitivity to legumes and milk
Vorherige Impfungen: Diarrhea for ten days following 2nd Pfizer COVID vaccination.

VAERS 2505804

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7143C

moderat

Staat: MI
Alter: 66,0
Geschlecht: F
Eingang: 11.11.2022
Impfdatum: 29.09.2022
Beginn: 01.11.2022
Tage bis Beginn: 33,0
Dosis: 5
Route/Site: SYR / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

COVID-19 Cough Dyspnoea Fatigue Feeling abnormal Headache SARS-CoV-2 test positive Sneezing

Symptomtext

I was sneezing, had a headache, coughing, tired. I tested myself and was positive. I felt for a couple of days then felt good. Today is my 10th day and I've been feeling bad again. I had trouble breathing yesterday. I did not take any antivirals.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Dyspnoea
Hospital-Tage: -
Labordaten: at home COVID-19 test - positive
Aktuelle Erkrankungen: No
Vorgeschichte: Prediabetic; High blood pressure; Emphysema
Andere Medikamente: Hydrochlorothiazide; Vitamin D; Potassium; Multivitamin; Probiotic; Simvastatin; Claritin
Allergien: Zyban
Vorherige Impfungen: -

VAERS 2502091

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7143C

moderat

Staat: PA
Alter: 42,0
Geschlecht: F
Eingang: 08.11.2022
Impfdatum: 09.09.2022
Beginn: 09.09.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: SYR / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Hypertension Palpitations

Symptomtext

After 4th does (Moderna Bivalent) pounding heart, high blood pressure. No issues with this before. BP at end of July was 110/78.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Hypertension
Hospital-Tage: -
Labordaten: Blood pressure cuff.
Aktuelle Erkrankungen: None
Vorgeschichte: Sleep apnea; allergies
Andere Medikamente: Vick's Sinex
Allergien: None
Vorherige Impfungen: -

VAERS 2460287

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7143C

moderat

Staat: FL
Alter: 68,0
Geschlecht: F
Eingang: 03.11.2022
Impfdatum: 09.09.2022
Beginn: 09.09.2022
Tage bis Beginn: 0,0
Dosis: 5
Route/Site: OT / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

Cold sweat Mobility decreased Pain Feeling abnormal Influenza like illness Joint range of motion decreased Myalgia Sluggishness

Symptomtext

Patient called yesterday and notified us that she was experiencing intense pain in the 1st week, could not move her arm because of the pain, taking motrin from the day of vaccination. Per her pain started 3 hours after the vaccination. even she has pain now on the 2to 3 on the scale of 10.Also she has been experiencing cold sweats until now. We called and informed her primary care physicians office She said doctor is going to follow up with her.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Mobility decreased
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2492758

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7143C

moderat

Staat: CA
Alter: 50,0
Geschlecht: M
Eingang: 28.10.2022
Impfdatum: 14.09.2022
Beginn: 01.10.2022
Tage bis Beginn: 17,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Condition aggravated Dyshidrotic eczema Impaired driving ability Pain Perfume sensitivity Skin fissures

Symptomtext

A week later, my sensitivity to fragrances became much more severe causing my skin to crack. Last Friday the 21st it got much worse by the 24th It was like a 7 or 8 on the pain scale. It became so severe I was not able to operate my vehicle properly. The provider recommended that I use LIDEX topical ointment and moisturizer. She diagnosed me with dyshidrotic eczema. After applying the treatment for about 2 days, my symptoms improved. I am about 80% recovered with the skin no longer being broken but there are still some issues.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Condition aggravated
Hospital-Tage: -
Labordaten: N/A
Aktuelle Erkrankungen: N/A
Vorgeschichte: Chronic Lower Back Pain
Andere Medikamente: CLARITIN; fish oil; lisinopril
Allergien: FLONASE; morphine; ginger
Vorherige Impfungen: -

VAERS 2487148

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7143C

moderat

Staat: CA
Alter: 77,0
Geschlecht: M
Eingang: 24.10.2022
Impfdatum: 09.09.2022
Beginn: 20.09.2022
Tage bis Beginn: 11,0
Dosis: 1
Route/Site: SYR / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Arthralgia Mobility decreased Pain Pain in extremity

Symptomtext

Developed arthritic pain in hands (never had arthritis before). Within two days, it had spread through my entire body, to the point I couldn't get out of bed without use of a chair (and a day later, crutches) or similarly had extreme difficulty getting up from a chair. Extreme pain throughout my body. It took three days to start to recede. I've subsequently learned of others, none of whom had previous reactions to the Covid or other vaccines and none of whom had previously had arthritis, who had the same, multiple day problems.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Mobility decreased
Hospital-Tage: -
Labordaten: None
Aktuelle Erkrankungen: None
Vorgeschichte: Developed arthritic pain in hands (never had arthritis before). Within two days, it had spread through my entire body, to the point I couldn't get out of bed without use of a chair (and a day later, crutches) or similarly had extreme difficulty getting up from a chair. Extreme pain throughout my body. It took three days to start to recede. I've subsequently learned of others, none of whom had previous reactions to the Covid or other vaccines and none of whom had previously had arthritis, who had the same, multiple day problems.
Andere Medikamente: Single pill every morning of a multiple vitamin, glucossamine, and fish oil.
Allergien: Amoxicillin
Vorherige Impfungen: -

VAERS 2479873

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7143C

moderat

Staat: IL
Alter: 72,0
Geschlecht: F
Eingang: 16.10.2022
Impfdatum: 07.09.2022
Beginn: 12.09.2022
Tage bis Beginn: 5,0
Dosis: 4
Route/Site: IM / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: ja ER: unbekannt Erholt: nein

Injected limb mobility decreased Injection site pain Loss of personal independence in daily activities

Symptomtext

about a week after the booster was administered, I began experiencing pain in the area between my shoulder and the point of the shot. I can still barely move my arm above 90 degrees. I was examined by my doctor, and he prescribed physical therapy. I can still feel the exact point of the shot. I have never, ever had this happen before in my life with any shot of any type. so I would like to know if you are receiving other reports like this. my activities are somewhat limited; things like putting on my seatbelt, dressing, reaching.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Injected limb mobility decreased
Hospital-Tage: -
Labordaten: just physical exam. not scan yet
Aktuelle Erkrankungen: none
Vorgeschichte: none
Andere Medikamente: blood pressure and statin
Allergien: none
Vorherige Impfungen: -

VAERS 2478417

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7143C

moderat

Staat: CA
Alter: 67,0
Geschlecht: M
Eingang: 14.10.2022
Impfdatum: 08.09.2022
Beginn: 11.09.2022
Tage bis Beginn: 3,0
Dosis: 1
Route/Site: SYR / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: ja

Anticoagulant therapy Atrial fibrillation Blood test Dyspnoea Electrocardiogram abnormal Fatigue Immediate post-injection reaction Pain in extremity

Symptomtext

I went out of town for an anniversary trip to a high altitude area. I had two glasses of wine the night before the next morning I had two cups of coffee. We went on a hike trail and I noticed that I was getting out of breath quickly so we decided to go back and around 11AM is when my smart watch notified me that I was in Afib. I went to the fire department for a consult and then they decided that I should go to the emergency room because I was in active Afib. Me and my wife decided to drive back home to my home town and I went to the emergency room there and I ended up spending 24 hours in the emergency room. I had a little bit of a sore arm and slight fatigue immediately after the vaccine but after 24 hours I bounced back. The medications that I am on now because of the Afib are apixaban 5mg, ELIQUIS 5mg, metoprolol 25mg. I had an angiogram scheduled in two weeks.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Dyspnoea
Hospital-Tage: 1,0
Labordaten: Blood panels; ECG
Aktuelle Erkrankungen: N/A
Vorgeschichte: N/A
Andere Medikamente: Omega 3 fatty acid; vitamin D; atorvastatin
Allergien: N/A
Vorherige Impfungen: -

VAERS 2473587

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7143C

moderat

Staat: AZ
Alter: 34,0
Geschlecht: M
Eingang: 10.10.2022
Impfdatum: 17.09.2022
Beginn: 24.09.2022
Tage bis Beginn: 7,0
Dosis: 4
Route/Site: SYR / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Condition aggravated Cyst Erythema Lymphadenopathy

Symptomtext

I have a history of a cyst on the right side of my upper back. A week after my vaccination I started to feel the cyst on my back when I would stretch. It was not painful but just annoying. Not too long after I noticed swelling on the right side of my neck where a lymph node was. I went to my physician and they did notate that my cyst had grown and it had become slightly red. I was prescribed, a medication to help reduce the swelling of the cyst , which was Doxycycline. I also met with my general surgeon and he recommended that we reduce the size of the cyst before removal and gave me a topical cream. My primary care agreed with treatment options and believe that the lymph node swelling has to do with the cyst. Right now I have stopped feeling my cyst which may mean it has reduced in size a bit. Lymph node swelling is still present however it is the size of about a pea. No notable symptoms other than swelling and if I move my head from side to side.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Condition aggravated
Hospital-Tage: -
Labordaten: N/A
Aktuelle Erkrankungen: N/A
Vorgeschichte: Asthma; History of Cyst for 5 Years
Andere Medikamente: N/A
Allergien: Penicillin
Vorherige Impfungen: -

VAERS 2471944

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7143C

moderat

Staat: IL
Alter: 35,0
Geschlecht: F
Eingang: 07.10.2022
Impfdatum: 12.09.2022
Beginn: 13.09.2022
Tage bis Beginn: 1,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Dyspnoea Dyspnoea exertional Heart rate increased

Symptomtext

Shortness of breath and increased heart rate, which are ongoing. Shortness of breath was more persistent the next day following vaccination, but still pronounced even with little exertion.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Dyspnoea
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: None
Vorgeschichte: -
Andere Medikamente: Multivitamin
Allergien: None
Vorherige Impfungen: -

VAERS 2471827

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7143C

moderat

Staat: KS
Alter: 70,0
Geschlecht: F
Eingang: 07.10.2022
Impfdatum: 08.09.2022
Beginn: 18.09.2022
Tage bis Beginn: 10,0
Dosis: 5
Route/Site: SYR / AR

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Angina pectoris Asthenia Blood test normal Chest pain Cold sweat Computerised tomogram normal Dyspnoea Echocardiogram normal Electrocardiogram normal Hyperhidrosis

Symptomtext

On Sunday, September 18th, I started having clammy sweats during the day. At night at 2AM, I woke up with severe pain in my chest. It felt like my heart was being squeezed. I went to the emergency room and they did blood work and an EKG. They said I had not had a heart attack. I followed up with my doctor later on Wednesday the 21st and during that time, I was continuing to have a squeezing pain feeling around my heart. I was also having the clammy sweats and having shortness of breath. My doctor sent me to have an echocardiogram on the 22nd and that came back fine. There was no problems. On Monday the 26th, she had me go do a pulmonary CAT scan and I didn't have a blood clot. For the last two weeks, I have been resting and not doing a lot. It's been progressively getting better. At 1:30 today, I'm going to see an infectious disease specialist. They thought maybe I had torn a chest muscle from my Ehlers Danlos, but it didn't explain the clammy sweats throughout my body. We don't know if it's due to the vaccine since it was 10 days after or if it was long COVID, so I will be seeing the infectious disease specialist today. I'm getting better, but I still experience the clamminess and shortness of breath when doing certain activities. I've just been feeling weak and I feel like I don't have as much stamina.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Chest pain
Hospital-Tage: -
Labordaten: Blood work 09/19/2022 normal results; EKG 09/19/2022 normal results; Echocardiogram 09/22/2022 normal results; Pulmonary CAT scan 09/26/2022 no blood clots indicated.
Aktuelle Erkrankungen: None
Vorgeschichte: Ehlers Danlos Syndrome; Obesity
Andere Medikamente: Losartan; hydrochlorothiazide; multivitamin; vitamin D; lutein; probiotic
Allergien: Quinolone
Vorherige Impfungen: -

VAERS 2470623

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7143C

moderat

Staat: IL
Alter: 66,0
Geschlecht: F
Eingang: 06.10.2022
Impfdatum: 09.09.2022
Beginn: 16.09.2022
Tage bis Beginn: 7,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Chest X-ray Computerised tomogram Cough Dyspnoea

Symptomtext

I experienced shortness of breath and severe cough.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Dyspnoea
Hospital-Tage: -
Labordaten: Chest X-Ray, CT Scan
Aktuelle Erkrankungen: N/A
Vorgeschichte: Sjogren's syndrome; Asthma
Andere Medikamente: Cevimeline; celecoxib; metoprolol; simvastatin; PLAQUENIL; esomeprazole; PEPCID complete
Allergien: Penicillin; AVELOX; CIPRO; mold; dust
Vorherige Impfungen: -

VAERS 2469540

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7143C

moderat

Staat: TN
Alter: -
Geschlecht: F
Eingang: 05.10.2022
Impfdatum: -
Beginn: 16.09.2022
Tage bis Beginn: -
Dosis: UNK
Route/Site: IM / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

Dyspnoea Urticaria

Symptomtext

Individual developed urticaria on bilateral upper extremities, chest and face. Mild shortness of breath reported. ER provider documented no angioedema.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Dyspnoea
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: Individual had no documented drug allergies
Vorherige Impfungen: -

VAERS 2467293

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7143C

moderat

Staat: MO
Alter: 92,0
Geschlecht: F
Eingang: 03.10.2022
Impfdatum: 26.09.2022
Beginn: 28.09.2022
Tage bis Beginn: 2,0
Dosis: 1
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Condition aggravated Confusional state Pyrexia Tremor

Symptomtext

On day 2 post vaccine, patient developed a low grade fever, was more confused than normal and was "shaking more that usual" This lasted 2 days then patient resumed to her normal

Weitere VAERSDATA-Felder

Praegender Schweregrund: Condition aggravated
Hospital-Tage: -
Labordaten: none
Aktuelle Erkrankungen: -
Vorgeschichte: Hypertension hypothyroidism alzheimers
Andere Medikamente: -
Allergien: nkda
Vorherige Impfungen: -

VAERS 2463784

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7143C

moderat

Staat: MD
Alter: 35,0
Geschlecht: M
Eingang: 28.09.2022
Impfdatum: 05.09.2022
Beginn: 21.09.2022
Tage bis Beginn: 16,0
Dosis: UNK
Route/Site: - / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: ja

Heart rate increased Illness Laboratory test normal Pyrexia Tremor White blood cell count increased

Symptomtext

Adverse event happened multiple weeks after booster on 9/21/22 at 11:45pm. Was told I still need to report this illness as an adverse event. Woke up shaking and ended up in urgent care with a fever of 101.2 and had an elevated heart rate. Given Tylenol and 1 Bag of Saline fluid via IV. Was checked on a little while later and fever went up to 101.6. Was then given IV Toradol and another bag of saline fluid via IV. Fever went away and was told to rest and take Ibuprofen every 6 hours as symptoms persist. Symptoms were alleviated in a couple days and I stopped taking Ibuprofen on Sunday 9/25/22.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Tremor
Hospital-Tage: -
Labordaten: Multiple and most came back normal. Elevated WBC is most of what I can remember.
Aktuelle Erkrankungen: None
Vorgeschichte: None
Andere Medikamente: None
Allergien: None
Vorherige Impfungen: -

VAERS 2463537

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge AS7143C

moderat

Staat: CA
Alter: 59,0
Geschlecht: M
Eingang: 28.09.2022
Impfdatum: 26.09.2022
Beginn: 27.09.2022
Tage bis Beginn: 1,0
Dosis: 5
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Arthralgia Dyspnoea Fatigue Feeling abnormal Headache Injection site pain Myalgia

Symptomtext

Pain at Injection Site, Bad Headache, Joint and Muscle Aches and Pain, 99.7 temperature, Slight Labor in Breathing, Pulse 86 Beats per Minute (at rest), Fatigue/Tiredness, Brain Fog

Weitere VAERSDATA-Felder

Praegender Schweregrund: Dyspnoea
Hospital-Tage: -
Labordaten: None
Aktuelle Erkrankungen: Adrenal Insufficiency, Anal Fissure, Arthritis, Depression, Complex Post Traumatic Stress Disorder, Erectile Dysfunction, High Cholesterol. Gastroesophageal Reflux Disorder, Heart Arrhythmia, Spinal Spondylosis
Vorgeschichte: Adrenal Insufficiency, Anal Fissure, Arthritis, Chronic Dry Eyes, Complex Post Traumatic Stress Disorder, Coronary Artery Disease, Cyst on Pituitary Gland, Depression, Erectile Dysfunction, High Cholesterol, Gastroesophageal Reflux Disorder, Gilbert's Syndrome, Heart Arrhythmia, Hemorrhoids, Hypogonadism, Ilial Tibial Band Friction Syndrom, Lumbar Discogenic Disease, Minor Non-Specific Chronic Dermatitis, MTHFR Gene Mutation C677T/A1298C, Periodontal Disease, REM Sleep Behavior Disorder, Sciatica, Sleep Apnea, Spinal Spondylosis, Vitamin D Deficiency
Andere Medikamente: Adderall, Bystolic, Crestor, Diclofenac Sodium Topical Gel 1%, Fluocinonide Cream USP 0.1%, Hydrocortisone, Klonopin, Lamotrigine, Lidocaine Patch 5%, Lovaza, Nifedipine 0.3%/Lidocaine 2% Ointment, Plavix, Praluent, Protonix, Trulance, Viag
Allergien: Adenosine, Pollen
Vorherige Impfungen: -

VAERS 2463244

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7143C

moderat

Staat: NC
Alter: 64,0
Geschlecht: F
Eingang: 28.09.2022
Impfdatum: 08.09.2022
Beginn: 13.09.2022
Tage bis Beginn: 5,0
Dosis: 5
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Asthenia Bedridden COVID-19 Cough Extra dose administered Fatigue Feeling abnormal Headache Migraine Pyrexia Rhinorrhoea SARS-CoV-2 test positive Tonsillar hypertrophy

Symptomtext

I received a third booster of Moderna Bivalent for COVID-19 on 9/8/2022. At around 6:15PM on 9/13/2022, I had a runny nose and a sore and swollen left tonsil. An acquaintance of mine had recently tested positive for COVID-19, so I decided to take a home test, and I got a positive result when I did. I decided that I needed to get an antiviral, as I have asthma, and I wanted to reduce my risk of having severe symptoms. I contacted an online source for visitless prescriptions and received a prescription for molnupiravir, which I started taking on 9/14/2022. On 9/14/2022, I was bedridden and extremely fatigued. I ran a fever that was 102 at its peak, and I treated this with Tylenol; the Tylenol helped relieve the fever somewhat, but it always returned once the medicine wore off. For about 36 hours, I had the fever off and on. I also had an extremely runny nose. It was so runny that it was literally a constant stream, and I never experienced this with any of my previous illnesses. I had a severe headache that lasted for about 4 days; I took Excedrin for a couple of days, and it helped a little. I then took a prescription medication for migraines, and it finally relieved it. I had a cough, which was relatively mild. I had brain fog, which lasted for more than 5 days. The fatigue also lasted for more than 5 days, and at the time of this writing, I still haven't regained my pre-COVID energy level. I get tired earlier in the evening than I used to as a result of this. When the fever finally broke on the evening of 9/15/2022, I began to feel better. I continued to improve. By 9/18/2022, I had finished taking the molnupiravir. Aside from the residual fatigue and mild cough, I pretty much felt normal again. On 9/20/2022, I took another home test and got a negative result.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Migraine
Hospital-Tage: -
Labordaten: 9/13/2022--Home COVID-19 Test--Positive Result; 9/20/2022--Home COVID-19 Test--Negative Result.
Aktuelle Erkrankungen: None.
Vorgeschichte: Asthma; Mild Hypertension; Familial Hyperlipidemia; Atrial Fibrillation (Corrected by Ablation); Generalized Anxiety Disorder; Acid Reflux.
Andere Medikamente: Allegra; Fenofibrate; Sertraline; Rx Omega 3; Vitamin C; CoQ10; Losartan; Montelukast; Clonazepam; Atorvastatin; Omeprazole; Magnesium; Psyllium Fiber.
Allergien: Iodine (Internal and External); Cilantro; Chocolate; All Peppers.
Vorherige Impfungen: -

VAERS 2459795

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7143C

moderat

Staat: CA
Alter: 53,0
Geschlecht: M
Eingang: 24.09.2022
Impfdatum: 15.09.2022
Beginn: 16.09.2022
Tage bis Beginn: 1,0
Dosis: UNK
Route/Site: - / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Asthenia Back pain Chest pain Dyspnoea Fatigue Feeling abnormal Influenza like illness Pain

Symptomtext

"MODERNA COVID-19 VACCINE, BIVALENT EUA". It has been about 10 days and I still feel the effects of extreme fatigue. Starting from the beginning: (I received both the Influenza and the COVID shot; I don't have any paperwork with me identifying which Flu shot I received. So, I could not list it above in Item 17), so, the day I got the shots, I was fine, I didn't feel any symptoms. However, the next day I felt terrible with flu like symptoms (aching all over and back pain, etc.) this has been normal with all the COVID-19 shots but by the second day I would be completely fine. However, in this case, from the third day to maybe the 5th day, I had difficulty breathing, I was out of breath just barely doing anything, some chest pain and no energy and extreme fatigue, I just didn't feel good. Now it is just extreme fatigue and no energy.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Chest pain
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: none
Vorgeschichte: Atrial Fibrillation (AFiB), Atriul Flutter, Degenerative discs.
Andere Medikamente: Multaq, Aspirin, Calcium Magnesium Vitamin D3, CoQ10, Vitamin C, Herbal Sleep.
Allergien: ibuprofen, Hyydrocodine, Hydrocodone, Vicodin, Xarelto, whole wheat, seafood (both saltwater and freshwater), sea salt, lactose intolerant.
Vorherige Impfungen: -

VAERS 2454314

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge AS7143C

moderat

Staat: TN
Alter: 63,0
Geschlecht: F
Eingang: 22.09.2022
Impfdatum: 16.09.2022
Beginn: 16.09.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: OT / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Dyspnoea Hypersensitivity Oral discomfort Pruritus Urticaria

Symptomtext

itching as if there's no tomorrow; Allergic reaction/severe reaction; hives/hives have progressed/progressed to cover her whole body, with hives on the face/hives have been recurring/mostly on her torso, legs and arms; discomfort in the mouth; could hardly breath; This spontaneous case was reported by a nurse and describes the occurrence of ORAL DISCOMFORT (discomfort in the mouth), DYSPNOEA (could hardly breath), PRURITUS (itching as if there's no tomorrow), HYPERSENSITIVITY (Allergic reaction/severe reaction) and URTICARIA (hives/hives have progressed/progressed to cover her whole body, with hives on the face/hives have been recurring/mostly on her torso, legs and arms) in a 63-year-old female patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. AS7143C) for COVID-19 vaccination. Patient had no allergy related to medications, food and other products. The patient's past medical history included COVID-19 (End of Apr-2022. Tested because of exposure, COVID-19 mild symptoms 5 days out of work.) in April 2022. Concurrent medical conditions included Anxiety and Regurgitation. Concomitant products included CLONAZEPAM (KLONOPIN) for Anxiety, OMEPRAZOLE (PRILOSEC [OMEPRAZOLE]) for Regurgitation. On 16-Sep-2022 at 9:30 AM, the patient received fourth dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On 16-Sep-2022, the patient experienced ORAL DISCOMFORT (discomfort in the mouth) and DYSPNOEA (could hardly breath). 16-Sep-2022, the patient experienced HYPERSENSITIVITY (Allergic reaction/severe reaction) and URTICARIA (hives/hives have progressed/progressed to cover her whole body, with hives on the face/hives have been recurring/mostly on her torso, legs and arms). On 19-Sep-2022, the patient experienced PRURITUS (itching as if there's no tomorrow). The patient was treated with ALUMINIUM HYDROXIDE, MAGNESIUM TRISILICATE, SODIUM ALGINATE (PEPCID [ALUMINIUM HYDROXIDE;MAGNESIUM TRISILICATE;SODIUM ALGINATE]) on 16-Sep-2022 at an unspecified dose and frequency; DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) on 16-Sep-2022 at an unspecified dose and frequency and CETIRIZINE HYDROCHLORIDE (ZYRTEC [CETIRIZINE HYDROCHLORIDE]) (oral) on 16-Sep-2022 at an unspecified dose and frequency. At the time of the report, ORAL DISCOMFORT (discomfort in the mouth), DYSPNOEA (could hardly breath), PRURITUS (itching as if there's no tomorrow), HYPERSENSITIVITY (Allergic reaction/severe reaction) and URTICARIA (hives/hives have progressed/progressed to cover her whole body, with hives on the face/hives have been recurring/mostly on her torso, legs and arms) had not resolved. For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter did not provide any causality assessments. Patient had first dose of primary series with Moderna on 30-Dec-2020 with lot number 037K20A. Patient had second dose of primary series with Moderna on 27-Jan-2021 with lot number 030L20A. Patient had first booster dose with Moderna on 29-Oct-2021 with lot number 077C21B. Patient stated that she got her fourth dose around 09:30 AM on 16-Sep-2022 and within as hour she developed hives. Patient reported that the right arm where she got vaccine had less hives than her left arm. Patient reported that her airway was not affected and hives were not on her face. Patient did not had similar event in past. Adverse events caused patient to visit Emergency Room. Treatment medication included steroids and IV fluids and patient started taking oral steroids from 17-Sep-2022. This case was linked to MOD-2022-647519 (Patient Link).

Weitere VAERSDATA-Felder

Praegender Schweregrund: Dyspnoea
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: Anxiety; Regurgitation
Vorgeschichte: Medical History/Concurrent Conditions: COVID-19 (End of Apr-2022. Tested because of exposure, COVID-19 mild symptoms 5 days out of work.); Comments: Patient had no allergy related to medications, food and other products.
Andere Medikamente: KLONOPIN; PRILOSEC [OMEPRAZOLE]
Allergien: -
Vorherige Impfungen: -

VAERS 2441076

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7143C

moderat

Staat: WA
Alter: 73,0
Geschlecht: F
Eingang: 22.09.2022
Impfdatum: 07.09.2022
Beginn: 08.09.2022
Tage bis Beginn: 1,0
Dosis: 1
Route/Site: SYR / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Angiogram Blood test Blood thyroid stimulating hormone Brain natriuretic peptide Cardiac stress test Blood pressure increased Chest discomfort Heart rate increased Palpitations Tremor Chest X-ray Chills Condition aggravated Differential white blood cell count Echocardiogram Electrocardiogram Fibrin D dimer Full blood count

Symptomtext

Woke up at 5:30 am with severe chest and upper back pressure. Took my BP - 215/95 - two other times which were about the same reading. I called a neighbor to come over. By the time she arrived (10 minutes) I was severely shaking and experiencing chills. Because my BP continued to be very high, she immediately took me to the Emergency site (about a mile from home). They immediately took me in and did an EKG and bloodwork. After several hours I was transported to Medical Center to be admitted. Multiple tests were taken, including chest x-ray, ECHO exam, pharmacologic stress test and an angiogram. I was in the hospital for 2.5 days; had bloodwork taken repeatedly; started receiving blood pressure medicine which was successful in finally getting my blood pressure down. I was discharged on 9/10/22 with a prescription for Lisinopril for my BP. As a footnote, the doctor who did the angiogram told me my heart was in good shape and he "speculated" that what I experienced was a result of the COVID19 booster I had received on 9/7/22, although he couldn't say for sure. I was encouraged to let the pharmacy know and the pharmacy gave me the VAERS information to submit a report.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Palpitations
Hospital-Tage: -
Labordaten: Nuclear Stress Test, ECHO complete, Basic metabolic panels, blood count platelet, TSH reflex FT4, Dimer Quantitative, POCT PCR Influenza A & B and COVID 19, Dimer POC, BNP POC, CDB with differential, Chest View X-ray, Troponin (POC) ISTAT, EKG
Aktuelle Erkrankungen: asthma, GERD, hypertension, bigeminal pulse, arthritis
Vorgeschichte: asthma/seasonal allergies
Andere Medikamente: Paroxetine, multiple vitamin, vitamin B-12, probiotic, famotidine, atorvastatin, Advair, omeprazole, fish oil, coq10
Allergien: Statins, magnesium, piroxicam, calcium
Vorherige Impfungen: -

VAERS 2441076

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge as7143c

moderat

Staat: WA
Alter: 73,0
Geschlecht: F
Eingang: 22.09.2022
Impfdatum: 07.09.2022
Beginn: 08.09.2022
Tage bis Beginn: 1,0
Dosis: 4
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Angiogram Blood test Blood thyroid stimulating hormone Brain natriuretic peptide Cardiac stress test Blood pressure increased Chest discomfort Heart rate increased Palpitations Tremor Chest X-ray Chills Condition aggravated Differential white blood cell count Echocardiogram Electrocardiogram Fibrin D dimer Full blood count

Symptomtext

Woke up at 5:30 am with severe chest and upper back pressure. Took my BP - 215/95 - two other times which were about the same reading. I called a neighbor to come over. By the time she arrived (10 minutes) I was severely shaking and experiencing chills. Because my BP continued to be very high, she immediately took me to the Emergency site (about a mile from home). They immediately took me in and did an EKG and bloodwork. After several hours I was transported to Medical Center to be admitted. Multiple tests were taken, including chest x-ray, ECHO exam, pharmacologic stress test and an angiogram. I was in the hospital for 2.5 days; had bloodwork taken repeatedly; started receiving blood pressure medicine which was successful in finally getting my blood pressure down. I was discharged on 9/10/22 with a prescription for Lisinopril for my BP. As a footnote, the doctor who did the angiogram told me my heart was in good shape and he "speculated" that what I experienced was a result of the COVID19 booster I had received on 9/7/22, although he couldn't say for sure. I was encouraged to let the pharmacy know and the pharmacy gave me the VAERS information to submit a report.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Palpitations
Hospital-Tage: -
Labordaten: Nuclear Stress Test, ECHO complete, Basic metabolic panels, blood count platelet, TSH reflex FT4, Dimer Quantitative, POCT PCR Influenza A & B and COVID 19, Dimer POC, BNP POC, CDB with differential, Chest View X-ray, Troponin (POC) ISTAT, EKG
Aktuelle Erkrankungen: asthma, GERD, hypertension, bigeminal pulse, arthritis
Vorgeschichte: asthma/seasonal allergies
Andere Medikamente: Paroxetine, multiple vitamin, vitamin B-12, probiotic, famotidine, atorvastatin, Advair, omeprazole, fish oil, coq10
Allergien: Statins, magnesium, piroxicam, calcium
Vorherige Impfungen: -

VAERS 2450625

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7143C

moderat

Staat: IL
Alter: 73,0
Geschlecht: M
Eingang: 18.09.2022
Impfdatum: 14.09.2022
Beginn: 14.09.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Arthralgia Mobility decreased Neck pain

Symptomtext

Severe soreness in neck and shoulders. Moved over three day period from left to right. Started to dissipate on third day(Sun). Still sensitivity when turning head. Received some relief with aspirin and/or acetaminophen.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Mobility decreased
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: None
Vorgeschichte: None
Andere Medikamente: Lisinopril/Hydrochlorot 20-25MG Levothyroxine Sodium 75 MCG Atorvastatin Calcium 10MG Finasteride 5MG D3 50MCG
Allergien: Augmentin
Vorherige Impfungen: -

VAERS 2447835

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge as7143c

moderat

Staat: PA
Alter: 75,0
Geschlecht: M
Eingang: 16.09.2022
Impfdatum: 07.09.2022
Beginn: 08.09.2022
Tage bis Beginn: 1,0
Dosis: 5
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Herpes zoster Paraesthesia Scab Skin lesion

Symptomtext

Patient developed shingles after vaccination. 9/7 vaccination around 2pm 9/8 around 5pm patient started to get a tingling feeling. 9/9-9/10 sores started to develop. 9/12 patient say family doctor and was prescribed medication (valacyclovir & prednisone taper). 9/16 sores have crusted over.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Paraesthesia
Hospital-Tage: -
Labordaten: n/a
Aktuelle Erkrankungen: N/A
Vorgeschichte: PROSTATE, GERD, SEASONAL ALLERGIES
Andere Medikamente: 1. SOLIFENACIN 2. TAMSULOSIN 3. TADALAFIL 4. PANTOPRAZOLE 5. LORATADINE 6. OLOPATADINE NASAL SPRAY 7. SUPER BETA PROSTATE 8. CENTRUM SILVER 9. OCCUVITES 10. TART CHERRY EXTRACT 11. PREVAGEN 12. ECHINACEA 13. ZINC PROPIONATE
Allergien: PENICILLIN
Vorherige Impfungen: -

VAERS 2441085

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7143C

moderat

Staat: PA
Alter: 57,0
Geschlecht: M
Eingang: 12.09.2022
Impfdatum: 12.02.2021
Beginn: 26.02.2021
Tage bis Beginn: 14,0
Dosis: 4
Route/Site: SYR / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Anxiety Panic attack Tremor

Symptomtext

Two weeks to the day after my second injection, I began waking up with the sensation that I was shaking after every time I would fall asleep. I eventually saw a neurologist who advised me that it was most likely anxiety, although I did not feel anxious. I recall asking my doctors if they thought it could be vaccine related and they didn't seem to think so. After a month or two, I began having panic attacks. I have been under the care of my psychiatrist, who has prescribed numerous medications. The anxiety attacks improved, but I have rarely had a day that I haven't woken up with anxiety since the second shot. I believe that my anxiety increased after the third shot, and then gradually decreased over time. I know that I reported this in at least one of my responses to text messages that I received. My anxiety had finally become more manageable without additional medication until I received a fourth shot on September 7, 2022. I began having anxiety attacks again on September 11, 2022.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Tremor
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: Lamictal 150 mg. B-12 Metoprolol 25mg Clonopin .5 mg
Allergien: Propafenone
Vorherige Impfungen: -

VAERS 2441070

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7143C

moderat

Staat: CA
Alter: 70,0
Geschlecht: F
Eingang: 12.09.2022
Impfdatum: 08.09.2022
Beginn: 10.09.2022
Tage bis Beginn: 2,0
Dosis: 5
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Chills Decreased appetite Dehydration Fatigue Feeling abnormal Full blood count normal Hypertension Laboratory test abnormal Nausea Neurological examination normal Restlessness Tachycardia Vertigo

Symptomtext

Chills and restlessness starting evening of 9/10. At 3am on 9/11 woke up suddenly with vertigo which lasted 7 hours. Meclizine at 6am. Temp was 100 despite round the clock Tylenol. Severe fatigue, nausea, inability to eat for two days. Seen in Urgent Care at 10:30am on 9/11. Vertigo was subsiding and neuro exam was normal. Received 500 cc IVF for mild dehydration., Continued with Tachycardia to 106 (normal 57 to 65) and hypertension 170/ 98. Tachycardia and hypertension started to subside by 6pm on 9/11. Slept 13 to 14 hours. On 9/12 no vertigo but with significant brain fog

Weitere VAERSDATA-Felder

Praegender Schweregrund: Dehydration
Hospital-Tage: -
Labordaten: Chem labs showed mild dehydration. CBC was normal
Aktuelle Erkrankungen: GERD
Vorgeschichte: Hypothyroid secondary to treatment of Graves
Andere Medikamente: Levothyroxine, Metoprolol, Irbesartan, Vit D3,, Vit B12, Magnesium, Vit C Culturelle probiotics, Tums, Prilosec
Allergien: Amoxicillin, Fiorinal, Fioricet
Vorherige Impfungen: -

VAERS 2437462

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7143C

moderat

Staat: AZ
Alter: 70,0
Geschlecht: M
Eingang: 09.09.2022
Impfdatum: 08.09.2022
Beginn: 09.09.2022
Tage bis Beginn: 1,0
Dosis: 5
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Muscle spasms Pyrexia Tremor

Symptomtext

At the hour of sleep, the patient reported vigorous shaking, a fever of 100.5, noted feeling as if he had muscle spasms, and had the sensation that he may collapse similar to prior episodes with Guillain Barre syndrome. 24 hours after the vaccine, the patient noted feeling back to normal.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Tremor
Hospital-Tage: -
Labordaten: None
Aktuelle Erkrankungen: None
Vorgeschichte: Guillain-Barre Syndrome Hypertension
Andere Medikamente: Losartan Potassium Oral Tablet 100 mg Valium Oral Tablet 5 mg Cozaar Oral Tablet 100 mg
Allergien: Morphine
Vorherige Impfungen: -

VAERS 2434616

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7143C

moderat

Staat: NY
Alter: 54,0
Geschlecht: F
Eingang: 08.09.2022
Impfdatum: 07.09.2022
Beginn: 07.09.2022
Tage bis Beginn: 0,0
Dosis: 5
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Affect lability Anxiety Chills Condition aggravated Depression Dizziness Headache Injection site pain

Symptomtext

within 15 minutes - wooziness, within 1 hour dissociative, lability then giddiness, within 9 hours - severe depressive thoughts and anxiety, so emotional rollercoaster, at 12 hours, chills, headache, arm ache at injection sight.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Condition aggravated
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: Sore throat a week ago - tested negative for COVID 19 and Strep
Vorgeschichte: Anxiety, PMDD, Migraine
Andere Medikamente: Prozac, Wellbutrin XL, Klonopin Daily Xanax PRN Ajovy Monthly injection
Allergien: Penicillin, Sulfa antibiotics allergies Cipro adverse effect - tendon tear
Vorherige Impfungen: -

VAERS 2433640

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7143C

moderat

Staat: MD
Alter: 70,0
Geschlecht: F
Eingang: 08.09.2022
Impfdatum: 04.09.2022
Beginn: 06.09.2022
Tage bis Beginn: 2,0
Dosis: UNK
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Back pain Dysstasia Gait disturbance Injection site erythema Injection site induration Injection site swelling Injection site warmth Interchange of vaccine products Mobility decreased

Symptomtext

I still have extreme pain in my lower back since 9/6/2022 after receiving the Moderna bivalent COVID-19 vaccine on 9/4/2022. I have difficulty walking standing up straight, and I could not bend at all for 2 days. I am still slowly recovering. In the past, I had 3 Pfizer vaccine shots and 1 Moderna booster shot administered. I never had problems with shots previously. I also have a severe reaction around the injection site that measures about 5 inches and is red, swollen, hot to the touch, and hardened. I am taking the maximum dose of ibuprofen everyday in order to recover.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Mobility decreased
Hospital-Tage: -
Labordaten: None
Aktuelle Erkrankungen: None
Vorgeschichte: None
Andere Medikamente: None
Allergien: None
Vorherige Impfungen: -

VAERS 2429330

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7143C

moderat

Staat: NM
Alter: 41,0
Geschlecht: F
Eingang: 06.09.2022
Impfdatum: 05.09.2022
Beginn: 05.09.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Arthralgia Bone pain Dizziness Dyspnoea Extra dose administered Eye pain Gait disturbance Headache Malaise Muscular weakness Nausea Pain Product administered to patient of inappropriate age Pyrexia Sleep disorder Thirst Vertigo

Symptomtext

Waking every 15 minutes with fever, nausea, headache, extreme thirst, my whole body hurts- especially bones and joints. Muscles are weak. Dizziness- can?t walk without the room spinning. Shortness of breath. General malaise. My eyeballs hurt, my hair follicles hurt. I have a very high pain tolerance (delivered two babies with no drugs no epidural).

Weitere VAERSDATA-Felder

Praegender Schweregrund: Dyspnoea
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: None
Vorgeschichte: None
Andere Medikamente: None
Allergien: Environmental allergies especially mold, some uncommon food allergies
Vorherige Impfungen: Covid-19 Moderna shot 1 & 2, same as this except far worse, including sleep paralysis for several hours

VAERS 2690849

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7143C

mild

Staat: VA
Alter: 77,0
Geschlecht: F
Eingang: 04.10.2023
Impfdatum: 09.05.2023
Beginn: 01.06.2023
Tage bis Beginn: 23,0
Dosis: UNK
Route/Site: - / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Fatigue

Symptomtext

fatigue; This spontaneous case was reported by a patient and describes the occurrence of FATIGUE (fatigue) in a 77-year-old female patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. AS7143C) for COVID-19 prophylaxis. The patient's past medical history included COVID-19 (two years ago). On 09-May-2023, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. In June 2023, the patient experienced FATIGUE (fatigue). At the time of the report, FATIGUE (fatigue) had resolved. For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter did not provide any causality assessments. Concomitant medications were not reported. Treatment medications were not reported. This case was linked to US-MODERNATX, INC.-MOD-2023-742771, US-MODERNATX, INC.-MOD-2023-742800 (E2B Linked Report).; Sender's Comments: US-MODERNATX, INC.-MOD-2023-742771:Master case (Spikevax 2023-2024 (same patient)) US-MODERNATX, INC.-MOD-2023-742800:

Weitere VAERSDATA-Felder

Praegender Schweregrund: Fatigue
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: Medical History/Concurrent Conditions: COVID-19 (two years ago)
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2632444

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7143C

mild

Staat: AZ
Alter: 75,0
Geschlecht: F
Eingang: 16.05.2023
Impfdatum: 09.09.2022
Beginn: 01.04.2023
Tage bis Beginn: 204,0
Dosis: 5
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

COVID-19 Cough Fatigue Feeling abnormal Influenza like illness Malaise Nasopharyngitis Pain Pyrexia SARS-CoV-2 test positive

Symptomtext

Had a cough for a few days prior to 4/1. Evening of 4/1 I got body aches and fever. 4/2 woke up with body aches and fever. Felt like having flu and a cold together. Tested positive on At Home COVID-19 test. 4/4 contacted doctor through Televisit. Proscribed antiviral and advised to treat symptomatically. 4/6 I noticed symptoms improving, just felt ?less awful.? By 4/8 symptoms were mostly gone with extreme fatigue lingering for a month.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Fatigue
Hospital-Tage: -
Labordaten: 2April2023 At Home COVID-19 test, positive
Aktuelle Erkrankungen: NA
Vorgeschichte: Spinal Stenosis
Andere Medikamente: Desvenlafaxine; Metoprolol; L-Methylfolate; NP Thyroid; multivitamin; Vitamin C; Vitamin D
Allergien: Sulfa; Avocado; Gluten intolerant
Vorherige Impfungen: All COVID-19 vaccines had strong immune reaction lasting about 24 hours that left us unable to function.

VAERS 2632024

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7143C

mild

Staat: AR
Alter: 73,0
Geschlecht: F
Eingang: 15.05.2023
Impfdatum: 21.09.2022
Beginn: 21.03.2023
Tage bis Beginn: 181,0
Dosis: 5
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

COVID-19 Cough Feeling abnormal Headache Pyrexia Rhinorrhoea SARS-CoV-2 test positive

Symptomtext

I had a low-grade fever, runny nose, a really bad headache, I used a home COVID-19 test that came back positive. I called my doctor to consult with her about my positive test and symptoms, she prescribed the PAXLOVID. I started taking the medication, I was feeling better within the five days of taking the course of the medication. Three days after finishing the medication I started feeling bad again, I started having a croupy cough. I stayed in quarantine; I wore a mask when no one was home walked to the front door to go outside walked around the neighborhood to get my lungs to take the deep breaths. In total I was in quarantine for a total of 21 days. My strength is returning, and I feel I have recovered fully.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Headache
Hospital-Tage: -
Labordaten: 21MAR2023 home COVID-19 test positive
Aktuelle Erkrankungen: No
Vorgeschichte: Asthma
Andere Medikamente: Lisinopril
Allergien: No
Vorherige Impfungen: Shingles vaccine made my arm at the sight of the vaccine, I had a 6" x 4" oval raised area. I was advised not to have the vaccin

VAERS 2629809

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7143C

mild

Staat: CA
Alter: 63,0
Geschlecht: F
Eingang: 10.05.2023
Impfdatum: 22.09.2022
Beginn: 06.05.2023
Tage bis Beginn: 226,0
Dosis: 5
Route/Site: IM / AR

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

COVID-19 Cough Fatigue Oropharyngeal pain Pain Pyrexia SARS-CoV-2 test positive Throat irritation

Symptomtext

On 5/6/2023, I woke up with a sore throat. I took a home antigen test that day and got a negative result. I began to feel achy and tired during the day. On 5/7/2023, I took another home antigen test and got a positive result. I had sore throat, body aches, fatigue, and fever. On 5/8/2023, I had all the same symptoms, plus a cough. I took TYLENOL and a cough syrup. I did a video visit with my doctor, who prescribed PAXLOVID. On 5/9/2023, I still pretty much had the same symptoms. Today, I finally feel like I'm getting better. I still have a little bit of a scratchy throat and an occasional cough. The body aches, fatigue, and fever are gone. I feel radically different from how I felt yesterday.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Fatigue
Hospital-Tage: -
Labordaten: 06MAY2023 home antigen test, negative result; 07MAY2023 home antigen test, positive result
Aktuelle Erkrankungen: None
Vorgeschichte: Hypertension; Hyperlipidemia
Andere Medikamente: Hydrochlorothiazide; LIPITOR; montelukast; albuterol; omega 3 fish oil; calcium; vitamin D; SAM-E; SYSTANE moisture eye drops
Allergien: Cat dander
Vorherige Impfungen: -

VAERS 2620633

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7143C

mild

Staat: NY
Alter: 57,0
Geschlecht: M
Eingang: 25.04.2023
Impfdatum: 12.09.2022
Beginn: 30.03.2023
Tage bis Beginn: 199,0
Dosis: 5
Route/Site: IM / AR

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

COVID-19 Cough Influenza like illness Pyrexia Respiratory tract congestion SARS-CoV-2 test positive

Symptomtext

I got COVID-19 6 months after my vaccine. I tested positive for 04/01/2023. I had fever and flu like symptoms, cough. I still have a cough and some congestion. I also tested negative on 04/10/2023.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Pyrexia
Hospital-Tage: -
Labordaten: 01APR2023 COVID-19 Test-Positive; 10APR2023 COVID-19 Test- Negative
Aktuelle Erkrankungen: None
Vorgeschichte: High Cholesterol
Andere Medikamente: Claritin; Vitamin D; Atorvastatin
Allergien: None
Vorherige Impfungen: -

VAERS 2614504

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7143C

mild

Staat: OH
Alter: 76,0
Geschlecht: F
Eingang: 13.04.2023
Impfdatum: 06.10.2022
Beginn: 20.12.2022
Tage bis Beginn: 75,0
Dosis: 5
Route/Site: SYR / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

COVID-19 Fatigue Increased upper airway secretion Respiratory tract congestion SARS-CoV-2 test positive

Symptomtext

I was positive for COVID-19 on 20DEC2022 , I felt tired and fatigued. I was congested and drainage in the back of my throat. That lasted for about 8 days and I started feeling better, unfortunately I got a rebound right after. I contacted my doctor and he prescribed me paxlovid.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Fatigue
Hospital-Tage: -
Labordaten: 20DEC2022 COVID-19- Test- Positive
Aktuelle Erkrankungen: N/A
Vorgeschichte: High cholesterol
Andere Medikamente: Lisanvastatin; Vitamin c; Calcium; Magnesium; Multi vitamin; Vitamin D
Allergien: Sulfa
Vorherige Impfungen: -

VAERS 2614453

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7143C

mild

Staat: TN
Alter: 71,0
Geschlecht: M
Eingang: 13.04.2023
Impfdatum: 30.09.2022
Beginn: 26.02.2023
Tage bis Beginn: 149,0
Dosis: 5
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

COVID-19 Cough Headache Myalgia Rhinorrhoea SARS-CoV-2 test positive

Symptomtext

First symptom was mild headache. That evening I had a cough, clear nasal discharge, muscle aches. In the morning the headache and cough were worse. I had a home test, and it came back positive. I was able to check my oxygen and it was still at 96. I had a telemedicine appointment with my doctor.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Headache
Hospital-Tage: -
Labordaten: 27FEB2023 COVID-19 test positive
Aktuelle Erkrankungen: N/A
Vorgeschichte: Borderline Cholesterol; Prostatic hypotrophy; Hypothyroidism; Mild Osteoarthritis
Andere Medikamente: Levothyroxine; FLOMAX; simvastatin; TYLENOL; vitamin D; vitamin E; omega 3
Allergien: N/A
Vorherige Impfungen: -

VAERS 2613891

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7143C

mild

Staat: MD
Alter: 49,0
Geschlecht: F
Eingang: 12.04.2023
Impfdatum: 08.09.2022
Beginn: 01.09.2022
Tage bis Beginn: -
Dosis: 5
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Axillary pain Blood test abnormal Clostridium difficile infection Eosinophil count increased Malaise Pain in extremity Peripheral swelling White blood cell count increased

Symptomtext

Shortly after receiving my vaccine in September of 2022. My arm was sore for a day and a half which is normal for me. A week later, I noticed that under my arm was quite sore. That kind of came and went. Some days very sore, some days not sore at all. In January, it really started to bother me. I talked to a couple of different doctors who said that it was not uncommon after a vaccine and told me not to worry. I got really sick and was diagnosed with C. diff in the beginning of February. I don't think that was associated with the vaccine or the swelling in my arm. I saw my primary doctor a few weeks ago and said it was really bothering me still. She did not see or feel any swelling, but she gave me a referral to receive mammogram and ultrasound later this month.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Axillary pain
Hospital-Tage: -
Labordaten: FEB2023 - Blood Work - Elevated White Blood Cells And Eosinophils
Aktuelle Erkrankungen: None
Vorgeschichte: Diabetes; High Blood Pressure; High Cholesterol; Bipolar 2
Andere Medikamente: Metformin; Atorvastatin; Lisinopril; Wellbutrin; Latuda; Lamictal; Zyrtec
Allergien: Vicodin; Antabuse; Shellfish
Vorherige Impfungen: -

VAERS 2613453

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7143C

mild

Staat: NM
Alter: 69,0
Geschlecht: F
Eingang: 11.04.2023
Impfdatum: 08.09.2022
Beginn: 23.11.2022
Tage bis Beginn: 76,0
Dosis: 5
Route/Site: IM / UN

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

COVID-19 Cough Fatigue Headache Pain Rhinorrhoea SARS-CoV-2 test positive

Symptomtext

I had a cough, fatigue, headache, body aches, and runny nose. I tested positive for COVID-19. I talked to a doctor, and I was prescribed Paxlovid. I was coughing for a couple of weeks.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Fatigue
Hospital-Tage: -
Labordaten: 11/24/2022, COVID-19 Test, Positive
Aktuelle Erkrankungen: N/A
Vorgeschichte: N/A
Andere Medikamente: Simvastatin; Lisinopril; Calcium; Vitamin E, D, Multivitamin; Fish Oil; CoQ10; Glucosamine
Allergien: N/A
Vorherige Impfungen: -

VAERS 2613403

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7143C

mild

Staat: CO
Alter: 72,0
Geschlecht: F
Eingang: 11.04.2023
Impfdatum: 24.09.2022
Beginn: 16.03.2023
Tage bis Beginn: 173,0
Dosis: 4
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

COVID-19 Chills Cough Nasopharyngitis Pain Pyrexia SARS-CoV-2 test negative SARS-CoV-2 test positive

Symptomtext

I had a bad cough, a fever, chills, and body aches. I took a home COVID-19 and that was positive so I called my doctor. He put me on Paxlovid. Within about two of starting the Paxlovid the symptoms started to decrease but I continued to test positive. I then developed a bad cold. It took a good 10 days before I got a negative test.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Chills
Hospital-Tage: -
Labordaten: 17MAR2023 - COVID-19 At Home Test - Positive; 18MAR2023 - COVID-19 At Home Test - Positive; 03APR2023 - COVID-16 At Home Test - Negative
Aktuelle Erkrankungen: N/A
Vorgeschichte: Muscle Disease IBM
Andere Medikamente: Escitalopram; Valacyclovir; Methotrexate; Metoprolol; Azelastine; Anoro; Folic Acid; CoQ-10; Calcium; Biotin
Allergien: N/A
Vorherige Impfungen: -

VAERS 2610849

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7143C

mild

Staat: CO
Alter: 81,0
Geschlecht: M
Eingang: 06.04.2023
Impfdatum: 20.09.2022
Beginn: 28.02.2023
Tage bis Beginn: 161,0
Dosis: 5
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

COVID-19 Exposure to SARS-CoV-2 Malaise Rhinorrhoea SARS-CoV-2 test positive

Symptomtext

My wife had been ill with COVID-19 prior. I then had a runny nose and tested and I was positive. We had been traveling a few days prior. My symptoms were very mild and I began my Paxlovid the same date and by the second day, I started feel better. I did not contact my doctor but I had Paxlovid on hand to take. I did have a rebound on 03/15/2023. I was due to leave on 3/16/2023. I had mild symptoms and I tested and I was COVID-19 positive. He recommended I wait it out so I did and within 5 days I tested negative.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Malaise
Hospital-Tage: -
Labordaten: 28FEB2023 - COVID-19 At Home Test - Positive; 05MAR2023 - COVID-19 At Home Test - Negative; 16MAR2023 - COVID-19 At Home Test - Positive; 21MAR2023 - COVID-19 At Home Test - Negative
Aktuelle Erkrankungen: N/A
Vorgeschichte: Diabetes; Prostate Cancer; Hypertension
Andere Medikamente: Levothyroxine; Lisinopril; Allopurinol; Jardiance; AREDS 2; Vitamin D; Vitamin B12; Atorvastatin; Metformin
Allergien: N/A
Vorherige Impfungen: -

VAERS 2610841

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7143C

mild

Staat: CA
Alter: 68,0
Geschlecht: F
Eingang: 06.04.2023
Impfdatum: 05.11.2022
Beginn: 15.03.2023
Tage bis Beginn: 130,0
Dosis: 5
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

COVID-19 Fatigue Headache Malaise Nasal congestion Nasal inflammation Pain in extremity Pyrexia SARS-CoV-2 test positive Tongue coated Upper-airway cough syndrome

Symptomtext

I had a sore arm and was pretty tired after vaccination. I had a slight headache and a fever as well. All of my symptoms lasted a few days. I recently caught COVID-19. I was pretty sick for three or four days. I started Paxlovid and took it for five days. I've had lingering symptoms afterwards. My tongue has a weird film on it. My nasal passage is swollen and inflamed. I also have postnasal drip. I keep testing positive.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Fatigue
Hospital-Tage: -
Labordaten: 15MAR2023 - COVID-19 Test - Positive
Aktuelle Erkrankungen: N/A
Vorgeschichte: Hypertension; Hyperlipidemia
Andere Medikamente: Lisinopril; Atorvastatin; Centrum Silver Vitamins; Famotidine; Triple Omega
Allergien: Penicillin
Vorherige Impfungen: -

VAERS 2610813

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7143C

mild

Staat: CA
Alter: 77,0
Geschlecht: M
Eingang: 06.04.2023
Impfdatum: 07.09.2022
Beginn: 08.01.2023
Tage bis Beginn: 123,0
Dosis: 5
Route/Site: SYR / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

COVID-19 Oropharyngeal pain SARS-CoV-2 test positive

Symptomtext

After traveling on a plane from another state on 01/05, 5 days later I had mild symptoms including sore throat. I took a home COVID-19 test and tested positive on 01/09/2023 in the morning. I called my physician's office and had a telehealth visit with a physician. I was prescribed PAXLOVID and my wife picked it up later that day. I took the medication and within 48 hours the symptoms went away. 5 days later, I tested negative and have not had any recurring symptoms.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Oropharyngeal pain
Hospital-Tage: -
Labordaten: 09JAN2023 at home COVID-19 test positive; 13JAN2023 at home COVID-19 test positive; 18JAN2023 at home COVID-19 test negative
Aktuelle Erkrankungen: None
Vorgeschichte: Arthritis; Arrhythmias of Heart
Andere Medikamente: Low dose aspirin; multivitamin; TYLENOL
Allergien: None
Vorherige Impfungen: December 2019 Pneumonia vaccine, experienced flu like symptoms for a week after vaccination

VAERS 2610742

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7143C

mild

Staat: MI
Alter: 73,0
Geschlecht: F
Eingang: 06.04.2023
Impfdatum: 09.09.2022
Beginn: 03.10.2022
Tage bis Beginn: 24,0
Dosis: 5
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

COVID-19 Cough Exposure to SARS-CoV-2 Fatigue Headache Oropharyngeal pain SARS-CoV-2 test positive

Symptomtext

I was going to visit family and I had gotten a COVID-19 PCR test because they have small children, and it was positive. I was fatigued and had a headache as well. I was put on PAXLOIVD and that did help. Earlier this month my husband test positive for COVID-19 on the 13th which was the last day of traveling and in another country. I had a sore throat, fatigue, headache, cough, and I took a COVID-19 home test, and it was positive for COVID-19. I went on PAXLOVID again and it did help but the headache and fatigue lasted.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Fatigue
Hospital-Tage: -
Labordaten: COVID-19 PCR test; COVID-19 home test
Aktuelle Erkrankungen: N/A
Vorgeschichte: N/A
Andere Medikamente: N/A
Allergien: Sulfa drugs
Vorherige Impfungen: -

VAERS 2610658

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7143C

mild

Staat: MD
Alter: 67,0
Geschlecht: F
Eingang: 06.04.2023
Impfdatum: 07.09.2022
Beginn: 15.12.2022
Tage bis Beginn: 99,0
Dosis: 5
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

COVID-19 Oropharyngeal pain Rhinorrhoea SARS-CoV-2 test positive Spirometry

Symptomtext

On 12/15/2022, my nose started running a lot and I had a slight sore throat. It was mostly a runny nose though. Because of my asthma, I use a spirometer every day and I was having trouble getting a reading from that. I don't have terrible asthma, but I take two medications a day and this was the first time that I had to use my rescue inhaler. It effected my oxygen. I took an at home COVID-19 test and the results were positive, but very light. I isolated and called my doctor, who prescribed Paxlovid. I can't remember the exact days of it, but I started feeling better and then had a rebound. I was still testing positive on 12/31/2022, but it was getting lighter. I think it was around January 3rd-5th that I finally tested negative.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Oropharyngeal pain
Hospital-Tage: -
Labordaten: 15DEC2022 - At Home COVID-19 Test - Negative; 16DEC2022 - At Home COVID-19 Test - Negative; 17DEC2022 - At Home COVID-19 Test - Positive; 18DEC2022 - At Home COVID-19 Test - Positive; 31DEC2022 - At Home COVID-19 Test - Positive; 03JAN2023 - At Home COVID-19 Test - Negative; 04JAN2023 - At Home COVID-19 Test - Negative; 05JAN2023 - At Home COVID-19 Test - Negative
Aktuelle Erkrankungen: None
Vorgeschichte: High Cholesterol; Low Ejection Fraction; Asthma; Lyme Disease; Dermatomyositis; Breast Cancer In Remission; Psoriasis
Andere Medikamente: Ezetimibe; Entresto; Coreg CR; Plaquenil; Anastrozole; Symbicort; Soolantra Cream 1%; Triamcinolone Acetonide; Dexamethasone Valerate .12%; Melatonin; Helio; Mucinex; Colace; Omega 3; Probiotic; Prebiotic; Calcium; Vitamin D; Multivitamin
Allergien: Penicillin; Azithromycin; Pert
Vorherige Impfungen: -

VAERS 2610643

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7143C

mild

Staat: NY
Alter: 67,0
Geschlecht: M
Eingang: 06.04.2023
Impfdatum: 09.09.2022
Beginn: 07.03.2023
Tage bis Beginn: 179,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Ageusia Anosmia COVID-19 Chills Cough Decreased appetite Fatigue SARS-CoV-2 test positive Weight decreased

Symptomtext

I started coughing and hacking really bad. I was really tired. I am usually active. I started getting chills. So, I took a COVID-19 test. It came back positive. I was just ungodly tired. I lost my sense of smell and taste right away. I am just getting it back. I am still tired and coughing. I didn't have much of an appetite. I lost 12 pounds. My doctor prescribed me Paxlovid. I had to stop taking my Simvastatin medication until I finished my Paxlovid prescription. My doctor gave me albuterol to help with the coughing.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Chills
Hospital-Tage: -
Labordaten: 07MAR2023 at home COVID-19 test- Positive
Aktuelle Erkrankungen: N/A
Vorgeschichte: N/A
Andere Medikamente: Simvastatin; Multivitamin; Vitamin D; Vitamin C
Allergien: N/A
Vorherige Impfungen: -

VAERS 2610167

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7143C

mild

Staat: MD
Alter: 74,0
Geschlecht: M
Eingang: 05.04.2023
Impfdatum: 06.09.2022
Beginn: 01.12.2022
Tage bis Beginn: 86,0
Dosis: 3
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

COVID-19 Malaise SARS-CoV-2 test positive

Symptomtext

I experienced COVID-19 after my vaccine. My symptoms began in December 2022. I also had a telehealth call with a nurse practitioner who prescribed PAXLOVID which was very beneficial that minimized my symptoms. I took a COVID test but do not remember the date. I have fully recovered from my symptoms.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Malaise
Hospital-Tage: -
Labordaten: DEC2022 COVID-19 test positive
Aktuelle Erkrankungen: None
Vorgeschichte: Diabetes Type II; Hemoptysis
Andere Medikamente: Metformin; LIPITOR; doxycycline; lisinopril; lutein; coQ10; turmeric
Allergien: Seafood
Vorherige Impfungen: -

VAERS 2609642

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge AS7143C

mild

Staat: MN
Alter: 62,0
Geschlecht: F
Eingang: 04.04.2023
Impfdatum: 07.09.2022
Beginn: 28.03.2023
Tage bis Beginn: 202,0
Dosis: 5
Route/Site: IM / AR

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

COVID-19 Cough Fatigue Nausea Pyrexia Respiratory tract congestion SARS-CoV-2 test positive Sinus headache

Symptomtext

I started to have a mild sinus headache, a mild fever at 100.6 degrees, I was coughing, I had congestion, I was super tired, and a little bit of nausea. I was taking Tylenol and Mucinex. I tested with a COVID-19 home test. I called the nurse line and I had to go in and they prescribed me Paxlovid.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Fatigue
Hospital-Tage: -
Labordaten: 30MAR2023 - COVID-19 At Home Test- Positive; 30MAR2023 - COVID-19 PCR - Positive
Aktuelle Erkrankungen: My neighbor was using meth and it was traveling through the ventilation system. Before this I was extremely healthy moving here. I was also taking allergy shots.
Vorgeschichte: N/A
Andere Medikamente: Urolithin A; Multivitamin over 55 Womens
Allergien: Nuts; Dust Mites; Invisible Mold
Vorherige Impfungen: -

VAERS 2608495

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7143C

mild

Staat: MN
Alter: 66,0
Geschlecht: M
Eingang: 03.04.2023
Impfdatum: 07.09.2022
Beginn: 03.01.2023
Tage bis Beginn: 118,0
Dosis: 5
Route/Site: IM / AR

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

COVID-19 Headache Nasopharyngitis SARS-CoV-2 test positive

Symptomtext

I started to feel like I was catching a cold, possibly the fl. I had a small headache. I took a home COVID-19 test, it did come back positive. I called my doctor to let them know I tested positive for COVID-19, I was prescribed the Paxlovid. I started taking it immediately. I was feeling better within a day of taking the medication.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Headache
Hospital-Tage: -
Labordaten: 3JAN2023 Home COVID-19 test - positive
Aktuelle Erkrankungen: No
Vorgeschichte: No
Andere Medikamente: Levothyroxine; Lipitor; Vitamin D3; Centrum Multivitamin; Lutein Xanthinin; CoQ10; Glucosamine/Chondroitin
Allergien: No
Vorherige Impfungen: -

VAERS 2607618

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7143C

mild

Staat: CO
Alter: 58,0
Geschlecht: F
Eingang: 31.03.2023
Impfdatum: 08.09.2022
Beginn: 27.02.2023
Tage bis Beginn: 172,0
Dosis: 5
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: ja

COVID-19 Cough Fatigue Oropharyngeal pain Rhinorrhoea SARS-CoV-2 test positive

Symptomtext

I woke up with a running nose, fatigue, cough, and a slight sore throat. The second day I saw a nurse at an urgent care, and she tested me for COVID-19 which was positive. I got a prescription for Paxlovid. I started feeling better day 4-5 of taking Paxlovid but my cough lasted for a couple weeks. I didn't test negative for COVID-19 until the 16th day. I still occasionally have a cough.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Fatigue
Hospital-Tage: -
Labordaten: 02/27/2023, COVID-19 Test, Positive
Aktuelle Erkrankungen: N/A
Vorgeschichte: Type 2 Diabetes
Andere Medikamente: Losartan; Atorvastatin; Metformin
Allergien: N/A
Vorherige Impfungen: -

VAERS 2607556

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7143C

mild

Staat: UT
Alter: 71,0
Geschlecht: F
Eingang: 31.03.2023
Impfdatum: 16.09.2022
Beginn: 29.01.2023
Tage bis Beginn: 135,0
Dosis: 5
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Blood test normal COVID-19 Chills Fatigue Lacrimation increased Nasal congestion Nausea Pyrexia SARS-CoV-2 test positive Throat irritation

Symptomtext

I had like a allergy in my throat that is how it felt. I started to get a stuffy nose and my eyes was getting watery and I started to get the chills. I had a fever 99.7. I started to get nausea for 2 days. When I woke up, I took a COVID test, and it was positive. I was really tired.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Chills
Hospital-Tage: -
Labordaten: 29JAN23 COVID-19 positive; Blood test -Normal;
Aktuelle Erkrankungen: None
Vorgeschichte: None
Andere Medikamente: Estradiol and Morethindrone; Motrin; Goodys; Vitamins
Allergien: Diuretics; Lortab
Vorherige Impfungen: -

VAERS 2605904

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7143C

mild

Staat: NC
Alter: 87,0
Geschlecht: F
Eingang: 29.03.2023
Impfdatum: 09.09.2022
Beginn: 01.12.2022
Tage bis Beginn: 83,0
Dosis: 5
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Arterial occlusive disease Catheterisation cardiac abnormal Chest discomfort Discomfort Pain Stent placement

Symptomtext

I had pressure in my chest, uncomfortable, some pain. I went to my doctor; she referred me to a cardiologist, ordered a heart catheterization and found some clogged arteries, he placed stents in my heart during surgery. I am feeling much better since the catheterization.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Pain
Hospital-Tage: -
Labordaten: N/A
Aktuelle Erkrankungen: No
Vorgeschichte: Type II Diabetes
Andere Medikamente: Vitamin B-12; Fish Oil; Vitamin D; Atenolol; Metformin
Allergien: Statins
Vorherige Impfungen: -

VAERS 2604032

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7143C

mild

Staat: IL
Alter: 56,0
Geschlecht: F
Eingang: 27.03.2023
Impfdatum: 19.09.2022
Beginn: 13.03.2023
Tage bis Beginn: 175,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

COVID-19 Cough Fatigue Impaired work ability Pain Respiratory tract congestion Rhinorrhoea SARS-CoV-2 test positive

Symptomtext

I had a stuffy head and runny nose I was just kind of tired. I waited a day to test at home and it was positive. They really hit on the third day, I developed a cough and body ache. Laying down was painful. My family contacted a local pharmacy, and they prescribed a PAXLOVID. I was feeling better by that Friday the 16th. I feel good now but, occasionally I have this deep cough. I have tested negative and went back to work.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Fatigue
Hospital-Tage: -
Labordaten: 14MAR2023 COVID-19 positive
Aktuelle Erkrankungen: N/A
Vorgeschichte: N/A
Andere Medikamente: Metformin; glipizide; enalapril; ezetimibe, omega 3; TRADJENTA; fish oil; turmeric; vitamin B; C; zinc; baby aspirin; probiotic; fiber; calcium
Allergien: Shrimp
Vorherige Impfungen: -

VAERS 2604005

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7143C

mild

Staat: KS
Alter: 57,0
Geschlecht: F
Eingang: 27.03.2023
Impfdatum: 23.09.2022
Beginn: 28.01.2023
Tage bis Beginn: 127,0
Dosis: 5
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: ja

Conjunctivitis Fatigue Headache Influenza virus test negative Pain Pyrexia Respiratory tract congestion SARS-CoV-2 test negative Throat irritation

Symptomtext

01/28/2023 symptoms; scratchy throat within 24 hours my symptoms became more severe. I had fatigue, body aches, congestion, headache, fever 101.0. Symptoms lasted for 2 weeks and I returned to urgent care on 02/09/2023, I was tested for Influenza and COVID-19 both results were negative. Physician did not prescribe any medication and throughout the day I was feeling worse. On 02/11/2023 I woke up with pink eye in both eyes and returned to urgent care and was prescribed a ZPAK and TYLENOL PRN.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Fatigue
Hospital-Tage: -
Labordaten: 02/09/2023 COVID-19 negative, 02/09/2023 Influenza negative
Aktuelle Erkrankungen: None
Vorgeschichte: None
Andere Medikamente: TTLENOL OTC; Z PAK
Allergien: Sulfa; latex; seasonal allergies
Vorherige Impfungen: -

VAERS 2603963

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7143C

mild

Staat: GA
Alter: 73,0
Geschlecht: F
Eingang: 27.03.2023
Impfdatum: 07.09.2022
Beginn: 17.10.2022
Tage bis Beginn: 40,0
Dosis: 4
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Cough Fatigue Malaise Pyrexia Respiratory tract congestion SARS-CoV-2 test negative

Symptomtext

I began getting sick on 10/17/2022 and they lasted a week, I decided to do some home COVID-19 test because I was not in my hometown and tested negative for COVID-19. I got to see my doctor the following week and he tested me and I was still negative for COVID-19 but I was still experiencing chest congestion, low grade fever, exhaustion, coughing.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Fatigue
Hospital-Tage: -
Labordaten: COVID-19 negative 10/27/2022
Aktuelle Erkrankungen: N/A
Vorgeschichte: N/A
Andere Medikamente: Sertraline
Allergien: Penicillin; CECLOR
Vorherige Impfungen: -

VAERS 2602422

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7143C

mild

Staat: WA
Alter: 59,0
Geschlecht: M
Eingang: 23.03.2023
Impfdatum: 19.09.2022
Beginn: 02.02.2023
Tage bis Beginn: 136,0
Dosis: 5
Route/Site: SYR / AR

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

COVID-19 Pyrexia SARS-CoV-2 test positive Throat irritation

Symptomtext

Tested positive for COVID-19 on 02/06/2023 and had a televisit with my primary care physician on 02/07/2023. My doctor prescribed PAXLOVID. My symptoms were very mild including a scratchy throat and felt feverish on the second night. Beyond that, I had essentially no symptoms. Symptoms were gone within 3 or 4 days. I tested negative on 02/14/2023.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Pyrexia
Hospital-Tage: -
Labordaten: 02/06/2023 COVID-19 antigen test positive
Aktuelle Erkrankungen: None
Vorgeschichte: Asthma
Andere Medikamente: Simvastatin; metformin; montelukast; famotidine; vitamin D3; vitamin B; vitamin C; fish oil
Allergien: Codeine
Vorherige Impfungen: -

VAERS 2602401

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7143C

mild

Staat: TX
Alter: 71,0
Geschlecht: F
Eingang: 23.03.2023
Impfdatum: 19.09.2022
Beginn: 13.01.2023
Tage bis Beginn: 116,0
Dosis: 5
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

COVID-19 Chills Cough Dizziness Fatigue Loss of personal independence in daily activities Oropharyngeal pain Pain Rhinorrhoea SARS-CoV-2 test positive Sinus congestion

Symptomtext

I developed a severe sore throat, aching, fatigue, a cough, chills and runny nose. I completed a COVID-19 home test on Sunday January 15, 2023. I contacted my doctor through the portal and the doctor call prescribed PAXLOVID. I began taking the medication the next day. On Thursday of that week, I was still tired and was getting dizziness with activities. The fatigue, cough and sinus stuffiness remained after the I had completed the PAXLOVID. The cough remained for a long time. By March 5, 2023, I felt completely recovered.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Chills
Hospital-Tage: -
Labordaten: COVID-19 home test January 15, 2023 positive
Aktuelle Erkrankungen: N/A
Vorgeschichte: High Blood Pressure; High Cholesterol; Laryngeal Reflux; Overactive Bladder; macular degeneration; Rosacea; Seborrheic Dermatitis
Andere Medikamente: Famotidine; losartan; MYRBETRIQ; pravastatin; AREDS 2; calcium with vitamin D; ketoconazole shampoo; metronidazole
Allergien: Erythromycin
Vorherige Impfungen: Flu vaccine, fatigue October 06, 2022 age 71

VAERS 2602368

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7143C

mild

Staat: TX
Alter: 72,0
Geschlecht: M
Eingang: 23.03.2023
Impfdatum: 19.09.2022
Beginn: 13.01.2023
Tage bis Beginn: 116,0
Dosis: 5
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

COVID-19 Diarrhoea Fatigue Feeling cold Headache Malaise Nausea Oropharyngeal pain Pain Pyrexia SARS-CoV-2 test positive Vomiting

Symptomtext

On 01/13/2023, I started feeling symptoms around the middle of the day and it just kept getting worse. The next day, I called my doctor's office to inform them of the positive results I received on an at home COVID-19 test. I was experiencing headache, nausea, diarrhea, sore throat, fatigue, aches, a slight fever, and chills. My temperature was 100.5. He sent a prescription of LAGEVRIO. I wasn't able to get that filled until the next day 01/16/2023. He prescribed 40 capsules to take for 5 days. I stayed pretty sick even after taking the prescription. The second night I was taking it, I couldn't keep anything on my stomach. I felt a lot worse for a few days and then I started to feel a little better. After I finished the medication, I was still testing positive. My doctor advised that I could test positive for a while but to watch it. After a few days, I finally tested negative but was still very tired. At this point, I finally feel back to normal.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Diarrhoea
Hospital-Tage: -
Labordaten: 14JAN2023 at home COVID-19 test positive; 21JAN2023 at home COVID-19 test positive; 23JAN2023 at home COVID-19 test negative
Aktuelle Erkrankungen: None
Vorgeschichte: COPD; Gastroparesis; Coronary Artery Disease; Sleep Apnea; Diabetes; Peripheral Nerve Disease; Gout; Anemia
Andere Medikamente: Oxygen; alopurinol; azelastine; bumetanide; cardia XT; cetirizine HCL; DALIRESP; digoxin; duloxetine HCL; persulfate; fluticasone; gabapentin; metformin; HUMALOG insulin 75/25 mix; SINGULAIR; losartan; omeprazole; olmesartan medoxomil; pred
Allergien: Azithromycin; terramycin; contrast iodine; streptomycin
Vorherige Impfungen: -

VAERS 2602359

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7143C

mild

Staat: IL
Alter: 73,0
Geschlecht: F
Eingang: 23.03.2023
Impfdatum: 20.09.2022
Beginn: 17.03.2023
Tage bis Beginn: 178,0
Dosis: 5
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Dizziness Eye discharge Eye irritation Influenza virus test negative Nasopharyngitis Nausea Pain SARS-CoV-2 test negative Streptococcus test negative

Symptomtext

I had cold-like symptoms on March 17, 2023. On the 20th I had burning runny eyes and body aches. I went to the doctor on the 21st. I got lightheaded in the shower and was nauseous. At the doctor I tested negative for COVID-19, strep and the flu. I was diagnosed with something in the RSV family. I was not prescribed any medication.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Dizziness
Hospital-Tage: -
Labordaten: COVID-19, negative, 03/21/2023; Influenza, negative, 03/21/2023; Strep, negative, 03/21/2023
Aktuelle Erkrankungen: N/A
Vorgeschichte: Subglottic Stenosis; Arthritis
Andere Medikamente: Valacyclovir; amoxycillin; EXCEDRIN; multivitamin; vitamin D3; IMODIUM
Allergien: Erythromycin; nickel; hydrocodone; adhesive
Vorherige Impfungen: -

VAERS 2602318

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7143C

mild

Staat: TX
Alter: 69,0
Geschlecht: F
Eingang: 23.03.2023
Impfdatum: 19.09.2022
Beginn: 22.02.2023
Tage bis Beginn: 156,0
Dosis: 5
Route/Site: IM / AR

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

COVID-19 Feeling abnormal Oropharyngeal pain Respiratory tract congestion SARS-CoV-2 test positive

Symptomtext

Started having a sore throat and congestion. Took a home COVID-19 test and was positive. Went to a clinic and was prescribed PAXLOVID. Started feeling better and took another home COVID-19 test and was negative. Started feeling bad again a week later and just rested.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Oropharyngeal pain
Hospital-Tage: -
Labordaten: 22FEB2023 home COVID-19 test positive; 01MAR2023 home COVID-19 test negative; 08MAR2023 home COVID-19 test positive.
Aktuelle Erkrankungen: N/A
Vorgeschichte: High Blood Pressure; High Cholesterol.
Andere Medikamente: Atorvastatin; lisinopril; calcium; folic acid; baby aspirin; multivitamin; biotin.
Allergien: N/A
Vorherige Impfungen: -

VAERS 2602223

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7143C

mild

Staat: TN
Alter: 72,0
Geschlecht: F
Eingang: 23.03.2023
Impfdatum: 13.09.2022
Beginn: 09.03.2023
Tage bis Beginn: 177,0
Dosis: 5
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

COVID-19 Chills Cough Exposure to SARS-CoV-2 Feeling abnormal Nasopharyngitis Oropharyngeal pain Pain SARS-CoV-2 test positive

Symptomtext

I had a sore throat, dry cough, aches and chills while on a cruise. My husband had been diagnosed with COVID-19 about three or four days prior so I figured I had contracted it from him. I took an at-home COVID-19 on 03/09/2023 when my results came back positive. We were isolated in our room; we felt terrible. We were prescribed the antiviral medication for recovery. Afterwards, I felt pretty bad for about 5 days and got a pretty bad cold afterwards that I'm still recovering from.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Chills
Hospital-Tage: -
Labordaten: 09MAR2023 COVID-19 test positive
Aktuelle Erkrankungen: N/A
Vorgeschichte: N/A
Andere Medikamente: ZOCOR; multivitamin; SYNTHROID; vitamin D
Allergien: N/A
Vorherige Impfungen: -

VAERS 2601764

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7143C

mild

Staat: KY
Alter: 69,0
Geschlecht: M
Eingang: 22.03.2023
Impfdatum: 17.09.2022
Beginn: 01.01.2023
Tage bis Beginn: 106,0
Dosis: 5
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Back pain Body temperature increased COVID-19 Decreased appetite Diarrhoea Fatigue Headache Influenza SARS-CoV-2 test positive Taste disorder

Symptomtext

I contacted COVID-19 in January. I tested at home and was positive. I was maybe tired; I did have a low grade temperature. I felt like it was a sinus thing. My temp stayed at 99.8. I sat tight and stayed inside. I started taking TYLENOL. It felt like I had a minor headache. I called my doctor and took PAXLOVID. It was a mild case in my opinion. It was like the same symptoms of the flu. I wasn't hungry and food didn't taste good. A little diarrhea and back pain, but that was all.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Back pain
Hospital-Tage: -
Labordaten: 20JAN2023 COVID-19 test positive
Aktuelle Erkrankungen: N/A
Vorgeschichte: N/A
Andere Medikamente: Omeprazole; CENTRUM SILVER
Allergien: N/A
Vorherige Impfungen: -

VAERS 2601741

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7143C

mild

Staat: KY
Alter: 70,0
Geschlecht: F
Eingang: 22.03.2023
Impfdatum: 20.09.2022
Beginn: 30.11.2022
Tage bis Beginn: 71,0
Dosis: 5
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Cough Headache Hypersomnia Influenza virus test positive Oropharyngeal pain SARS-CoV-2 test negative

Symptomtext

I had cough and a horrendous headache. I made an appointment with at my doctor's office where I was tested for both COVID-19 and Influenza. The test for COVID--19 came back negative the influenza test came positive. I was given medication, I picked up sore throat lozenges to help with my sore throat. I think I may have slept off and on for two days but I was able to sing in the choir that Sunday.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Headache
Hospital-Tage: -
Labordaten: 30NOV2022 PCR COVID-19 test negative; 30NOV2022 Influenza - positive
Aktuelle Erkrankungen: No
Vorgeschichte: Hypertension; High Cholesterol; Allergies
Andere Medikamente: Gabapentin; Pravastatin; Losartan/hctz: Fluticasone; Loratadine; Singular; Fish Oil; Vitamin D; Calcium: Turmeric; Glucosamine;
Allergien: Erythromycin
Vorherige Impfungen: The old shingles vaccine made my arm red and swollen for a day.

VAERS 2601736

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7143C

mild

Staat: OR
Alter: 32,0
Geschlecht: M
Eingang: 22.03.2023
Impfdatum: 19.09.2022
Beginn: 27.02.2023
Tage bis Beginn: 161,0
Dosis: 4
Route/Site: SYR / UN

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: ja

Cough Pyrexia SARS-CoV-2 test negative

Symptomtext

I had my vaccination on 09/19/2022. On 02/27/2023 I developed symptoms to include congestion low grade fever and cough. The urgent care gave me a cough suppressant and decongestant. I went back to the urgent care 4 days later as I was getting worse and they prescribed an antibiotic.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Pyrexia
Hospital-Tage: -
Labordaten: COVID-19 Negative 02/27/2023
Aktuelle Erkrankungen: N/A
Vorgeschichte: N/A
Andere Medikamente: N/A
Allergien: N/A
Vorherige Impfungen: All COVID-19 and flu vaccinations; soreness at injection site and fatigue

VAERS 2601719

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7143C

mild

Staat: ME
Alter: 67,0
Geschlecht: F
Eingang: 22.03.2023
Impfdatum: 19.09.2022
Beginn: 18.02.2023
Tage bis Beginn: 152,0
Dosis: 5
Route/Site: IM / UN

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

COVID-19 Fatigue Gastrointestinal disorder Headache Pyrexia Respiratory symptom SARS-CoV-2 test positive Sinus congestion

Symptomtext

I had severe fatigue. Later on came some upper respitory symptoms. I had sinus congestion, headache and a fever-- 101.2. I had GI symptoms but that may have been from the pacslovid.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Fatigue
Hospital-Tage: -
Labordaten: at home rapid COVID-19 test- positive 02/18/2023
Aktuelle Erkrankungen: No
Vorgeschichte: No
Andere Medikamente: Fish oil; Vitamin D; Women's multivitamin
Allergien: No
Vorherige Impfungen: -

VAERS 2601657

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7143C

mild

Staat: GA
Alter: 78,0
Geschlecht: F
Eingang: 22.03.2023
Impfdatum: 19.09.2022
Beginn: 08.01.2023
Tage bis Beginn: 111,0
Dosis: 5
Route/Site: SYR / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Body temperature increased COVID-19 Influenza virus test negative Lethargy Loss of personal independence in daily activities Malaise Mental fatigue SARS-CoV-2 test positive Sneezing Throat irritation

Symptomtext

On 08JAN2023 I felt sick scratchy throat I had astonishingly sneezing, I had a temperature one hundred and one I tested negative on a home COVID-19 and my Doctor ran two tests a COVID-19 and a flu test, the COVID-19 was positive. I started Paxlovid the next morning. I was very, very, sick. I stayed in on Tuesday and Wednesday. On Wednesday I started to fill a little better and by Thursday better and on Friday semi normal. I really felt pretty good but had a reaction where I was very lethargic for the next five days, I felt lethargic mentally and this persisted for another week. I just felt like I couldn't get up and do my normal things.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Malaise
Hospital-Tage: -
Labordaten: COVID-19 test positive. Influenza negative.
Aktuelle Erkrankungen: None
Vorgeschichte: Cardiac disease
Andere Medikamente: Klor Con; Sotalol; Metoprolol; Furosemide
Allergien: None
Vorherige Impfungen: -

VAERS 2600211

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7143C

mild

Staat: MA
Alter: 44,0
Geschlecht: F
Eingang: 21.03.2023
Impfdatum: 09.09.2022
Beginn: 03.02.2023
Tage bis Beginn: 147,0
Dosis: 4
Route/Site: SYR / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: ja

COVID-19 Fatigue Influenza virus test negative Malaise Nausea Pain Pyrexia SARS-CoV-2 test positive

Symptomtext

I woke up feeling achy, fatigued and nauseous a COVID-19 test was negative but with house guests and feeling so sick I called for a doctors appointment thinking I had the flu. I had two doctors appointments that day telemedicine who told me to go to urgent care, a flu test there was negative. I continued to feel nauseous and fatigued for the next three days with a fever of one hundred point four and tested negative throughout COVID-19 on 07FEB2023 I finally tested positive.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Fatigue
Hospital-Tage: -
Labordaten: COVID-19 test positive.
Aktuelle Erkrankungen: None
Vorgeschichte: None
Andere Medikamente: APRI birth control
Allergien: None
Vorherige Impfungen: -

VAERS 2599662

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7143C

mild

Staat: MI
Alter: 42,0
Geschlecht: F
Eingang: 20.03.2023
Impfdatum: 15.09.2022
Beginn: 01.10.2022
Tage bis Beginn: 16,0
Dosis: 4
Route/Site: IM / AR

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Chills Malaise Menstruation irregular Pain Pyrexia

Symptomtext

The vaccine made me sick with chills, fever and body aches for three days. In 10/2022, I began having very irregular menstrual cycles. I am unable to take hormones as I have bad side effects. I will start my period between 7 to 8 days early and my cycle will last nine days. At this time, I am waiting or my system to self-regulate.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Chills
Hospital-Tage: -
Labordaten: N/A
Aktuelle Erkrankungen: N/A
Vorgeschichte: Basil Cell Carcinoma
Andere Medikamente: Vitamin D
Allergien: Penicillin; gluten; latex; NEOSPORIN; breathing treatments; generic birth control
Vorherige Impfungen: -

VAERS 2599575

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7143C

mild

Staat: KY
Alter: 48,0
Geschlecht: F
Eingang: 20.03.2023
Impfdatum: 16.09.2022
Beginn: 23.10.2022
Tage bis Beginn: 37,0
Dosis: 4
Route/Site: IM / AR

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Cough Exposure to communicable disease Malaise

Symptomtext

I did not have an adverse reaction to the vaccine. My husband and son tested positive for the flu and negative for COVID-19. I got sick within a few days after them. I was never tested but my doctor treated me for the flu. I had a cough that lasted three months.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Malaise
Hospital-Tage: -
Labordaten: N/A
Aktuelle Erkrankungen: N/A
Vorgeschichte: Asthma; Auto Immune Disorder
Andere Medikamente: N/A
Allergien: Penicillin
Vorherige Impfungen: Pneumonia vaccine, in 2017 in my early 40's, I had rash

VAERS 2599504

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7143C

mild

Staat: MI
Alter: 61,0
Geschlecht: M
Eingang: 20.03.2023
Impfdatum: 07.09.2022
Beginn: 28.02.2023
Tage bis Beginn: 174,0
Dosis: 5
Route/Site: SYR / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

COVID-19 Headache Pyrexia Respiratory tract congestion SARS-CoV-2 test positive

Symptomtext

I was positive for COVID-19 on 28FEB2023, I had bad congestion, headache, fever and I was prescribed PAXLOVID. After taking it, I was nauseous for 6 days and throwing up. I started feeling better after 6 days.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Headache
Hospital-Tage: -
Labordaten: 28FEB2023 COVID-19 test positive
Aktuelle Erkrankungen: N/A
Vorgeschichte: N/A
Andere Medikamente: N/A
Allergien: N/A
Vorherige Impfungen: -

VAERS 2598659

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7143C

mild

Staat: CO
Alter: 51,0
Geschlecht: M
Eingang: 17.03.2023
Impfdatum: 15.09.2022
Beginn: 23.01.2023
Tage bis Beginn: 130,0
Dosis: 5
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

COVID-19 Cough Dysgeusia Exposure to SARS-CoV-2 Malaise Pyrexia SARS-CoV-2 test positive

Symptomtext

Three members of my family tested positive for COVID-19. They were all living in my house with me. One of the members was not wearing a mask. My wife and I got COVID-19 soon thereafter. On or about 1/23/2023, I tested positive for COVID-19. I phoned a telehealth helpline through my provider, and I was prescribed Paxlovid. I felt like I had a bad case of the flu, and I started taking the Paxlovid on 1/25/2023. I had a fever, a bit of a cough, and general malaise. After I started taking the Paxlovid, I had a metallic aftertaste in my mouth. I started to feel better about two or three days after starting the Paxlovid. I didn't have the flu-like symptoms any longer. I took a home antigen test sometime in early February 2023 and got a negative result. I don't think I have any residual symptoms from the COVID-19. My blood oxygen level is fine, and so is my heart function.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Malaise
Hospital-Tage: -
Labordaten: 23JAN2023(?) - Home Antigen Test - Positive Result; FEB2023 - Home Antigen Test - Negative Result
Aktuelle Erkrankungen: None
Vorgeschichte: None
Andere Medikamente: None
Allergien: None
Vorherige Impfungen: -

VAERS 2597965

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7143C

mild

Staat: WA
Alter: 74,0
Geschlecht: F
Eingang: 16.03.2023
Impfdatum: 12.09.2022
Beginn: 19.12.2022
Tage bis Beginn: 98,0
Dosis: 5
Route/Site: IM / AR

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Back disorder COVID-19 Headache Oropharyngeal pain SARS-CoV-2 test positive

Symptomtext

I got up with a sore throat, with a headache. I was hosting the book club at house that day, so I thought I need to test to make sure that I don't spread anything to anyone. The home COVID-19 test came back positive; I called the doctor's office, spoke to the nurse. I was prescribed PAXLOVID. The PAXLOVID helped me to recover. I feel much better now, I feel that having to be in bed for five days has thrown my back out and I am still having problems.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Headache
Hospital-Tage: -
Labordaten: 19DEC2022 home COVID-19 test positive
Aktuelle Erkrankungen: No
Vorgeschichte: No
Andere Medikamente: ELIQUIS; SINGULAIR; latanoprost; estradiol; glucosamine/chondroitin/MSM; calcium/magnesium; vitamin D3; coQ10; fish oil; vitamin B-12
Allergien: Melon; hay fever; trees; weed
Vorherige Impfungen: -

VAERS 2597763

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge AS7143C

mild

Staat: WA
Alter: 75,0
Geschlecht: M
Eingang: 16.03.2023
Impfdatum: 14.09.2022
Beginn: 26.02.2023
Tage bis Beginn: 165,0
Dosis: 5
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

COVID-19 Cough Fatigue Hypersomnia Rhinorrhoea SARS-CoV-2 test positive

Symptomtext

On 02/27/2023 I tested positive for COVID-19. I was really tired, slept a lot, cough, runny nose. I had a telehealth visit and provider prescribed Paxlovid.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Fatigue
Hospital-Tage: -
Labordaten: 27FEB2023- COVID-19 Test- Positive; 06MARCH2023- COVID-19 Test- Negative
Aktuelle Erkrankungen: N/A
Vorgeschichte: Hypertension; Hyperplasia; Hyperthyroid
Andere Medikamente: Lisinopril; Myrbetriq; levothyroxine; Alfuzosin; Tadalafil; Vitamin D; Iron Supplements
Allergien: N/A
Vorherige Impfungen: -

VAERS 2597673

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7143C

mild

Staat: CA
Alter: 63,0
Geschlecht: M
Eingang: 16.03.2023
Impfdatum: 12.09.2022
Beginn: 06.03.2023
Tage bis Beginn: 175,0
Dosis: 5
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

COVID-19 Headache Pain Pyrexia Respiratory tract congestion SARS-CoV-2 test positive

Symptomtext

I tested positive for COVID-19 on 3/6/23. I had congestion, fever, headache, and body aches. This lasted for about 6 days total. I contacted my doctor and was prescribed Paxlovid. My doctor had me stop taking Atorvastatin and cut my Amlodipine dose in half while taking Paxlovid. I started getting some congestion again last night, so I am not sure if I am getting a rebound case or not.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Headache
Hospital-Tage: -
Labordaten: 06MAR2023 COVID-19 Test - Positive; 12MAR2023 COVID-19 Test - Negative
Aktuelle Erkrankungen: N/A
Vorgeschichte: High Blood Pressure
Andere Medikamente: Lipitor; Hydrochlorothiazide; Amlodipine; Lisinopril; Finasteride; Multivitamin; Aspirin
Allergien: N/A
Vorherige Impfungen: -

VAERS 2597663

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7143C

mild

Staat: WY
Alter: 69,0
Geschlecht: F
Eingang: 16.03.2023
Impfdatum: 08.09.2022
Beginn: 15.02.2023
Tage bis Beginn: 160,0
Dosis: 5
Route/Site: SYR / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Eye disorder Eye pain Ocular discomfort Photophobia Strabismus

Symptomtext

Around 02/15/2023, my eyes started bothering me. They were light sensitive and aching. It began with my right eye and a little bit into the left but it was mostly the right eye. It has kept on going today. The right eye is a little better but the left eye is getting me with the same symptoms. It's gotten worse in the left eye. I've been squinting and needing to wear sunglasses outside. I've been to the eye doctor twice, with yesterday being my 2nd appointment. The first appointment was on 02/16/2023. The doctor prescribed eye drops. Some for moisture and an antibiotic steroid mixture. I used that to the completion but it did not help much. I made the 2nd appointment and yesterday the doctor noted that my left eye looked like it was burned, rough, and bumpy. A little on the bottom of the right eye is some dots and splotches. He prescribed erythromycin eye drops that I picked up this morning and I will be using that for 3 days for both eyes. I have another new eye drop which is SYSTANE preservative free moisture drops. At night, I use a preservative free SYSTANE gel. I don't feel any different at this point today, but I haven't started the erythromycin yet. They do hurt and I was squinting, and in my profession, I need to be able to see. I do feel better in the dark and they don't hurt as bad. The eyeball itself kind of aches.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Eye pain
Hospital-Tage: -
Labordaten: None
Aktuelle Erkrankungen: None
Vorgeschichte: Ileostomy; COPD
Andere Medikamente: Flecainide; ATIVAN; aspirin; biotin; zinc; vitamin B12; vitamin B1; multivitamin; vitamin D; calcium
Allergien: None
Vorherige Impfungen: -

VAERS 2597631

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7143C

mild

Staat: TX
Alter: 74,0
Geschlecht: M
Eingang: 16.03.2023
Impfdatum: 07.09.2022
Beginn: 01.01.2023
Tage bis Beginn: 116,0
Dosis: 5
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Pruritus Rash erythematous Urticaria

Symptomtext

I broke out in hives on my back. It is extremely itchy with red bumps. It has spread up to the back of my neck. I contacted my doctor, and they recommended taking antihistamines. I am taking XYZAL currently. I feel like my pravastatin medication contributes to it, so I have stopped taking it at this time to see if it helps. I am still dealing with this at this time.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Pruritus
Hospital-Tage: -
Labordaten: N/A
Aktuelle Erkrankungen: N/A
Vorgeschichte: High Blood Pressure; Chronic Neck Pain; Hypothyroidism
Andere Medikamente: XTAMPZA; LYRICA; tramadol; lisinopril; hydrochlorothiazide; levothyroxine; tadalafil; tizanidine; trazadone; pravastatin; clonidine; tamsulosin; omeprazole; testosterone; anastrozole; ibuprofen; melatonin; multivitamin; saw palmetto; coQ10;
Allergien: N/A
Vorherige Impfungen: -

VAERS 2597598

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7143C

mild

Staat: TX
Alter: 72,0
Geschlecht: M
Eingang: 16.03.2023
Impfdatum: 13.09.2022
Beginn: 10.03.2023
Tage bis Beginn: 178,0
Dosis: 5
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

COVID-19 Cough Dysphagia Nasal congestion Odynophagia Oropharyngeal pain Pain Pyrexia Rhinorrhoea SARS-CoV-2 test positive

Symptomtext

I contracted COVID-19. I had body aches all over my body, coughing, runny nose, nasal congestion, and a fever of 100.6 maximum. I also had an extreme sore throat. It was very hard to swallow and it was painful. I was prescribed Paxlovid and was given cough medication. The Paxlovid was very helpful and made me feel better. I'm not completely better though, but I'm feeling way better than the first three days.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Oropharyngeal pain
Hospital-Tage: -
Labordaten: 11March2023 - COVID-19 test - Positive
Aktuelle Erkrankungen: None
Vorgeschichte: High blood pressure; Asthma
Andere Medikamente: Losartan; Rosuvastatin; Metformin; Triamterene/HCTZ; Omeprazole; Baby Aspirin; Vitamin D3
Allergien: Penicillin; Pollen
Vorherige Impfungen: Penicillin vaccine - I received it when I was a baby and had a bad reaction to it.

VAERS 2597593

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7143C

mild

Staat: CA
Alter: 75,0
Geschlecht: F
Eingang: 16.03.2023
Impfdatum: 08.09.2022
Beginn: 01.03.2023
Tage bis Beginn: 174,0
Dosis: 5
Route/Site: SYR / UN

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: ja

COVID-19 Chills Cough Dizziness Fatigue Headache Lymphadenopathy Malaise Pyrexia SARS-CoV-2 test positive

Symptomtext

My COVID-19 infection symptoms started in the early morning on 03/01/2023. I had a severe headaches including back of my head, chills, fever, extremely tired and my lymph nodes were swollen. I had a productive cough that started from the night of 03/02/2023 through 03/03/2023. I took a COVID-19 test on 03/02/2023 which was positive. In the morning when I was going to the bathroom I felt like I was going to faint. I went to the urgent care on 03/02/2023 they just checked my blood pressure but they didn't do any other test. They prescribe me PAXLOVID for 5 days. I still have the cough as of today 03/16/2023 but better than before.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Chills
Hospital-Tage: -
Labordaten: 02MAR2023 COVID-19 test positive
Aktuelle Erkrankungen: N/A
Vorgeschichte: High Blood Pressure
Andere Medikamente: Amlodipine; baby aspirin
Allergien: NAPROSYN
Vorherige Impfungen: -

VAERS 2597197

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7143C

mild

Staat: AZ
Alter: 68,0
Geschlecht: F
Eingang: 15.03.2023
Impfdatum: 09.09.2022
Beginn: 13.02.2023
Tage bis Beginn: 157,0
Dosis: 5
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

COVID-19 Cough Fatigue Oropharyngeal pain Pain SARS-CoV-2 test positive Sinus headache

Symptomtext

I had a cough, sore throat, head sinus, fatigue, mild aches, and pain. I tested positive for COVID-19 at home. My doctor prescribed me Paxlovid, and it help.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Fatigue
Hospital-Tage: -
Labordaten: COVID-19 Test, 02/14/2023, Positive
Aktuelle Erkrankungen: N/A
Vorgeschichte: N/A
Andere Medikamente: Atorvastatin; Multivitamin Calcium
Allergien: Sulfa Drugs; Erythromycin
Vorherige Impfungen: -

VAERS 2597103

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7143C

mild

Staat: WI
Alter: 47,0
Geschlecht: F
Eingang: 15.03.2023
Impfdatum: 10.09.2022
Beginn: 05.03.2023
Tage bis Beginn: 176,0
Dosis: 3
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

COVID-19 Cough Fatigue Pain Respiratory tract congestion Rhinorrhoea SARS-CoV-2 test positive

Symptomtext

On 03/05/2023, I woke up feeling achy and extra tired even though I had just woken up. I also had a little congestion and cough. I assumed it was allergies and wasn't concerned about exposure since I work from home. As the week progressed my symptoms got worse. By Wednesday, my nose was running constantly, so I took a COVID-19 test and it was positive. I did a telehealth visit and began taking Paxlovid on 03/08/2023. After beginning the Paxlovid, my runny nose began decreasing rapidly. The rest of the symptoms gradually got better. I still have a bit of achiness and soreness but am otherwise feeling pretty normal.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Fatigue
Hospital-Tage: -
Labordaten: 08MAR2023 - At Home COVID-19 Test - Positive
Aktuelle Erkrankungen: None
Vorgeschichte: Asthma
Andere Medikamente: Montelukast; Flovent Inhaler; Prozac; Albuterol Inhaler; Cetirizine; Famotidine
Allergien: Promethazine; Aspergillus Mold
Vorherige Impfungen: -

VAERS 2597061

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7143C

mild

Staat: WI
Alter: 82,0
Geschlecht: F
Eingang: 15.03.2023
Impfdatum: 08.09.2022
Beginn: 17.01.2023
Tage bis Beginn: 131,0
Dosis: 5
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

COVID-19 Malaise Nasal congestion Oropharyngeal pain Pain Pyrexia SARS-CoV-2 test positive Sinus congestion

Symptomtext

It's started with a sore throat and congestion in the nasal and sinus area. I also had a sore throat, achy with malaise and a low-grade fever of 99.4. I completed a COVID-19 home test and it was positive. The doctor prescribed Paxlovid. I started taking the medication on the 20th of January. I began to feel better on the 2nd day. My symptoms resolved by the 25th of January.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Malaise
Hospital-Tage: -
Labordaten: COVID-19 Home test-January 19, 2023-positive
Aktuelle Erkrankungen: N/A
Vorgeschichte: N/A
Andere Medikamente: Metformin; Atorvastatin; Amlodipine; Metoprolol; Letrosole;
Allergien: NSAIDS
Vorherige Impfungen: -

VAERS 2596945

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7143C

mild

Staat: MO
Alter: 68,0
Geschlecht: F
Eingang: 15.03.2023
Impfdatum: 08.09.2022
Beginn: 28.12.2022
Tage bis Beginn: 111,0
Dosis: 5
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

COVID-19 Diarrhoea Headache Nasopharyngitis Nausea SARS-CoV-2 test positive Sluggishness

Symptomtext

On 12/28/2022 I had a head cold, headache, felt sluggish. Then on 12/30/2022 diarrhea, sick to the stomach I tested positive for COVID-19 that day. Called provided and prescribed LAGEVRIO.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Diarrhoea
Hospital-Tage: -
Labordaten: 28DEC2022 COVID-19 test negative; 29DEC2022 COVID-19 test negative; 30DEC2022 COVID-19 test positive
Aktuelle Erkrankungen: N/A
Vorgeschichte: Lupus; High Blood Pressure; Blood Clot Disorder
Andere Medikamente: N/A
Allergien: N/A
Vorherige Impfungen: Flu shot, 09/15/2022, chills, body aches

VAERS 2596916

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7143C

mild

Staat: CO
Alter: 74,0
Geschlecht: F
Eingang: 15.03.2023
Impfdatum: 09.09.2022
Beginn: 28.02.2023
Tage bis Beginn: 172,0
Dosis: 5
Route/Site: SYR / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

COVID-19 Feeling cold Influenza like illness Myalgia Nasal congestion Oropharyngeal pain Pain Pyrexia SARS-CoV-2 test positive

Symptomtext

It was on 02/28/2023. I started with a little sore throat and on that day, it progressed into flu like symptoms. I was very cold, had a fever and felt achy. Muscular aches and pains. I had nasal congestion. I think that's about it symptom wise. I took an at home COVID-19 test that day. It was positive. I called that day for a telehealth visit and had that the next day 03/01/2023. He did prescribe Paxlovid and so I filled that prescription and started taking that medication. I started that on 03/01/2023. On the 2nd day of taking the medication, I started feeling itchy all over. I took the medication for one more day and the itching began to get worse and there was a rash on my torso. I called the doctor from the telehealth visit and he said to stop taking it. It sounded like I was having an allergic reaction to it so he mentioned to start taking Benadryl. After the first day, I felt better and better each successive day during the infection. Eventually after 6 days, I felt like my symptoms had all subsided.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Myalgia
Hospital-Tage: -
Labordaten: 28FEB2023 At Home COVID-19 Test - Positive; 06MAR2023 t Home COVID-19 Test - Negative
Aktuelle Erkrankungen: None
Vorgeschichte: Asthma; Peripheral Neuropathy in Feet
Andere Medikamente: Levothyroxine; Gabapentin; Mega Flora Probiotic; Vitamin D3; DHA Omega 3; Vitamin A; Vitamin C; Grapeseed Extract; Turmeric; Calcium, Vitamin D, & K Stronger Bones
Allergien: Iodine; Feldene; Ampicillin; Naproxen; Paxlovid
Vorherige Impfungen: -

VAERS 2596342

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7143C

mild

Staat: PA
Alter: 58,0
Geschlecht: F
Eingang: 14.03.2023
Impfdatum: 09.09.2022
Beginn: 13.01.2023
Tage bis Beginn: 126,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

COVID-19 Fatigue Headache Hypersomnia Illness SARS-CoV-2 test positive Wheezing

Symptomtext

I didn't know I had COVID-19. I just thought I was tired. I slept for 16 hours, which is unusual for me. I then took a home antigen test on 1/14/2023 and got a negative result. I also had a headache, but I thought that maybe it was because I hadn't eaten anything. My fatigue continued, though. I tested myself three times on 1/14/2023 for COVID-19. The first two doses yielded negative results, but the third yielded a positive result. I then went to bed. On 1/15/2023, I had a little bit of a headache, and I ate and took Tylenol and ibuprofen, which helped with a headache. I was tired every day during my illness. The only symptoms I had for the first couple of days were fatigue and headache. On 1/17/2023, I began wheezing in the wee hours of the morning. I took my albuterol inhaler. I called the doctor's office and informed them of my test results and my wheezing. I was prescribed Paxlovid and ordered me another emergency inhaler. I started taking Paxlovid on 1/17/2023. I stopped wheezing that day, but I was still really exhausted. I went back to work on 1/19/2023. I was tired for about two weeks. It was about two weeks before the fatigue subsided.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Fatigue
Hospital-Tage: -
Labordaten: 14JAN2023 - Two Home Antigen Tests - Negative Results; 14JAN2023 - Home Antigen Test - Positive Result
Aktuelle Erkrankungen: None
Vorgeschichte: Osteoarthritis; Asthma
Andere Medikamente: Celebrex; Tylenol
Allergien: Seasonal Allergies: Cat Dander
Vorherige Impfungen: -

VAERS 2596268

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7143C

mild

Staat: IL
Alter: 67,0
Geschlecht: F
Eingang: 14.03.2023
Impfdatum: 12.09.2022
Beginn: 10.03.2023
Tage bis Beginn: 179,0
Dosis: 5
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Body temperature increased COVID-19 Chills Malaise Oropharyngeal pain Respiratory tract congestion Rhinorrhoea SARS-CoV-2 test positive

Symptomtext

I begin experiencing symptoms of Covid 03/10/2023 sore throat elevated body temperature, no fever runny nose mild congestion and chills.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Chills
Hospital-Tage: -
Labordaten: Covid home test positive 10Mar2023
Aktuelle Erkrankungen: N/A
Vorgeschichte: N/A
Andere Medikamente: CLARITIN; turmeric; calcium supplement
Allergien: N/A
Vorherige Impfungen: -

VAERS 2596267

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7143C

mild

Staat: WA
Alter: 64,0
Geschlecht: F
Eingang: 14.03.2023
Impfdatum: 12.09.2022
Beginn: 19.10.2022
Tage bis Beginn: 37,0
Dosis: 5
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: ja

COVID-19 Fatigue Headache SARS-CoV-2 test positive Throat irritation

Symptomtext

I had a scratchy throat, a headache for a day, and fatigue. I tested positive for COVID-19 at home. I went to the urgent care and they prescribed me PAXLOVID. I don't if it helped or not because I wasn't that sick. But I wasn't sick for a long time. I still have fatigue.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Fatigue
Hospital-Tage: -
Labordaten: COVID-19 test, 10/23/2022, positive
Aktuelle Erkrankungen: N/A
Vorgeschichte: Hypertension; Hypermedia
Andere Medikamente: Losartan; levothyroxine; atorvastatin; vitamin D; fish oil
Allergien: N/A
Vorherige Impfungen: -

VAERS 2596173

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH BIVALENT)) · Charge AS7143C

mild

Staat: TN
Alter: 75,0
Geschlecht: M
Eingang: 14.03.2023
Impfdatum: 12.09.2022
Beginn: 25.02.2023
Tage bis Beginn: 166,0
Dosis: 5
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

COVID-19 Cough Pain Respiratory tract congestion Rhinorrhoea SARS-CoV-2 test positive Vaccine breakthrough infection

Symptomtext

I experienced a breakthrough case of COVID-19 with runny nose, cough, chest congestion and body aches.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Pain
Hospital-Tage: -
Labordaten: COVID-19- Positive
Aktuelle Erkrankungen: N/A
Vorgeschichte: Heart disease
Andere Medikamente: Levothyroxine; Metoprolol; Metformin; Benazepril
Allergien: Penicillin
Vorherige Impfungen: -

VAERS 2596163

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7143C

mild

Staat: NJ
Alter: 57,0
Geschlecht: F
Eingang: 14.03.2023
Impfdatum: 12.09.2022
Beginn: 02.01.2023
Tage bis Beginn: 112,0
Dosis: 5
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

COVID-19 Cough Ear discomfort Lung disorder Pyrexia SARS-CoV-2 test positive Sinusitis Vaccine breakthrough infection

Symptomtext

I experienced a breakthrough case of COVID-19 with coughing, fever, pressure in my right ear, inflamed sinuses and lung issues.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Pyrexia
Hospital-Tage: -
Labordaten: COVID-19- Positive
Aktuelle Erkrankungen: N/A
Vorgeschichte: Lactose
Andere Medikamente: Doxycycline; Benicar Hpz; Omeprazole; Montelukast; Cetirizine
Allergien: Milk
Vorherige Impfungen: -

VAERS 2596158

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7143C

mild

Staat: WA
Alter: 72,0
Geschlecht: M
Eingang: 14.03.2023
Impfdatum: 10.09.2022
Beginn: 01.01.2023
Tage bis Beginn: 113,0
Dosis: 5
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

COVID-19 Cough Fatigue Headache Pyrexia Rhinorrhoea SARS-CoV-2 test positive Somnolence

Symptomtext

My symptoms began on with a cough and low-grade fever. I spoke to the doctor on January 23, 2023, Monday, and now I had a runny nose and slight headache. I was prescribed an antiviral and began taking it that day. I had fatigue through the entire infection and took two naps a day. I tested positive for 3 weeks. I still have a bit a fatigue and notice this while swimming.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Fatigue
Hospital-Tage: -
Labordaten: COVID-19 home, positive, 01/23/2023
Aktuelle Erkrankungen: N/A
Vorgeschichte: High Blood Pressure; High Cholesterol; COPD; Aortic Aneurism
Andere Medikamente: Lisinopril; Crestor; Ciravent Inhaler; Spiriva; Testosterone Shot; Multi Vitamin; Flaxseed Oil; CoQ10; Vitamin D; Baby Aspirin
Allergien: N/A
Vorherige Impfungen: -

VAERS 2596132

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7143C

mild

Staat: VA
Alter: 72,0
Geschlecht: M
Eingang: 14.03.2023
Impfdatum: 13.09.2022
Beginn: 09.02.2023
Tage bis Beginn: 149,0
Dosis: 6
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Asthenia COVID-19 Cough Decreased appetite Fatigue Oropharyngeal pain Pyrexia Respiratory tract congestion SARS-CoV-2 test positive Sinus disorder

Symptomtext

The morning of 02/09/2023, I woke up with a cough, fever, loss of appetite, and fatigue. I tested myself for COVID-19 and was positive. My symptoms continued through to 02/11/2023. I went to a local urgent care who tested me again and confirmed COVID-19 and prescribed Paxlovid. My symptoms improved after taking that. By Sunday, I was still fatigued with loss of appetite. I still had some congestion but that was better. On 02/14/2023, I was still testing positive. On 02/16/2023, I was testing negative. I never had any trouble breathing really, it was all just sinuses and sore throat. From the 16th onward, I gradually got my appetite and energy back. Within a week or 10 days it was all past.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Fatigue
Hospital-Tage: -
Labordaten: 09FEB2023 - At Home COVID-19 Test - Positive; 11FEB2023 - COVID-19 Test - Positive; 14FEB2023 - At Home COVID-19 Test - Positive; 16FEB2023 - At Home COVID-19 Test - Negative
Aktuelle Erkrankungen: None
Vorgeschichte: None
Andere Medikamente: Lisinopril; Omeprazole; Metformin; Rosuvastatin; Tamsulosin; Multivitamin; Glucosamine
Allergien: Penicillin; Sulfa
Vorherige Impfungen: -

VAERS 2596085

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7143C

mild

Staat: SC
Alter: 36,0
Geschlecht: M
Eingang: 14.03.2023
Impfdatum: 09.09.2022
Beginn: 07.02.2023
Tage bis Beginn: 151,0
Dosis: 4
Route/Site: SYR / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Influenza Influenza virus test positive Malaise Pyrexia SARS-CoV-2 test negative

Symptomtext

I had just returned from a trip out of town in airports etc.. I began to take Covid tests but I began symptoms at night and had a fever the next morning or had a fever my girlfriend had symptoms and tested positive with for the flu on09FEB20223 I went to the clinic and came back positive for the flu and was prescribed cough syrup plus rest and fluids by the 19FEB2023 the flu had run its course.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Malaise
Hospital-Tage: -
Labordaten: Influenza positive. COVID-19 test negative.
Aktuelle Erkrankungen: None
Vorgeschichte: Asthma
Andere Medikamente: Zyrtec; Flonase
Allergien: Penicillin; Amoxicillin; Eggs
Vorherige Impfungen: -

VAERS 2595791

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7143C

mild

Staat: CA
Alter: 87,0
Geschlecht: F
Eingang: 13.03.2023
Impfdatum: 09.09.2022
Beginn: 18.12.2022
Tage bis Beginn: 100,0
Dosis: 5
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Ageusia Anosmia COVID-19 Nasopharyngitis Pyrexia Respiratory tract congestion Rhinorrhoea SARS-CoV-2 test positive

Symptomtext

In December 2022 I had cold-like symptoms but I had a fever of 102-103. I took a COVID-19 test and it was positive. The doctor called me and asked me to go to the doctor to check my kidney function so they would know which type of PAXLOVID to prescribe. I had runny nose and congestion only last for about five. I also lost my sense of taste and smell. I still have not regained 100% of my sense of taste or smell.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Pyrexia
Hospital-Tage: -
Labordaten: COVID-19 home, positive, 12/2022; Blood panel, normal, 12/2022
Aktuelle Erkrankungen: N/A
Vorgeschichte: High Blood Pressure; High Cholesterol; Macular Degeneration
Andere Medikamente: Atorvastatin; hydrochlorothiazide; pantoprazole; potassium; AREDS 2; multivitamin
Allergien: Penicillin
Vorherige Impfungen: -

VAERS 2595625

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7143C

mild

Staat: NM
Alter: 77,0
Geschlecht: M
Eingang: 13.03.2023
Impfdatum: 11.09.2022
Beginn: 06.03.2023
Tage bis Beginn: 176,0
Dosis: 5
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Cough Fatigue Human rhinovirus test Influenza virus test negative Respiratory syncytial virus test negative SARS-CoV-2 test negative

Symptomtext

On 03/06/2023, I began to have a dry cough, accompanied with fatigue. I went to a local clinic where I was tested for COVID-19 and flu and a few other things, which were negative. I didn't have a fever or sore throat and my lungs are clear. I don't have congestion or mucus. I'm feeling a lot better now, but I still have a lingering dry cough. The doctor couldn't diagnose me with anything for sure and did not prescribe anything. I've been treating myself with an over-the-counter cough medicine.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Fatigue
Hospital-Tage: -
Labordaten: 10MAR2023 - COVID-19 Test - Negative; Flu Test - Negative; -RSV Test - Negative; Rhinovirus Test - Negative
Aktuelle Erkrankungen: None
Vorgeschichte: High Blood Pressure
Andere Medikamente: Lisinopril; Fish Oil; Vitamin D; Vitamin B Complex; Trithala; Turmeric; Tart Cherry Extract; Ashwagandha Root; Eleuthero Root; Holy Basel Leaf; Astragalus Root; Fo-Ti Root
Allergien: None
Vorherige Impfungen: -

VAERS 2595609

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7143C

mild

Staat: KS
Alter: 66,0
Geschlecht: F
Eingang: 13.03.2023
Impfdatum: 09.09.2022
Beginn: 10.03.2023
Tage bis Beginn: 182,0
Dosis: 5
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

COVID-19 Exposure to SARS-CoV-2 Pain Respiratory tract congestion SARS-CoV-2 test positive

Symptomtext

Started feeling achy with head congestion. Husband had just tested positive 2 days before. Took a Home COVID-19 test and it was positive. Called doctor and was prescribed Paxlovid. Currently taking it.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Pain
Hospital-Tage: -
Labordaten: 2023MAR10 Home COVID-19 test - Positive.
Aktuelle Erkrankungen: N/A
Vorgeschichte: Hypertension; Sarcoidosis; Sleep Apnea.
Andere Medikamente: Amlodipine; Indapamide; Prednisone; Fish Oil; Baby Aspirin; Vitamin D; Turmeric.
Allergien: Amoxicillin
Vorherige Impfungen: -

VAERS 2595530

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7143C

mild

Staat: VA
Alter: 43,0
Geschlecht: F
Eingang: 13.03.2023
Impfdatum: 09.09.2022
Beginn: 01.10.2022
Tage bis Beginn: 22,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Acne Allergy to vaccine Autoimmune disorder Lymphadenopathy Pyrexia Tinnitus

Symptomtext

I experienced a auto immune response to a allergy in the vaccination with fever, swollen lymph nodes, inflammatory acne and tinnitus

Weitere VAERSDATA-Felder

Praegender Schweregrund: Pyrexia
Hospital-Tage: -
Labordaten: N/A
Aktuelle Erkrankungen: N/A
Vorgeschichte: Asthma; depression; postoperative hypothyroidism
Andere Medikamente: Levothyroxine; Propranolol; Adderall; Gabapentin; Formoterol; Hydroxyzine; Duloxetine; Albuterol Sulfate; Clindamycin
Allergien: Gelatin
Vorherige Impfungen: -

VAERS 2594838

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7143C

mild

Staat: CA
Alter: 72,0
Geschlecht: M
Eingang: 10.03.2023
Impfdatum: 08.09.2022
Beginn: 23.02.2023
Tage bis Beginn: 168,0
Dosis: 5
Route/Site: IM / AR

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

COVID-19 Chills Cough Feeling abnormal Oropharyngeal pain Pollakiuria Rhinorrhoea SARS-CoV-2 test positive Sneezing

Symptomtext

It started with runny nose and sneezing and some coughing with a sore throat. I also had frequent urgent urination about once an hour. It was very unpleasant as I was also experiencing chills. It was the same the next night but then it got smooth. I did not have a fever, but I do get chills very easily. I completed a home COVID-19 test that was positive on 02/23/2023. I called my doctor and was prescribed PAXLOVID. I had a profound diarrhea which I believe were contributed by the drug. It took about 2 days for my symptoms to improve. I slowly but progressively started to feel better. It took a sold week before I felt more normal.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Chills
Hospital-Tage: -
Labordaten: COVID-19 home test positive 02/23/2023.
Aktuelle Erkrankungen: N/A
Vorgeschichte: High Blood Pressure; High Cholesterol; Acid Reflux; Hip Arthritis
Andere Medikamente: Atorvastatin; lisinopril; omeprazole
Allergien: N/A
Vorherige Impfungen: -

VAERS 2594824

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7143C

mild

Staat: WA
Alter: 70,0
Geschlecht: F
Eingang: 10.03.2023
Impfdatum: 07.09.2022
Beginn: 26.11.2022
Tage bis Beginn: 80,0
Dosis: 4
Route/Site: IM / UN

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Cough Oropharyngeal pain SARS-CoV-2 test Upper-airway cough syndrome X-ray

Symptomtext

sore throat cough postnasal drip.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Oropharyngeal pain
Hospital-Tage: -
Labordaten: X-Ray, Covid test
Aktuelle Erkrankungen: Sinus
Vorgeschichte: Fatty Liver: Liver Disease Osteopenia: Multinodular Goiter
Andere Medikamente: Multivitamin: Coputin: Zyrtec: Claritin: Omeprazole: Probiotic: Estradiol: flu shot
Allergien: Iodine: Codine
Vorherige Impfungen: -

VAERS 2594758

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7143C

mild

Staat: CA
Alter: 35,0
Geschlecht: F
Eingang: 10.03.2023
Impfdatum: 08.09.2022
Beginn: 07.02.2023
Tage bis Beginn: 152,0
Dosis: 4
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

COVID-19 Cough Disturbance in attention Fatigue Feeling abnormal Headache Hypersomnia Impaired work ability Malaise Oropharyngeal pain Respiratory tract congestion Rhinorrhoea SARS-CoV-2 antibody test positive Throat clearing Upper-airway cough syndrome

Symptomtext

I'm normally pretty careful about masking up indoors, but the weekend before I got sick, I went to brunch, and I think that's where I picked it up. I woke up on 2/7/2023 with a sore throat. I took a home antigen test, and the result was negative. The sore throat lasted for most of the day, and I felt tired. On 2/8/2023, I woke up feeling worse. I had congestion, sore throat, and a headache. I also felt really fatigued. I fully isolated myself and stayed around an air purifier. I took SUDAFED, but it didn't help. On 2/9/2023, I took a home test and got a positive result. I worked half a day remotely and then took the rest of the day off, because I was so fatigued and felt so sick that it affected my concentration. I slept for most of the day. I took DAYQUIL and NYQUIL that day and night, but they weren't as effective as I wanted them to be. After the first hour or two, they were effective, but they quickly wore off. They were better than nothing, though. On 2/10/2023, I still felt fatigued and sick. I again took DAYQUIL and NYQUIL. I slept all day. On 2/11/2023 and 2/12/2023, I felt better, but I had a little bit of a headache, plus runny nose and postnasal drip. On 2/13/2023, I still had a little bit of a runny nose and an annoying cough in which I felt the need to clear my throat. By 2/15/2023, I felt fine otherwise, but I was still testing positive. I stayed home, though, and I took precautions to not infect my husband. I finally tested negative on 2/18/2023. When I tested again on 2/19/2023, I was still negative. I had a telehealth appointment on 2/9/2023, and the doctor told me about PAXLOVID, and I ultimately decided not to take it.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Fatigue
Hospital-Tage: -
Labordaten: 07FEB2023 home antigen test, negative result; 09FEB2023 home antigen test, positive result; 18FEB2023 home antigen test, negative result; 19FEB2023 BinaxNOW test, negative result
Aktuelle Erkrankungen: None
Vorgeschichte: None
Andere Medikamente: Hormonal intrauterine device
Allergien: None
Vorherige Impfungen: -

VAERS 2594713

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7143C

mild

Staat: WI
Alter: 67,0
Geschlecht: F
Eingang: 10.03.2023
Impfdatum: 08.09.2022
Beginn: 26.02.2023
Tage bis Beginn: 171,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Brain fog COVID-19 Cough Fatigue Nasopharyngitis Respiratory tract congestion SARS-CoV-2 test positive

Symptomtext

In the evening of February of 26th it felt like I was getting a head cold. It progressed to coughing, congestion and low-grade, at which point I decided to use home COVID-19 test that came back positive. I retested the next day to make sure that it was indeed positive. I called my doctor and let them know I had tested positive for COVID-19, they called in a prescription for the Paxlovid. I started taking it immediately. Within three days I started feeling better, the brain fog was gone, the fatigue took a little longer, but it is gone now.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Fatigue
Hospital-Tage: -
Labordaten: 2/27/23 Home COVID-19 test - positive.
Aktuelle Erkrankungen: No
Vorgeschichte: No
Andere Medikamente: Vitamin C
Allergien: No
Vorherige Impfungen: -

VAERS 2594694

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7143C

mild

Staat: WI
Alter: 60,0
Geschlecht: F
Eingang: 10.03.2023
Impfdatum: 08.09.2022
Beginn: 25.12.2022
Tage bis Beginn: 108,0
Dosis: 5
Route/Site: SYR / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

COVID-19 Cough Fatigue Oropharyngeal pain Respiratory tract congestion SARS-CoV-2 test positive

Symptomtext

I tested positive for COVID-19 on December 25, 2022 I experienced congestion, fatigue, a cough, a sore throat.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Fatigue
Hospital-Tage: -
Labordaten: N/A
Aktuelle Erkrankungen: N/A
Vorgeschichte: N/A
Andere Medikamente: SYNTHROID; metoprolol; latanoprost
Allergien: N/A
Vorherige Impfungen: -

VAERS 2594655

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH BIVALENT)) · Charge AS7143C

mild

Staat: DC
Alter: 64,0
Geschlecht: M
Eingang: 10.03.2023
Impfdatum: 08.09.2022
Beginn: 08.02.2023
Tage bis Beginn: 153,0
Dosis: 5
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Asthenia COVID-19 Malaise SARS-CoV-2 test positive Sinus headache

Symptomtext

I felt terrible, low energy with a little bit of a sinus headache.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Malaise
Hospital-Tage: -
Labordaten: at home rapid COVID-19 test- positive 02/08/2023
Aktuelle Erkrankungen: No
Vorgeschichte: Prostate Cancer
Andere Medikamente: Amlodipine; Atorvastatin; Dutasteride Vitamin D3
Allergien: No
Vorherige Impfungen: -

VAERS 2594654

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge AS7143C

mild

Staat: MN
Alter: 46,0
Geschlecht: M
Eingang: 10.03.2023
Impfdatum: 08.04.2022
Beginn: 19.02.2023
Tage bis Beginn: 317,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

COVID-19 Cough Exposure to SARS-CoV-2 Oropharyngeal pain Respiratory tract congestion Rhinorrhoea SARS-CoV-2 test positive

Symptomtext

On February 19, 2023 I started having a sore throat, as my wife had tested positive the day before I decided to use a home COVID-19 test. Once it came back positive, I called my doctor who called a prescription of Paxlovid to my pharmacy that I started immediately. I was testing negative by the 24th of February. I did get rebound COVID-19 on February 27th that I felt was much worse, I had a cough, congestion, runny nose. My doctor advised me to use over the counter medication to help combat the rebound as I had already taken the Paxlovid. I was testing negative by March 3.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Oropharyngeal pain
Hospital-Tage: -
Labordaten: 2/19/23 COVID-19 - positive
Aktuelle Erkrankungen: No
Vorgeschichte: GERD; Blood Pressure
Andere Medikamente: No
Allergien: No
Vorherige Impfungen: -

VAERS 2594000

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7143C

mild

Staat: WA
Alter: 73,0
Geschlecht: F
Eingang: 09.03.2023
Impfdatum: 07.09.2022
Beginn: 15.09.2022
Tage bis Beginn: 8,0
Dosis: 5
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Arthralgia Gait disturbance Pain in extremity Walking aid user

Symptomtext

8 days later I had pain in my right knee and went up to my thigh. It got so bad that I had to get a cane because I could not walk on it. I went to the doctor and she did not know what it was. It took me about a month to recover.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Arthralgia
Hospital-Tage: -
Labordaten: N/A
Aktuelle Erkrankungen: Stroke
Vorgeschichte: Allergies; Hyperthyroidism; Glaucoma
Andere Medikamente: Unknown
Allergien: Hypersensitive; LEVAQUIN; penicillin; aspirin; AUGMENTIN; TYLENOL
Vorherige Impfungen: 3rd Moderna COVID-19, March 31 2022, leg problem and rash

VAERS 2593944

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7143C

mild

Staat: MD
Alter: 61,0
Geschlecht: M
Eingang: 09.03.2023
Impfdatum: 07.09.2022
Beginn: 20.12.2022
Tage bis Beginn: 104,0
Dosis: 5
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

COVID-19 Cough Malaise Nasopharyngitis Pyrexia Rhinorrhoea SARS-CoV-2 test positive

Symptomtext

I had moderate cold like symptoms, low-grade fever, runny nose, cough. I tested positive on day two of not feeling well. I emailed my doctor who prescribed Paxlovid. Within 48 hours I started feeling like my old self. I am now back in the gym and working out like normal.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Malaise
Hospital-Tage: -
Labordaten: 12/18/22 Home COVID-19 test positive
Aktuelle Erkrankungen: No
Vorgeschichte: Hypertension; High Cholesterol
Andere Medikamente: Lisinopril; Atorvastatin; Omeprazole; Arunita Ellipta; Creatine; Glycine Powder; NAC; Protein Powder
Allergien: Penicillin
Vorherige Impfungen: -

VAERS 2593933

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7143C

mild

Staat: NV
Alter: 70,0
Geschlecht: F
Eingang: 09.03.2023
Impfdatum: 07.09.2022
Beginn: 21.11.2022
Tage bis Beginn: 75,0
Dosis: 5
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

COVID-19 Chills Cough Eye disorder Eye haemorrhage Fatigue Feeling abnormal Headache Malaise Nausea Respiratory tract congestion SARS-CoV-2 test positive Visual impairment

Symptomtext

I had started noticing some issues with my left eye on about 11/23/2022. I wasn't seeing as well out of my left eye, and I noticed that whenever I looked at things, my vision in my left eye seemed darker than that in the right eye. And whenever I closed my eyes, I could see little shapes in the left eye. On 11/27/2022, when I woke up, I couldn't see much out of the left eye, so I called my ophthalmologist and went to see him that same day for an emergency visit. He said that I had a bleed in the left eye, and he referred me to a retina specialist, whom I saw the first week in December 2022. The retina specialist informed me that I had a "massive bleed" in the left eye and injected EYLEA in the left eye on 1/5/2023. On 1/6/2023, he injected a gas bubble in the left eye. I had to hold my head down for nine days afterwards, which wasn't easy. I received another EYLEA injection on 2/9/2023, and I am scheduled for another EYLEA injection in March 2023. At the time of this writing, I think that my vision is improving to some degree. The dark spot in my left is now smaller, and I can see the eye chart better whenever I go to the eye doctor. During the December 2022 visit, the ophthalmologist advised me to begin taking PRESERVISION supplements, which I have done. On 2/19/2023, I woke up and felt awful. I had a horrible headache, a cough, a little bit of congestion, and a horrible fatigue. I decided to go to urgent care. I was tested for COVID-19, and the result was positive. The urgent care prescribed LAGEVRIO. I felt somewhat better within a couple of days of starting. The cough went away. I still have the residual fatigue. I had a couple of days in which I had a headache, a couple of days in which I had nausea. I also had the chills for quite a few days. During my time with COVID-19, I seemed to roll through all the symptoms that are listed by the CDC, except I didn't lose my senses of taste and smell. The fatigue was pervasive and persistent, though. Whenever I would perform simple tasks, I would have to stop and rest for a while. I consulted with my GP, and he told me that I needed to move as much as possible and not succumb to the fatigue. I had to force myself to move, but I think it helped me feel better. I also kept an eye on my oxygen levels, and they were always within normal range. The COVID-19 was at its worst for three days, but it got better afterwards, though I still wasn't completely over it. At this point, the fatigue persists and I still get the chills, but otherwise I feel fine.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Chills
Hospital-Tage: -
Labordaten: 27NOV2022 Eye exams, eye bleed detected; DEC2022 Eye exam, massive eye bleed detected; 19FEB2023 Rapid antigen test COVID-19 detected
Aktuelle Erkrankungen: None
Vorgeschichte: Hypertension; Hypothyroidism; History of Pulmonary Embolism
Andere Medikamente: LEVOTHROID; LOTENSIN; XARELTO; omeprazole; metoprolol; vitamin D
Allergien: None
Vorherige Impfungen: After the COVID-19 boosters, my arm was sorer than it was after I received the primary doses. After the boosters, it hurt to mov

VAERS 2593906

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7143C

mild

Staat: NY
Alter: 64,0
Geschlecht: M
Eingang: 09.03.2023
Impfdatum: 07.09.2022
Beginn: 10.01.2023
Tage bis Beginn: 125,0
Dosis: 5
Route/Site: SYR / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

COVID-19 Chills Pyrexia SARS-CoV-2 test positive

Symptomtext

I went to bed with a fever. I awoke at four in the morning with chills. If I did not get chills I would have not tested. I had a at home test, it was positive. My Wednesday evening, I had not symptoms. It was like 24hrs or less. I felt fine. I stayed positive for three weeks. I called my doctor, I was normal, but I knew it would be hard to get that medicine. I demanded the medicine of PAXLOVID, but never used it.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Chills
Hospital-Tage: -
Labordaten: 10JAN2023 COVID-19 home test positive
Aktuelle Erkrankungen: N/A
Vorgeschichte: Acid Reflux; Sleep Apnea
Andere Medikamente: Lisinopril; atorvastatin; PREVACID
Allergien: N/A
Vorherige Impfungen: -

VAERS 2593891

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7143C

mild

Staat: OR
Alter: 66,0
Geschlecht: F
Eingang: 09.03.2023
Impfdatum: 07.09.2022
Beginn: 31.12.2022
Tage bis Beginn: 115,0
Dosis: 5
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

COVID-19 Cough Exercise tolerance decreased Fatigue Oropharyngeal pain Pyrexia Respiratory tract congestion SARS-CoV-2 test positive Throat irritation

Symptomtext

I started with a scratchy throat on 12/31/2022, which got worse. It was pretty sore for a couple of days. That seemed to subside, and then I had a fever on 1/1/2023. I pretty much had a fever for the whole time I was sick. At one point, it got up to 104 degrees. Prior to this, I had not taken anything, because my fever had been about 102. When it was 104, though, I took TYLENOL, which brought it down. On 1/3/2023, I took a home test and got a positive result. I was also very congested. On 1/5/2023, my temperature was 101. On 1/6/2023, I saw a PA. At this point, I was still testing positive. I explained my symptoms to the PA, who examined my ears, nose, and throat. I also had a cough, so he listened to my chest, as well. On that day, my temperature was 97.5. He advised me to stay hydrated, rest, use a humidifier, and take TYLENOL as needed. If I got worse, I was to contact them. He prescribed me a codeine cough syrup, but I didn't use it very long. I started feeling better, though I was still very tired. Altogether, I wasn't myself for about ten days, but I rebounded very quickly. I normally exercise every day, and I was able to resume that after my recovery. I had no lingering effects.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Fatigue
Hospital-Tage: -
Labordaten: 03JAN2023 home antigen test positive result; 06JAN2023 home antigen test positive result; 09JAN2023 home antigen test positive result; 11JAN2023(?) home antigen test negative result
Aktuelle Erkrankungen: None
Vorgeschichte: Restless Legs Syndrome; Acid Reflux Disease
Andere Medikamente: Lansoprazole; pramipexole; CENTRUM mini vitamins; PREVACID
Allergien: Sulfa drugs; penicillin; possible Malignant Hyperthermia
Vorherige Impfungen: After each of my Moderna COVID-19 injections, I was sick for 12-24 hours. I had fever and chills. After the first dose, I had re

VAERS 2593887

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7143C

mild

Staat: CT
Alter: 55,0
Geschlecht: F
Eingang: 09.03.2023
Impfdatum: 07.09.2022
Beginn: 06.11.2022
Tage bis Beginn: 60,0
Dosis: 5
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

COVID-19 Chills Cough Lethargy Malaise Nasopharyngitis Oropharyngeal pain Pain Respiratory tract congestion SARS-CoV-2 test positive Throat irritation

Symptomtext

I contracted COVID-19 twice; the first was in early November with mild symptoms. I didn't even know I had COVID-19 for about 3 days. I had a tickle in my throat, cough and congestion. I had body chills for one night very briefly. I took an at-home COVID-19 on 11/07/2022 which came back negative. I went to work the next couple of days assuming I just had a cold. I took another test on 11/09/2022 which came back positive. I called my doctor who prescribed me PAXLOVID on 11/10/2022; I isolated myself and tested again on 11/14/2022 to come back negative. Months later, on 03/05/2023 I started having a tickling sore throat again. I caught body chills and aches that disappeared the next day. I took an at-home test on 03/06/2023 which came back negative so I followed normal routine and went to work. I started developing significant body aches and chills again in the day. By evening time, I had a persistent cough and felt lethargic. I took another test that same evening which came back positive. I'm currently home and isolating again for the rest of the week as I'm taking PAXLOVID and cough medication which was prescribed for current treatment again.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Chills
Hospital-Tage: -
Labordaten: 07NOV2022, 09NOV2022, 14NOV202 COVID-19 tests negative, positive, negative, 05MAR2023, 06MAR2023 COVID-19 tests negative, positive
Aktuelle Erkrankungen: N/A
Vorgeschichte: N/A
Andere Medikamente: Escitalopram
Allergien: N/A
Vorherige Impfungen: -

VAERS 2593876

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7143C

mild

Staat: TX
Alter: 69,0
Geschlecht: F
Eingang: 09.03.2023
Impfdatum: 07.09.2022
Beginn: 04.01.2023
Tage bis Beginn: 119,0
Dosis: 5
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

COVID-19 Dizziness Fatigue Feeling abnormal Oropharyngeal pain Pyrexia SARS-CoV-2 test positive

Symptomtext

Started feeling fatigued and light headed and had a sore throat, the next day had a fever as well. Took a Home COVID-19 test and it was positive. Contacted Doctor and was prescribed Paxlovid and took full course. Took another Took another Home COVID-19 test 4 days later and tested Negative. Fatigue never did subside, and started feeling bad again with a sore throat and fever 2 weeks later. Took another Home COVID-19 test and was positive. Spoke with Doctor and was offered Paxlovid again, but decided not to take it. Symptoms lasted for 5 days before testing negative. Still feels more fatigued than I did before getting COVID-19.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Dizziness
Hospital-Tage: -
Labordaten: 04JAN2023 Home COVID-19 test - Positive; 08JAN2023 Home COVID-19 test - Negative; 23JAN2023 Home COVID-19 test - Positive; 28JAN2023 Home COVID-19 test - Negative.
Aktuelle Erkrankungen: N/A
Vorgeschichte: Joint Pain
Andere Medikamente: Fish Oil; Magnesium; Biotin; Potassium; Calcium; Multivitamin; Glucosamine Chondroitin Supplement; Prempro every other day; Phenetamine; Fiber.
Allergien: Codeine; Adhesive tape.
Vorherige Impfungen: -

VAERS 2593861

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7143C

mild

Staat: DE
Alter: 75,0
Geschlecht: F
Eingang: 09.03.2023
Impfdatum: 07.09.2022
Beginn: 14.02.2023
Tage bis Beginn: 160,0
Dosis: 5
Route/Site: SYR / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

COVID-19 Chills Cough Fatigue Myalgia SARS-CoV-2 test positive Secretion discharge Symptom recurrence Upper respiratory tract congestion

Symptomtext

A lot of upper respiratory mucous congestion coughing chills and muscle aches. The next day I took a home COVID-19 test which was immediately positive. I called my Doctor and he prescribed Pacxlovid for me and I noticed it was for five days as it was the reduced dosage. I started to get better about the third after starting my medication. I completed the course of medication and was feeling pretty good and retested and had a negative Covid test. Then two days later my symptoms returned almost as bad as previous, on the fourth day of this about ten days out I tested positive again foe COVID-19. A second tele visit regarding the rebound and the decision was no more Pacxlovid so I was prescribed Medrol dose Pak in case my asthma got worse but I never took it. I was tired for about a week and tested again which this time it was negative. I am now I am fully recovered.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Chills
Hospital-Tage: -
Labordaten: COVID-19 test positive
Aktuelle Erkrankungen: None
Vorgeschichte: Asthma; Hypothyroidism; Rheumatoid Arthritis
Andere Medikamente: Albuterol; Singular; Synthroid; Vascepa; Naproxen
Allergien: Codeine; Penicillin; Peanuts; Soy; Gluten
Vorherige Impfungen: -

VAERS 2593803

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7143C

mild

Staat: FL
Alter: 56,0
Geschlecht: M
Eingang: 09.03.2023
Impfdatum: 07.09.2022
Beginn: 08.09.2022
Tage bis Beginn: 1,0
Dosis: 5
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Arthralgia Burning sensation Incorrect route of product administration

Symptomtext

After I received the vaccine, I had pain, aches and burning in the right shoulder. I massaged my arm to help with the discomfort. I went to my doctor and was referred to physical therapy. I believe the physical therapy has helped. I believe the injection was done incorrectly.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Arthralgia
Hospital-Tage: -
Labordaten: N/A
Aktuelle Erkrankungen: N/A
Vorgeschichte: N/A
Andere Medikamente: CLARITIN
Allergien: N/A
Vorherige Impfungen: -

VAERS 2593174

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7143C

mild

Staat: WA
Alter: 40,0
Geschlecht: F
Eingang: 08.03.2023
Impfdatum: 05.09.2022
Beginn: 13.02.2023
Tage bis Beginn: 161,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Diarrhoea Dizziness Gastrointestinal disorder Headache Loss of personal independence in daily activities Mole excision Nausea Urine analysis normal Wound infection

Symptomtext

I had a mole removed on 2/11/2023. On 2/13/2023, the site became infected. There was brownish discharge that increased in subsequent days. I called my doctor's PA, who prescribed me cefalexin. This didn't clear up the problem, so the doctor who removed the mole prescribed me another round of cefalexin. Altogether, I took cefalexin for ten days. I took probiotics during that period. However, a week after I finished taking the cefalexin, I developed gastrointestinal issues (nausea, headache, intermittent diarrhea, intermittent dizziness). I went to an urgent care. While I was at urgent care, I underwent a urine test, and the results were normal. They then prescribed me an anti-nausea pill, which I am still taking. At the time of this writing, I think that I am recovering. I am able to work and go about my normal activities, though the issues I've had have affected my ability to do my tasks at my normal level. I am in the midst of treatment right now.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Diarrhoea
Hospital-Tage: -
Labordaten: 07MAR2023 Urine tests normal results
Aktuelle Erkrankungen: None
Vorgeschichte: Allergies; Anxiety; Depression
Andere Medikamente: FLONASE SENSIMIST; ALLEGRA 24-Hour; turmeric; omega 3; vitamin B12; vitamin D; NAD+; NMN
Allergien: Sulfa drugs
Vorherige Impfungen: -

VAERS 2591921

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7143C

mild

Staat: CA
Alter: 60,0
Geschlecht: F
Eingang: 06.03.2023
Impfdatum: 02.09.2022
Beginn: 06.02.2023
Tage bis Beginn: 157,0
Dosis: 6
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Asthenia COVID-19 Hypersomnia Lethargy Malaise Pyrexia Respiratory tract congestion SARS-CoV-2 test positive Upper-airway cough syndrome

Symptomtext

I felt a little feverish and weak. I slept a lot. I began taking Paxlovid on the second day. I had one more day in which I had a fever. Afterwards, I felt lethargic; I had some energy, but not as much as I did before getting sick. I then developed a lot of head congestion and post-nasal drip. After that passed, I felt fine.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Malaise
Hospital-Tage: -
Labordaten: 7FEB2023 - Home Antigen Test - Positive Result; 9FEB2023 - IntelliSwab Test - Positive Result; 13FEB2023 - Home Antigen Test - Negative Result; 14FEB2023 - IntelliSwab Test - Negative Result; 16FEB2023 - Home Antigen Test - Negative Result; 16FEB2023 - IntelliSwab Test - Negative Result
Aktuelle Erkrankungen: None
Vorgeschichte: None
Andere Medikamente: Estradiol Patch; Multivitamin; Calcium
Allergien: Gluten Intolerance; Lactose Intolerance; Codeine Sensitivity
Vorherige Impfungen: -

VAERS 2591072

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7143C

mild

Staat: WI
Alter: 78,0
Geschlecht: F
Eingang: 03.03.2023
Impfdatum: 19.09.2022
Beginn: 05.12.2022
Tage bis Beginn: 77,0
Dosis: 5
Route/Site: UN / UN

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein

Asthenia Blood sodium decreased COVID-19 Chest X-ray normal Chills Cough Fatigue Hyponatraemia Malaise Nasal congestion Nausea SARS-CoV-2 test positive

Symptomtext

12/4/2022: Presented to the ED with generalized weakness and chills in the setting of COVID-positive yesterday. Started to develop some fatigue, weakness, nausea, cough, and nasal congestion. Not eating or taking meds due to nausea. Presented to the ED and was initially discharged home. Returned to the ED the next day due to increased weakness. Admitted for weakness and severe hyponatremia. Noted to have returned to the ED also 12/18/2023 with Covid symptom complaints. No evidence of re-admission at that time. Submitter does not have access to further medical information on this case. If more information is needed, please contact the admitting hospital.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Chills
Hospital-Tage: -
Labordaten: 12/4/2022 Covid Positive per antigen Sodium 115 Chest x-ray negative.
Aktuelle Erkrankungen: unknown
Vorgeschichte: Past Medical History: Diagnosis Date ? Anemia ? Anterior corneal dystrophy ? Arthritis neck? Back fracture PHY TX ? Cancer 2010 skin melonoma situ right arm ? Cataract no surgery ? Diverticulosis ? Endometriosis tx years ago ? Fibromyalgia ? GERD (gastroesophageal reflux disease) ? Headache years ago ? Hearing loss no aids ? Heart murmur faint, occasional ? HTN (hypertension) 1/21/2022 ? Local reaction to pneumovax 12/16/2010 ? Nerve injury from surgery; numbness,sensitivity in lower left jaw ? Osteoporosis osteopenia? Vertigo occasional
Andere Medikamente: unknown
Allergien: ? Augmentin [Amoxicillin-Pot Clavulanate ] Nausea And Vomiting ? Macrobid [Nitrofurantoin Monohyd/M-Cryst ] Dermatitis ? Vicodin [Hydrocodone-Acetaminophen ] Nausea And Vomiting
Vorherige Impfungen: Local reaction to pneumovax 12/16/2010 (per medical history)

VAERS 2587170

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7143C

mild

Staat: CA
Alter: 57,0
Geschlecht: M
Eingang: 24.02.2023
Impfdatum: 07.09.2022
Beginn: -
Tage bis Beginn: -
Dosis: 5
Route/Site: OT / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Fatigue

Symptomtext

low level fatigue for a day; This spontaneous case was reported by a patient and describes the occurrence of FATIGUE (low level fatigue for a day) in a 57-year-old male patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. AS7143C) for COVID-19 prophylaxis. No Medical History information was reported. On 07-Sep-2022, the patient received fifth dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On an unknown date, the patient experienced FATIGUE (low level fatigue for a day). At the time of the report, FATIGUE (low level fatigue for a day) had resolved. For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter did not provide any causality assessments. Concomitant product information was not provided by the reporter. Treatment medication was not provided. This case was linked to US-MODERNATX, INC.-MOD-2023-711664 (E2B Linked Report).; Sender's Comments: US-MODERNATX, INC.-MOD-2023-711664:Monovalent case

Weitere VAERSDATA-Felder

Praegender Schweregrund: Fatigue
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2584692

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7143C

mild

Staat: IL
Alter: 75,0
Geschlecht: M
Eingang: 21.02.2023
Impfdatum: 08.09.2022
Beginn: 14.11.2022
Tage bis Beginn: 67,0
Dosis: 5
Route/Site: IM / AR

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: ja

Abdominal pain Computerised tomogram abdomen abnormal Peptic ulcer

Symptomtext

I started having severe abdominal pains for several days. I went to urgent care and they referred me to the ER at a local facility I was diagnosed with a Peptic Stomach Ulcer I was prescribed pantoprazole which I am still taking at this time.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Abdominal pain
Hospital-Tage: -
Labordaten: 11/2023 CT scan, Peptic Stomach Ulcer
Aktuelle Erkrankungen: None
Vorgeschichte: Arthritis
Andere Medikamente: Tramadol; CELEBREX; simvastatin; FLOMAX; losartan; metformin; baby aspirin
Allergien: Penicillin
Vorherige Impfungen: -

VAERS 2554754

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7143C

mild

Staat: NV
Alter: 72,0
Geschlecht: F
Eingang: 09.01.2023
Impfdatum: 16.09.2022
Beginn: 27.12.2022
Tage bis Beginn: 102,0
Dosis: 4
Route/Site: IM / UN

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

COVID-19 Fatigue Headache Rhinorrhoea SARS-CoV-2 test positive Sneezing Throat irritation

Symptomtext

On December 27, 2022, I began to have a scratchy throat. I tested negative for three days. On December 31, 2022, I went to the urgent care and received antibiotic and steroid. On January 2, 2023, I tested at home and was positive for COVID-19. I had a runny nose and sneezing and fatigue that included a headache. I took PAXLOVID and I tested negative yesterday.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Fatigue
Hospital-Tage: -
Labordaten: COVID-19 home, positive, 01/02/2023
Aktuelle Erkrankungen: N/A
Vorgeschichte: High Blood Pressure; GERD; Depression; Reynaud's Syndrome
Andere Medikamente: Nifedipine; montelukast; losartan; omeprazole; sertraline; amitriptyline; CITRACAL; multivitamin
Allergien: CIPRO; LEVAQUIN; BIAXIN; CEFTIN; CORTIZONE
Vorherige Impfungen: -

VAERS 2550319

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7143C

mild

Staat: MI
Alter: 79,0
Geschlecht: M
Eingang: 04.01.2023
Impfdatum: 07.09.2022
Beginn: 27.12.2022
Tage bis Beginn: 111,0
Dosis: 5
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: ja

COVID-19 Chills Cough Hypoxia Pyrexia

Symptomtext

PRESENTING PROBLEM: COVID-19 [U07.1] HOSPITAL COURSE: Patient is a 79 y.o. male with history of chronic atrial fib (on pradaxa), hypertension and chronic back pain who presented to Hospital on 12/27/2022 with 3 days of of fever, chills and nonproductive cough and was found to have COVID-19 with hypoxia. The patient was admitted to the hospital for further monitoring. He was treated with decadron and remdesivir, will transition to prednisone 20mg daily for an additional 3 days upon discharge as well as mucinex for supportive care. He required up to 2L NC during the stay but has been weaned to room air. Recommend post-hospitalization follow-up with PCP in 1-week. Other medical issues addressed this stay: Chronic midline low back pain, unspecified whether sciatica present Has spinal stimulator in place to help with pain control PRN pain control with tylenol Essential hypertension Controlled, continue atenolol Chronic atrial fibrillation Rate controlled, continue atenolol Continue pradaxa

Weitere VAERSDATA-Felder

Praegender Schweregrund: Chills
Hospital-Tage: 2,0
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: Respiratory Hypoxia Circulatory Chronic atrial fibrillation Essential hypertension Carotid aneurysm, left Digestive Obese Infectious/Inflammatory COVID-19 Nervous Chronic midline low back pain, unspecified whether sciatica present Other Elevated glucose level Encounter for surgical aftercare following surgery of nervous system Status post lumbar spine operation Decreased functional activity tolerance Weakness of both hips
Andere Medikamente: acetaminophen (TYLENOL) 500 MG tablet atenolol (TENORMIN) 50 MG tablet atorvastatin (LIPITOR) 20 MG tablet benzonatate (TESSALON) 100 MG capsule cholecalciferol (VITAMIN D3) 50 MCG (2000 UT) TABS dabigatran etexilate mesylate (PRADAXA) 150
Allergien: No Known Allergies
Vorherige Impfungen: -

VAERS 2547088

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7143C

mild

Staat: -
Alter: 63,0
Geschlecht: M
Eingang: 30.12.2022
Impfdatum: 20.01.2021
Beginn: 17.11.2022
Tage bis Beginn: 666,0
Dosis: 5
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

COVID-19 Cough Fatigue Headache Myalgia Nasal congestion Nasopharyngitis Oropharyngeal pain SARS-CoV-2 test positive Sinusitis Tonsillar hypertrophy Vaccine breakthrough infection

Symptomtext

This is a COVID breakthrough report - requested by CDC by phone call. I'm vacinated 2 course Moderna, 2 booters and a 3 bivalent booster just 2 months prior to contracting Covid. First symptom (11/17/22) was a sore throat, followed by nasal congestion. Started intermittent dry coughing day 2. I felt like I had a cold for 3-4 days. Sore throat would resolve then return 3 times. I was tired, head and muscle aches. The 3rd time my tonsils were swollen so I went to urgent care (11/25/22) to get them checked out. Was told my lungs sounded clear. Took over the counter meds for the sinusitis. I never had a fever. Tested positive until 12/5/22

Weitere VAERSDATA-Felder

Praegender Schweregrund: Fatigue
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2544978

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7143C

mild

Staat: MA
Alter: 51,0
Geschlecht: F
Eingang: 28.12.2022
Impfdatum: 24.09.2022
Beginn: 17.11.2022
Tage bis Beginn: 54,0
Dosis: 5
Route/Site: IM / AR

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

COVID-19 Fatigue Headache Oropharyngeal pain Pyrexia Respiratory tract congestion

Symptomtext

I started having head congestion and a severe sore throat and then had a high fever over 101F, headache and fatigue. I used a home COVID-19 test that came back positive, had a telehealth visit. We discussed my symptoms, I was prescribed Paxlovid but decided against taking it since it did not get into my lungs. I opted to only take over the counter medications. I am feeling good.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Fatigue
Hospital-Tage: -
Labordaten: Home COVID-19 test
Aktuelle Erkrankungen: No
Vorgeschichte: N/A
Andere Medikamente: N/A
Allergien: Xifaxan
Vorherige Impfungen: -

VAERS 2540723

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7143C

mild

Staat: VA
Alter: 48,0
Geschlecht: M
Eingang: 22.12.2022
Impfdatum: 21.09.2022
Beginn: 02.10.2022
Tage bis Beginn: 11,0
Dosis: 4
Route/Site: IM / AR

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

COVID-19 Cough Fatigue Respiratory tract congestion SARS-CoV-2 test positive

Symptomtext

I started to feel tired I had lots of cough and concession and was tired. The doctor gave me prescription albuterol, and PAXLOVID. This was the 8th of November and within 3 days I started to feel better. In a complete week I was back to my normal self.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Fatigue
Hospital-Tage: -
Labordaten: COVID-19 at home test
Aktuelle Erkrankungen: N/A
Vorgeschichte: Type 2 Diabetes; High Blood Pressure; Cholesterol
Andere Medikamente: Aspirin; LIPITOR; BYDUREON; ZYRTEC; ZETIA; glipizide; JARDIANCE; lisinopril; metformin; PROTONIX; VALTREX
Allergien: N/A
Vorherige Impfungen: -

VAERS 2536667

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7143C

mild

Staat: CO
Alter: 55,0
Geschlecht: M
Eingang: 19.12.2022
Impfdatum: 07.09.2022
Beginn: 17.12.2022
Tage bis Beginn: 101,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

COVID-19 Pyrexia SARS-CoV-2 test positive

Symptomtext

I tested positive for Covid -19 on 12/18/2022, began feeling febrile on 12/17/2022

Weitere VAERSDATA-Felder

Praegender Schweregrund: Pyrexia
Hospital-Tage: -
Labordaten: At Home Covid-19 test
Aktuelle Erkrankungen: Urinary tract infection
Vorgeschichte: Renal insufficiency, Primary hypertension
Andere Medikamente: Amlodipine 10 mg daily, Hydrochlorothiazide 25 mg daily, Tamsulosin 0.4 mg daily, 1200 mg Omega -3 daily, 5000 iu Vitamin D3 daily
Allergien: Sulfa drigs
Vorherige Impfungen: -

VAERS 2535276

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7143C

mild

Staat: MA
Alter: 69,0
Geschlecht: M
Eingang: 16.12.2022
Impfdatum: 12.09.2022
Beginn: 05.11.2022
Tage bis Beginn: 54,0
Dosis: 5
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

COVID-19 Illness Oropharyngeal pain Rhinorrhoea SARS-CoV-2 test positive

Symptomtext

TESTED POSITIVE for COVID-19 after 5 vaccinations. Tested positive for COVID-19 (At-Home BD Veritor COVID-19 Test) on November 5, 2022 with mild symptoms (runny nose). On November 7, symptoms grew worse with severe sore throat Started prescription of Paxlovid on November 8 with quickly reduced severity of my illness. By November 11, I was feeling nearly normal and essentially no symptoms, however tested positive with At-Home BD Veritor COVID-19 Test On November 14 continued to test positive. On November 15 tested negative and had no symptoms.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Oropharyngeal pain
Hospital-Tage: -
Labordaten: At-Home BD Veritor COVID-19 test Tested positive on November 5, 2022 Tested positive on November 11, 2022 Tested positive on November 14, 2022 Tested negative on November 15, 2022 Tested negative on November 24, 2022
Aktuelle Erkrankungen: None
Vorgeschichte: High blood pressure Atrial Fibrillation Bradycardia (pacemaker)
Andere Medikamente: Carvedilol 12.5 mg tablets ? twice a day Cholecalciferol (Vitamin D3) 5,000 I.U. (Daily) Daily Fiber (Psyllium husk) ? 5 capsules twice daily Eliquis 5 mg tablet ? twice a day Fluticasone propionate 50mcg/spray (Once daily) Ketoconazole 2%
Allergien: None
Vorherige Impfungen: -

VAERS 2535140

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7143C

mild

Staat: NY
Alter: 70,0
Geschlecht: F
Eingang: 16.12.2022
Impfdatum: 15.09.2022
Beginn: 12.11.2022
Tage bis Beginn: 58,0
Dosis: 5
Route/Site: SYR / AR

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Blood potassium decreased Canalith repositioning procedure Computerised tomogram head normal Electrocardiogram normal Fear Hypoacusis Magnetic resonance imaging head normal Nausea SARS-CoV-2 test negative Tinnitus Vertigo Vertigo positional

Symptomtext

11/12/2022 I experienced extreme vertigo around 8:00PM. I have tinnitus and just before the vertigo, it became abnormally loud. By around 11:00PM, the vertigo was so bad and the pounding in my ears was very scary. I had never experienced anything like that. This continued through the night into the morning. When I would wake up, the room was spinning. I called the doctor and was told to go to the urgent care or hospital. All day long the vertigo continued, and I was unable to do much. When I went to urgent care, they did an EKG, did not say the results, and said it could be a sign of a stroke, so I needed to go to the emergency department. I went to the emergency department. I had a negative COVID test. A CT was done that evening. I stayed in observation room overnight. I was given meclizine for the vertigo. I was also given ZOFRAN for nausea because I had become nauseated. The next morning around 9:00, I had an MRI. The results of the CT and MRI ruled out a stroke. I had an EKG that was normal. They also did blood work which showed I had low potassium. Later that day the physical therapist assessed me and believed it was a benign positional vertigo position which a Neurologist confirmed later that afternoon. He did an Epley maneuver. I was discharged a few hours later with physical therapy prescribed to continue treating the vertigo. I just finished physical therapy. I am still experiencing dizziness and reduced hearing in my left ear. I was advised to follow up with an ENT. I have that appointment next week. I have a follow up appointment with a Neurologist in February. I still have not fully recovered. I still experience dizziness and my balance is off.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Nausea
Hospital-Tage: -
Labordaten: COVID test was negative; CT of head, normal; MRI of head, normal: EKG, normal: blood work showed low potassium.
Aktuelle Erkrankungen: None
Vorgeschichte: High blood pressure; a possible Micro myocardial infarction
Andere Medikamente: Amlodipine; carvedilol; atorvastatin; lisinopril; estradiol; low dose aspirin; loratadine; calcium; NASACORT
Allergien: Sulfa drugs; dust mites
Vorherige Impfungen: Mild flu symptoms for 24 hours after COVID 19 shots, flu shot, very mild.

VAERS 2533808

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7143C

mild

Staat: IL
Alter: 63,0
Geschlecht: F
Eingang: 15.12.2022
Impfdatum: 08.09.2022
Beginn: 12.11.2022
Tage bis Beginn: 65,0
Dosis: 4
Route/Site: IM / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

COVID-19 Cough Myalgia Oropharyngeal pain Pyrexia Rhinorrhoea SARS-CoV-2 test positive Sinus headache

Symptomtext

I did not have an adverse response to the vaccine. I tested positive for COVID 11/12/2022. I had sinus headache/cough/runny nose/sore throat/fever/muscle aches for 2 days. I had a video visit to have Paxlovid prescribed. I took it for 2 days, but I was getting better anyway, so I discontinued it. I had mild/moderate cough/runny nose/sore throat for 2 weeks. Now I'm back to my usual self. I had a flu vaccine on the same day, but did not receive documentation of what type or lot number

Weitere VAERSDATA-Felder

Praegender Schweregrund: Myalgia
Hospital-Tage: -
Labordaten: None
Aktuelle Erkrankungen: none
Vorgeschichte: hypercholesterol, osteoarthritis
Andere Medikamente: atorvastatin 40mg daily, Calcium citrate 200mg QOD, fish oil 1000mg QOD, Quercetin 500mg QOD, Glucosamine 750mg daily Vitamin C 1000mg QOD, Aspirin 81mg QOD, Turmeric 500mg QOD
Allergien: Azithromycin>>hives bandage adhesive>>bullae
Vorherige Impfungen: -

VAERS 2530989

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7143C

mild

Staat: DC
Alter: 71,0
Geschlecht: M
Eingang: 14.12.2022
Impfdatum: 09.09.2022
Beginn: 03.12.2022
Tage bis Beginn: 85,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: ja

COVID-19 Cough Fatigue Influenza virus test negative Oropharyngeal pain Pyrexia SARS-CoV-2 test positive

Symptomtext

I tested positive for COVID-19 on 12/5/22. I had extreme fatigue, cough, sore throat, and a fever of 102. I contacted my doctor, and she told me to go to urgent care. I went to urgent care, and they prescribed 5 days' worth of PAXLOVID. I am feeling much better now.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Fatigue
Hospital-Tage: -
Labordaten: 05DEC2022 COVID-19 test positive; 05DEC2022 flu test negative
Aktuelle Erkrankungen: N/A
Vorgeschichte: ADHD
Andere Medikamente: WELLBUTRIN; ADDERALL; AMBIEN; BENADRYL; ibuprofen; TYLENOL; TRUVADA; CIALIS; VALTREX
Allergien: N/A
Vorherige Impfungen: -

VAERS 2530951

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7143C

mild

Staat: NV
Alter: 61,0
Geschlecht: M
Eingang: 14.12.2022
Impfdatum: 09.09.2022
Beginn: 02.12.2022
Tage bis Beginn: 84,0
Dosis: 1
Route/Site: - / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

COVID-19 Chills Cough Lethargy Pyrexia Respiratory tract congestion SARS-CoV-2 test positive

Symptomtext

2 Dec 2022: Got Covid. Fever, lethargy, Cough, Congestion, Chills.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Chills
Hospital-Tage: -
Labordaten: + Covid test
Aktuelle Erkrankungen: None
Vorgeschichte: Htn, hyperlipidemia, hypogonadism, BPH
Andere Medikamente: Atorvastatin, Vit E, Lisinopril, Alfuzosin, Testosterone
Allergien: None
Vorherige Impfungen: -

VAERS 2529495

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7143C

mild

Staat: IL
Alter: 77,0
Geschlecht: M
Eingang: 12.12.2022
Impfdatum: 08.09.2022
Beginn: 01.12.2022
Tage bis Beginn: 84,0
Dosis: 5
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

COVID-19 Cough Headache Myalgia Nasal congestion SARS-CoV-2 test positive

Symptomtext

On the afternoon of December 1, 2022, I tested positive for COVID-19 using an antigen test kit. I continue to test positive until the evening of December 5, 2022. I exhibited mild symptoms (slight headache, nasal congestion) of COVID-19 during this time but none in the first few days after I first tested negative. I obtained a prescription for Paxlovid from a doctor the afternoon I first tested positive and began taking it that evening. I completed my course of Paxlovid on the morning of December 6, 2022. During the night of December 9, 2022 I began exhibiting strong symptoms (headache, muscle soreness, nasal congestion, and cough) of COVID-19. These symptoms have continued until the present time (the night of December 12, 2022).

Weitere VAERSDATA-Felder

Praegender Schweregrund: Headache
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: None.
Vorgeschichte: None.
Andere Medikamente: Multivitamins, vitamin D3, magnesium taurate, and fexofenadine hydrochloride tablets.
Allergien: Intolerance to casein protein in cow's milk.
Vorherige Impfungen: -

VAERS 2528997

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7143C

mild

Staat: WA
Alter: 73,0
Geschlecht: M
Eingang: 12.12.2022
Impfdatum: 08.09.2022
Beginn: 22.10.2022
Tage bis Beginn: 44,0
Dosis: 5
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

COVID-19 Cough Headache Myalgia Oropharyngeal pain Pyrexia SARS-CoV-2 test positive X-ray

Symptomtext

I contracted COVID-19. I was on a cruise ship at the time. I experienced a fever with a temperature of 102 at its peak, headache, muscle aches, sore throat, and coughing. I received treatment from the doctor on the ship. They gave me some cough drops and a fever reducer tablet. I later went to urgent care around 11/06/2022. I was not prescribed anything when I was at urgent care. I am still dealing with an occasional cough.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Headache
Hospital-Tage: -
Labordaten: November 2022 X-ray
Aktuelle Erkrankungen: None
Vorgeschichte: None
Andere Medikamente: Mature multivitamin; D3; calcium, citrate; magnesium; zinc all-in-one tablet; omeprazole; aspirin
Allergien: None
Vorherige Impfungen: -

VAERS 2528943

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge AS7143C

mild

Staat: NC
Alter: 62,0
Geschlecht: F
Eingang: 12.12.2022
Impfdatum: 09.09.2022
Beginn: 30.09.2022
Tage bis Beginn: 21,0
Dosis: 5
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Bronchitis COVID-19 Malaise SARS-CoV-2 test positive

Symptomtext

Covid symptoms and positive covid test 3 weeks after having received 3rd booster. Symptoms cleared in 2 1/2 weeks but then developed bronchitis during last week of Oct. 2022.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Malaise
Hospital-Tage: -
Labordaten: At-home Covid test was positive on Sept 30, 2022.
Aktuelle Erkrankungen: None
Vorgeschichte: osteopenia, occasional migraine headaches, mild hypertension
Andere Medikamente: lisinopril, progesterone, estrogen patch, Calcium citrate +vitD, biotin, HydroEye gel capsules (for dry eyes), Imitrex PRN
Allergien: sulfa, azythromycin
Vorherige Impfungen: -

VAERS 2528772

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7143C

mild

Staat: PA
Alter: 71,0
Geschlecht: M
Eingang: 12.12.2022
Impfdatum: 07.09.2022
Beginn: 05.12.2022
Tage bis Beginn: 89,0
Dosis: 6
Route/Site: SYR / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

COVID-19 Cough Diarrhoea Headache Infection Nasal congestion Pain SARS-CoV-2 test positive

Symptomtext

I had a breakthrough case of Covid with cough, nasal congestion, body aches, diarrhea, headache.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Diarrhoea
Hospital-Tage: -
Labordaten: No
Aktuelle Erkrankungen: None
Vorgeschichte: Asthma; GERD; Depression
Andere Medikamente: Trazadone; citalopram; LYRICA; famotidine; oxybutynin; ZETIA; sumatriptan; DULERA; TALTZ; tamsulosin; finasteride; multivitamin; vitamin D; vitamin B12; NASACORT
Allergien: Dander; pollen; dust
Vorherige Impfungen: -

VAERS 2527874

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7143C

mild

Staat: AZ
Alter: 67,0
Geschlecht: F
Eingang: 09.12.2022
Impfdatum: 09.09.2022
Beginn: 28.11.2022
Tage bis Beginn: 80,0
Dosis: 1
Route/Site: SYR / AR

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

COVID-19 Cough Dysphonia Fatigue Headache Influenza virus test Oropharyngeal pain Respiratory syncytial virus test SARS-CoV-2 test positive

Symptomtext

Contracted Covid again after being vaccinated. I had a sore throat, hoarse voice, chest cough, bad fatigue and a strong headache. I then was taking PAXLOVID and it cleared for 5 days then rebounded. Everything came back, a bit milder but I was tested again and came back positive for Covid. So I was prescribed another round of PAXLOVID.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Fatigue
Hospital-Tage: -
Labordaten: Covid test with positive result; RSV testing and flu testing.
Aktuelle Erkrankungen: None
Vorgeschichte: Rheumatoid arthritis; pre-diabetes; asthma
Andere Medikamente: Leucovorin; RINVOQ; SINGULAIR; vit C; LYRICA; ALEVE
Allergien: Contrast with iodine; codeine
Vorherige Impfungen: -

VAERS 2527750

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7143C

mild

Staat: DC
Alter: 32,0
Geschlecht: M
Eingang: 09.12.2022
Impfdatum: 08.09.2022
Beginn: 02.12.2022
Tage bis Beginn: 85,0
Dosis: 4
Route/Site: SYR / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

COVID-19 Dry throat Epistaxis Headache Oropharyngeal pain Pyrexia SARS-CoV-2 test positive

Symptomtext

December second 2022 I had a slight headache and a slight dry throat on the fourth of December 2022 I had a slight dry throat and headache then in the evening around eleven PM I tested positive with a COVID-19 antigen test. On the fifth of December I had a 102 degree fever and a more severe sore throat with a bit of phlegm and blood that I produced through my nose, after some sleep my fever reduced to 100 degrees, the same day my doctor prescribed PAXLOVID which I started that evening and I mostly had the same symptoms with the fever gone and then the next few days after that I stayed at home from work resting and hydrating with symptoms improving.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Headache
Hospital-Tage: -
Labordaten: COVID-19 antigen test result was positive.
Aktuelle Erkrankungen: None
Vorgeschichte: Sleep Apnea; Depression; Anxiety; Hypothyroidism
Andere Medikamente: LEXAPRO; levothyroxine; CLARITIN generic; vitamin D
Allergien: None
Vorherige Impfungen: -

VAERS 2527422

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7143C

mild

Staat: WI
Alter: 47,0
Geschlecht: F
Eingang: 08.12.2022
Impfdatum: 07.09.2022
Beginn: 13.11.2022
Tage bis Beginn: 67,0
Dosis: 4
Route/Site: IM / UN

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

COVID-19 Chills Constipation Cough Diarrhoea Fatigue Headache Nasal congestion Pain Pyrexia Rhinorrhoea SARS-CoV-2 test positive

Symptomtext

I had a fever, chills, body aches, runny nose, diarrhea, headache, fatigue, nasal congestion, cough, and constipation. I tested positive for COVID-19 at home. I went to the doctor, and they tested me again. They prescribed me PAXLOVID. I still have a cough and fatigue.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Chills
Hospital-Tage: -
Labordaten: COVID-19 test, positive, 11/15/2022
Aktuelle Erkrankungen: N/A
Vorgeschichte: Chronic Pain; Frozen Shoulder
Andere Medikamente: Multivitamin; ibuprofen
Allergien: N/A
Vorherige Impfungen: -

VAERS 2526771

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7143C

mild

Staat: IL
Alter: 36,0
Geschlecht: M
Eingang: 08.12.2022
Impfdatum: 07.09.2022
Beginn: 23.10.2022
Tage bis Beginn: 46,0
Dosis: 4
Route/Site: SYR / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Anosmia COVID-19 Chills Cough Fatigue Feeling abnormal Headache Influenza virus test Pain Pain in extremity Pyrexia SARS-CoV-2 test positive

Symptomtext

Sunday October 23 2022 before I was diagnosed with COVID-19 I had symptoms of a dry cough and headache, and then on Monday morning I felt under the weather with chills, headache, body aches, fatigue. My legs would hurt if at rest and not up moving around. I went to a clinic and was swabbed for the flu and COVID-19 the COVID-19 was positive. I had a fever from October 24-26 2022 after October 26 2022 I lost sense of smell and this loss for four to five days, my cough lasted for two weeks.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Chills
Hospital-Tage: -
Labordaten: CODID-19 test result was positive.
Aktuelle Erkrankungen: None
Vorgeschichte: None
Andere Medikamente: Men's health ONE A DAY; fish oil
Allergien: None
Vorherige Impfungen: -

VAERS 2525836

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7143C

mild

Staat: WA
Alter: 69,0
Geschlecht: M
Eingang: 07.12.2022
Impfdatum: 06.09.2022
Beginn: 02.11.2022
Tage bis Beginn: 57,0
Dosis: 5
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

COVID-19 Discomfort Fatigue Feeling abnormal Middle insomnia Nasal congestion SARS-CoV-2 test positive Sinus congestion Throat irritation

Symptomtext

I received the Moderna Bivalent booster for COVID-19 on 9/6/2022, On the night of 11/2/2022, I woke up with head congestion, stuffy nose, and scratchy throat. When I woke up on the morning of 11/3/2022, I still had the same symptoms and felt pretty run-down, so I took a home antigen test twice, and both times I received a positive result. On 11/4/2022, I had a virtual visit with a NP at the hospital with which my cardiologist is affiliated. I was prescribed PAXLOVID, and he also recommended that I use OTC medicines like TYLENOL and MUCINEX to treat the symptoms. The NP also suggested that I stop taking rosuvastatin for 8 days on account of contraindications with PAXLOVID. I took the full course of PAXLOVID for 5 days. My symptoms resolved pretty quickly after the first 5 days or so, and I finally tested negative on both 11/11/2022 and 11/13/2022. However, on 11/14/2022, I began to get a scratchy throat again, along with mild head congestion and mild fatigue. I tested myself again twice that day, and I got a positive result both times. I had a rebound. Whenever I felt any discomfort, I just treated it with OTC medicine. I also periodically tested myself, and it wasn't until 11/24/2022 that I finally tested negative again. Ever since then, I have been symptom-free and am doing fine.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Fatigue
Hospital-Tage: -
Labordaten: 11/3/2022 2 home antigen tests positive results; 11/11/2022 home antigen test negative result; 11/13/2022 home antigen test negative result; 11/14/2022 2 home antigen tests positive results; 11/24/2022 home antigen test negative result.
Aktuelle Erkrankungen: None.
Vorgeschichte: Coronary Artery Disease; Bicuspid Aortic Valve; Peripheral Artery Disease; Osteoarthritis (Right Knee).
Andere Medikamente: Rosuvastatin; metoprolol; ZETIA; multivitamin; coQ10; vitamin D; baby aspirin.
Allergien: None.
Vorherige Impfungen: -

VAERS 2525519

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7143C

mild

Staat: UT
Alter: 45,0
Geschlecht: F
Eingang: 07.12.2022
Impfdatum: 06.09.2022
Beginn: 27.11.2022
Tage bis Beginn: 82,0
Dosis: 5
Route/Site: SYR / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Abdominal pain Ageusia COVID-19 Cough Diarrhoea Fatigue Feeling abnormal Nasal pruritus Respiratory tract congestion SARS-CoV-2 test positive Tinnitus Wheezing

Symptomtext

I had my vaccination on 09/06/2022. I started to have an itchy nose on 11/27/2022. On 11/28/2022 I started to feel run down and fatigued cough congestion wheezing tinnitus loss of taste abdominal pain and diarrhea by the afternoon. I took a COVID-19 test and it was positive. I started PAXLOVID on 11/29/2022. I am feeling ok on 12/07/2022 but feeling more fatigued with congestion and wondering if I am rebounding.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Abdominal pain
Hospital-Tage: -
Labordaten: 11/28/2022 COVID-19 positive
Aktuelle Erkrankungen: N/A
Vorgeschichte: N/A
Andere Medikamente: Meloxicam; NEXIUM; ZYRTEC
Allergien: Penicillin
Vorherige Impfungen: -

VAERS 2521393

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge AS7143C

mild

Staat: IL
Alter: 64,0
Geschlecht: F
Eingang: 02.12.2022
Impfdatum: 07.09.2022
Beginn: -
Tage bis Beginn: -
Dosis: 5
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Chills Fatigue Pain

Symptomtext

Ache; with the 5th dose just a little tired; Chills; This spontaneous case was reported by a patient and describes the occurrence of PAIN (Ache), FATIGUE (with the 5th dose just a little tired) and CHILLS (Chills) in a 64-year-old female patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. AS7143C) for COVID-19 prophylaxis. Previously administered products included for Product used for unknown indication: Flu shot (Had Pneumonia 1 day after flu shot). Past adverse reactions to the above products included Pneumonia with Flu shot. On 07-Sep-2022, the patient received fifth dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On an unknown date, the patient experienced PAIN (Ache), FATIGUE (with the 5th dose just a little tired) and CHILLS (Chills). At the time of the report, PAIN (Ache), FATIGUE (with the 5th dose just a little tired) and CHILLS (Chills) outcome was unknown. Patient previously had Moderna vaccines as 1st Dose on 11-Mar-2021, 2nd Dose on 08-Apr-2021 with lot number 030B21A, 3rd Dose on 29-Oct-2021 with lot number 047C21A and Dose 4 on 08-Apr-2022 with lot number 046L21A. It was reported that patient received Dose 5 which was recorded as Moderna Bivalent on patient's record card, However, the state registry information on patient's record list was stated as Monovalent. No concomitant medications were reported. No treatment details were reported. This case was linked to MOD-2022-679862, MOD-2022-679857 (Patient Link).

Weitere VAERSDATA-Felder

Praegender Schweregrund: Chills
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2520492

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7143C

mild

Staat: WA
Alter: 77,0
Geschlecht: M
Eingang: 30.11.2022
Impfdatum: 08.09.2022
Beginn: 08.09.2022
Tage bis Beginn: 0,0
Dosis: 5
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Pain Pain in extremity

Symptomtext

On Nov 28th, patient reported that his arm is still sore and he has pain lifting arm above the shoulder level. Deep ache all the time since the vaccinations.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Pain
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: no known
Vorgeschichte: unknown
Andere Medikamente: gabapentin 600mg, and tadalafil 5mg
Allergien: sulfa and codeine
Vorherige Impfungen: -

VAERS 2513586

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge AS7143C

mild

Staat: MA
Alter: 65,0
Geschlecht: F
Eingang: 22.11.2022
Impfdatum: 07.09.2022
Beginn: 07.09.2022
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: OT / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Inappropriate schedule of product administration Vaccination site pain

Symptomtext

Slightly sore left arm; Patient received 1st booster dose on 15-Jul-2022/2nd booster on 07-Sep-2022; This spontaneous case was reported by a patient and describes the occurrence of VACCINATION SITE PAIN (Slightly sore left arm) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Patient received 1st booster dose on 15-Jul-2022/2nd booster on 07-Sep-2022) in a 65-year-old female patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. AS7143C) for COVID-19 prophylaxis. The patient's past medical history included Chemotherapy, Radiation therapy, Lumpectomy and Lymphadenectomy (lymph nodes on her left side were removed). Previously administered products included for Product used for unknown indication: Pfizer vaccine (primary series). Past adverse reactions to the above products included No adverse event with Pfizer vaccine. Concurrent medical conditions included Type 1 diabetes mellitus since 1987, Breast cancer (Left) since 2006, Hypertension and Graves' disease. Concomitant products included INSULIN GLARGINE (LANTUS), INSULIN LISPRO (HUMALOG), ATORVASTATIN, LISINOPRIL, METOPROLOL SUCCINATE, ALENDRONATE SODIUM (ALENDRONATE), AMLODIPINE, ASPIRIN [ACETYLSALICYLIC ACID] and CEPHALEXIN [CEFALEXIN] for an unknown indication. On 07-Sep-2022, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On 07-Sep-2022, the patient experienced VACCINATION SITE PAIN (Slightly sore left arm) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Patient received 1st booster dose on 15-Jul-2022/2nd booster on 07-Sep-2022). At the time of the report, VACCINATION SITE PAIN (Slightly sore left arm) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Patient received 1st booster dose on 15-Jul-2022/2nd booster on 07-Sep-2022) outcome was unknown. For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter did not provide any causality assessments. No treatment medications were reported. This case was linked to MOD-2022-674650, MOD-2022-674619 (Patient Link).

Weitere VAERSDATA-Felder

Praegender Schweregrund: Vaccination site pain
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: Breast cancer (Left); Graves' disease; Hypertension; Type 1 diabetes mellitus
Vorgeschichte: Medical History/Concurrent Conditions: Chemotherapy; Lumpectomy; Lymphadenectomy (lymph nodes on her left side were removed); Radiation therapy
Andere Medikamente: LANTUS; HUMALOG; ATORVASTATIN; LISINOPRIL; METOPROLOL SUCCINATE; ALENDRONATE; AMLODIPINE; ASPIRIN [ACETYLSALICYLIC ACID]; CEPHALEXIN [CEFALEXIN]
Allergien: -
Vorherige Impfungen: -

VAERS 2513030

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7143C

mild

Staat: CT
Alter: 76,0
Geschlecht: F
Eingang: 21.11.2022
Impfdatum: 12.09.2022
Beginn: 10.11.2022
Tage bis Beginn: 59,0
Dosis: 1
Route/Site: IM / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

COVID-19 Cough Ear discomfort Malaise Pyrexia SARS-CoV-2 test positive

Symptomtext

Was not feeling well on 11/10/22 low grade fever, clogged ear and dry cough and went to walk in clinic and tested positive. Took OTC meds to dry up sinus and ear. Symptoms began improving instantly and seemed mostly resolved by 11/14.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Malaise
Hospital-Tage: -
Labordaten: COVID-19 positive
Aktuelle Erkrankungen: No
Vorgeschichte: Osteoporosis
Andere Medikamente: Losartan; LIPITOR; SYNTHROID; PRILOSEC; ca; zinc; mg; aspirin; vitamin C; B12
Allergien: High dose aspirin
Vorherige Impfungen: Fever and chills after 2nd dose of COVID-19 vaccine 02/2021

VAERS 2510676

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7143C

mild

Staat: TN
Alter: 76,0
Geschlecht: F
Eingang: 17.11.2022
Impfdatum: 12.10.2022
Beginn: 16.11.2022
Tage bis Beginn: 35,0
Dosis: 5
Route/Site: SYR / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Abdominal discomfort Asthenia COVID-19 Diarrhoea Fatigue Headache Nausea Oropharyngeal pain SARS-CoV-2 test positive

Symptomtext

I woke up with a weird headache. I had COVID-19 before and I knew what this headache felt like. I was sick to my stomach and I had diarrhea. I did a home COVID-19 test and it immediately came back positive. When the doctor's office opened, I called and asked for the prescription Paxlovid. They sent that in yesterday morning and I had someone pick it up. I started taking that yesterday. My headache has subsided. I'm still nauseous and have a sore throat and some diarrhea. I'm feeling weak and tired, but no where near the first time I had COVID-19.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Diarrhoea
Hospital-Tage: -
Labordaten: 11/16/2022 At Home COVID-19 Test - Positive
Aktuelle Erkrankungen: None
Vorgeschichte: Extreme Ezcema
Andere Medikamente: Alendronate; Dupixent; Gabapentin; Lorazepam; Primidone; Rosuvastatin; Topiramate; Vitamin C; Vitamin D; Multivitamin; AREDS 2 Eye Vitamin; Vitamin B12 Injection
Allergien: Compazine; Dilaudid; Doxycycline; Mycophenolate; Reglan; Nickel; Latex; Sulfa Drugs; Pregabalin; Aspirin; Depakote
Vorherige Impfungen: -

VAERS 2506947

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge AS7143C

mild

Staat: IL
Alter: 72,0
Geschlecht: F
Eingang: 14.11.2022
Impfdatum: 12.09.2022
Beginn: 12.09.2022
Tage bis Beginn: 0,0
Dosis: 5
Route/Site: OT / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Arthralgia Flushing Headache Mass Musculoskeletal stiffness Rash Vaccination site pain Vaccination site reaction

Symptomtext

Bumps, rash-like 50-60 in all, most around face, neck, shoulder and upper body; Bumps, rash-like 50-60 in all, most around face, neck, shoulder and upper body; Headache; Face flushing; Quite sore/ Sore arm; Pain in shoulder; Injection site reaction; Stiff neck due to tensing up to pain in shoulder/ Stiff shoulder; This spontaneous case was reported by a patient and describes the occurrence of VACCINATION SITE REACTION (Injection site reaction), MUSCULOSKELETAL STIFFNESS (Stiff neck due to tensing up to pain in shoulder/ Stiff shoulder), FLUSHING (Face flushing), MASS (Bumps, rash-like 50-60 in all, most around face, neck, shoulder and upper body) and RASH (Bumps, rash-like 50-60 in all, most around face, neck, shoulder and upper body) in a 72-year-old female patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. AS7143C) for COVID-19 prophylaxis. The occurrence of additional non-serious events is detailed below. Co-suspect products included non-company products TRIAMCINOLONE ACETONIDE (ZILRETTA) injection for an unknown indication and BIFIDOBACTERIUM INFANTIS (ALIGN) for an unknown indication. No acute illnesses when vaccinated. There were no other vaccines taken on day of covid 19 vaccine and no other vaccines taken prior to or after 30 days of covid 19 vaccine. The patient's past medical history included GI pain (hernia was almost surely the cause of many of the more minor GI pains that resolved w/o antibiotics.), Hernia (a previously undetected hernia (1.5cm x 3 cm) was found; the pocket was cleaned out and the tear repaired.), Joint arthroplasty (TMJ arthroplasty. No recent changes) on 03-Apr-1985, Hysterectomy (ovaries not removed) on 14-Nov-1989, Lymph node dissection (sentinel node dissection, port placement (though updated diagnosis changed and no chemo TX needed)) on 07-Mar-2016, Mastectomy bilateral (right side at my option) on 15-Apr-2016, Port removal (swap out expander for implants AND port removal) on 23-Sep-2016 and Bunionectomy on 25-Jan-2018. Previously administered products included for Breast cancer: Arimidex from 2016 to 28-Apr-2017 and Arimidex (Feeling awful) from 2016 to 28-Apr-2017; for Product used for unknown indication: Shingrix vaccination on 08-Aug-2018 and PFIZER DRUG (Minimal soreness at injection site) on 30-Mar-2022; for Knee arthritis: Hymovis shots on 11-Mar-2021 and Hymovis shots on 18-Mar-2021. Past adverse reactions to the above products included Feeling abnormal with Arimidex; Hot flashes with Arimidex; No adverse event with Hymovis shots, Hymovis shots and Shingrix vaccination; and Vaccination site pain with PFIZER DRUG. Concurrent medical conditions included Drug allergy (Danocrin (significant hives)), Drug allergy (depo-medrol (severe headache, insomnia, several days of hot flushing?red faced)), Latex allergy (blistering with prolonged contact), Drug allergy (possible other drug (rash that is currently presumed to be due to new probiotics introduced after multiple rounds of antibiotics in the spring)), Diverticulitis (Subsequent bouts 15AUG2018 (possibly exacerbated by 08AUG2018 Shingrix vaccination), 22JUL2019, 23MAR2021, 23DEC 2021, 17MAR2022) since 28-Apr-2017, Estrogen receptor positive breast cancer (Arimidex was stopped on April 28 2017 due to onset of substantial side effects) since 2016, TMJ syndrome since 1980, Knee arthritis (TX for arthritis in Rt knee: some Hymovis injections and Zilretta injections every 3 months.) since December 2018, AFib, Progesterone receptor positive breast cancer since 2016 and HER2 negative breast cancer since 2016. On 12-Sep-2022, the patient received fifth dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On 15-Sep-2022, the patient started TRIAMCINOLONE ACETONIDE (ZILRETTA) (unknown route) at an unspecified dose. On an unknown date, the patient started BIFIDOBACTERIUM INFANTIS (ALIGN) (unknown route) at an unspecified dose. On 12-Sep-2022, the patient experienced VACCINATION SITE REACTION (Injection site reaction), MUSCULOSKELETAL STIFFNESS (Stiff neck due to tensing up to pain in shoulder/ Stiff shoulder), ARTHRALGIA (Pain in shoulder) and VACCINATION SITE PAIN (Quite sore/ Sore arm). On 16-Sep-2022, the patient experienced FLUSHING (Face flushing) and HEADACHE (Headache). On 23-Sep-2022, the patient experienced MASS (Bumps, rash-like 50-60 in all, most around face, neck, shoulder and upper body) and RASH (Bumps, rash-like 50-60 in all, most around face, neck, shoulder and upper body). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. On 15-Sep-2022, MUSCULOSKELETAL STIFFNESS (Stiff neck due to tensing up to pain in shoulder/ Stiff shoulder) and VACCINATION SITE PAIN (Quite sore/ Sore arm) had resolved. On 20-Sep-2022, FLUSHING (Face flushing) and HEADACHE (Headache) had resolved. At the time of the report, VACCINATION SITE REACTION (Injection site reaction) and ARTHRALGIA (Pain in shoulder) had resolved and MASS (Bumps, rash-like 50-60 in all, most around face, neck, shoulder and upper body) and RASH (Bumps, rash-like 50-60 in all, most around face, neck, shoulder and upper body) was resolving. Patient received first dose of Moderna COVID-19 vaccine on 27-Jan-2021 at 10am (Lot 029L20A) of 0.5 milliliter on right arm. Patient received second dose of Moderna COVID-19 vaccine on 24-Feb-2021 at 11am (Lot 023M20A) of 0.5 milliliter on right thigh. Patient received third dose of Moderna COVID-19 vaccine on 27-Aug-2021 (Lot 002F21A) of 0.5 milliliter on right arm. Patient thought the rash was attributable to the introduction of new probiotics (following a lot of antibiotics in the spring and colon surgery), and patient wanted to wait to do another challenge with a new probiotic and that worked like another rash. Patient had done the September probiotic challenge to get more confidence that the introduction of new probiotics was the likely cause of the rashes. So the patient did not think the rash was caused by the vaccine. 4 different probiotic challenges have resulted in a rash. Each time, the rash cleared over then subsequent 1-3 weeks. Patient reported that the introduction of new probiotics seems to have been the triggers 4 times for the 4 rounds of rash. Patient had experienced similar adverse events Sore arm and Stiff shoulder to all flu and COVID vaccine shots. Patient had experienced similar adverse events Face flushing and headache but the reaction to depo-medrol was much worse. No previous reaction to any. It was reported that other possible causes of Face flushing and Headache was Zilretta injection on 15-Sep-2022. It was reported that other possible causes of Bumps, rash-like was any drug in previous year contribute (Rash started after an intentional challenge with a different probiotic, Align). Face flushing, headache was recovered approximately on 20-SEP-2022 Rash had faded in approximately 2 weeks. This case was linked to MOD-2022-628835, MOD-2022-628837, MOD-2022-628840 (Patient Link).

Weitere VAERSDATA-Felder

Praegender Schweregrund: Arthralgia
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: AFib; Diverticulitis (Subsequent bouts 15AUG2018 (possibly exacerbated by 08AUG2018 Shingrix vaccination), 22JUL2019, 23MAR2021, 23DEC 2021, 17MAR2022); Drug allergy (possible other drug (rash that is currently presumed to be due to new probiotics introduced after multiple rounds of antibiotics in the spring)); Drug allergy (depo-medrol (severe headache, insomnia, several days of hot flushing?red faced)); Drug allergy (Danocrin (significant hives)); Estrogen receptor positive breast cancer (Arimidex was stopped on April 28 2017 due to onset of substantial side effects); HER2 negative breast cancer; Knee arthritis (TX for arthritis in Rt knee: some Hymovis injections and Zilretta injections every 3 months.); Latex allergy (blistering with prolonged contact); Progesterone receptor positive breast cancer; TMJ syndrome
Vorgeschichte: Medical History/Concurrent Conditions: Bunionectomy; GI pain (hernia was almost surely the cause of many of the more minor GI pains that resolved w/o antibiotics.); Hernia (a previously undetected hernia (1.5cm x 3 cm) was found; the pocket was cleaned out and the tear repaired.); Hysterectomy (ovaries not removed); Joint arthroplasty (TMJ arthroplasty. No recent changes); Lymph node dissection (sentinel node dissection, port placement (though updated diagnosis changed and no chemo TX needed)); Mastectomy bilateral (right side at my option); Port removal (swap out expander for implants AND port removal); Comments: No acute illnesses when vaccinated. There were no other vaccines taken on day of covid 19 vaccine and no other vaccines taken prior to or after 30 days of covid 19 vaccine
Andere Medikamente: ZILRETTA; ALIGN
Allergien: -
Vorherige Impfungen: -

VAERS 2504372

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7143C

mild

Staat: -
Alter: 71,0
Geschlecht: M
Eingang: 10.11.2022
Impfdatum: 10.11.2022
Beginn: 10.11.2022
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

Muscle spasms Nausea

Symptomtext

Patient within 15 complains of back spasm with nausea. Patient affirms hx. of back-related problems.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Nausea
Hospital-Tage: -
Labordaten: Patient screened by oncall medical provider and released for follow-up with PCM or Emergency room if symptoms return or worsen.
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2499963

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7143C

mild

Staat: WA
Alter: 67,0
Geschlecht: F
Eingang: 05.11.2022
Impfdatum: 08.09.2022
Beginn: 09.09.2022
Tage bis Beginn: 1,0
Dosis: 5
Route/Site: SYR / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: ja ER: ja Erholt: nein

Allodynia Antinuclear antibody negative Arthralgia Balance disorder Blood creatine phosphokinase normal Blood folate normal C-reactive protein normal Computerised tomogram abdomen normal Computerised tomogram pelvis abnormal Culture urine negative Differential white blood cell count normal Electromyogram abnormal Electrophoresis protein normal Full blood count normal Gait disturbance Groin pain Hypoaesthesia Immediate post-injection reaction

Symptomtext

8 hours after vax woke at 2AM on 9/9/22 to pain in Right groin/hip area radiating down the inside of my Right leg to my ankle. This pain became excruciating (10/10) over the next few hours. I could not put weight on my R leg or walk without assistance. I found that if I laid on my L side in a fetal position the pain was more tolerable, but any other position/movement was excruciating. At 3PM on 9/9/22 I went to the ER. They did labs and a Pelvic/hip CT and all results were normal. They ended up just treating my pain with 100 mg Fentanyl thru IV and sent me home with Rx for Oxycodone/Acetamenophin. On 9/10/22 I woke to find that my Right leg was mostly numb from the knee down, with areas of Allodynia. I also had

Weitere VAERSDATA-Felder

Praegender Schweregrund: Arthralgia
Hospital-Tage: -
Labordaten: ANA Reflexive - 8/10/22, Paraneoplastic - 8/10/22, Methylmalonic AC - 8/10/22, B12 & Folate - 8/10/22, MRI Cervical and MRI Brain 8/28/22, Urine culture 9/9/22, UA Microscopic 9/9/22
Aktuelle Erkrankungen: -
Vorgeschichte: Type 1 Diabetes (40 years), Psoriatic Arthritis (12 years), Osteoporosis (4 years), Heart disease (heart attack 6/22)
Andere Medikamente: Insulin, Atorvastatin, Losartan, Hydrochlorothiazide, Carvedil
Allergien: Gluten Intolerant, Sulfa drugs, Clindamycin, Quinolone Antibio
Vorherige Impfungen: Moderna 1 - 1/22/21, Moderna 2 - 2/18/21, Age 66 In March 2021 I began to experience Nerve pain/numbness/

VAERS 2499347

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge as7143c

mild

Staat: SC
Alter: 67,0
Geschlecht: F
Eingang: 04.11.2022
Impfdatum: 26.02.2021
Beginn: 26.02.2021
Tage bis Beginn: 0,0
Dosis: 5
Route/Site: - / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Alopecia Arthralgia Immune-mediated adverse reaction Lichen sclerosus

Symptomtext

My last dose was bivalent but this site does not allow for multiple vaccinations/dates to be the potential source of the problem. I am having signs of over active immune functions with autoimmune symptoms of hair loss, lichen sclerosus, joint pain and the like. The hair loss worsened with time. I have no way of knowing if its related to my covid vaccinations but thought I should report it.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Arthralgia
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: none
Vorgeschichte: graves disease Please note I had covid vaccinations on 2/21, 3/21, with boosters on 11/21, 4/22 and 9/311/22. I am having signs of excessive autoimmune activity with hair loss, lichen sclerosus, joint pain, and sciatica. While there is no way to know for sure if it is related to the vaccinations, I felt I should report it to VSafe who suggested I file a report.
Andere Medikamente: synthroid, pravastatin, D3, tumeric, b complex, omega 3's, estradiol
Allergien: latex, demerol, augmentin
Vorherige Impfungen: -

VAERS 2494209

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7143C

mild

Staat: DC
Alter: 50,0
Geschlecht: M
Eingang: 31.10.2022
Impfdatum: 13.10.2022
Beginn: 22.10.2022
Tage bis Beginn: 9,0
Dosis: 3
Route/Site: SYR / AR

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

COVID-19 Fatigue Nasal congestion Oropharyngeal pain Respiratory tract congestion SARS-CoV-2 test positive

Symptomtext

After my vaccination on 10/13/2022. I did not have any reaction. On 10/22/2022 I took a COVID-19 test that came back positive. I started to feel my nose becoming more congested. I then contacted my doctor and they did put me on Paxlovid that day. After taking Paxlovid within two days I felt that I no longer had a sore throat or congestion and on Day 3 I tested again and was negative. After that I have been negative since then. I have been fatigued more than usual since.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Fatigue
Hospital-Tage: -
Labordaten: 22OCT2022 COVID-19 Home Test - Positive
Aktuelle Erkrankungen: N/A
Vorgeschichte: Type 2 Diabetes; Long Standing Nose Congestion
Andere Medikamente: Atorvastatin; Metformin;
Allergien: Terbinafine
Vorherige Impfungen: -

VAERS 2491432

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7143C

mild

Staat: NH
Alter: 72,0
Geschlecht: F
Eingang: 27.10.2022
Impfdatum: 12.09.2022
Beginn: 18.10.2022
Tage bis Beginn: 36,0
Dosis: 5
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Arthralgia COVID-19 Fatigue Headache Oropharyngeal pain Rhinorrhoea SARS-CoV-2 test positive

Symptomtext

I contracted COVID-19. I had a sore throat, headache, runny nose, joint pain, and experienced a lot of tiredness. I took a five day course of Paxlovid. I am also taking Dayquil medication.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Arthralgia
Hospital-Tage: -
Labordaten: 20Oct22 - Home COVID-19 test - Positive
Aktuelle Erkrankungen: None
Vorgeschichte: Parkinson's Disease; Reflux; High Cholesterol; Hypothyroid
Andere Medikamente: Levothyroxine; Atorvastatin; Famotidine; Clonazepam; Carbidopa Levodopa; Osteoplex; Multi-vitamin; Calcium; Magnesium; Potassium; Vitamin B12; Vitamin C; Omega 3; Lutein
Allergien: None
Vorherige Impfungen: -

VAERS 2490188

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH BIVALENT)) · Charge AS7143C

mild

Staat: CA
Alter: 77,0
Geschlecht: F
Eingang: 26.10.2022
Impfdatum: 13.09.2022
Beginn: 25.10.2022
Tage bis Beginn: 42,0
Dosis: 1
Route/Site: SYR / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

COVID-19 Chest discomfort Chills Cough Rhinorrhoea SARS-CoV-2 test positive Sneezing

Symptomtext

I tested positive for Covid 19 on October 26, 2022 I experienced sneezing, coughing, runny nose, tighten of the chest, chills no fever. I was taking SUDAFED and TYLENOL.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Chills
Hospital-Tage: -
Labordaten: No
Aktuelle Erkrankungen: N/A
Vorgeschichte: N/A
Andere Medikamente: Levoxyl; valacyclovir; progesterone; calcium
Allergien: Gluten; seafood
Vorherige Impfungen: -

VAERS 2489995

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7143C

mild

Staat: CA
Alter: 68,0
Geschlecht: M
Eingang: 26.10.2022
Impfdatum: 14.09.2022
Beginn: 25.09.2022
Tage bis Beginn: 11,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Fatigue Hypersensitivity Pain in extremity Pruritus Rash Urticaria

Symptomtext

The day after receiving the vaccine I felt tired, and my arm was sore for about a day. One 09/25/2022 I started breaking out in hives on my arms and forehead. This continued all week, but the rash and itching would never stay in one spot, it would disappear. On 10/01/2022, I went to my doctor to get a diagnosis and he said it was hives or an allergic reaction and gave me a prescription for prednisone. As of today, I continue to be itchy, but I don't have outbreaks of hives.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Fatigue
Hospital-Tage: -
Labordaten: N/A
Aktuelle Erkrankungen: N/A
Vorgeschichte: N/A
Andere Medikamente: Losartan
Allergien: N/A
Vorherige Impfungen: -

VAERS 2488867

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7143C

mild

Staat: WI
Alter: 69,0
Geschlecht: M
Eingang: 25.10.2022
Impfdatum: 17.09.2022
Beginn: 20.10.2022
Tage bis Beginn: 33,0
Dosis: 5
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

COVID-19 Headache Oropharyngeal pain Pyrexia SARS-CoV-2 test positive Sinus congestion

Symptomtext

I had recently spent some time with someone who had tested positive for COVID-19. On 10/20/2022, I woke up with more sinus congestion than normal, a slight headache, and a sore throat. I felt a little suspicious since these symptoms were not normal for me. I tested myself for COVID-19 and it was positive. I took some Alka Seltzer Plus and used some nose spray and then called my physician. He recommended against taking Paxlovid due to some of the medications I am on and the mild nature of my symptoms. He advised that if I get worse, to call him again, but they didn't get much worse. Thursday and Friday, I had the most trouble with my sinuses and I ran a mild fever that reached 100 degrees. I continued to treat congestion with Afrin nose spray and Alka Seltzer Plus, which seemed to control the symptoms. Saturday, I got a little bit better but was still using over the counter medications. On the fourth day, I did not use the nasal spray, but did use the Alka Seltzer Plus and a nasal rinse. Yesterday, I used the nasal spray again and Alka Seltzer Plus. Today, I'm feeling much better but am still congested in my sinuses and using the Afrin nasal spray and I also took Claritin.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Headache
Hospital-Tage: -
Labordaten: 20OCT2022- At Home COVID-19 Test- Positive
Aktuelle Erkrankungen: None
Vorgeschichte: Primary Hyper Aldosteronism; High Blood Pressure; High Cholesterol; Diabetes; Chronic Shoulder Pain; Polio
Andere Medikamente: Diltiazem; Triamterene Hydrochlorothiazide; Losartan; Metoprolol; Clonidine; Potassium Chloride; Lovastatin; Celecoxib; Nortriptyline; Metformin; Jardiance; Finasteride; Multivitamin; Afrin
Allergien: None
Vorherige Impfungen: -

VAERS 2484393

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7143C

mild

Staat: WY
Alter: 66,0
Geschlecht: F
Eingang: 20.10.2022
Impfdatum: 08.09.2022
Beginn: 13.10.2022
Tage bis Beginn: 35,0
Dosis: 1
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Rash

Symptomtext

Rash started to develop on the thighs, spread down to legs and feet and then to arms, hands and legs. Rash began on September 21 and lasted until October 13. During this time, client took OTC Benadryl, topical lotions and baths with little to no relief but did not seek medical care. Client reports that the rash went away abruptly on October 13, 2022 while she was continuing at home measures.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Rash
Hospital-Tage: -
Labordaten: None
Aktuelle Erkrankungen: No
Vorgeschichte: Hypothyroidism, osteoporosis
Andere Medikamente: Synthroid, Multi vitamin, D3
Allergien: No
Vorherige Impfungen: -

VAERS 2482000

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7143C

mild

Staat: WA
Alter: 74,0
Geschlecht: F
Eingang: 18.10.2022
Impfdatum: 17.09.2022
Beginn: 12.10.2022
Tage bis Beginn: 25,0
Dosis: 5
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Arthralgia COVID-19 Exposure to SARS-CoV-2 Headache Malaise Myalgia Neck pain Oropharyngeal pain Respiratory tract congestion SARS-CoV-2 test positive Sinusitis Sneezing

Symptomtext

10/12/2022 at 1:00 AM, when I came off the plane, I woke up the next morning with a sore throat and significant congestion. I am prone to sinus infections and that is what is was. On 10/12/2022 I started testing till 10/16/2022. I was testing every day. I was negative every day. On the 10/15/2022 I tested positive. On 10/16/2022 I went to urgent care for the medication. They did not test me at the urgent. They did prescribe me the Paxlovid because I have a non-essential tremor. They wanted to put me on Lagevrio. It was not used. They said they did not get much efficacy from it. I was on the 5 day cut off point, I chose not to take it because my symptoms were mild as far as the congestion. My congestion has stayed, and I have a little bit of a headache off and on. Yesterday was a little bit of muscle ache, mostly in the shoulder and neck area. It feels achier than it does tight. I have no cough; my oxygen has stayed 98 consistently. On Sunday and Monday, I had 97.7 temperature. I have not had fatigue. I started sneezing a few days into it. I have been using saline rinse. My sore throat is much better today. I was exposed by my two travel friends. Today, 10/18/2022, is my 7th day with symptoms. I have not tested since Sunday.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Arthralgia
Hospital-Tage: -
Labordaten: 10/12/2022 through 10/14/2022 COVID-19 home test-negative 10/15/2022 COVID-19 home test - positive
Aktuelle Erkrankungen: N/A
Vorgeschichte: chronic back issues
Andere Medikamente: Calcium; Probiotic; B Complex; Magnesium
Allergien: Dolobid; Macadamia nuts, mangoes; bees; wasp; figs
Vorherige Impfungen: -

VAERS 2481784

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge AS7143C

mild

Staat: MO
Alter: 57,0
Geschlecht: F
Eingang: 18.10.2022
Impfdatum: 21.09.2022
Beginn: 21.09.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Fatigue Lymphadenopathy

Symptomtext

Developed enlarged lymph nodes along back of head, along clavicle (largest one), and sides of neck. Severe fatigue, fever X 4 days. Lymph node along clavicle remains somewhat swollen.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Fatigue
Hospital-Tage: -
Labordaten: None
Aktuelle Erkrankungen: None
Vorgeschichte: Epstein Barr
Andere Medikamente: Escitalopram 20 mg, Tumeric, Acyclovir 500mg, Black Cohosh
Allergien: Sulfa, Morphine, Propofol
Vorherige Impfungen: -

VAERS 2481159

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7143C

mild

Staat: NC
Alter: 66,0
Geschlecht: F
Eingang: 17.10.2022
Impfdatum: 07.09.2022
Beginn: 29.09.2022
Tage bis Beginn: 22,0
Dosis: 5
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

COVID-19 Cough Extra dose administered Fatigue Malaise Nasal congestion Oropharyngeal pain Rhinorrhoea SARS-CoV-2 test positive Sneezing

Symptomtext

I received my 5th Moderna Covid-19 vaccine on 9-7-22. On 9-27-22 I developed moderate nasal congestion & sneezing; treated successfully with a nasal decongestant. I was fatigued on 9-28 and 9-29 developed cough & mild sore throat. A week before I had been exposed to family members with a cold who tested negative for covid and assumed I caught what they had; when the cough started and my husband (who also had the Covid vaccine on 9-7 at a different pharmacy) started feeling sick too we both tested for covid and were both positive on 9-29. We were treated with Paxlovid and got 90% better in a few days, but on the evening of October 11 (day 8 after Paxlovid) we started feeling sick again with cough & runny nose.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Fatigue
Hospital-Tage: -
Labordaten: Covid home antigen positive Sept 29. Covid home antigen tests negative October 8, 9, 12
Aktuelle Erkrankungen: none
Vorgeschichte: sleep apnea, hyperlipidemia, scoliosis
Andere Medikamente: Zetia, Vitamin D, Protonix
Allergien: Ceftin
Vorherige Impfungen: -

VAERS 2477952

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge AS7143C

mild

Staat: VA
Alter: 51,0
Geschlecht: M
Eingang: 13.10.2022
Impfdatum: 17.09.2022
Beginn: 01.10.2022
Tage bis Beginn: 14,0
Dosis: UNK
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Mechanical urticaria

Symptomtext

patient called and reported he developed Dermographism.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Mechanical urticaria
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: PREVACID, PRILOSEC, SYNTHROID, PROZAC.
Allergien: PHENERGAN
Vorherige Impfungen: -

VAERS 2475759

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7143C

mild

Staat: AZ
Alter: 75,0
Geschlecht: F
Eingang: 11.10.2022
Impfdatum: 07.09.2022
Beginn: 07.09.2022
Tage bis Beginn: 0,0
Dosis: 5
Route/Site: SYR / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Arthralgia Asthenia Fatigue Feeling abnormal Myalgia Pain Urine analysis

Symptomtext

In the evening of my vaccination date I began to have symptoms of muscle and joint pain lack of strength and fatigue. I did have the flu vaccine on the same day as my COVID-19 Vaccine. The symptoms were much worse on the second day and I was miserable, I spent most of the day in bed napping as a result. The symptoms started to get better after the third day and I finally started to feel back to my normal self. However, since the vaccine my pain has become significantly worse and I am now prescribed codeine to ease the pain. About a week ago I did go to urgent care with what I thought was a UTI, they did take a sample and did not find anything. I was given an antibiotic to treat the symptoms however they did state that there was an issue with the sample. Now I do have mild pain still that is lasting despite finishing my round of antibiotics.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Arthralgia
Hospital-Tage: -
Labordaten: Urine test: results were inconclusive due failure in delivery to lab. 10/2022.
Aktuelle Erkrankungen: N/A
Vorgeschichte: Poly Arthritis; Asthma; Rheumatoid Arthritis; Fibromyalgia; History of Migraine; Sleep Apnea; Chronic Kidney Disease; Heartburn; Hypertension; Occasional Vertigo
Andere Medikamente: Triamterene HCTZ; losartan; metoprolol; tritanol cream; TYLENOL arthritis; OZEMPIC sample; prebiotic; probiotic; glucosamine; berberine
Allergien: N/A
Vorherige Impfungen: Influenza vaccines in general; Last vaccine received 09/07/2022; Feeling worse after every flu vaccine received for as long as I

VAERS 2475697

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7143C

mild

Staat: WA
Alter: 71,0
Geschlecht: M
Eingang: 11.10.2022
Impfdatum: 12.09.2022
Beginn: 08.10.2022
Tage bis Beginn: 26,0
Dosis: 5
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Bed sharing Oropharyngeal pain Rhinorrhoea SARS-CoV-2 test positive

Symptomtext

Flew home on 10/6/22; didn't wear a mask, sadly. On 10/8, I had a very minor sore throat which continued on 10/9. The evening of 10/9 I also started have a bit of a runny nose. On 10/10, mid-morning, I took an iHealth Covid home test which I'd received via the post office - I tested POSITIVE. I am quarantining in-home (to protect my wife). On 10/10, I contacted my health providers and received a 5-day anti-viral course of Paxlovid.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Oropharyngeal pain
Hospital-Tage: -
Labordaten: 10/10/22 - took iHealth home Covid test - POSITIVE.
Aktuelle Erkrankungen: none
Vorgeschichte: high cholesterol & high Blood Pressure
Andere Medikamente: Pravastatin (high cholesterol) Benazepril (high BP) Amlodipine (high BP) HCTZ (high BP) Vitamin D Centrum Plus 50+ multivitamin stool softener
Allergien: none
Vorherige Impfungen: -

VAERS 2473389

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7143C

mild

Staat: MI
Alter: 60,0
Geschlecht: F
Eingang: 10.10.2022
Impfdatum: 09.09.2022
Beginn: 10.09.2022
Tage bis Beginn: 1,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Asthenia Blood glucose normal Diarrhoea Fatigue Illness

Symptomtext

The evening I received my vaccine I experienced fatigue and side effects that you expect from COVID-19 vaccine. The next morning began experiencing diarrhea. Stools where very loose and I went to the restroom multiple times per day. Went in to see PCP because I was still having diarrhea and weakness. Dr. thought it could be a stomach bug that is going around and also advised me to increase my protein intake.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Diarrhoea
Hospital-Tage: -
Labordaten: Blood glucose normal
Aktuelle Erkrankungen: Seasonal allergies
Vorgeschichte: High blood pressure
Andere Medikamente: Candesartan; TOPROL; multivitamin; vitamin E; vitamin D
Allergien: Penicillin; erythromycin
Vorherige Impfungen: As a child I fainted after receiving vaccine. Unknown age and vaccine.

VAERS 2473357

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge AS7143C

mild

Staat: IL
Alter: 70,0
Geschlecht: F
Eingang: 10.10.2022
Impfdatum: 26.09.2022
Beginn: 03.10.2022
Tage bis Beginn: 7,0
Dosis: 5
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

COVID-19 Cough Ear discomfort Fatigue Feeling abnormal Influenza virus test negative Lacrimation increased Pyrexia SARS-CoV-2 test positive Sinus congestion Sneezing Throat irritation

Symptomtext

I originally thought it was allergies because I was having watery eyes, itchy throat, and sneezing. On 10/5/2022 I went to the doctor to be tested for COVID and the results came back the following morning showing that, I was positive. Since having COVID I have experienced some brain fog, fatigue, head congestion, and pressure in my ears. The doctor prescribed me some medication which has helped with my cough.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Fatigue
Hospital-Tage: -
Labordaten: The doctor did perform an Influenza test on me because I had a high fever which came back negative.
Aktuelle Erkrankungen: None
Vorgeschichte: None
Andere Medikamente: Cymbalta; Lamictal
Allergien: Penicillin; Clindamycin
Vorherige Impfungen: -

VAERS 2472787

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7143C

mild

Staat: KS
Alter: 63,0
Geschlecht: F
Eingang: 09.10.2022
Impfdatum: 05.10.2022
Beginn: 06.10.2022
Tage bis Beginn: 1,0
Dosis: 6
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Injection site erythema Injection site pruritus Injection site swelling Injection site vesicles

Symptomtext

swelling redness vesicles and some itching to right deltoid, right upper arm, right forearm, right wrist

Weitere VAERSDATA-Felder

Praegender Schweregrund: Injection site erythema
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: none known
Vorgeschichte: type 2 diabetes, hypertension, hyperlipidemia
Andere Medikamente: -
Allergien: none known
Vorherige Impfungen: -

VAERS 2471913

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7143C

mild

Staat: CA
Alter: 61,0
Geschlecht: F
Eingang: 07.10.2022
Impfdatum: 07.09.2022
Beginn: 04.10.2022
Tage bis Beginn: 27,0
Dosis: 5
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

COVID-19 Cough Oropharyngeal pain Palatal disorder Respiratory tract congestion SARS-CoV-2 test positive

Symptomtext

I felt a minor pain in my throat, the soft pallet was swollen, this was on Monday. I was wondering if this could possibly be COVID-19 as I had just returned from a trip. On Tuesday I went to the Doctor and had a PCR test done and was alerted late that evening via the online medical record that it was positive for COVID-19. Once I tested positive, I was given a prescription for Paxlovid but did not take it. The sore throat went away fairly quickly, I still have some congestion and a bit of a cough but otherwise in general I feel fine. I never had a headache or fever.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Oropharyngeal pain
Hospital-Tage: -
Labordaten: PCR COVID-19 test
Aktuelle Erkrankungen: No
Vorgeschichte: No
Andere Medikamente: Sinuglair; Advair; Multivitamin; Vitamin D3
Allergien: Neomycin
Vorherige Impfungen: -

VAERS 2470918

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7143C

mild

Staat: WY
Alter: 77,0
Geschlecht: F
Eingang: 06.10.2022
Impfdatum: 09.09.2022
Beginn: 10.09.2022
Tage bis Beginn: 1,0
Dosis: 5
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Arthralgia Contusion Decreased appetite Headache Influenza like illness Injection site pain Lymphadenopathy Malaise Pain Pyrexia Swelling

Symptomtext

Next evening-Headache to back of the head. Saturday-Am with fever of 101, achy, not feeling well and no appetite. "Flu like" Saturday evening -Tender to the Left Deltoid region. Sunday-Am Swelling to Left clavicle,, shoulder very sore, fever of 104., could feel lympth nodes of axillary, Left side of the neck bruised. Monday-fever gone. X1week of not feeling well and swelling. Opted not to go to MD.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Arthralgia
Hospital-Tage: -
Labordaten: N/A
Aktuelle Erkrankungen: Unknown
Vorgeschichte: Unknown
Andere Medikamente: Unknown
Allergien: Unknown
Vorherige Impfungen: -

VAERS 2470897

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7143C

mild

Staat: IN
Alter: 79,0
Geschlecht: F
Eingang: 06.10.2022
Impfdatum: 16.09.2022
Beginn: 16.09.2022
Tage bis Beginn: 0,0
Dosis: 5
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Arthralgia Pain in extremity Rash Tenderness

Symptomtext

Patient called pharmacy and informed us of a delayed reaction to the covid vaccine. Her complaint was "DELAYED REACTION TO COVID VACCINE- SORENESS IN RIGHT ARM SINCE VACCINE ON 09/16/22. ALSO HAD RASH ON RIGHT TIGHT ON 09/21/22- WENT AWAY. NOW BACK AGAIN- COMPLAINS OF TERRIBLE JOINT PAINS- WORSE AS THE DAYS GO ON- SAYS PAIN IS WORSE WHEN SHE GETS COLD- NO KNOWN TEMPS- STATES RASH DOESN'T ITCH- JUST TENDER TO THE TOUCH" according to letter received on 10/06/22 at the pharmacy

Weitere VAERSDATA-Felder

Praegender Schweregrund: Arthralgia
Hospital-Tage: -
Labordaten: unknown
Aktuelle Erkrankungen: unknown
Vorgeschichte: unknown
Andere Medikamente: unknown
Allergien: sulfa antibiotics
Vorherige Impfungen: -

VAERS 2470718

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge AS7143C

mild

Staat: GA
Alter: 62,0
Geschlecht: F
Eingang: 06.10.2022
Impfdatum: 07.09.2022
Beginn: 01.10.2022
Tage bis Beginn: 24,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

COVID-19 Exposure to SARS-CoV-2 Malaise SARS-CoV-2 test positive

Symptomtext

On Tuesday September 27, 2022, my husband and I found out that a friend we spent the weekend with had tested positive for COVID-19. We both tested with a home test that came negative. By Thursday, September 29, 2022 I started feeling ill so I took another home COVID-19 and again on Friday, September 30, 2022, as I was feeling really ill by then. Both test came back negative. On Saturday I went to the local Minute Clinic to get a PCR test that came back positive on 10/02/2022, I was not given medication. I have been taken over the counter medication that I have at my home.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Malaise
Hospital-Tage: -
Labordaten: Home COVID-19 test PCR COVID-19 test
Aktuelle Erkrankungen: No
Vorgeschichte: Hypothyroidism
Andere Medikamente: Levothyroxine; Wellbutrin XL; Estrogen Patch
Allergien: SSRI's cause a rash
Vorherige Impfungen: -

VAERS 2470308

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7143C

mild

Staat: NJ
Alter: 66,0
Geschlecht: M
Eingang: 05.10.2022
Impfdatum: 05.10.2022
Beginn: 05.10.2022
Tage bis Beginn: 0,0
Dosis: 5
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Back pain Headache Neck pain

Symptomtext

After administration patient experienced significant back pain, neck pain and throbbing headache. Patient was given water, offered crackers, ems and offer to contact spouse. All but water was declined. After approximately 25 minutes symptoms resolved. Patient denied any itching, tingling, swelling, puffiness or trouble breathing.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Back pain
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2470109

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7143C

mild

Staat: WA
Alter: 80,0
Geschlecht: M
Eingang: 05.10.2022
Impfdatum: 07.09.2022
Beginn: 16.09.2022
Tage bis Beginn: 9,0
Dosis: 4
Route/Site: SYR / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

COVID-19 Cough Fatigue Nasal congestion Rhinorrhoea SARS-CoV-2 test positive

Symptomtext

On the 16th I was a little bit tired from being out of town. I slept an hour or so. I noticed I had a little stuffy nose. The next day I tested positive. I had a runny nose, cough, and fatigue but nothing severe. On Monday I was feeling a tad bit better but still tired. I called the doctor the next day and he prescribed the antiviral medication in case I started to feel worse. I never took it.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Fatigue
Hospital-Tage: -
Labordaten: COVID-19 test- Positive
Aktuelle Erkrankungen: N/A
Vorgeschichte: N/A
Andere Medikamente: Chlorothiazide; Atorvastatin; Vitamin D, Zinc, Fish Oil
Allergien: N/A
Vorherige Impfungen: -

VAERS 2469706

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge as7143c

mild

Staat: NC
Alter: 69,0
Geschlecht: F
Eingang: 05.10.2022
Impfdatum: 19.09.2022
Beginn: 19.09.2022
Tage bis Beginn: 0,0
Dosis: 5
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Arthralgia Musculoskeletal stiffness Neck pain Pain in extremity Product administered at inappropriate site

Symptomtext

9/19/2022 received Moderna bilvalent vaccine in I arm. The young man who administered it seemed hesitant. I normally get my injections in my right arm because I will be moving that arm more but he wanted to put it in my left because that is the way the room was set up. I agreed. I am an RN who just retired from Public Health and have given hundreds of shots. I felt like the place was not correct. It was high and proximal rather than centered on my arm. I developed a stiff neck and sore arm within 12 hours and it has continued for almost 3 weeks now. The pain is more in my should neck area when standing and when laying down it is in my shoulder joint only. I have gone from Advil every 12 hours to every 6 hours along with ice and heat. I contacted my primary care doctor 10/3 and she said to wait an other week. The pain is severe enough that I now have an appointment with a musculoskeletal Dr tomorrow.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Arthralgia
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: None
Vorgeschichte: Arthritis
Andere Medikamente: Estradiol 0.025 mg/day
Allergien: Sulfa
Vorherige Impfungen: -

VAERS 2469538

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7143C

mild

Staat: SC
Alter: 71,0
Geschlecht: F
Eingang: 05.10.2022
Impfdatum: -
Beginn: 10.09.2022
Tage bis Beginn: -
Dosis: UNK
Route/Site: SC / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

Exposure to SARS-CoV-2 Headache Pyrexia Vision blurred Visual impairment

Symptomtext

After receiving the new Moderna BiValent vaccine, I began to notice some visual changes the 2nd day, and worsening to some degree on the 3rd day. This also happened after my 2nd regular Moderna booster, and it was irritating for about 2 weeks, and cleared up without any treatment. I thought it was possibly allergies at the time. But, since this has occurred again, I felt I should let the FDA know. Distance vision has seemed stable, but reading was blurry when it happened before, and it seems the same this time. If it doesn't clear up in a few days, I will see my ophthalmologist for evaluation. I have experienced headaches after each vaccine and booster, but more severe with the 1st one. Also ran a low grade fever for about 2 days each time. Temp less than 100 degrees. All vaccines and boosters have been Moderna. I am 71 years of age, and in good health. No underlying medical conditions, and do not take any prescription meds on a regular basis. I do take vitamins and mineral supplements I have not had Covid to the best of my knowledge. I have been directly exposed several times, but have never tested positive.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Headache
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: Drink several glasses of wine weekly
Vorgeschichte: Insomnia, migraines
Andere Medikamente: Zolpidem prn for insomnia Butalbital/caffeine/ASA prn for migraines, Calcium, Magnesium, Zinc, multi-vitamin, Resveratrol, Fish Oil, Red Yeast Rice, CoQ-10, Tart Cherry
Allergien: Penicillin, Erythromycin, Tamiflu, Pollen
Vorherige Impfungen: -

VAERS 2468843

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7143C

mild

Staat: NJ
Alter: 58,0
Geschlecht: F
Eingang: 04.10.2022
Impfdatum: 06.09.2022
Beginn: 10.09.2022
Tage bis Beginn: 4,0
Dosis: UNK
Route/Site: SYR / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Alopecia Headache Lymphadenopathy Nightmare

Symptomtext

Swollen glands under left armpit lasted 5 days Frequent headaches for a few weeks Terrible dreams for a few weeks Significant hair loss started a few days after vaccine, still experiencing this 4 weeks later.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Headache
Hospital-Tage: -
Labordaten: For hair loss issue, did Thyroid test to rule out hormonal issues on 9/21, normal results.
Aktuelle Erkrankungen: No
Vorgeschichte: Arthritis early Sjogrens
Andere Medikamente: Synthroid, Tylenol
Allergien: Soy, shellfish, chick peas, penicillin
Vorherige Impfungen: -

VAERS 2466897

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7143c

mild

Staat: TX
Alter: 81,0
Geschlecht: M
Eingang: 02.10.2022
Impfdatum: 01.10.2022
Beginn: 01.10.2022
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: SYR / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Asthenia Fatigue Hyperhidrosis Influenza like illness Pain Pain in extremity

Symptomtext

Sore Arm, flu-like symptoms, aches and pains, sweating, general weakness, fatigue,

Weitere VAERSDATA-Felder

Praegender Schweregrund: Fatigue
Hospital-Tage: -
Labordaten: N/A
Aktuelle Erkrankungen: N/A
Vorgeschichte: N/A
Andere Medikamente: Olmesa Medox, Doxycycl HYC 100mg, Amlodipine 2.5mg, Atorvastatin 20mg, Fluoxetine 20mg, probiotics, calcium.
Allergien: Lactose Intolerance
Vorherige Impfungen: -

VAERS 2465551

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7143C

mild

Staat: NC
Alter: 56,0
Geschlecht: M
Eingang: 30.09.2022
Impfdatum: 08.09.2022
Beginn: 11.09.2022
Tage bis Beginn: 3,0
Dosis: 5
Route/Site: SYR / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

COVID-19 Dizziness Fatigue Insomnia Malaise Nausea Rhinorrhoea SARS-CoV-2 test positive Secretion discharge Throat tightness Vertigo

Symptomtext

So on Sunday 9/11/2022 I started feeling run down and had drainage to the back of my throat and Monday I had felt run down, tightness in my throat and tested with a COVID-19 home test kit provided by the government and tested negative just went thru the whole day feeling yuck didn't sleep much with runny nose on Tuesday. I did another COVID-19 home test and it came back positive. On Wednesday I woke up feeling a little better the nasal stuff was shutting down and I had really bad vertigo and unless I didn't move at all, I was dizzy and nauseated and I went out ad got some Dramamine and that helped a lot with the vertigo and on Thursday I still had dizziness but less nausea and my wife encouraged me to speak with my physician and on Friday I still had mucus but never got into my lungs had a tele health visit and he recommended Dramamine for the vertigo and on Sunday I stopped taking it but had small interments bouts of nausea.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Dizziness
Hospital-Tage: -
Labordaten: COVID-19 Home test on 9/12/22 Negative; COVID-19 Home test on 9/13/22 Positive
Aktuelle Erkrankungen: None
Vorgeschichte: Hypothyroidism: Arthritis
Andere Medikamente: Allegra; Iron Supplement; Levothyroxine;
Allergien: Penicillin; Minocycline
Vorherige Impfungen: -

VAERS 2465468

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7143C

mild

Staat: FL
Alter: 73,0
Geschlecht: F
Eingang: 30.09.2022
Impfdatum: 08.09.2022
Beginn: 16.09.2022
Tage bis Beginn: 8,0
Dosis: UNK
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

COVID-19 Cough Fatigue Headache Nasal disorder Pain Pyrexia Respiratory tract congestion SARS-CoV-2 test positive Sinus disorder Upper-airway cough syndrome

Symptomtext

I started getting symptoms of a headache, congestion, sinus and nasal issues, cough, post nasal drip, fever, and aches and pains. I had a positive COVID-19 test. I was prescribed molnupiravir. I feel like the medication did help. My symptoms lasted for 5 days strong then lingered on like a sinus infections with fatigue. I still have tiredness and fatigue.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Fatigue
Hospital-Tage: -
Labordaten: COVID-19 test
Aktuelle Erkrankungen: None
Vorgeschichte: Diabetes; High Blood Pressure; Cardiac Issues; GERD; Sleep Apnea; Asthma
Andere Medikamente: Diabetes medication; blood medication
Allergien: N/A
Vorherige Impfungen: -

VAERS 2459889

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge AS7143C

mild

Staat: NC
Alter: 71,0
Geschlecht: M
Eingang: 30.09.2022
Impfdatum: 19.09.2022
Beginn: 19.09.2022
Tage bis Beginn: 0,0
Dosis: 5
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Blood lactic acid normal Chest X-ray normal Differential white blood cell count normal Headache Immunisation reaction Body temperature Dysuria Fatigue Laboratory test Metabolic function test normal Pyrexia Urine analysis normal White blood cell count normal Pollakiuria

Symptomtext

previous symptom from enlarged prostate worsening: difficulty urinating; previous symptom from enlarged prostate worsening: increased frequency of urination; persistent fever of up to 103?F; fatigue; mild headache; This spontaneous case was reported by a physician and describes the occurrence of DYSURIA (previous symptom from enlarged prostate worsening: difficulty urinating), POLLAKIURIA (previous symptom from enlarged prostate worsening: increased frequency of urination), PYREXIA (persistent fever of up to 103?F), FATIGUE (fatigue) and HEADACHE (mild headache) in a 71-year-old male patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. AS7143C) for COVID-19 vaccination. No allergies to medications, food and other products. Patient not had COVID positive test or diagnosis. The patient's past medical history included Mitral valve replacement (Condition was worsening.). Concurrent medical conditions included Enlarged prostate (Condition was worsening.) since 1990, Blood pressure high (Condition was worsening.), Hypercholesteraemia (Condition was worsening.), Dysuria (due to enlarged prostate) and Pollakiuria (due to enlarged prostate). Concomitant products included INFLUENZA VACCINE from 19-Sep-2022 to an unknown date for Flu prophylaxis, WARFARIN, ATORVASTATIN and HYDROCHLOROTHIAZIDE, LISINOPRIL (ZESTORETIC) for an unknown indication. On 19-Sep-2022, the patient received fifth dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On 19-Sep-2022, the patient experienced FATIGUE (fatigue) and HEADACHE (mild headache). On 22-Sep-2022, the patient experienced DYSURIA (previous symptom from enlarged prostate worsening: difficulty urinating), POLLAKIURIA (previous symptom from enlarged prostate worsening: increased frequency of urination) and PYREXIA (persistent fever of up to 103?F). The patient was treated with PARACETAMOL (TYLENOL) in September 2022 for Urination frequency of and Urination difficulty, at an unspecified dose and frequency and IBUPROFEN in September 2022 for Urination frequency of and Urination difficulty, at an unspecified dose and frequency. On 21-Sep-2022, FATIGUE (fatigue) and HEADACHE (mild headache) had resolved. At the time of the report, DYSURIA (previous symptom from enlarged prostate worsening: difficulty urinating) and POLLAKIURIA (previous symptom from enlarged prostate worsening: increased frequency of urination) outcome was unknown and PYREXIA (persistent fever of up to 103?F) had not resolved. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 22-Sep-2022, Body temperature: persistent fever of up to 103?F. On 24-Sep-2022, Laboratory test: were all good, with no evidence of infection or other unusual reaction. and were all good, with no evidence of infection or other unusual reaction.. For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter did not provide any causality assessments. Patient had previous doses of Moderna covid-19 vaccine -1st dose on 29-Jan-2021 (lot-012M20A and expiry date: 20-Jul-2021), 2nd dose on 26-Feb-2021 (lot-014M20A and expiry date: 12-Aug-2021), 1st booster dose on 22-Oct-2021 (lot-011F21A), 2nd booster on 02-Apr-2022 (lot-027L21A). It was reported that after bivalent booster, first couple of days patient only experienced minimum side effects, fatigue and mild headache. Patient spoke with his cardiologist and visited ER on 24-Sep-2022, but laboratory values and tests done to patient were all good, with no evidence of infection or other unusual reaction. Patient not experienced difficulty urinating and increased frequency of urination in the past. This case was linked to MOD-2022-651184, MOD-2022-651186 (Patient Link).

Weitere VAERSDATA-Felder

Praegender Schweregrund: Headache
Hospital-Tage: -
Labordaten: Test Date: 20220922; Test Name: Fever; Result Unstructured Data: persistent fever of up to 103?F; Test Date: 20220924; Test Name: laboratory values; Result Unstructured Data: were all good, with no evidence of infection or other unusual reaction.; Test Date: 20220924; Test Name: tests; Result Unstructured Data: were all good, with no evidence of infection or other unusual reaction.
Aktuelle Erkrankungen: Blood pressure high (Condition was worsening.); Dysuria (due to enlarged prostate); Enlarged prostate (Condition was worsening.); Hypercholesteraemia (Condition was worsening.); Pollakiuria (due to enlarged prostate)
Vorgeschichte: Medical History/Concurrent Conditions: Mitral valve replacement (Condition was worsening.); Comments: No allergies to medications, food and other products. Patient not had COVID positive test or diagnosis.
Andere Medikamente: INFLUENZA VACCINE; WARFARIN; ATORVASTATIN; ZESTORETIC
Allergien: -
Vorherige Impfungen: -

VAERS 2464417

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7143C

mild

Staat: TX
Alter: 75,0
Geschlecht: F
Eingang: 29.09.2022
Impfdatum: 22.09.2022
Beginn: 23.09.2022
Tage bis Beginn: 1,0
Dosis: 4
Route/Site: SYR / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Erythema Fatigue Hypersomnia Injection site erythema Injection site reaction Injection site swelling Injection site warmth Pain Rash papular

Symptomtext

About 24 hours after I had the vaccine, I was very tired, and I laid down to take a nap, I was going to take a short nap. And I didnt wake up up until about 4 hours and 15 mins later, when I woke up my body was achy all over, I was sore. And then more than 48 hours later, on the 24th, around midnight around 1am, that's when I noticed the arm that I had the vaccine in, was really red and not a bumpy rash, but it was below where I had the shot, and it took up the top part of my arm. It was very very red, and swollen and hot. It went all the way down the top of that arm and even went below the elbow, on the forearm and it was very red. That lasted till the next day and all day Sunday, and by Monday, it was starting to fade. I went and showed the pharmacy. He told me to take some Benadryl and I took some of those.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Fatigue
Hospital-Tage: -
Labordaten: None
Aktuelle Erkrankungen: Infected finger.
Vorgeschichte: Diabetic - Type 2, High blood pressure, Glycoma- Bilateral, Cellulitis of left finger, overweight, have sleep apnea, Osteoarthritis, Restless leg syndrome, dry eye syndrom, iron deficiency,
Andere Medikamente: Triamt/hctz tablets 37.5-25mg, lisinopril 5mg (half everymorning). Metformin extended release 500mg, low dose aspirin 81 mg, maximum strength municinex 1200mg 2 a day, Fenofibric acid 135mg 1 daily, Tylenol 8h arthritis pain 650 mg -take 2
Allergien: Atorvastatin: Myalgia , Augmentin hives, Bactrium
Vorherige Impfungen: 2nd Moderna-I had a very sore arm

VAERS 2463404

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7143C

mild

Staat: NV
Alter: 51,0
Geschlecht: F
Eingang: 28.09.2022
Impfdatum: 27.09.2022
Beginn: 27.09.2022
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Incorrect product formulation administered Pain in extremity

Symptomtext

Patient received a Moderna Bivalent booster dose instead of a Moderna (Red Cap) dose for her 1st immunization. This was her very first covid vaccine. She is not having any major symptoms. She only has a sore arm.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Pain in extremity
Hospital-Tage: -
Labordaten: None
Aktuelle Erkrankungen: Unknown
Vorgeschichte: Unknown
Andere Medikamente: Unknown
Allergien: Unknown
Vorherige Impfungen: -

VAERS 2463319

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7143C

mild

Staat: FL
Alter: 79,0
Geschlecht: F
Eingang: 28.09.2022
Impfdatum: 05.09.2022
Beginn: 12.09.2022
Tage bis Beginn: 7,0
Dosis: 5
Route/Site: SYR / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Pruritus

Symptomtext

I started itching on my arms, wrists, hands, ankles. This went on for about 3 days. Then I took Zyrtec and it stopped. Two days later it started again and I took another Zyrtec and it hasn't come back since then.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Pruritus
Hospital-Tage: -
Labordaten: No
Aktuelle Erkrankungen: No
Vorgeschichte: No
Andere Medikamente: Levothyroxine; Pantoprazole; Lexapro; Calcium/Magnesium/Vitamin D; Antioxidants; Annuity inhaler
Allergien: Sulfur
Vorherige Impfungen: -

VAERS 2463134

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7143C

mild

Staat: MD
Alter: 71,0
Geschlecht: F
Eingang: 28.09.2022
Impfdatum: 08.09.2022
Beginn: 25.09.2022
Tage bis Beginn: 17,0
Dosis: 5
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

COVID-19 Diarrhoea Lethargy Nasal congestion Oropharyngeal pain Pain Pyrexia SARS-CoV-2 test positive Wheezing

Symptomtext

We recently took a trip out of town and attended the theater. I wore a mask for the entire trip, but others were not always masked. We returned home on 09/24/2022. On 09/25/2022 at 05:00PM my throat began to hurt, and my husband was also not feeling well. We both tested negative on at home COVID-19 tests. The next day, 09/26/2022, we tested again, and the results were positive. I called my doctor who prescribed us each PAXLOVID which we began taking that same day. My symptoms have not begun to improve yet. I'm still experiencing sore throat, fever, aches and pains, lethargy, stuffy nose, respiratory wheezing in my chest, and diarrhea.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Diarrhoea
Hospital-Tage: -
Labordaten: At home COVID-19 test: 09/25/2022-negative; At home COVID-19 test; 09/26/2022-postive
Aktuelle Erkrankungen: None
Vorgeschichte: None
Andere Medikamente: Simvastatin; lorazepam; amitriptyline; NEXIUM; calcium citrate; biotin; magnesium citrate; potassium; L-methyl folate; vitamin D3; vitamin B12
Allergien: Doxycycline; FLAGYL
Vorherige Impfungen: -

VAERS 2460897

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge AS7143C

mild

Staat: MD
Alter: 72,0
Geschlecht: F
Eingang: 26.09.2022
Impfdatum: 06.09.2022
Beginn: 11.09.2022
Tage bis Beginn: 5,0
Dosis: 5
Route/Site: SYR / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: nein

Computerised tomogram head normal Dysstasia Eye disorder Laboratory test Magnetic resonance imaging head Nausea Scan with contrast Sitting disability Vertigo Vestibular neuronitis

Symptomtext

I received the shot at my local grocery store's pharmacy on Tuesday, Sept. 6. On Sunday, Sept. 11 I woke at my son's home at 6 a.m. unable to open my eyes, could not sit or stand because of violent vertigo and intense nausea. 911 responders took me to local Hospital where I was was admitted as a possible stroke patient. CT determined no cranial bleeding. Severe vertigo continued. I was treated with anti-nausea medications and admitted to the hospital. Dr. Private, was my attending physician, though she is not my primary care doctor as I was visiting my son. I was discharged on Wednesday, Sept. 14, with the diagnosis of no stroke, but no reason for the vertigo. I was referred to vestibular therapist who recommended seeing ENT doctor. On Sept. 21 Dr. diagnosed vestibular neuritis. I am now in PT and am recovering gradually. When I l do a search engine I find vestibular neuritis I found abstracts and reports relating it as a rare side effect of the COVID vaccine. Which is what prompted me to report this event to you.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Nausea
Hospital-Tage: 3,0
Labordaten: Vast number of tests including CT scan, Sept. 11, and brain MRI with and without contrast on Sept. 12 (?) If you are able to access my records in the "Private hospital", you will find 20+ tests that were administered. I do not know how to link them to this report.
Aktuelle Erkrankungen: none
Vorgeschichte: lichen planopilaris
Andere Medikamente: No prescriptions multi vitamin Calcium Iron supplement
Allergien: Percocet - makes me nauseous
Vorherige Impfungen: "COVID arm" large swelling at injection site 2/16/21 70 yo Moderna 013M20A.

VAERS 2459549

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge AS7143C

mild

Staat: CA
Alter: 55,0
Geschlecht: F
Eingang: 24.09.2022
Impfdatum: 08.09.2022
Beginn: 20.09.2022
Tage bis Beginn: 12,0
Dosis: 5
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Dizziness Feeding disorder Nausea Pain in extremity Pruritus Pyrexia SARS-CoV-2 test

Symptomtext

Couldn't eat; Arm was itchy; Dizzy; Nauseous; Fever; Arm was itchy and a bit sore; This spontaneous case was reported by a patient and describes the occurrence of FEEDING DISORDER (Couldn't eat), PRURITUS (Arm was itchy), DIZZINESS (Dizzy), NAUSEA (Nauseous) and PYREXIA (Fever) in a 55-year-old female patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. AS7143C) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. The patient did not had any allergies to any food or medications. On 08-Sep-2022, the patient received fifth dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On 20-Sep-2022, the patient experienced FEEDING DISORDER (Couldn't eat), PRURITUS (Arm was itchy), DIZZINESS (Dizzy), NAUSEA (Nauseous), PYREXIA (Fever) and PAIN IN EXTREMITY (Arm was itchy and a bit sore). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, FEEDING DISORDER (Couldn't eat), PRURITUS (Arm was itchy), NAUSEA (Nauseous), PYREXIA (Fever) and PAIN IN EXTREMITY (Arm was itchy and a bit sore) was resolving and DIZZINESS (Dizzy) outcome was unknown. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 19-Sep-2022, SARS-CoV-2 test: (Negative) Negative. No concomitant medications were reported. Patient received first dose on 26-Aug-2021 lot number 036A21A, second dose on 25-Sep-2021 lot number 038B21A, first booster dose on 05-Dec-2021 lot number 011F21A and second booster dose on 04-Apr-2022. It was reported that the patient had a whole roster of symptoms that seemed like the coronavirus or booster side effects. It took a long time. Patient wanted to know if that was something that usually happen. Reportedly, the patient stated that the symptoms had improved. Patient felt better on that day 21-Sep-2022. This case was linked to MOD-2022-648677 (Patient Link).

Weitere VAERSDATA-Felder

Praegender Schweregrund: Dizziness
Hospital-Tage: -
Labordaten: Test Date: 20220919; Test Name: COVID-19 virus test; Test Result: Negative ; Result Unstructured Data: Negative
Aktuelle Erkrankungen: -
Vorgeschichte: Comments: The patient did not had any allergies to any food or medications.
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2459233

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7143C

mild

Staat: IL
Alter: 42,0
Geschlecht: F
Eingang: 24.09.2022
Impfdatum: 12.09.2022
Beginn: 20.09.2022
Tage bis Beginn: 8,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Decreased appetite Diarrhoea Fatigue Nausea Pruritus

Symptomtext

Itchy palms (started 9/20), low grade nausea/lack of appetite (started a day after vaccination), diarrhea (started 9/13), extreme fatigue (9/21 - 9/22).

Weitere VAERSDATA-Felder

Praegender Schweregrund: Diarrhoea
Hospital-Tage: -
Labordaten: None
Aktuelle Erkrankungen: Long COVID
Vorgeschichte: Long COVID
Andere Medikamente: B-Complex, vegan Omega 3, D3 + K2, Alpha Lipoic Acid, Magnesium, vegan Glucosamine
Allergien: Amoxicillin
Vorherige Impfungen: 04/15/2021 - Pfizer 2nd COVID vaccine

VAERS 2454802

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7143C

mild

Staat: WA
Alter: 60,0
Geschlecht: F
Eingang: 22.09.2022
Impfdatum: 07.09.2022
Beginn: 12.09.2022
Tage bis Beginn: 5,0
Dosis: 5
Route/Site: SYR / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Abdominal pain upper Blood culture Diarrhoea Differential white blood cell count Full blood count Laboratory test Platelet count Pyrexia Sleep disorder Smear test

Symptomtext

day 1: (MON 9/12) Went to bed and woke in the night with hard stomach cramps - high, not low - day 2: (TUES 9/13) same with addition of fever - max 100.2 day 3: (WED 9/14) cramping less frequent, still hard, continued fever - spoke to on-call dr late afternoon, made plan to come in next day day 4: (THURS 9/15) cramping less and less frequent, no fever, but addition of diarrhea days 5-7 (FRI 9/16 - SUN 9/18) continued mild cramping - no fever or diarrhea

Weitere VAERSDATA-Felder

Praegender Schweregrund: Abdominal pain upper
Hospital-Tage: -
Labordaten: CBC with differential platelet CMP14 Hematopath consultation smear blood culture
Aktuelle Erkrankungen: -
Vorgeschichte: typically inflammation rate is high - unknown etiology
Andere Medikamente: Losartan 50mg Clonazepam .25mg Bio-Kult probiotic Magnesium Lactate
Allergien: penicillin; erythromycin; sulfa; azithromycin; levofloxacin; morphine; codeine; demerol; darvon
Vorherige Impfungen: -

VAERS 2453782

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH BIVALENT)) · Charge as7143c

mild

Staat: KS
Alter: 52,0
Geschlecht: F
Eingang: 21.09.2022
Impfdatum: 19.09.2022
Beginn: 21.09.2022
Tage bis Beginn: 2,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Fatigue Headache Pain Pyrexia Rash

Symptomtext

headache, sore and tired, low grade fever and rash developed on day2 inside of arms, shoulders, neck and chest and stomach

Weitere VAERSDATA-Felder

Praegender Schweregrund: Fatigue
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2453701

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge AS7143C

mild

Staat: MO
Alter: 78,0
Geschlecht: F
Eingang: 21.09.2022
Impfdatum: 14.09.2022
Beginn: 14.09.2022
Tage bis Beginn: 0,0
Dosis: 5
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Asthenia Cough Pyrexia

Symptomtext

Client states evening after receiving shot, she developed a new cough that is still ongoing. She states also developed a fever that last approximately 3 days, but has become weak and "can't hardly get out of the house" since receiving the shot. States her PCP has been notified.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Pyrexia
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2453631

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge AS7143c

mild

Staat: MD
Alter: 65,0
Geschlecht: F
Eingang: 21.09.2022
Impfdatum: 16.09.2022
Beginn: 16.09.2022
Tage bis Beginn: 0,0
Dosis: 5
Route/Site: SYR / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Abdominal pain Fatigue Feeling abnormal Headache Malaise Painful respiration SARS-CoV-2 test negative

Symptomtext

I'm still experiencing bad side effects from the shot which is unusual because all the other 4 shots I only felt bad for less than 24hours. It's been 5 days and I still feel ill, headache, abdominal pain; fatigue; it hurts to take a deep breath. I went to the ER and they took my vitals and did a COVID-19 test and after 6 hours I had to leave because they hadn't seen me and I was in a COVID room.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Abdominal pain
Hospital-Tage: -
Labordaten: Rapid COVID-19 test - negative
Aktuelle Erkrankungen: No
Vorgeschichte: No
Andere Medikamente: Tumoxapine; Flonase; Clarinex; Levothyroxine
Allergien: Penicillin; Levaquin; Mobic; Bactrim
Vorherige Impfungen: -

VAERS 2453603

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7143C

mild

Staat: MD
Alter: 79,0
Geschlecht: F
Eingang: 21.09.2022
Impfdatum: 06.09.2022
Beginn: 08.09.2022
Tage bis Beginn: 2,0
Dosis: UNK
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Activated partial thromboplastin time Arthralgia Back pain Blood magnesium Blood pressure fluctuation Blood pressure increased Blood test Chest X-ray Differential white blood cell count Electrocardiogram Fatigue Full blood count Headache International normalised ratio Laboratory test Lipase Metabolic function test Muscle spasms

Symptomtext

Patient reports starting 9/8/2022 muscles were extremely sore -- across shoulders and upper back, in hips, and down both arms and legs and she was extremely tired. Right shoulder started to go into severe spasms. The shoulder spasms lasted 4 days ending 9/12/2022.. Then beginning Friday 9/16/2022 the patient' blood pressure because to rise and fluctuate. On Sunday 9/18/2022 patient work with severe headache and BP 181/101 prompting patient to go to the Emergency Room at Hospital. in the ER her blood pressure was 225/105.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Arthralgia
Hospital-Tage: -
Labordaten: ECG 12 Lead 1154 Comprehensive Metabolic Panel Lipase Magnesium Prothrombin Time + INR APTT Troponin Complete Blood Count (CBC) + Auto Diff Pro-B Natriuretic Peptide CHEMISTRY BLOOD INDICES 1348 diazepam 5 mg 1412 XR Chest AP Only (Portable)
Aktuelle Erkrankungen: None
Vorgeschichte: Spinal stenosis, lumbar region, with neurogenic claudication Acquired spondylolisthesis Primary osteoarthritis of right hip Sacroiliac dysfunction Myofascial pain, deep gluteal muscles Greater trochanteric bursitis of right hip Status post total hip replacement, right Lumbar back pain Hypertension
Andere Medikamente: acetaminophen (TYLENOL) 500 MG tablet Take by mouth. b complex vitamins capsule Take 1 capsule by mouth daily. cholecalciferol (VITAMIN D3) 2,000 unit Cap Take 2,000 Units by mouth daily. diazePAM (VALIUM) 5 MG tablet Take 1 tablet (5 mg to
Allergien: no known allergies
Vorherige Impfungen: -

VAERS 2453039

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge AS7143C

mild

Staat: -
Alter: -
Geschlecht: U
Eingang: 21.09.2022
Impfdatum: 16.09.2022
Beginn: 16.09.2022
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Vaccination site pain

Symptomtext

just got the new Moderna booster and it felt like I got mosquito bites on my arm; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (just got the new Moderna booster and it felt like I got mosquito bites on my arm) in a patient of an unknown age and gender who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. AS7143C) for COVID-19 prophylaxis. No Medical History information was reported. On 16-Sep-2022, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On 16-Sep-2022, the patient experienced VACCINATION SITE PAIN (just got the new Moderna booster and it felt like I got mosquito bites on my arm). At the time of the report, VACCINATION SITE PAIN (just got the new Moderna booster and it felt like I got mosquito bites on my arm) outcome was unknown. No concomitant medications were reported. It was reported that, the patient got booster and it felt like mosquito bites on arm. It was unknown, if the patient had mosquito bite. No treatment details were reported.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Vaccination site pain
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2453038

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge AS7143C

mild

Staat: NY
Alter: 66,0
Geschlecht: F
Eingang: 21.09.2022
Impfdatum: 14.09.2022
Beginn: 14.09.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: OT / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Balance disorder Vaccination site pain Vertigo

Symptomtext

Felt like the room is spinning after her booster dose of the Moderna Covid-19 of balance/she has had episodes of the room spinning and feeling "off"; Patient says that her balance is off when she is walking.; patient complains of a sore left arm where the injection was; This spontaneous case was reported by a patient and describes the occurrence of VERTIGO (Felt like the room is spinning after her booster dose of the Moderna Covid-19 of balance/she has had episodes of the room spinning and feeling "off"), BALANCE DISORDER (Patient says that her balance is off when she is walking.) and VACCINATION SITE PAIN (patient complains of a sore left arm where the injection was) in a 66-year-old female patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. AS7143C) for COVID-19 prophylaxis. No Medical History information was reported. On 14-Sep-2022, the patient received fourth dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On 14-Sep-2022, the patient experienced BALANCE DISORDER (Patient says that her balance is off when she is walking.) and VACCINATION SITE PAIN (patient complains of a sore left arm where the injection was). On 15-Sep-2022, the patient experienced VERTIGO (Felt like the room is spinning after her booster dose of the Moderna Covid-19 of balance/she has had episodes of the room spinning and feeling "off"). At the time of the report, VERTIGO (Felt like the room is spinning after her booster dose of the Moderna Covid-19 of balance/she has had episodes of the room spinning and feeling "off"), BALANCE DISORDER (Patient says that her balance is off when she is walking.) and VACCINATION SITE PAIN (patient complains of a sore left arm where the injection was) outcome was unknown. No concomitant medications were reported. On 25-Apr-2021, the patient received first dose of Moderna COVID-19 vaccine (lot number: 048B21A) in unspecified arm, second dose on 23-May-2021 (lot number: 005C21A and expiry date: 22-Oct-2021) in unspecified arm and first monovalent booster on 29-nov-2021 (lot number: unknown) in left arm. No treatment medications were reported. This case was linked to MOD-2022-646300 (Patient Link).

Weitere VAERSDATA-Felder

Praegender Schweregrund: Vaccination site pain
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2444029

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge AS7143C

mild

Staat: MA
Alter: 72,0
Geschlecht: F
Eingang: 21.09.2022
Impfdatum: 09.09.2022
Beginn: 01.09.2022
Tage bis Beginn: -
Dosis: 5
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Body temperature increased Burning sensation Erythema Feeling hot Injection site pain Body temperature Oedema Pruritus Rash Skin burning sensation Local reaction Pain Swelling Vaccination site erythema Vaccination site pain Vaccination site warmth

Symptomtext

burning sensation in my scalp; increased warmth in an area about 5 inches below the site of vaccination; local pain/increased pain in an area about 5 inches below the vaccination site; disseminated rash/residual rash/ rash/generalized skin rash/ face also had the rash; local erythema/increased erythema in an area about 5 inches below the site of vaccination; local itching present/ itching ankles/ itching all over my body; swelling all over my body/arms and face; pitting edema/minimal edema/pitting edema more prominent in patient arms; This spontaneous case was reported by a physician and describes the occurrence of PRURITUS (local itching present/ itching ankles/ itching all over my body), SWELLING (swelling all over my body/arms and face), OEDEMA (pitting edema/minimal edema/pitting edema more prominent in patient arms), SKIN BURNING SENSATION (burning sensation in my scalp) and VACCINATION SITE WARMTH (increased warmth in an area about 5 inches below the site of vaccination) in a 72-year-old female patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. AS7143C) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. Concurrent medical conditions included Drug allergy (NSAIDs), Drug allergy (chlorthalidone) and Asthma. On 09-Sep-2022, the patient received fifth dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On 11-Sep-2022, the patient experienced SKIN BURNING SENSATION (burning sensation in my scalp), VACCINATION SITE WARMTH (increased warmth in an area about 5 inches below the site of vaccination), VACCINATION SITE PAIN (local pain/increased pain in an area about 5 inches below the vaccination site), RASH (disseminated rash/residual rash/ rash/generalized skin rash/ face also had the rash) and VACCINATION SITE ERYTHEMA (local erythema/increased erythema in an area about 5 inches below the site of vaccination). In September 2022, the patient experienced PRURITUS (local itching present/ itching ankles/ itching all over my body), SWELLING (swelling all over my body/arms and face) and OEDEMA (pitting edema/minimal edema/pitting edema more prominent in patient arms). The patient was treated with FEXOFENADINE HYDROCHLORIDE (ALLEGRA [FEXOFENADINE HYDROCHLORIDE]) on 11-Sep-2022 at a dose of 180 milligram. At the time of the report, PRURITUS (local itching present/ itching ankles/ itching all over my body) and RASH (disseminated rash/residual rash/ rash/generalized skin rash/ face also had the rash) had not resolved and SWELLING (swelling all over my body/arms and face), OEDEMA (pitting edema/minimal edema/pitting edema more prominent in patient arms), SKIN BURNING SENSATION (burning sensation in my scalp), VACCINATION SITE WARMTH (increased warmth in an area about 5 inches below the site of vaccination), VACCINATION SITE PAIN (local pain/increased pain in an area about 5 inches below the vaccination site) and VACCINATION SITE ERYTHEMA (local erythema/increased erythema in an area about 5 inches below the site of vaccination) was resolving. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In September 2022, Body temperature: increased temperature about 10 hrs after the vaccination that receded spontaneously. For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter did not provide any causality assessments. No concomitant drug information was provided. Patient had received dose 1 Moderna COVID-19 vaccine on 19Feb2021, lot number 024M20A, Dose 2 on 19Mar2021, lot number 006B21A, Dose 3 on 18Sep2021, lot number 048F21A and initial booster on 03Apr2022, lot number 002M21A. Patient was administered a 0.5 booster of Moderna COVID-19 vaccine. Patient had reported that the initial symptoms were mild. It was also reported that patient had a burning sensation in the face as face also had the rash. The patient was very close to going to the hospital and she was nervous about getting additional doses. It was reported that patient had experienced the similar events with chlorthalidone. On 11 Sep 2022, patient immediately took Allegra. she medicated herself because she was a doctor. Patient continued to take the Allegra, on 12 and 13 Sep2022. Patient still had rash, local itching with triple Lewis response when rubbing. Patient was going to see the doctor that afternoon. At the time of this report, patient had minimal symptoms. Most recent FOLLOW-UP information incorporated above includes: On 14-Sep-2022: Follow-up received, New events added and I narrative was updated.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Injection site pain
Hospital-Tage: -
Labordaten: Test Date: 202209; Test Name: Body temperature; Result Unstructured Data: increased temperature about 10 hrs after the vaccination that receded spontaneously
Aktuelle Erkrankungen: Asthma; Drug allergy (NSAIDs); Drug allergy (chlorthalidone)
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2444029

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7143C

mild

Staat: MA
Alter: 72,0
Geschlecht: F
Eingang: 21.09.2022
Impfdatum: 09.09.2022
Beginn: 01.09.2022
Tage bis Beginn: -
Dosis: 5
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Body temperature increased Burning sensation Erythema Feeling hot Injection site pain Body temperature Oedema Pruritus Rash Skin burning sensation Local reaction Pain Swelling Vaccination site erythema Vaccination site pain Vaccination site warmth

Symptomtext

burning sensation in my scalp; increased warmth in an area about 5 inches below the site of vaccination; local pain/increased pain in an area about 5 inches below the vaccination site; disseminated rash/residual rash/ rash/generalized skin rash/ face also had the rash; local erythema/increased erythema in an area about 5 inches below the site of vaccination; local itching present/ itching ankles/ itching all over my body; swelling all over my body/arms and face; pitting edema/minimal edema/pitting edema more prominent in patient arms; This spontaneous case was reported by a physician and describes the occurrence of PRURITUS (local itching present/ itching ankles/ itching all over my body), SWELLING (swelling all over my body/arms and face), OEDEMA (pitting edema/minimal edema/pitting edema more prominent in patient arms), SKIN BURNING SENSATION (burning sensation in my scalp) and VACCINATION SITE WARMTH (increased warmth in an area about 5 inches below the site of vaccination) in a 72-year-old female patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. AS7143C) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. Concurrent medical conditions included Drug allergy (NSAIDs), Drug allergy (chlorthalidone) and Asthma. On 09-Sep-2022, the patient received fifth dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On 11-Sep-2022, the patient experienced SKIN BURNING SENSATION (burning sensation in my scalp), VACCINATION SITE WARMTH (increased warmth in an area about 5 inches below the site of vaccination), VACCINATION SITE PAIN (local pain/increased pain in an area about 5 inches below the vaccination site), RASH (disseminated rash/residual rash/ rash/generalized skin rash/ face also had the rash) and VACCINATION SITE ERYTHEMA (local erythema/increased erythema in an area about 5 inches below the site of vaccination). In September 2022, the patient experienced PRURITUS (local itching present/ itching ankles/ itching all over my body), SWELLING (swelling all over my body/arms and face) and OEDEMA (pitting edema/minimal edema/pitting edema more prominent in patient arms). The patient was treated with FEXOFENADINE HYDROCHLORIDE (ALLEGRA [FEXOFENADINE HYDROCHLORIDE]) on 11-Sep-2022 at a dose of 180 milligram. At the time of the report, PRURITUS (local itching present/ itching ankles/ itching all over my body) and RASH (disseminated rash/residual rash/ rash/generalized skin rash/ face also had the rash) had not resolved and SWELLING (swelling all over my body/arms and face), OEDEMA (pitting edema/minimal edema/pitting edema more prominent in patient arms), SKIN BURNING SENSATION (burning sensation in my scalp), VACCINATION SITE WARMTH (increased warmth in an area about 5 inches below the site of vaccination), VACCINATION SITE PAIN (local pain/increased pain in an area about 5 inches below the vaccination site) and VACCINATION SITE ERYTHEMA (local erythema/increased erythema in an area about 5 inches below the site of vaccination) was resolving. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In September 2022, Body temperature: increased temperature about 10 hrs after the vaccination that receded spontaneously. For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter did not provide any causality assessments. No concomitant drug information was provided. Patient had received dose 1 Moderna COVID-19 vaccine on 19Feb2021, lot number 024M20A, Dose 2 on 19Mar2021, lot number 006B21A, Dose 3 on 18Sep2021, lot number 048F21A and initial booster on 03Apr2022, lot number 002M21A. Patient was administered a 0.5 booster of Moderna COVID-19 vaccine. Patient had reported that the initial symptoms were mild. It was also reported that patient had a burning sensation in the face as face also had the rash. The patient was very close to going to the hospital and she was nervous about getting additional doses. It was reported that patient had experienced the similar events with chlorthalidone. On 11 Sep 2022, patient immediately took Allegra. she medicated herself because she was a doctor. Patient continued to take the Allegra, on 12 and 13 Sep2022. Patient still had rash, local itching with triple Lewis response when rubbing. Patient was going to see the doctor that afternoon. At the time of this report, patient had minimal symptoms. Most recent FOLLOW-UP information incorporated above includes: On 14-Sep-2022: Follow-up received, New events added and I narrative was updated.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Injection site pain
Hospital-Tage: -
Labordaten: Test Date: 202209; Test Name: Body temperature; Result Unstructured Data: increased temperature about 10 hrs after the vaccination that receded spontaneously
Aktuelle Erkrankungen: Asthma; Drug allergy (NSAIDs); Drug allergy (chlorthalidone)
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2452394

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7143C

mild

Staat: OR
Alter: 83,0
Geschlecht: F
Eingang: 20.09.2022
Impfdatum: 01.09.2022
Beginn: 16.09.2022
Tage bis Beginn: 15,0
Dosis: 6
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Body temperature decreased Rash Rash erythematous

Symptomtext

I received my sixth dose and later that day, I went to visit a friend at a nursing home and they took my temp and it was 90.2. They checked it twice and it was still 90.2 The next day, I started to break out in a rash and my entire body was light red. The rash didn't itch though.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Rash
Hospital-Tage: -
Labordaten: N/A
Aktuelle Erkrankungen: N/A
Vorgeschichte: Psoriatic Arthritis; Hypothyroidism
Andere Medikamente: Levothyroxine; Methotrexate (But I stopped taking it a week before I received my vaccination)
Allergien: Bee's
Vorherige Impfungen: -

VAERS 2452287

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge AS7143C

mild

Staat: ID
Alter: 58,0
Geschlecht: F
Eingang: 20.09.2022
Impfdatum: 12.09.2022
Beginn: 14.09.2022
Tage bis Beginn: 2,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Abdominal pain Back pain Herpes zoster Rash Sensitive skin

Symptomtext

Wednesday my skin on the left side of my back got sensitive, on Friday I had a pain in my back, but I went on Saturday to the ER with extreme abdominal pain and in my back (that started on Friday) and then I had a rash on Sunday, a visible rash, on Monday I went to the doctor, and he verified that I had shingles.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Abdominal pain
Hospital-Tage: -
Labordaten: N/A
Aktuelle Erkrankungen: N/A
Vorgeschichte: Hypertension; Fibromyalgia
Andere Medikamente: Levothyroxine; Losartan; Spironolactone ;Topiramate; Allegra
Allergien: Erythromycin; Penicillin; Bactrim; Macrobid; Keflex; Cortisone; Pristiq; Onions; Peanuts; Soy; Coconut; Fragance
Vorherige Impfungen: -

VAERS 2450841

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7143C

mild

Staat: MA
Alter: 59,0
Geschlecht: F
Eingang: 19.09.2022
Impfdatum: 15.09.2022
Beginn: 17.09.2022
Tage bis Beginn: 2,0
Dosis: UNK
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Chills Erythema Nausea Peripheral swelling Skin warm

Symptomtext

SWELLING,REDNESS AND HOT MID ARM ABOVE ELBOW,CHILLS,NAUSEA

Weitere VAERSDATA-Felder

Praegender Schweregrund: Chills
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2450838

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7143C

mild

Staat: RI
Alter: 65,0
Geschlecht: F
Eingang: 19.09.2022
Impfdatum: 13.09.2022
Beginn: 15.09.2022
Tage bis Beginn: 2,0
Dosis: UNK
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Erythema Peripheral swelling Pruritus

Symptomtext

SWELLING,REDNESS,ITCHING MID ARM ABOVE ELBOW

Weitere VAERSDATA-Felder

Praegender Schweregrund: Pruritus
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2450835

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7143C

mild

Staat: NC
Alter: 75,0
Geschlecht: F
Eingang: 19.09.2022
Impfdatum: 13.09.2022
Beginn: 14.09.2022
Tage bis Beginn: 1,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

Chills Fatigue Joint range of motion decreased Pain Pain in extremity

Symptomtext

Patient presented to pharmacy 9/19/22 with complaints of significant arm pain in RIGHT arm (OPPOSITE arm from vaccination). She states she had normal side effects of fatigue, aches, chills starting 9/14/22 and lasting for 2 days but that this arm pain has lingered through today. She states she has limited range of motion in neck and opposite arm and that pain is intense. Not relieved by NSAID use. Patient advised to contact MD and pharmacy notified MD as well.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Chills
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: SULFA AND PHENAZOPYRIDINE
Vorherige Impfungen: -

VAERS 2450680

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge as7143c

mild

Staat: TX
Alter: 40,0
Geschlecht: F
Eingang: 18.09.2022
Impfdatum: 11.09.2022
Beginn: 13.09.2022
Tage bis Beginn: 2,0
Dosis: 1
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: ja

Rash Tongue eruption

Symptomtext

Patient received vaccine on 9/11/22 called us on 9/15/22 to report had started on 9/13 with rash on arm and upper body leading to tongue, went to allergist on 9/13 received epipen, went to er on 9/14 received another epipen and steroids. Spoked to pt on 9/18 and says doing fine.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Rash
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: singulair, depakote, bupropion xl, tri-sprintec, zyrtec, allegra, benadryl as needed
Allergien: eggs, a lot of other food and enviromental allergies, animals and penicillin
Vorherige Impfungen: -

VAERS 2450502

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7143C

mild

Staat: PA
Alter: 75,0
Geschlecht: M
Eingang: 17.09.2022
Impfdatum: 15.09.2022
Beginn: 17.09.2022
Tage bis Beginn: 2,0
Dosis: 5
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Urticaria

Symptomtext

WIFE CALLED 09/17/2022 STATING PT IS EXPERIENCING HIVES AFTER THE SHOT, PT HAS TAKEN BENADRYL AS THEY HAVE BEFORE FOR HIVES FROM A FLU SHOT PREVISOULY, COUNSELED PT TO GO TO ER IF REACTION GETS WORSE TO THE POINT OF DIFFICULTY BREATHING

Weitere VAERSDATA-Felder

Praegender Schweregrund: Urticaria
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: NKDA
Vorherige Impfungen: -

VAERS 2449856

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge AS7143C

mild

Staat: -
Alter: 68,0
Geschlecht: M
Eingang: 17.09.2022
Impfdatum: 08.09.2022
Beginn: 08.09.2022
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Accidental underdose Feeling abnormal Pyrexia

Symptomtext

like something was working in my body; felt somewhat feverish/it wasn't measurable; lower than authorized dose of Moderna bivalent administered to patient/.25 dose for bivalent; This spontaneous case was reported by a patient and describes the occurrence of FEELING ABNORMAL (like something was working in my body), PYREXIA (felt somewhat feverish/it wasn't measurable) and ACCIDENTAL UNDERDOSE (lower than authorized dose of Moderna bivalent administered to patient/.25 dose for bivalent) in a 68-year-old male patient who received mRNA-1273 BIVALENT (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. AS7143C) for COVID-19 prophylaxis. Co-suspect product included non-company product INFLUENZA VACCINE for an unknown indication. Concurrent medical conditions included Blood cholesterol abnormal. Concomitant products included PRAVASTATIN for Blood cholesterol abnormal. On 08-Sep-2022, the patient received dose of mRNA-1273 BIVALENT (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) .25 milliliter and dose of INFLUENZA VACCINE (unknown route) 1 dosage form. On 08-Sep-2022, the patient experienced FEELING ABNORMAL (like something was working in my body), PYREXIA (felt somewhat feverish/it wasn't measurable) and ACCIDENTAL UNDERDOSE (lower than authorized dose of Moderna bivalent administered to patient/.25 dose for bivalent). On 09-Sep-2022, FEELING ABNORMAL (like something was working in my body) and PYREXIA (felt somewhat feverish/it wasn't measurable) had resolved. At the time of the report, ACCIDENTAL UNDERDOSE (lower than authorized dose of Moderna bivalent administered to patient/.25 dose for bivalent) outcome was unknown. The action taken with mRNA-1273 BIVALENT (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown) was unknown. It was reported that, the patient received the bivalent vaccine 0.25 mL dosage instead of 0.5 mL. A couple days after receiving the bivalent vaccine, the vaccine provider called the patient and told about the error and wanted the patient to come in to get an additional 0.25 mL dosage of the bivalent vaccine. Patient also had received his flu shot along with his Moderna bivalent vaccine on the same day. Later, the patient felt somewhat feverish for 24 hours but was not sure if it was caused due to the flu shot or the bivalent vaccine. Patient reported that, it was not a measurable temperature rise and did not feel sick, but felt like something was working in body. No treatment medication was reported. Most recent FOLLOW-UP information incorporated above includes: On 12-Sep-2022: Significant follow up received contains additional event information. On 12-Sep-2022: Follow-up document received includes no new information.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Pyrexia
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: Blood cholesterol abnormal
Vorgeschichte: -
Andere Medikamente: PRAVASTATIN
Allergien: -
Vorherige Impfungen: -

VAERS 2449816

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge AS7143C

mild

Staat: NY
Alter: 67,0
Geschlecht: F
Eingang: 17.09.2022
Impfdatum: 09.09.2022
Beginn: 09.09.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: OT / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Arthralgia Body temperature COVID-19 immunisation Fatigue Headache Interchange of vaccine products Myalgia Nausea Oropharyngeal pain Pyrexia Swelling Vaccination site pain

Symptomtext

Sore throat; Left side of her neck felt puffy; high fever of 101.8 F; Sore arm; Muscle ache; Severe headache; Joint pain; felt nausea but never vomited; Tired; Revaccination with different COVID-19 vaccine; Interchange of vaccine products; This spontaneous case was reported by a patient and describes the occurrence of OROPHARYNGEAL PAIN (Sore throat), SWELLING (Left side of her neck felt puffy), PYREXIA (high fever of 101.8 F), VACCINATION SITE PAIN (Sore arm) and MYALGIA (Muscle ache) in a 67-year-old female patient who received mRNA-1273 BIVALENT (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. AS7143C) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. Previously administered products included for Drug use for unknown indication: Pfizer (Dose Number: 1st dose, Lot number: EL8982, Route: Left arm IM, Expiration date: 31May2021) on 25-Jan-2021, Pfizer (Dose Number: 2nd dose, Lot number: EN6201, Route: Left arm IM, Expiration date: 30June2021) on 15-Feb-2021, Pfizer (Dose Number: 1st booster, Lot number: FF8839 and Route: left arm IM) on 27-Sep-2021. Past adverse reactions to the above products included Vaccination adverse reaction with Pfizer, Pfizer and Pfizer. Concurrent medical conditions included Sulfonamide allergy (Itchy eyes), Pollen allergy, Dust allergy, Allergy to molds, Diabetes, Blood pressure high, Hyperthyroidism, Lichen sclerosus (Vaginal only, use steroid), High cholesterol, Fatty liver and Unilateral renal agenesis. Concomitant products included PLANTAGO OVATA (METAMUCIL [PLANTAGO OVATA]), CEPHALEXIN [CEFALEXIN], VALSARTAN, LEVOTHYROXINE, METFORMIN HYDROCHLORIDE (METFORMIN HCL), ATORVASTATIN, SITAGLIPTIN PHOSPHATE (JANUVIA), ESTRADIOL, ASCORBIC ACID, VACCINIUM SPP. (CRANBERRY [ASCORBIC ACID;VACCINIUM SPP.]), D-MANNOSE, PROBIOTICS NOS, COENZYME Q10 [UBIDECARENONE] and VITAMIN D [VITAMIN D NOS] for an unknown indication. On 09-Sep-2022, the patient received fourth dose of mRNA-1273 BIVALENT (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Intramuscular) 1 dosage form. On 09-Sep-2022, the patient experienced COVID-19 IMMUNISATION (Revaccination with different COVID-19 vaccine) and INTERCHANGE OF VACCINE PRODUCTS (Interchange of vaccine products). On 11-Sep-2022, the patient experienced FATIGUE (Tired). On an unknown date, the patient experienced OROPHARYNGEAL PAIN (Sore throat), SWELLING (Left side of her neck felt puffy), PYREXIA (high fever of 101.8 F), VACCINATION SITE PAIN (Sore arm), MYALGIA (Muscle ache), HEADACHE (Severe headache) and ARTHRALGIA (Joint pain). an unknown date, the patient experienced NAUSEA (felt nausea but never vomited). At the time of the report, OROPHARYNGEAL PAIN (Sore throat), SWELLING (Left side of her neck felt puffy), PYREXIA (high fever of 101.8 F), VACCINATION SITE PAIN (Sore arm), MYALGIA (Muscle ache), HEADACHE (Severe headache), ARTHRALGIA (Joint pain), NAUSEA (felt nausea but never vomited), FATIGUE (Tired), COVID-19 IMMUNISATION (Revaccination with different COVID-19 vaccine) and INTERCHANGE OF VACCINE PRODUCTS (Interchange of vaccine products) outcome was unknown. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Body temperature: 101.8 F.. She said she had a high fever of 101.8 F. She had sore arm, muscle ache, severe headache, and sore throat. The left side of her neck felt puffy. She also had joint pain. All her side effect started 16 hours after receiving the vaccine. 36 hours later, the next night she felt nausea but never vomited. Yesterday (11Sep2022) she woke up tired the next day. She stated she had similar side effect with the Pfizer vaccine. She believes with Pfizer vaccine the fever was slightly lower. The patient never had COVID positive test or diagnosis. No other vaccines given within 1 month prior to Moderna COVID-19 vaccine. No treatment information was provided.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Arthralgia
Hospital-Tage: -
Labordaten: Test Name: Body temperature; Result Unstructured Data: 101.8 F.
Aktuelle Erkrankungen: Allergy to molds; Blood pressure high; Diabetes; Dust allergy; Fatty liver; High cholesterol; Hyperthyroidism; Lichen sclerosus (Vaginal only, use steroid); Pollen allergy; Sulfonamide allergy (Itchy eyes); Unilateral renal agenesis
Vorgeschichte: -
Andere Medikamente: METAMUCIL [PLANTAGO OVATA]; CEPHALEXIN [CEFALEXIN]; VALSARTAN; LEVOTHYROXINE; METFORMIN HCL; ATORVASTATIN; JANUVIA; ESTRADIOL; CRANBERRY [ASCORBIC ACID;VACCINIUM SPP.]; D-MANNOSE; PROBIOTICS NOS; COENZYME Q10 [UBIDECARENONE]; VITAMIN D [VIT
Allergien: -
Vorherige Impfungen: -

VAERS 2449815

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7143C

mild

Staat: NY
Alter: 67,0
Geschlecht: M
Eingang: 17.09.2022
Impfdatum: 09.09.2022
Beginn: -
Tage bis Beginn: -
Dosis: 4
Route/Site: OT / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Fatigue Headache

Symptomtext

After the second booster patient had a mild headache which lasted until the next day.; Fatigue/ Patient went to bed early; This spontaneous case was reported by a patient family member or friend and describes the occurrence of HEADACHE (After the second booster patient had a mild headache which lasted until the next day.) and FATIGUE (Fatigue/ Patient went to bed early) in a 67-year-old male patient who received mRNA-1273 BIVALENT (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. AS7143C) for COVID-19 vaccination. Previously administered products included for Product used for unknown indication: Tetanus shot on 10-Aug-2022 and Influenza vaccine (Flu Vaccine). Past adverse reactions to the above products included No adverse event with Influenza vaccine and Tetanus shot. Concurrent medical conditions included Pollen allergy, COPD and Anxiety. Concomitant products included QUETIAPINE FUMARATE and BUPROPION for an unknown indication. On 09-Sep-2022, the patient received fourth dose of mRNA-1273 BIVALENT (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On an unknown date, the patient experienced HEADACHE (After the second booster patient had a mild headache which lasted until the next day.) and FATIGUE (Fatigue/ Patient went to bed early). At the time of the report, HEADACHE (After the second booster patient had a mild headache which lasted until the next day.) had resolved and FATIGUE (Fatigue/ Patient went to bed early) outcome was unknown. On 14-Jan-2021, the patient received first dose of Moderna vaccine with lot number reported as 039K20A. On 11-Feb-2021, the patient received second dose of Moderna vaccine with lot number reported as 029L20A. On 26-Oct-2021, the patient received first booster dose of Moderna vaccine with lot number reported as 019F21A. Anatomical location for all the doses related to suspect product (Moderna vaccine) was reported as Left arm bicep and it was reported that patient was taking other medication.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Fatigue
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: Anxiety; COPD; Pollen allergy.
Vorgeschichte: -
Andere Medikamente: QUETIAPINE FUMARATE; BUPROPION.
Allergien: -
Vorherige Impfungen: -

VAERS 2447614

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7143C

mild

Staat: IL
Alter: 70,0
Geschlecht: F
Eingang: 16.09.2022
Impfdatum: 12.09.2022
Beginn: 12.09.2022
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: SYR / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Dizziness Ear swelling Eye pruritus Headache Periorbital swelling Rash Rhinorrhoea Swelling face

Symptomtext

Swelling on right side of face, puffy itchy eye, nasal discharge right side of nose 2 hours after injection, swelling and rash moved from left tip of ear to ear lope and rash on cheeks. Dizzy first 24 hours, headache 48 hours.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Dizziness
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: Raynaulds; Reflex Sympathetic Nerve Dystrophy
Vorgeschichte: Both Chronic
Andere Medikamente: Quinapril
Allergien: Sulfa drugs; Clonidine; Escrolopram
Vorherige Impfungen: -

VAERS 2446389

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge as7143c

mild

Staat: IL
Alter: 69,0
Geschlecht: F
Eingang: 15.09.2022
Impfdatum: 08.09.2022
Beginn: 09.09.2022
Tage bis Beginn: 1,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Arthralgia Movement disorder Muscle spasms X-ray abnormal

Symptomtext

Patient received bivalent Covid-19 booster on 9/8 evening, pain set in Friday morning 9/9. She had pain in her shoulder. On Sunday 9/11, she could not move and went to ER to seek help. ER took X-ray and informed her that she had muscle spasms on her back. She went to her PCP during the week and was saw by NP and going through signs and symptoms was concluded maybe shoulder injury. Prescribed Pain medication, steroid pack & muscle relaxant. not much improvement but not getting worst. will have followup appointment next week with her PCP

Weitere VAERSDATA-Felder

Praegender Schweregrund: Arthralgia
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2446365

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7143C

mild

Staat: OR
Alter: 72,0
Geschlecht: F
Eingang: 15.09.2022
Impfdatum: 09.09.2022
Beginn: 13.09.2022
Tage bis Beginn: 4,0
Dosis: 5
Route/Site: SYR / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Fatigue Headache Heart rate increased SARS-CoV-2 test negative

Symptomtext

Extreme fatigue, headache and elevated heartrate came on 4 days after injection and 2 days after more moderate side effects had cleared; I called nurseline two nights and doctor's office on 9/14; all said my symptoms were within normal range, but to call back if they got worse. I self-treated with tylenol, heat wraps, hydrating and rest. I still feel mild headache and fatigue, but better than yesterday and through the night last night.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Fatigue
Hospital-Tage: -
Labordaten: negative rapid covid test 9/14
Aktuelle Erkrankungen: none
Vorgeschichte: past high cholesterol, fibromyalgia, irritable bowel, arthritis, but all currently asymptomatic or mildly symptomatic for several years
Andere Medikamente: vitamin c, vitamin d
Allergien: codeine, amytriptilene,
Vorherige Impfungen: -

VAERS 2446291

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7143C

mild

Staat: MD
Alter: 30,0
Geschlecht: F
Eingang: 15.09.2022
Impfdatum: 03.09.2022
Beginn: 04.09.2022
Tage bis Beginn: 1,0
Dosis: 4
Route/Site: SYR / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Enlarged uvula Erythema Mouth swelling Ocular hyperaemia Oral mucosal erythema Peripheral swelling Pharyngeal erythema Pharyngeal swelling Pruritus Rash Swelling face Urticaria

Symptomtext

Hives started on the night of 9/4 around the mouth and on the abdomen. Worsening hives were experienced upon waking on 9/5 around 7:45 am including on the back of the right arm, on the right side of the neck spreading to the left side, hives down both arms, and unraised hives on the abdomen and thighs. Swelling and redness was present in the mouth (checks, throat, uvula). Face and eyes were bright red. The patient took Benadryl at around 8:00 am and then was seen at Urgent Care at 10:00 am when symptoms were not improved. Urgent Care referred patient to the ER due to throat swelling. Patient was treated with steroids, Benadryl, and Pepcid at around 11:45 am. Received a prescription for prednisone 20 mg for 10 days, pepcid 20 mg 2/day for 10 days, and hydroxyzine hcl. After discharge from ER the patient developed swelling/rash on hands and feet that persisted for a week. Patient had follow-up appointments with primary care, allergist, and dermatologist and was further put on Zyrtec 20 mg/ twice a day for 1 month and Clobetasol Propionate cream 0.05% for severe itching in hands and feet. Some mild itching/redness is still present on hands and feet.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Pruritus
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: None
Vorgeschichte: POTS Lyme disease positive HPV+ IBS-D GERD Chronic Nausea
Andere Medikamente: Domperidone, 10 mg x 3/day Flonase Pepcid, 20 x 2/day Zyretc, 10 mg Emgality, 120 ml Rizatriptan, 10 mg as needed Ubiquinol CoQ10, 200 mg Vitamin B1, 100 mg Vitamin B2, 400 mg Vitamin D3, 4,000 IU Magnesium glycinate 500 mg
Allergien: Dayquil-caused hives
Vorherige Impfungen: COVID-19 Moderna Vaccine caused typical flu-like symptoms each time with the shots 2 and 3 causing migraines/headaches for appro

VAERS 2445060

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7143C

mild

Staat: CA
Alter: 43,0
Geschlecht: F
Eingang: 14.09.2022
Impfdatum: 12.09.2022
Beginn: 12.09.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Injection site erythema Injection site induration Injection site pain Injection site pruritus Injection site swelling Injection site urticaria Injection site warmth

Symptomtext

Hard, red, tender, circular raised welt. Warm to the touch, approx size of a quarter, located at the site of the COVID vaccine injection. Overnight it expanded toward elbow to about 2 inches in diameter with same symptoms/characteristics, plus itchiness. (At this point, the area encompasses both the flu and COVID injection sites.) Approx 48 hours after initial symptoms, the area looks about the same as 24 hours ago, but slightly expanded at the bottom and sides. Note that 1st and 2nd vaccinations in series were Pfizer and 3rd was Moderna. Mild symptoms (primarily muscle aches & fatigue) following 1st booster / 3rd in series. Sore arm, but no other symptoms at site of injection.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Injection site erythema
Hospital-Tage: -
Labordaten: None
Aktuelle Erkrankungen: Mild iron deficiency
Vorgeschichte: ADHD
Andere Medikamente: Methylphenidate, Guanfacine, Sertraline, gummy multivitamin, gummy probiotic/prebiotic
Allergien: None
Vorherige Impfungen: -

VAERS 2444991

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge AS7143C

mild

Staat: IL
Alter: 50,0
Geschlecht: M
Eingang: 14.09.2022
Impfdatum: 08.09.2022
Beginn: 09.09.2022
Tage bis Beginn: 1,0
Dosis: 4
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Decreased appetite Headache Intracranial pressure increased Sexual dysfunction

Symptomtext

1. Loss of Appetite 09-09-22, subsided 09-11-22 2. Severe headache during sex starting 09-09-22 3. Residual headache 09-10 through 09-12 4. Intracranial Pressure (started 09-13, subsided 09-14) - head felt like my skull was too small for my brain and my eyes were being pushed against. Very minor headache all day, no loss or blurring of vision. Called nurse hotline-planned to go to Emergency room if pressure got worse or caused vision blurring.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Headache
Hospital-Tage: -
Labordaten: None
Aktuelle Erkrankungen: None
Vorgeschichte: Prehypertension
Andere Medikamente: Omega 3, Turmeric, Vitamin D, Eye Vitamin
Allergien: None
Vorherige Impfungen: -

VAERS 2444906

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7143C

mild

Staat: CT
Alter: 45,0
Geschlecht: F
Eingang: 14.09.2022
Impfdatum: 07.09.2022
Beginn: 08.09.2022
Tage bis Beginn: 1,0
Dosis: 4
Route/Site: SYR / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Injection site pruritus Injection site rash Injection site swelling Injection site warmth Loss of personal independence in daily activities

Symptomtext

It started as a rash 6" x 3" with some swelling, it was very hot. By the next day it was 10" x 4" and hot and swelling more. By the 3rd day, the worst, it was from my elbow to my shoulder; more swollen, more hot and went 3'4s up my arm. I went to the Pharmacist and sought their opinion. It got worse for 3 days, with day 3 being the worst. Day 4 it was better. Today is day 7 and it's much much paler but still swollen and occasionally itchy but definitely improved. I've had rashes with the other 3 COVID-19 vaccines but this was significantly different and worse because it kept me from doing my daily activities.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Injection site pruritus
Hospital-Tage: -
Labordaten: No
Aktuelle Erkrankungen: No
Vorgeschichte: No
Andere Medikamente: Pepcid; Tylenol; Advil
Allergien: Amoxicillin; Ciroracet; Erythromycin
Vorherige Impfungen: After all my Moderna vaccines I've had a rash and things like fatigue, headache and muscle aches.

VAERS 2444848

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge AS7143C

mild

Staat: NC
Alter: 73,0
Geschlecht: F
Eingang: 14.09.2022
Impfdatum: 07.09.2022
Beginn: 08.09.2022
Tage bis Beginn: 1,0
Dosis: N/A
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Fatigue Headache Heart rate increased Injection site pain Myalgia

Symptomtext

Mild headache, increased heart rate, muscle aches, mild fatigue, moderate pain at injection site.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Fatigue
Hospital-Tage: -
Labordaten: none
Aktuelle Erkrankungen: none
Vorgeschichte: HTN, hypothyroid
Andere Medikamente: -
Allergien: Cymbalta, Macrobid
Vorherige Impfungen: -

VAERS 2444789

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge AS7143C

mild

Staat: TN
Alter: 33,0
Geschlecht: F
Eingang: 14.09.2022
Impfdatum: 09.09.2022
Beginn: 10.09.2022
Tage bis Beginn: 1,0
Dosis: 4
Route/Site: SYR / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Back pain COVID-19 Cough Ear pain Fatigue Headache Heart rate increased Lacrimation increased Nasal congestion Nasopharyngitis Oropharyngeal pain Respiratory tract congestion Rhinorrhoea SARS-CoV-2 test positive Sneezing Somnolence

Symptomtext

So on Saturday 9/10/22 I felt worn down and had a headache and just thought I was having effects from the vaccines. It felt just groggy and tired. On Sunday I felt congestion with lower back pain and headache. I had to use a heating pad for my back. I was also sneezing a lot and the next day I felt like my back pain was getting better but I still congested and sneezing a lot with watery eyes. So on Monday my ears were hurting and tired and then on Tuesday I was having a sore throat with a dry cough and congestion with either a stopped up nose or running with sneezing feeling similar to a chest cold with allergies. Today I am doing better but I have watery eyes. sore throat, headache. I sought treatment on Monday 9/12/22 I took a home COVID-19 test and it was positive. My employer requested a PCR test and I went and got tested and was positive and I was advised to drink more fluids because my heart rate was elevated from the nurse practitioner.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Back pain
Hospital-Tage: -
Labordaten: COVID-19 Home 9/12/22 Positive COVID-19 PCR 9/12/22 Positive
Aktuelle Erkrankungen: None
Vorgeschichte: Epilepsy;
Andere Medikamente: Keppra; Haley FE; Vitamin B12; Folic Acid; Vitamin D3;
Allergien: Codeine; Penicillin; Metronidazole; Bananas; Agave;
Vorherige Impfungen: Flu makes me feel sluggish and tired Age 33

VAERS 2440677

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7143C

mild

Staat: CA
Alter: 56,0
Geschlecht: F
Eingang: 12.09.2022
Impfdatum: 06.09.2022
Beginn: 09.09.2022
Tage bis Beginn: 3,0
Dosis: 5
Route/Site: - / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Arthralgia Diarrhoea Extra dose administered Injection site reaction Joint warmth Nausea Rash erythematous Vomiting

Symptomtext

Nausea, vomiting, diarrhea, red rash at injection site, and sore hot shoulder for 3 days. The arm is better now but not the gastric issues.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Arthralgia
Hospital-Tage: -
Labordaten: None
Aktuelle Erkrankungen: seizure disorder, asthma, thyroid disease
Vorgeschichte: seizure disorder, asthma, thyroid disease
Andere Medikamente: Lacosamine, Synthroid, liothyronine sodium, montelukast, albuterol inhaler, Advair inhaler, Flonase nasal spray, vitamin D3, daily centrum for women
Allergien: adhesive and other sticky stuff, peaches, mango, several high blood pressure medications
Vorherige Impfungen: Similar symptoms, but not as bad as this time.

VAERS 2440104

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge As7143c

mild

Staat: MD
Alter: 68,0
Geschlecht: M
Eingang: 11.09.2022
Impfdatum: 03.09.2022
Beginn: 03.09.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Chills Hyperhidrosis Pain Pain in extremity

Symptomtext

Sore arm and body aches began after two hours. Chills began at 10 hours and continued until 24 hours. Periods of sweating within the same timeframe.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Chills
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: None
Vorgeschichte: Arthritis in right leg.
Andere Medikamente: Extreme chills for over first 24 hours with intermittent periods of sweating.
Allergien: None
Vorherige Impfungen: -

VAERS 2440051

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7143C

mild

Staat: NY
Alter: 34,0
Geschlecht: F
Eingang: 10.09.2022
Impfdatum: 08.09.2022
Beginn: 10.09.2022
Tage bis Beginn: 2,0
Dosis: 4
Route/Site: SYR / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Injection site erythema Injection site induration Injection site mass Injection site swelling

Symptomtext

Swollen, red and hard lump at the injection site.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Injection site erythema
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: N/A
Vorgeschichte: Iron deficiency anemia
Andere Medikamente: Spironolactone 50mg once a day, Levonorgestrel, Feosol Bifera iron supplement, Probiotic gummies
Allergien: Sulfa
Vorherige Impfungen: -

VAERS 2439659

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge AS7143C

mild

Staat: VA
Alter: 44,0
Geschlecht: M
Eingang: 10.09.2022
Impfdatum: 03.09.2022
Beginn: 04.09.2022
Tage bis Beginn: 1,0
Dosis: UNK
Route/Site: OT / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Fatigue

Symptomtext

felt a little tired the next day after receiving the vaccine; This spontaneous case was reported by a patient family member or friend and describes the occurrence of FATIGUE (felt a little tired the next day after receiving the vaccine) in a 44-year-old male patient who received mRNA-1273 BIVALENT (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. AS7143C) for COVID-19 prophylaxis. Previously administered products included for COVID-19 vaccination: Pfizer COVID-19 vaccine (All previous doses were Pfizer COVID-19 vaccine.). Past adverse reactions to the above products included No adverse event with Pfizer COVID-19 vaccine. On 03-Sep-2022, the patient received dose of mRNA-1273 BIVALENT (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On 04-Sep-2022, after starting mRNA-1273 BIVALENT (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)), the patient experienced FATIGUE (felt a little tired the next day after receiving the vaccine). The patient was treated with PARACETAMOL (TYLENOL) for Tiredness, at an unspecified dose and frequency. At the time of the report, FATIGUE (felt a little tired the next day after receiving the vaccine) had resolved. No concomitant drug was reported. It was reported that patient felt a little tired the next day after receiving the vaccine but felt fine after. Patient received Tylenol for symptoms. This case was linked to US-MODERNATX, INC.-MOD-2022-640766, US-MODERNATX, INC.-MOD-2022-640772 (E2B Linked Report).; Sender's Comments: US-MODERNATX, INC.-MOD-2022-640766:Wife case US-MODERNATX, INC.-MOD-2022-640772:daugter's case

Weitere VAERSDATA-Felder

Praegender Schweregrund: Fatigue
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2439657

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge AS7143C

mild

Staat: VA
Alter: 47,0
Geschlecht: F
Eingang: 10.09.2022
Impfdatum: 03.09.2022
Beginn: 04.09.2022
Tage bis Beginn: 1,0
Dosis: UNK
Route/Site: OT / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Fatigue

Symptomtext

Felt a little tired the next day after receiving the vaccine; This spontaneous case was reported by a patient and describes the occurrence of FATIGUE (Felt a little tired the next day after receiving the vaccine) in a 47-year-old female patient who received mRNA-1273 BIVALENT (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. AS7143C) for COVID-19 prophylaxis. Previously administered products included for COVID-19 vaccination: Pfizer (All previous doses for them were the Pfizer COVID-19 vaccine.). Past adverse reactions to the above products included No adverse event with Pfizer. On 03-Sep-2022, the patient received dose of mRNA-1273 BIVALENT (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On 04-Sep-2022, the patient experienced FATIGUE (Felt a little tired the next day after receiving the vaccine). At the time of the report, FATIGUE (Felt a little tired the next day after receiving the vaccine) had resolved. Concomitant product use was not provided by the reporter. It was reported that patient felt a little tired the next day after receiving the vaccine but felt fine after. Treatment information was not provided. This case was linked to US-MODERNATX, INC.-MOD-2022-640773, US-MODERNATX, INC.-MOD-2022-640772 (Linked Report).; Sender's Comments: US-MODERNATX, INC.-MOD-2022-640773:Husband case US-MODERNATX, INC.-MOD-2022-640772:same reporter as ( Case for husband and wife )

Weitere VAERSDATA-Felder

Praegender Schweregrund: Fatigue
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2439488

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7143C

mild

Staat: CA
Alter: 41,0
Geschlecht: F
Eingang: 10.09.2022
Impfdatum: 08.09.2022
Beginn: 08.09.2022
Tage bis Beginn: 0,0
Dosis: 3
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Pain Thyroid disorder Thyroid mass

Symptomtext

Pain in thyroid started about 2 hours after getting the new booster on 9/8/2022. It is still sore 2 days after. I also had thyroid pain 1 week after 1st dose of Moderna vaccine on 4/10/2021 and what felt like athyroid nodule. It seemed to get worse after 2nd dose and got better after 6 months without vaccination (lump gotmsmaller and stopped being sore). I reported the symptoms last year but was not sure it was connected to the vaccine. Due to extenuating circumstances, I did not see a doctor and might not see a doctor for several weeks or months from now.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Pain
Hospital-Tage: -
Labordaten: None yet.
Aktuelle Erkrankungen: None
Vorgeschichte: None
Andere Medikamente: Diphenhydramine 50mg
Allergien: Pollen
Vorherige Impfungen: Thyroid pain and swelling after 1st and 2nd doses of Moderna COVID vaccine

VAERS 2436455

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge As7143C

mild

Staat: KY
Alter: 33,0
Geschlecht: F
Eingang: 09.09.2022
Impfdatum: 07.09.2022
Beginn: 09.09.2022
Tage bis Beginn: 2,0
Dosis: 3
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Lip pruritus Lip swelling Oral discomfort

Symptomtext

Swelling of bottom lip at site of previous dermal filler, burning and itching of lips

Weitere VAERSDATA-Felder

Praegender Schweregrund: Lip pruritus
Hospital-Tage: -
Labordaten: None
Aktuelle Erkrankungen: None
Vorgeschichte: Endometriosis, seasonal allergies
Andere Medikamente: Pristiq 50mg daily, Singulair 10mg daily, Mutivitamin
Allergien: PCN hives, metronidazole rash
Vorherige Impfungen: -

VAERS 2436323

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7143C

mild

Staat: TN
Alter: 26,0
Geschlecht: F
Eingang: 09.09.2022
Impfdatum: 07.09.2022
Beginn: 07.09.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Arthralgia Lymphadenopathy Nausea Pyrexia Vomiting

Symptomtext

Severe hip and knee joint pain starting in the evening after vaccine received, fever of 102 or greater for more than 24 hours, nausea and multiple instances of vomiting, excessively swollen lymph nodes in arm where COVID vaccine administered (left armpit). All signs and symptoms treated with OTC acetaminophen, ibuprofen, and ice compresses with minimal relief 48 hours after vaccine administration. Joint pain still lingering.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Arthralgia
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: None
Vorgeschichte: Major Depressive Disorder
Andere Medikamente: Escitalopram 10mg QD
Allergien: None
Vorherige Impfungen: Same s/sx, with moderna booster (Spikevax), and with second dose of Pfizer primary series

VAERS 2434095

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge AS7143C

mild

Staat: NY
Alter: 81,0
Geschlecht: F
Eingang: 08.09.2022
Impfdatum: 08.09.2022
Beginn: 08.09.2022
Tage bis Beginn: 0,0
Dosis: 5
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Pruritus

Symptomtext

PATIENT CALLED PHARMACY 4 HOURS AFTER RECIEVING THE NEW COVID BIVALENT (MODERNA) BOOSTER, STATING THAT HER LEGS WERE VERY ITCHY (NO RASH REPORTED. SHE WAS INSTRUCTED TO TAKE BENADRYL TO HELP COUNTER THE REACTION

Weitere VAERSDATA-Felder

Praegender Schweregrund: Pruritus
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: RHEUMATOID ARTHRITIS ATRIAL FIBRILLATION
Andere Medikamente: -
Allergien: TETRACYCLINE
Vorherige Impfungen: FEELING DIZZY

VAERS 2433682

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7143C

mild

Staat: CT
Alter: 76,0
Geschlecht: F
Eingang: 08.09.2022
Impfdatum: 07.09.2022
Beginn: 08.09.2022
Tage bis Beginn: 1,0
Dosis: 4
Route/Site: SYR / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Pain in extremity Pyrexia

Symptomtext

Sore arm Low grade temperature 100.4?

Weitere VAERSDATA-Felder

Praegender Schweregrund: Pain in extremity
Hospital-Tage: -
Labordaten: None
Aktuelle Erkrankungen: None
Vorgeschichte: Obesity
Andere Medikamente: Arorvastatin Metoprolol Clopidogril Ramipril Bupropion Levothyroxin Baby aspirin Generic allerest
Allergien: None
Vorherige Impfungen: -

VAERS 2431075

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7143C

mild

Staat: MD
Alter: 28,0
Geschlecht: M
Eingang: 07.09.2022
Impfdatum: 03.09.2022
Beginn: 03.09.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: SYR / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Arthralgia Arthritis Extra dose administered Oedema peripheral Walking aid user Weight bearing difficulty Wheelchair user X-ray limb abnormal

Symptomtext

About 12 hours after the shot I was laying in bed and got a sudden pain in my right knee. That night I took an ADVIL and iced it. At midnight I took TYLENOL. It was very severe I couldn't put weight on it and used a cane. I went to the Dr. the next morning and had to use a wheelchair. They wrapped my knee and gave me ibuprofen. That day it was severe and it's gotten progressively better.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Arthralgia
Hospital-Tage: -
Labordaten: X-ray- fluid in knee and arthritis.
Aktuelle Erkrankungen: No
Vorgeschichte: Overweight
Andere Medikamente: No
Allergien: No
Vorherige Impfungen: From 1st Covid- I had nausea and pain in the arm and fatigue. 2nd and 3rd shots I was tired and had pain in the arm.

VAERS 2429295

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7143C

mild

Staat: NC
Alter: 71,0
Geschlecht: F
Eingang: 06.09.2022
Impfdatum: 03.09.2022
Beginn: 03.09.2022
Tage bis Beginn: 0,0
Dosis: 5
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Pyrexia

Symptomtext

Fever x 48 hrs (as high as 104)

Weitere VAERSDATA-Felder

Praegender Schweregrund: Pyrexia
Hospital-Tage: -
Labordaten: None
Aktuelle Erkrankungen: None
Vorgeschichte: Hypothyroid ADD
Andere Medikamente: Focal in Fexofenedine Bupropion
Allergien: Penicillin, Bactrim, Erthromyxin
Vorherige Impfungen: Fever x 24 hrs 104 F Vaccine Pfizer Dose 4 3/30/2022

VAERS 2428986

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7143C

mild

Staat: TX
Alter: 65,0
Geschlecht: F
Eingang: 05.09.2022
Impfdatum: 04.09.2022
Beginn: 05.09.2022
Tage bis Beginn: 1,0
Dosis: 5
Route/Site: IM / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Pyrexia

Symptomtext

Running 101 fever.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Pyrexia
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: None
Vorgeschichte: Diabetes Type 2
Andere Medikamente: -
Allergien: Sulfa and Penicillin
Vorherige Impfungen: -

VAERS 2428611

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7143C

mild

Staat: CA
Alter: 56,0
Geschlecht: F
Eingang: 03.09.2022
Impfdatum: 02.09.2022
Beginn: 02.09.2022
Tage bis Beginn: 0,0
Dosis: 3
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Pain in extremity Underdose

Symptomtext

Patient was given .25ml of Moderna Bivalent Booster instead of .5ml on 9/2/2022. She was contacted the following afternoon, 9/3/2022, to come back to pharmacy for revaccination. During the course of the conversation, she said she had the typical sore arm that patients experience post vaccination. It was unclear as to whether she was going to return despite explaining the importance of a full booster dose.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Pain in extremity
Hospital-Tage: -
Labordaten: NA. there were no adverse events. It is a matter of under dosing
Aktuelle Erkrankungen: none
Vorgeschichte: none
Andere Medikamente: unknown
Allergien: unknown
Vorherige Impfungen: -

VAERS 2693372

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge AS7143C

gering

Staat: AR
Alter: 66,0
Geschlecht: F
Eingang: 10.10.2023
Impfdatum: 30.09.2022
Beginn: 02.10.2023
Tage bis Beginn: 367,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein

COVID-19

Symptomtext

hospitalized with covid; fully vaccinated with 2 boosters

Weitere VAERSDATA-Felder

Praegender Schweregrund: COVID-19
Hospital-Tage: -
Labordaten: positive covid pcr 10/2/23
Aktuelle Erkrankungen: unknown
Vorgeschichte: HFrEF, COPD, chronic respiratory failure, CAD, Afib, AAA, HLD
Andere Medikamente: unknown
Allergien: NKA
Vorherige Impfungen: -

VAERS 2683566

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7143C

gering

Staat: AR
Alter: 83,0
Geschlecht: M
Eingang: 19.09.2023
Impfdatum: 27.10.2022
Beginn: 18.09.2023
Tage bis Beginn: 326,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein

COVID-19 SARS-CoV-2 test positive

Symptomtext

hospitalized with covid; fully vaccinated with 2 boosters

Weitere VAERSDATA-Felder

Praegender Schweregrund: COVID-19
Hospital-Tage: -
Labordaten: positive covid pcr 9/18/23
Aktuelle Erkrankungen: unknown
Vorgeschichte: COPD on O2 PRN CAD s/p 3 stents DMII HTN BPH HFpEF Diabetic foot A.fib
Andere Medikamente: unknown
Allergien: vancomycin
Vorherige Impfungen: -

VAERS 2683558

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge AS7143C

gering

Staat: AR
Alter: 72,0
Geschlecht: F
Eingang: 19.09.2023
Impfdatum: 28.10.2022
Beginn: 17.09.2023
Tage bis Beginn: 324,0
Dosis: 4
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: ja

COVID-19 SARS-CoV-2 test positive

Symptomtext

hospitalized with covid; fully vaccinated with boosters

Weitere VAERSDATA-Felder

Praegender Schweregrund: COVID-19
Hospital-Tage: 1,0
Labordaten: positive covid pcr 9/16/23
Aktuelle Erkrankungen: unknown
Vorgeschichte: Cancer, Hyperlipidemia, Thyroid and Other (depression, fibromyalgia )
Andere Medikamente: unknown
Allergien: hydromorphone
Vorherige Impfungen: -

VAERS 2676832

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge AS7143C

gering

Staat: MD
Alter: 49,0
Geschlecht: F
Eingang: 25.08.2023
Impfdatum: 10.09.2022
Beginn: 01.08.2023
Tage bis Beginn: 325,0
Dosis: 5
Route/Site: - / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

COVID-19 Drug ineffective

Symptomtext

COVID-19; COVID-19; This is a spontaneous report received from a contactable reporter(s) (Physician). The reporter is the patient. A 50-year-old female patient (not pregnant) received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 10Sep2022 as dose 5 (booster), single (Lot number: AS7143C) at the age of 49 years, in left arm for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown), as dose 2, single (Batch/Lot number: unknown), as dose 3 (booster), single (Batch/Lot number: unknown) and as dose 4 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "Type 1 diabetes" (unspecified if ongoing). The patient's concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset Aug2023, outcome "unknown" and all described as "COVID-19". Therapeutic measures were taken as a result of drug ineffective, covid-19.

Weitere VAERSDATA-Felder

Praegender Schweregrund: COVID-19
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: Medical History/Concurrent Conditions: Type 1 diabetes mellitus
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2667102

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7143C

gering

Staat: -
Alter: -
Geschlecht: U
Eingang: 07.08.2023
Impfdatum: 05.06.2023
Beginn: 05.06.2023
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered No adverse event Product storage error

Symptomtext

The vial was stored in the refrigerator on 04-JUN-2023 after expiration date 11-MAY-2023; No adverse event; Dose administered to patient on 5-JUN-2023 from vials of the Moderna COVID-19 bivalent vaccine that was expired on 11-MAY-2023; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Dose administered to patient on 5-JUN-2023 from vials of the Moderna COVID-19 bivalent vaccine that was expired on 11-MAY-2023), PRODUCT STORAGE ERROR (The vial was stored in the refrigerator on 04-JUN-2023 after expiration date 11-MAY-2023) and NO ADVERSE EVENT (No adverse event) in an adult patient of an unknown gender who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. AS7143C) for COVID-19 prophylaxis. No Medical History information was reported. On 05-Jun-2023, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On 05-Jun-2023, after starting mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)), the patient experienced EXPIRED PRODUCT ADMINISTERED (Dose administered to patient on 5-JUN-2023 from vials of the Moderna COVID-19 bivalent vaccine that was expired on 11-MAY-2023). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (The vial was stored in the refrigerator on 04-JUN-2023 after expiration date 11-MAY-2023) and NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Dose administered to patient on 5-JUN-2023 from vials of the Moderna COVID-19 bivalent vaccine that was expired on 11-MAY-2023), PRODUCT STORAGE ERROR (The vial was stored in the refrigerator on 04-JUN-2023 after expiration date 11-MAY-2023) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for EXPIRED PRODUCT ADMINISTERED (Dose administered to patient on 5-JUN-2023 from vials of the Moderna COVID-19 bivalent vaccine that was expired on 11-MAY-2023) and PRODUCT STORAGE ERROR (The vial was stored in the refrigerator on 04-JUN-2023 after expiration date 11-MAY-2023). No concomitant medication was reported. Suspect product dosage text was reported as unknown. It was reported that no adverse reactions have been reported by any patients. The vial was initially stored in the refrigerator on 4-JUN-2023 and did not underwent any temperature excursions. No treatment medication was reported. This case is reported for patient 1 out of 50 patients. This case was linked to US-MODERNATX, INC.-MOD-2023-735334, US-MODERNATX, INC.-MOD-2023-735345, US-MODERNATX, INC.-MOD-2023-735346, US-MODERNATX, INC.-MOD-2023-735347, US-MODERNATX, INC.-MOD-2023-735350, US-MODERNATX, INC.-MOD-2023-735351, US-MODERNATX, INC.-MOD-2023-735363, US-MODERNATX, INC.-MOD-2023-735367, US-MODERNATX, INC.-MOD-2023-735368, US-MODERNATX, INC.-MOD-2023-735369, US-MODERNATX, INC.-MOD-2023-735371, US-MODERNATX, INC.-MOD-2023-735372, US-MODERNATX, INC.-MOD-2023-735370, US-MODERNATX, INC.-MOD-2023-735373, US-MODERNATX, INC.-MOD-2023-735375, US-MODERNATX, INC.-MOD-2023-735378, US-MODERNATX, INC.-MOD-2023-735379, US-MODERNATX, INC.-MOD-2023-735384, US-MODERNATX, INC.-MOD-2023-735380, US-MODERNATX, INC.-MOD-2023-735382, US-MODERNATX, INC.-MOD-2023-735386, US-MODERNATX, INC.-MOD-2023-735387, US-MODERNATX, INC.-MOD-2023-735390, US-MODERNATX, INC.-MOD-2023-735388, US-MODERNATX, INC.-MOD-2023-735389, US-MODERNATX, INC.-MOD-2023-735396, US-MODERNATX, INC.-MOD-2023-735395, US-MODERNATX, INC.-MOD-2023-735398, US-MODERNATX, INC.-MOD-2023-735397, US-MODERNATX, INC.-MOD-2023-735399, US-MODERNATX, INC.-MOD-2023-735400, US-MODERNATX, INC.-MOD-2023-735401, US-MODERNATX, INC.-MOD-2023-735402, US-MODERNATX, INC.-MOD-2023-735403, US-MODERNATX, INC.-MOD-2023-735404, US-MODERNATX, INC.-MOD-2023-735407, US-MODERNATX, INC.-MOD-2023-735405, US-MODERNATX, INC.-MOD-2023-735410, US-MODERNATX, INC.-MOD-2023-735415, US-MODERNATX, INC.-MOD-2023-735418, US-MODERNATX, INC.-MOD-2023-735430, US-MODERNATX, INC.-MOD-2023-735435, US-MODERNATX, INC.-MOD-2023-735443, US-MODERNATX, INC.-MOD-2023-735452, US-MODERNATX, INC.-MOD-2023-735340, US-MODERNATX, INC.-MOD-2023-735349, US-MODERNATX, INC.-MOD-2023-735348 (Linked Report).; Sender's Comments: US-MODERNATX, INC.-MOD-2023-735334:Patient 2 out of 50 (Lot AS7143C was administered on 5Jun2023) US-MODERNATX, INC.-MOD-2023-735347:Patient 7out of 50 (Lot AS7143C was administered on 5Jun2023) US-MODERNATX, INC.-MOD-2023-735350:Patient 10 out of 50 (Lot AS7143C was administered on 5Jun2023) US-MODERNATX, INC.-MOD-2023-735346:Patient 6 out of 50 (Lot AS7143C was administered on 5Jun2023) US-MODERNATX, INC.-MOD-2023-735345:Patient 5 out of 50 (Lot AS7143C was administered on 5Jun2023) US-MODERNATX, INC.-MOD-2023-735351:Patient 11 out of 50 (Lot AS7143C was administered on 5Jun2023) US-MODERNATX, INC.-MOD-2023-735403:Patient 30 out of 50 (Lot AS7143C was administered on 5Jun2023) US-MODERNATX, INC.-MOD-2023-735404:Patient 37 out of 50 (Lot AS7143C was administered on 5Jun2023) US-MODERNATX, INC.-MOD-2023-735395:Patient 28 out of 50 (Lot AS7143C was administered on 5Jun2023) US-MODERNATX, INC.-MOD-2023-735380:Patient 26 out of 50 (Lot AS7143C was administered on 5Jun2023) US-MODERNATX, INC.-MOD-2023-735399:Patient 21 out of 50 (Lot AS7143C was administered on 5Jun2023) US-MODERNATX, INC.-MOD-2023-735379:Patient 16 out of 50 (Lot AS7143C was administered on 5Jun2023) US-MODERNATX, INC.-MOD-2023-735405:Patient 47 out of 50 (Lot 019H22A was administered on 5Jun2023) US-MODERNATX, INC.-MOD-2023-735389:Patient 44 out of 50 (Lot 019H22A was administered on 5Jun2023) US-MODERNATX, INC.-MOD-2023-735397:Patient 45 out of 50 (Lot 019H22A was administered on 5Jun2023) US-MODERNATX, INC.-MOD-2023-735415:Patient 49 out of 50 (Lot 019H22A was administered on 5Jun2023) US-MODERNATX, INC.-MOD-2023-735371:Patient 14 out of 50 (Lot AS7143C was administered on 5Jun2023) US-MODERNATX, INC.-MOD-2023-735430:Patient 38 out of 50 (Lot AS7143C was administered on 5Jun2023) US-MODERNATX, INC.-MOD-2023-735386:Patient 18 out of 50 (Lot AS7143C was administered on 5Jun2023) US-MODERNATX, INC.-MOD-2023-735363:Patient 22 out of 50 (Lot AS7143C was administered on 5Jun2023) US-MODERNATX, INC.-MOD-2023-735369:Patient 13 out of 50 (Lot AS7143C was administered on 5Jun2023) US-MODERNATX, INC.-MOD-2023-735372:Patient 33 out of 50 (Lot AS7143C was administered on 5Jun2023) US-MODERNATX, INC.-MOD-2023-735375:Patient 15 out of 50 (Lot AS7143C was administered on 5Jun2023) US-MODERNATX, INC.-MOD-2023-735382:Patient 43 out of 50 (Lot 019H22A was administered on 5Jun2023) US-MODERNATX, INC.-MOD-2023-735390:Patient 19 out of 50 (Lot AS7143C was administered on 5Jun2023) US-MODERNATX, INC.-MOD-2023-735418:Patient 50 out of 50 (Lot 019H22A was administered on 5Jun2023) US-MODERNATX, INC.-MOD-2023-735368:Patient 32 out of 50 (Lot AS7143C was administered on 5Jun2023) US-MODERNATX, INC.-MOD-2023-735378:Patient 25 out of 50 (Lot AS7143C was administered on 5Jun2023) US-MODERNATX, INC.-MOD-2023-735410:Patient 48 out of 50 (Lot 019H22A was administered on 5Jun2023) US-MODERNATX, INC.-MOD-2023-735435:Patient 39 out of 50 (Lot AS7143C was administered on 5Jun2023) US-MODERNATX, INC.-MOD-2023-735384:Patient 17 out of 50 (Lot AS7143C was administered on 5Jun2023) US-MODERNATX, INC.-MOD-2023-735452:Patient 41 out of 50 (Lot 019H22A was administered on 5Jun2023) US-MODERNATX, INC.-MOD-2023-735443:Patient 40 out of 50 (Lot AS7143C was administered on 5Jun2023) US-MODERNATX, INC.-MOD-2023-735396:Patient 20 out of 50 (Lot AS7143C was administered on 5Jun2023) US-MODERNATX, INC.-MOD-2023-735370:Patient 42 out of 50 (Lot 019H22A was administered on 5Jun2023) US-MODERNATX, INC.-MOD-2023-735367:Patient 12 out of 50 (Lot AS7143C was administered on 5Jun2023) US-MODERNATX, INC.-MOD-2023-735407:Patient 31 out of 50 (Lot AS7143C was administered on 5Jun2023) US-MODERNATX, INC.-MOD-2023-735402:Patient 46 out of 50 (Lot 019H22A was administered on 5Jun2023) US-MODERNATX, INC.-MOD-2023-735401:Patient 36 out of 50 (Lot AS7143C was administered on 5Jun2023) US-MODERNATX, INC.-MOD-2023-735400:Patient 29 out of 50 (Lot AS7143C was administered on 5Jun2023) US-MODERNATX, INC.-MOD-2023-735398:Patient 35 out of 50 (Lot AS7143C was administered on 5Jun2023) US-MODERNATX, INC.-MOD-2023-735388:Patient 34 out of 50 (Lot AS7143C was administered on 5Jun2023) US-MODERNATX, INC.-MOD-2023-735373:Patient 24 out of 50 (Lot AS7143C was administered on 5Jun2023) US-MODERNATX, INC.-MOD-2023-735387:Patient 27 out of 50 (Lot AS7143C was administered on 5Jun2023) US-MODERNATX, INC.-MOD-2023-735340:Patient 03 out of 50 (Lot AS7143C was administered on 5Jun2023) US-MODERNATX, INC.-MOD-2023-735349:Patient 09 out of 50 (Lot AS7143C was administered on 5Jun2023) US-MODERNATX, INC.-MOD-2023-735348:Patient 08 out of 50 (Lot AS7143C was administered on 5Jun2023)

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2667099

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7143C

gering

Staat: -
Alter: -
Geschlecht: U
Eingang: 07.08.2023
Impfdatum: 05.06.2023
Beginn: 05.06.2023
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered No adverse event Product storage error

Symptomtext

The vial was stored in the refrigerator on 04-JUN-2023 after expiration date 11-MAY-2023.; No adverse event; Dose administered to patient on 5-JUN-2023 from vials of the Moderna COVID-19 bivalent vaccine that was expired on 11-MAY-2023.; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Dose administered to patient on 5-JUN-2023 from vials of the Moderna COVID-19 bivalent vaccine that was expired on 11-MAY-2023.), PRODUCT STORAGE ERROR (The vial was stored in the refrigerator on 04-JUN-2023 after expiration date 11-MAY-2023.) and NO ADVERSE EVENT (No adverse event) in an adult patient of an unknown gender who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. AS7143C) for COVID-19 prophylaxis. No Medical History information was reported. On 05-Jun-2023, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On 05-Jun-2023, the patient experienced EXPIRED PRODUCT ADMINISTERED (Dose administered to patient on 5-JUN-2023 from vials of the Moderna COVID-19 bivalent vaccine that was expired on 11-MAY-2023.). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (The vial was stored in the refrigerator on 04-JUN-2023 after expiration date 11-MAY-2023.) and NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Dose administered to patient on 5-JUN-2023 from vials of the Moderna COVID-19 bivalent vaccine that was expired on 11-MAY-2023.), PRODUCT STORAGE ERROR (The vial was stored in the refrigerator on 04-JUN-2023 after expiration date 11-MAY-2023.) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for EXPIRED PRODUCT ADMINISTERED (Dose administered to patient on 5-JUN-2023 from vials of the Moderna COVID-19 bivalent vaccine that was expired on 11-MAY-2023.) and PRODUCT STORAGE ERROR (The vial was stored in the refrigerator on 04-JUN-2023 after expiration date 11-MAY-2023.). No concomitant medication was reported. Suspect product dosage text was reported as unknown. The vial did not undergo any temperature excursions. Suspect vaccine expiry date was 11-May-2023. It was reported that no adverse reactions have been reported by any patients. No treatment medication was reported. This case is reported for patient 40th out of 50 adult patients. This case was linked to US-MODERNATX, INC.-MOD-2023-735331 (Linked Report).; Sender's Comments: US-MODERNATX, INC.-MOD-2023-735331:Patient 1 out of 50 (Lot AS7143C was administered on 5Jun2023)

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2667098

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7143C

gering

Staat: -
Alter: -
Geschlecht: U
Eingang: 07.08.2023
Impfdatum: 05.06.2023
Beginn: 05.06.2023
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered No adverse event Product storage error

Symptomtext

The vial was stored in the refrigerator on 04-JUN-2023 after expiration date 11-MAY-2023; No adverse event; Dose administered to patient on 5-JUN-2023 from vials of the Moderna COVID-19 bivalent vaccine that was expired on 11-MAY-2023; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Dose administered to patient on 5-JUN-2023 from vials of the Moderna COVID-19 bivalent vaccine that was expired on 11-MAY-2023), PRODUCT STORAGE ERROR (The vial was stored in the refrigerator on 04-JUN-2023 after expiration date 11-MAY-2023) and NO ADVERSE EVENT (No adverse event) in an adult patient of an unknown gender who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. AS7143C) for COVID-19 prophylaxis. No Medical History information was reported. On 05-Jun-2023, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On 05-Jun-2023, the patient experienced EXPIRED PRODUCT ADMINISTERED (Dose administered to patient on 5-JUN-2023 from vials of the Moderna COVID-19 bivalent vaccine that was expired on 11-MAY-2023). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (The vial was stored in the refrigerator on 04-JUN-2023 after expiration date 11-MAY-2023) and NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Dose administered to patient on 5-JUN-2023 from vials of the Moderna COVID-19 bivalent vaccine that was expired on 11-MAY-2023), PRODUCT STORAGE ERROR (The vial was stored in the refrigerator on 04-JUN-2023 after expiration date 11-MAY-2023) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for EXPIRED PRODUCT ADMINISTERED (Dose administered to patient on 5-JUN-2023 from vials of the Moderna COVID-19 bivalent vaccine that was expired on 11-MAY-2023) and PRODUCT STORAGE ERROR (The vial was stored in the refrigerator on 04-JUN-2023 after expiration date 11-MAY-2023). No concomitant medication was reported. Suspect product dosage text was reported as unknown. It was reported that no adverse reactions have been reported by any patients. The vial was initially stored in the refrigerator on 4-JUN-2023 and did not underwent any temperature excursions. No treatment medication was reported. This case is reported for patient 39 out of 50 patients This case was linked to US-MODERNATX, INC.-MOD-2023-735331 (Linked Report).; Sender's Comments: US-MODERNATX, INC.-MOD-2023-735331:Master case

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2667097

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7143C

gering

Staat: -
Alter: -
Geschlecht: U
Eingang: 07.08.2023
Impfdatum: 05.06.2023
Beginn: 05.06.2023
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered No adverse event Product storage error

Symptomtext

Vaccine was expired on 11-May-2023 and was stored in referigerator on 04-Jun-2023; No adverse event; Dose to patient on 5JUN2023 from vials of the Moderna COVID-19 bivalent vaccine that had expired; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Dose to patient on 5JUN2023 from vials of the Moderna COVID-19 bivalent vaccine that had expired), PRODUCT STORAGE ERROR (Vaccine was expired on 11-May-2023 and was stored in referigerator on 04-Jun-2023) and NO ADVERSE EVENT (No adverse event) in a patient of an unknown age and gender who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. AS7143C) for COVID-19 prophylaxis. No Medical History information was reported. On 05-Jun-2023, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On 05-Jun-2023, the patient experienced EXPIRED PRODUCT ADMINISTERED (Dose to patient on 5JUN2023 from vials of the Moderna COVID-19 bivalent vaccine that had expired). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Vaccine was expired on 11-May-2023 and was stored in referigerator on 04-Jun-2023) and NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Dose to patient on 5JUN2023 from vials of the Moderna COVID-19 bivalent vaccine that had expired), PRODUCT STORAGE ERROR (Vaccine was expired on 11-May-2023 and was stored in referigerator on 04-Jun-2023) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for EXPIRED PRODUCT ADMINISTERED (Dose to patient on 5JUN2023 from vials of the Moderna COVID-19 bivalent vaccine that had expired) and PRODUCT STORAGE ERROR (Vaccine was expired on 11-May-2023 and was stored in referigerator on 04-Jun-2023). No concomitant medication was reported. Suspect product dosage text was reported as unknown. It was reported that no adverse reactions have been reported by any patients. The vial was initially stored in the refrigerator on 4-JUN-2023 and did not underwent any temperature excursions. No treatment medication was reported. This case is reported for patient 38 out of 50 patients. This case was linked to US-MODERNATX, INC.-MOD-2023-735331 (Linked Report).; Sender's Comments: US-MODERNATX, INC.-MOD-2023-735331:master case

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2667096

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7143C

gering

Staat: -
Alter: -
Geschlecht: U
Eingang: 07.08.2023
Impfdatum: 05.06.2023
Beginn: 05.06.2023
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered No adverse event Product storage error

Symptomtext

The vial was initially stored in the refrigerator on 4-JUN-2023 and expired on 11-MAY-2023.; No adverse event; doses to patients on 5JUN2023 from vials of the Moderna COVID-19 bivalent vaccine that had expired; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (doses to patients on 5JUN2023 from vials of the Moderna COVID-19 bivalent vaccine that had expired), PRODUCT STORAGE ERROR (The vial was initially stored in the refrigerator on 4-JUN-2023 and expired on 11-MAY-2023.) and NO ADVERSE EVENT (No adverse event) in a patient of an unknown age and gender who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. AS7143C) for COVID-19 prophylaxis. No Medical History information was reported. On 05-Jun-2023, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On 05-Jun-2023, the patient experienced EXPIRED PRODUCT ADMINISTERED (doses to patients on 5JUN2023 from vials of the Moderna COVID-19 bivalent vaccine that had expired). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (The vial was initially stored in the refrigerator on 4-JUN-2023 and expired on 11-MAY-2023.) and NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (doses to patients on 5JUN2023 from vials of the Moderna COVID-19 bivalent vaccine that had expired), PRODUCT STORAGE ERROR (The vial was initially stored in the refrigerator on 4-JUN-2023 and expired on 11-MAY-2023.) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for EXPIRED PRODUCT ADMINISTERED (doses to patients on 5JUN2023 from vials of the Moderna COVID-19 bivalent vaccine that had expired) and PRODUCT STORAGE ERROR (The vial was initially stored in the refrigerator on 4-JUN-2023 and expired on 11-MAY-2023.). No concomitant medication was reported. Suspect product dosage text was reported as unknown. It was reported that no adverse reactions have been reported by any patients. The vial was initially stored in the refrigerator on 4-JUN-2023 and did not underwent any temperature excursions. No treatment medication was reported. This case is reported for patient 31 out of 50 patients. This case was linked to US-MODERNATX, INC.-MOD-2023-735331 (Linked Report).; Sender's Comments: US-MODERNATX, INC.-MOD-2023-735331:Master case, Patient 1 out of 50 (Lot AS7143C was administered on 5-JUN-2023)

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2667095

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7143C

gering

Staat: -
Alter: -
Geschlecht: U
Eingang: 07.08.2023
Impfdatum: 05.06.2023
Beginn: 05.06.2023
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered No adverse event Product storage error

Symptomtext

The vial was stored in the refrigerator on 04 JUN 2023 after expiration date 11 MAY 2023 and Dose administered to patient on 5 JUN 2023; No adverse event; Dose administered to patient on 5-JUN-2023 from vials of the Moderna COVID-19 bivalent vaccine that was expired on 11-MAY-2023; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Dose administered to patient on 5-JUN-2023 from vials of the Moderna COVID-19 bivalent vaccine that was expired on 11-MAY-2023), PRODUCT STORAGE ERROR (The vial was stored in the refrigerator on 04 JUN 2023 after expiration date 11 MAY 2023 and Dose administered to patient on 5 JUN 2023) and NO ADVERSE EVENT (No adverse event) in an adult patient of an unknown gender who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. AS7143C) for COVID-19 prophylaxis. No Medical History information was reported. On 05-Jun-2023, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On 05-Jun-2023, the patient experienced EXPIRED PRODUCT ADMINISTERED (Dose administered to patient on 5-JUN-2023 from vials of the Moderna COVID-19 bivalent vaccine that was expired on 11-MAY-2023). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (The vial was stored in the refrigerator on 04 JUN 2023 after expiration date 11 MAY 2023 and Dose administered to patient on 5 JUN 2023) and NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Dose administered to patient on 5-JUN-2023 from vials of the Moderna COVID-19 bivalent vaccine that was expired on 11-MAY-2023), PRODUCT STORAGE ERROR (The vial was stored in the refrigerator on 04 JUN 2023 after expiration date 11 MAY 2023 and Dose administered to patient on 5 JUN 2023) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for EXPIRED PRODUCT ADMINISTERED (Dose administered to patient on 5-JUN-2023 from vials of the Moderna COVID-19 bivalent vaccine that was expired on 11-MAY-2023) and PRODUCT STORAGE ERROR (The vial was stored in the refrigerator on 04 JUN 2023 after expiration date 11 MAY 2023 and Dose administered to patient on 5 JUN 2023). No concomitant medication was reported. Suspect product dosage text was reported as unknown. It was reported that no adverse reactions have been reported by any patients. The vial was initially stored in the refrigerator on 4-JUN-2023 and did not underwent any temperature excursions. No treatment medication was reported. This case was reported for patient 37 out of 50 patients. This case was linked to US-MODERNATX, INC.-MOD-2023-735331 (E2B Linked Report).; Sender's Comments: US-MODERNATX, INC.-MOD-2023-735331:Patient 1 out of 50 (Lot AS7143C was administered on 5Jun2023)

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2667094

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7143C

gering

Staat: -
Alter: -
Geschlecht: U
Eingang: 07.08.2023
Impfdatum: 05.06.2023
Beginn: 05.06.2023
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered No adverse event Product storage error

Symptomtext

The vial was stored in the refrigerator on 04-JUN-2023 after expiration date 11-MAY-2023.; No adverse event; Dose administered to patient on 5-JUN-2023 from vials of the Moderna COVID-19 bivalent vaccine that was expired on 11-MAY-2023.; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Dose administered to patient on 5-JUN-2023 from vials of the Moderna COVID-19 bivalent vaccine that was expired on 11-MAY-2023.), PRODUCT STORAGE ERROR (The vial was stored in the refrigerator on 04-JUN-2023 after expiration date 11-MAY-2023.) and NO ADVERSE EVENT (No adverse event) in an adult patient of an unknown gender who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. AS7143C) for COVID-19 prophylaxis. No Medical History information was reported. On 05-Jun-2023, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On 05-Jun-2023, the patient experienced EXPIRED PRODUCT ADMINISTERED (Dose administered to patient on 5-JUN-2023 from vials of the Moderna COVID-19 bivalent vaccine that was expired on 11-MAY-2023.). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (The vial was stored in the refrigerator on 04-JUN-2023 after expiration date 11-MAY-2023.) and NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Dose administered to patient on 5-JUN-2023 from vials of the Moderna COVID-19 bivalent vaccine that was expired on 11-MAY-2023.), PRODUCT STORAGE ERROR (The vial was stored in the refrigerator on 04-JUN-2023 after expiration date 11-MAY-2023.) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for EXPIRED PRODUCT ADMINISTERED (Dose administered to patient on 5-JUN-2023 from vials of the Moderna COVID-19 bivalent vaccine that was expired on 11-MAY-2023.) and PRODUCT STORAGE ERROR (The vial was stored in the refrigerator on 04-JUN-2023 after expiration date 11-MAY-2023.). No concomitant medication was reported. Suspect product dosage text was reported as unknown. The vial did not undergo any temperature excursions. Suspect vaccine expiry date was 11-May-2023. It was reported that no adverse reactions have been reported by any patients. No treatment medication was reported. This case is reported for patient 30th out of 50 adult patients. This case was linked to US-MODERNATX, INC.-MOD-2023-735331 (E2B Linked Report).; Sender's Comments: US-MODERNATX, INC.-MOD-2023-735331:Master case, Patient 1 out of 50 (Lot AS7143C was administered on 5-JUN-2023)

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2667093

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7143C

gering

Staat: -
Alter: -
Geschlecht: U
Eingang: 07.08.2023
Impfdatum: 05.06.2023
Beginn: 05.06.2023
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered No adverse event Product storage error

Symptomtext

the vial was initially stored in the refrigerator on 4-Jun-2023 and was administered on 5-Jun-2023; No adverse event; the dose the patient received on 5JUN2023 from vials of the Moderna COVID-19 bivalent vaccine that had expired; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (the dose the patient received on 5JUN2023 from vials of the Moderna COVID-19 bivalent vaccine that had expired), PRODUCT STORAGE ERROR (the vial was initially stored in the refrigerator on 4-Jun-2023 and was administered on 5-Jun-2023) and NO ADVERSE EVENT (No adverse event ) in an adult patient of an unknown gender who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. AS7143C) for COVID-19 prophylaxis. No Medical History information was reported. On 05-Jun-2023, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On 05-Jun-2023, the patient experienced EXPIRED PRODUCT ADMINISTERED (the dose the patient received on 5JUN2023 from vials of the Moderna COVID-19 bivalent vaccine that had expired). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (the vial was initially stored in the refrigerator on 4-Jun-2023 and was administered on 5-Jun-2023) and NO ADVERSE EVENT (No adverse event ). At the time of the report, EXPIRED PRODUCT ADMINISTERED (the dose the patient received on 5JUN2023 from vials of the Moderna COVID-19 bivalent vaccine that had expired), PRODUCT STORAGE ERROR (the vial was initially stored in the refrigerator on 4-Jun-2023 and was administered on 5-Jun-2023) and NO ADVERSE EVENT (No adverse event ) outcome was unknown. For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event ) to be not related. No further causality assessments were provided for EXPIRED PRODUCT ADMINISTERED (the dose the patient received on 5JUN2023 from vials of the Moderna COVID-19 bivalent vaccine that had expired) and PRODUCT STORAGE ERROR (the vial was initially stored in the refrigerator on 4-Jun-2023 and was administered on 5-Jun-2023). No concomitant medication was reported. The doses text of the suspect was reported as Unknown. It was reported that a facility administered 50 doses to patients on 5JUN2023 from vials of the Moderna COVID-19 bivalent vaccine that had expired. Lot AS7143C was administered on 5-JUN-2023 to 40 patients. Lot 019H22A was administered on 5-JUN-2023 to 10 patients. The HCP does not have any patient details at this time. No adverse reactions have been reported by any patients. The expiry date for Lot-AS7143C was reported as 11-MAY-2023 and Lot-019H22A was reported as 30-MAY-2023. The vial size was unknown. The vials did not undergo any temperature excursions. No treatment medication was reported. This case contains information about patient 36th out of 50 patients. This case was linked to US-MODERNATX, INC.-MOD-2023-735331 (E2B Linked Report).; Sender's Comments: US-MODERNATX, INC.-MOD-2023-735331:Patient 1 out of 50 (Lot AS7143C was administered on 5Jun2023)

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2667092

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7143C

gering

Staat: -
Alter: -
Geschlecht: U
Eingang: 07.08.2023
Impfdatum: 05.06.2023
Beginn: 05.06.2023
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered No adverse event Product storage error

Symptomtext

The vial was stored in the refrigerator on 04-JUN-2023 after expiration date 11-MAY-2023; No adverse event; Dose administered to patient on 5-JUN-2023 from vials of the Moderna COVID-19 bivalent vaccine that was expired on 11-MAY-2023; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Dose administered to patient on 5-JUN-2023 from vials of the Moderna COVID-19 bivalent vaccine that was expired on 11-MAY-2023), PRODUCT STORAGE ERROR (The vial was stored in the refrigerator on 04-JUN-2023 after expiration date 11-MAY-2023) and NO ADVERSE EVENT (No adverse event) in an adult patient of an unknown gender who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. AS7143C) for COVID-19 prophylaxis. No Medical History information was reported. On 05-Jun-2023, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On 05-Jun-2023, the patient experienced EXPIRED PRODUCT ADMINISTERED (Dose administered to patient on 5-JUN-2023 from vials of the Moderna COVID-19 bivalent vaccine that was expired on 11-MAY-2023). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (The vial was stored in the refrigerator on 04-JUN-2023 after expiration date 11-MAY-2023) and NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Dose administered to patient on 5-JUN-2023 from vials of the Moderna COVID-19 bivalent vaccine that was expired on 11-MAY-2023), PRODUCT STORAGE ERROR (The vial was stored in the refrigerator on 04-JUN-2023 after expiration date 11-MAY-2023) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for EXPIRED PRODUCT ADMINISTERED (Dose administered to patient on 5-JUN-2023 from vials of the Moderna COVID-19 bivalent vaccine that was expired on 11-MAY-2023) and PRODUCT STORAGE ERROR (The vial was stored in the refrigerator on 04-JUN-2023 after expiration date 11-MAY-2023). No concomitant medication was reported. Suspect product dosage text was reported as unknown. It was reported that no adverse reactions have been reported by any patients. The vial was initially stored in the refrigerator on 4-JUN-2023 and did not underwent any temperature excursions. No treatment medication was reported. This case is reported for patient 29 out of 50 patients This case was linked to US-MODERNATX, INC.-MOD-2023-735331 (E2B Linked Report).; Sender's Comments: US-MODERNATX, INC.-MOD-2023-735331:Master case

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2667091

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7143C

gering

Staat: -
Alter: -
Geschlecht: U
Eingang: 07.08.2023
Impfdatum: 05.06.2023
Beginn: 05.06.2023
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered No adverse event Product storage error

Symptomtext

the vial was initially stored in the refrigerator on 4-Jun-2023 and was administered on 5-Jun-2023; No adverse event; the dose the patient received on 5JUN2023 from vials of the Moderna COVID-19 bivalent vaccine that had expired; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (the dose the patient received on 5JUN2023 from vials of the Moderna COVID-19 bivalent vaccine that had expired), PRODUCT STORAGE ERROR (the vial was initially stored in the refrigerator on 4-Jun-2023 and was administered on 5-Jun-2023) and NO ADVERSE EVENT (No adverse event) in an adult patient of an unknown gender who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. AS7143C) for COVID-19 prophylaxis. No Medical History information was reported. On 05-Jun-2023, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On 05-Jun-2023, the patient experienced EXPIRED PRODUCT ADMINISTERED (the dose the patient received on 5JUN2023 from vials of the Moderna COVID-19 bivalent vaccine that had expired). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (the vial was initially stored in the refrigerator on 4-Jun-2023 and was administered on 5-Jun-2023) and NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (the dose the patient received on 5JUN2023 from vials of the Moderna COVID-19 bivalent vaccine that had expired), PRODUCT STORAGE ERROR (the vial was initially stored in the refrigerator on 4-Jun-2023 and was administered on 5-Jun-2023) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for EXPIRED PRODUCT ADMINISTERED (the dose the patient received on 5JUN2023 from vials of the Moderna COVID-19 bivalent vaccine that had expired) and PRODUCT STORAGE ERROR (the vial was initially stored in the refrigerator on 4-Jun-2023 and was administered on 5-Jun-2023). No concomitant medication was reported. The doses text of the suspect was reported as Unknown. It was reported that a facility administered 50 doses to patients on 5JUN2023 from vials of the Moderna COVID-19 bivalent vaccine that had expired. Lot AS7143C was administered on 5-JUN-2023 to 40 patients. Lot 019H22A was administered on 5-JUN-2023 to 10 patients. The HCP does not have any patient details at this time. No adverse reactions have been reported by any patients. The expiry date for Lot-AS7143C was reported as 11-MAY-2023 and Lot-019H22A was reported as 30-MAY-2023. The vial size was unknown. The vials did not undergo any temperature excursions. No treatment medication was reported. This case contains information about patient 21st out of 50 patients. This case was linked to US-MODERNATX, INC.-MOD-2023-735331 (E2B Linked Report).; Sender's Comments: US-MODERNATX, INC.-MOD-2023-735331:Master case, Patient 1 out of 50 (Lot AS7143C was administered on 5Jun2023)

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2667090

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7143C

gering

Staat: -
Alter: -
Geschlecht: U
Eingang: 07.08.2023
Impfdatum: 05.06.2023
Beginn: 05.06.2023
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered No adverse event Product storage error

Symptomtext

Vaccine was expired on 11-May-2023 and was stored in referigerator on 04-Jun-2023; No adverse event; Dose to patient on 5JUN2023 from vials of the Moderna COVID-19 bivalent vaccine that had expired.; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Dose to patient on 5JUN2023 from vials of the Moderna COVID-19 bivalent vaccine that had expired.), PRODUCT STORAGE ERROR (Vaccine was expired on 11-May-2023 and was stored in referigerator on 04-Jun-2023) and NO ADVERSE EVENT (No adverse event) in an adult patient of an unknown gender who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. AS7143C) for COVID-19 prophylaxis. No Medical History information was reported. On 05-Jun-2023, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On 05-Jun-2023, the patient experienced EXPIRED PRODUCT ADMINISTERED (Dose to patient on 5JUN2023 from vials of the Moderna COVID-19 bivalent vaccine that had expired.). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Vaccine was expired on 11-May-2023 and was stored in referigerator on 04-Jun-2023) and NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Dose to patient on 5JUN2023 from vials of the Moderna COVID-19 bivalent vaccine that had expired.), PRODUCT STORAGE ERROR (Vaccine was expired on 11-May-2023 and was stored in referigerator on 04-Jun-2023) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for EXPIRED PRODUCT ADMINISTERED (Dose to patient on 5JUN2023 from vials of the Moderna COVID-19 bivalent vaccine that had expired.) and PRODUCT STORAGE ERROR (Vaccine was expired on 11-May-2023 and was stored in referigerator on 04-Jun-2023). No concomitant medication was reported. Suspect product dosage text was reported as unknown. It was reported that no adverse reactions have been reported by any patients. The vial was initially stored in the refrigerator on 4-JUN-2023 and did not underwent any temperature excursions. No treatment medication was reported. This case is reported for patient 35 out of 50 patients. This case was linked to US-MODERNATX, INC.-MOD-2023-735331 (E2B Linked Report).; Sender's Comments: US-MODERNATX, INC.-MOD-2023-735331:master case

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2666934

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7143C

gering

Staat: -
Alter: -
Geschlecht: U
Eingang: 07.08.2023
Impfdatum: 05.06.2023
Beginn: 05.06.2023
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered No adverse event Product storage error

Symptomtext

The vial was stored in the refrigerator on 04-JUN-2023 after expiration date 11-MAY-2023; No adverse event; Dose administered to patient on 5-JUN-2023 from vials of the Moderna COVID-19 bivalent vaccine that was expired on 11-MAY-2023; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Dose administered to patient on 5-JUN-2023 from vials of the Moderna COVID-19 bivalent vaccine that was expired on 11-MAY-2023), PRODUCT STORAGE ERROR (The vial was stored in the refrigerator on 04-JUN-2023 after expiration date 11-MAY-2023) and NO ADVERSE EVENT (No adverse event) in an adult patient of an unknown gender who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. AS7143C) for COVID-19 prophylaxis. No Medical History information was reported. On 05-Jun-2023, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On 05-Jun-2023, the patient experienced EXPIRED PRODUCT ADMINISTERED (Dose administered to patient on 5-JUN-2023 from vials of the Moderna COVID-19 bivalent vaccine that was expired on 11-MAY-2023). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (The vial was stored in the refrigerator on 04-JUN-2023 after expiration date 11-MAY-2023) and NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Dose administered to patient on 5-JUN-2023 from vials of the Moderna COVID-19 bivalent vaccine that was expired on 11-MAY-2023), PRODUCT STORAGE ERROR (The vial was stored in the refrigerator on 04-JUN-2023 after expiration date 11-MAY-2023) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for EXPIRED PRODUCT ADMINISTERED (Dose administered to patient on 5-JUN-2023 from vials of the Moderna COVID-19 bivalent vaccine that was expired on 11-MAY-2023) and PRODUCT STORAGE ERROR (The vial was stored in the refrigerator on 04-JUN-2023 after expiration date 11-MAY-2023). No concomitant medication was reported. Suspect product dosage text was reported as unknown. It was reported that no adverse reactions have been reported by any patients. The vial was initially stored in the refrigerator on 4-JUN-2023 and did not underwent any temperature excursions. No treatment medication was reported. This case is reported for patient 20 out of 50 patients This case was linked to US-MODERNATX, INC.-MOD-2023-735331 (E2B Linked Report).; Sender's Comments: US-MODERNATX, INC.-MOD-2023-735331:Master case

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2666933

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7143C

gering

Staat: -
Alter: -
Geschlecht: U
Eingang: 07.08.2023
Impfdatum: 05.06.2023
Beginn: 05.06.2023
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered No adverse event Product storage error

Symptomtext

The vial was initially stored in the refrigerator on 4-JUN-2023 and expired on 11-MAY-2023.; No adverse event; doses to patients on 5JUN2023 from vials of the Moderna COVID-19 bivalent vaccine that had expired; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (doses to patients on 5JUN2023 from vials of the Moderna COVID-19 bivalent vaccine that had expired), PRODUCT STORAGE ERROR (The vial was initially stored in the refrigerator on 4-JUN-2023 and expired on 11-MAY-2023.) and NO ADVERSE EVENT (No adverse event) in an adult patient of an unknown gender who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. AS7143C) for COVID-19 prophylaxis. No Medical History information was reported. On 05-Jun-2023, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On 05-Jun-2023, the patient experienced EXPIRED PRODUCT ADMINISTERED (doses to patients on 5JUN2023 from vials of the Moderna COVID-19 bivalent vaccine that had expired). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (The vial was initially stored in the refrigerator on 4-JUN-2023 and expired on 11-MAY-2023.) and NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (doses to patients on 5JUN2023 from vials of the Moderna COVID-19 bivalent vaccine that had expired), PRODUCT STORAGE ERROR (The vial was initially stored in the refrigerator on 4-JUN-2023 and expired on 11-MAY-2023.) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for EXPIRED PRODUCT ADMINISTERED (doses to patients on 5JUN2023 from vials of the Moderna COVID-19 bivalent vaccine that had expired) and PRODUCT STORAGE ERROR (The vial was initially stored in the refrigerator on 4-JUN-2023 and expired on 11-MAY-2023.). No concomitant medication was reported. Suspect product dosage text was reported as unknown. It was reported that no adverse reactions have been reported by any patients. The vial was initially stored in the refrigerator on 4-JUN-2023 and did not underwent any temperature excursions. No treatment medication was reported. This case is reported for patient 28 out of 50 patients. This case was linked to US-MODERNATX, INC.-MOD-2023-735331 (E2B Linked Report).; Sender's Comments: US-MODERNATX, INC.-MOD-2023-735331:Master case, Patient 1 out of 50 (Lot AS7143C was administered on 5-JUN-2023)

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2666932

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7143C

gering

Staat: -
Alter: -
Geschlecht: U
Eingang: 07.08.2023
Impfdatum: 05.06.2023
Beginn: 05.06.2023
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered No adverse event Product storage error

Symptomtext

Vaccine was expired on 11-May-2023 and was stored in referigerator on 04-Jun-2023; No adverse event; Dose to patient on 5JUN2023 from vials of the Moderna COVID-19 bivalent vaccine that had expired; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Dose to patient on 5JUN2023 from vials of the Moderna COVID-19 bivalent vaccine that had expired), PRODUCT STORAGE ERROR (Vaccine was expired on 11-May-2023 and was stored in referigerator on 04-Jun-2023) and NO ADVERSE EVENT (No adverse event) in an adult patient of an unknown gender who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. AS7143C) for COVID-19 prophylaxis. No Medical History information was reported. On 05-Jun-2023, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On 05-Jun-2023, the patient experienced EXPIRED PRODUCT ADMINISTERED (Dose to patient on 5JUN2023 from vials of the Moderna COVID-19 bivalent vaccine that had expired). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Vaccine was expired on 11-May-2023 and was stored in referigerator on 04-Jun-2023) and NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Dose to patient on 5JUN2023 from vials of the Moderna COVID-19 bivalent vaccine that had expired), PRODUCT STORAGE ERROR (Vaccine was expired on 11-May-2023 and was stored in referigerator on 04-Jun-2023) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for EXPIRED PRODUCT ADMINISTERED (Dose to patient on 5JUN2023 from vials of the Moderna COVID-19 bivalent vaccine that had expired) and PRODUCT STORAGE ERROR (Vaccine was expired on 11-May-2023 and was stored in referigerator on 04-Jun-2023). No concomitant medication was reported. Suspect product dosage text was reported as unknown. It was reported that no adverse reactions have been reported by any patients. The vial was initially stored in the refrigerator on 4-JUN-2023 and did not underwent any temperature excursions. No treatment medication was reported. This case is reported for patient 19 out of 50 patients. This case was linked to US-MODERNATX, INC.-MOD-2023-735331 (E2B Linked Report).; Sender's Comments: US-MODERNATX, INC.-MOD-2023-735331:master case

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2666931

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7143C

gering

Staat: -
Alter: -
Geschlecht: U
Eingang: 07.08.2023
Impfdatum: 05.06.2023
Beginn: 05.06.2023
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered No adverse event Product storage error

Symptomtext

The vial was stored in the refrigerator on 04 JUN 2023 after expiration date 11 MAY 2023 and Dose administered to patient on 5 JUN 2023; No adverse event; Dose administered to patient on 5-JUN-2023 from vials of the Moderna COVID-19 bivalent vaccine that was expired on 11-MAY-2023; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Dose administered to patient on 5-JUN-2023 from vials of the Moderna COVID-19 bivalent vaccine that was expired on 11-MAY-2023), PRODUCT STORAGE ERROR (The vial was stored in the refrigerator on 04 JUN 2023 after expiration date 11 MAY 2023 and Dose administered to patient on 5 JUN 2023) and NO ADVERSE EVENT (No adverse event) in an adult patient of an unknown gender who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. AS7143C) for COVID-19 prophylaxis. No Medical History information was reported. On 05-Jun-2023, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On 05-Jun-2023, the patient experienced EXPIRED PRODUCT ADMINISTERED (Dose administered to patient on 5-JUN-2023 from vials of the Moderna COVID-19 bivalent vaccine that was expired on 11-MAY-2023). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (The vial was stored in the refrigerator on 04 JUN 2023 after expiration date 11 MAY 2023 and Dose administered to patient on 5 JUN 2023) and NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Dose administered to patient on 5-JUN-2023 from vials of the Moderna COVID-19 bivalent vaccine that was expired on 11-MAY-2023), PRODUCT STORAGE ERROR (The vial was stored in the refrigerator on 04 JUN 2023 after expiration date 11 MAY 2023 and Dose administered to patient on 5 JUN 2023) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for EXPIRED PRODUCT ADMINISTERED (Dose administered to patient on 5-JUN-2023 from vials of the Moderna COVID-19 bivalent vaccine that was expired on 11-MAY-2023) and PRODUCT STORAGE ERROR (The vial was stored in the refrigerator on 04 JUN 2023 after expiration date 11 MAY 2023 and Dose administered to patient on 5 JUN 2023). No concomitant medication was reported. Suspect product dosage text was reported as unknown. It was reported that no adverse reactions have been reported by any patients. The vial was initially stored in the refrigerator on 4-JUN-2023 and did not underwent any temperature excursions. No treatment medication was reported. This case was reported for patient 34 out of 50 patients. This case was linked to US-MODERNATX, INC.-MOD-2023-735331 (E2B Linked Report).; Sender's Comments: US-MODERNATX, INC.-MOD-2023-735331:Patient 1 out of 50 (Lot AS7143C was administered on 5Jun2023)

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2666930

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7143C

gering

Staat: -
Alter: -
Geschlecht: U
Eingang: 07.08.2023
Impfdatum: 05.06.2023
Beginn: 05.06.2023
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered No adverse event Product storage error

Symptomtext

The vial was stored in the refrigerator on 04-JUN-2023 after expiration date 11-MAY-2023.; She states that no adverse reactions have been reported by any patients; Dose administered to patient on 5-JUN-2023 from vials of the Moderna COVID-19 bivalent vaccine that was expired on 11-MAY-2023.; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Dose administered to patient on 5-JUN-2023 from vials of the Moderna COVID-19 bivalent vaccine that was expired on 11-MAY-2023.), PRODUCT STORAGE ERROR (The vial was stored in the refrigerator on 04-JUN-2023 after expiration date 11-MAY-2023.) and NO ADVERSE EVENT (She states that no adverse reactions have been reported by any patients) in an adult patient of an unknown gender who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. AS7143C) for COVID-19 prophylaxis. No Medical History information was reported. On 05-Jun-2023, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On 05-Jun-2023, the patient experienced EXPIRED PRODUCT ADMINISTERED (Dose administered to patient on 5-JUN-2023 from vials of the Moderna COVID-19 bivalent vaccine that was expired on 11-MAY-2023.). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (The vial was stored in the refrigerator on 04-JUN-2023 after expiration date 11-MAY-2023.) and NO ADVERSE EVENT (She states that no adverse reactions have been reported by any patients). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Dose administered to patient on 5-JUN-2023 from vials of the Moderna COVID-19 bivalent vaccine that was expired on 11-MAY-2023.), PRODUCT STORAGE ERROR (The vial was stored in the refrigerator on 04-JUN-2023 after expiration date 11-MAY-2023.) and NO ADVERSE EVENT (She states that no adverse reactions have been reported by any patients) outcome was unknown. For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (She states that no adverse reactions have been reported by any patients) to be not related. No further causality assessments were provided for EXPIRED PRODUCT ADMINISTERED (Dose administered to patient on 5-JUN-2023 from vials of the Moderna COVID-19 bivalent vaccine that was expired on 11-MAY-2023.) and PRODUCT STORAGE ERROR (The vial was stored in the refrigerator on 04-JUN-2023 after expiration date 11-MAY-2023.). No concomitant medication was reported. Suspect product dosage text was reported as unknown. The vial did not undergo any temperature excursions. Suspect vaccine expiry date was 11-May-2023. It was reported that no adverse reactions have been reported by any patients. No treatment medication was reported. This case is reported for patient 27th out of 50 adult patients. This case was linked to US-MODERNATX, INC.-MOD-2023-735331 (E2B Linked Report).; Sender's Comments: US-MODERNATX, INC.-MOD-2023-735331:Master case, Patient 1 out of 50 (Lot AS7143C was administered on 5-JUN-2023)

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2666929

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7143C

gering

Staat: -
Alter: -
Geschlecht: U
Eingang: 07.08.2023
Impfdatum: 05.06.2023
Beginn: 05.06.2023
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered No adverse event Product storage error

Symptomtext

The vial was initially stored in the refrigerator on 4-JUN-2023 and expired on 11-MAY-2023.; No adverse event; doses to patients on 5JUN2023 from vials of the Moderna COVID-19 bivalent vaccine that had expired; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (doses to patients on 5JUN2023 from vials of the Moderna COVID-19 bivalent vaccine that had expired), PRODUCT STORAGE ERROR (The vial was initially stored in the refrigerator on 4-JUN-2023 and expired on 11-MAY-2023.) and NO ADVERSE EVENT (No adverse event) in an adult patient of an unknown gender who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. AS7143C) for COVID-19 prophylaxis. No Medical History information was reported. On 05-Jun-2023, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On 05-Jun-2023, the patient experienced EXPIRED PRODUCT ADMINISTERED (doses to patients on 5JUN2023 from vials of the Moderna COVID-19 bivalent vaccine that had expired). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (The vial was initially stored in the refrigerator on 4-JUN-2023 and expired on 11-MAY-2023.) and NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (doses to patients on 5JUN2023 from vials of the Moderna COVID-19 bivalent vaccine that had expired), PRODUCT STORAGE ERROR (The vial was initially stored in the refrigerator on 4-JUN-2023 and expired on 11-MAY-2023.) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for EXPIRED PRODUCT ADMINISTERED (doses to patients on 5JUN2023 from vials of the Moderna COVID-19 bivalent vaccine that had expired) and PRODUCT STORAGE ERROR (The vial was initially stored in the refrigerator on 4-JUN-2023 and expired on 11-MAY-2023.). No concomitant medication was reported. Suspect product dosage text was reported as unknown. It was reported that no adverse reactions have been reported by any patients. The vial was initially stored in the refrigerator on 4-JUN-2023 and did not underwent any temperature excursions. No treatment medication was reported. This case is reported for patient 18 out of 50 patients. This case was linked to US-MODERNATX, INC.-MOD-2023-735331 (E2B Linked Report).; Sender's Comments: US-MODERNATX, INC.-MOD-2023-735331:Master case, Patient 1 out of 50 (Lot AS7143C was administered on 5Jun2023)

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2666928

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7143C

gering

Staat: -
Alter: -
Geschlecht: U
Eingang: 07.08.2023
Impfdatum: 05.06.2023
Beginn: 05.06.2023
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered No adverse event Product storage error

Symptomtext

The vial was stored in the refrigerator on 04 JUN 2023 after expiration date 11 MAY 2023 and Dose administered to patient on 5 JUN 2023; No adverse event; Dose administered to patient on 5-JUN-2023 from vials of the Moderna COVID-19 bivalent vaccine that was expired on 11-MAY-2023; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Dose administered to patient on 5-JUN-2023 from vials of the Moderna COVID-19 bivalent vaccine that was expired on 11-MAY-2023), PRODUCT STORAGE ERROR (The vial was stored in the refrigerator on 04 JUN 2023 after expiration date 11 MAY 2023 and Dose administered to patient on 5 JUN 2023) and NO ADVERSE EVENT (No adverse event) in an adult patient of an unknown gender who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. AS7143C) for COVID-19 prophylaxis. No Medical History information was reported. On 05-Jun-2023, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On 05-Jun-2023, the patient experienced EXPIRED PRODUCT ADMINISTERED (Dose administered to patient on 5-JUN-2023 from vials of the Moderna COVID-19 bivalent vaccine that was expired on 11-MAY-2023). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (The vial was stored in the refrigerator on 04 JUN 2023 after expiration date 11 MAY 2023 and Dose administered to patient on 5 JUN 2023) and NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Dose administered to patient on 5-JUN-2023 from vials of the Moderna COVID-19 bivalent vaccine that was expired on 11-MAY-2023), PRODUCT STORAGE ERROR (The vial was stored in the refrigerator on 04 JUN 2023 after expiration date 11 MAY 2023 and Dose administered to patient on 5 JUN 2023) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for EXPIRED PRODUCT ADMINISTERED (Dose administered to patient on 5-JUN-2023 from vials of the Moderna COVID-19 bivalent vaccine that was expired on 11-MAY-2023) and PRODUCT STORAGE ERROR (The vial was stored in the refrigerator on 04 JUN 2023 after expiration date 11 MAY 2023 and Dose administered to patient on 5 JUN 2023). No concomitant medication was reported. Suspect product dosage text was reported as unknown. It was reported that no adverse reactions have been reported by any patients. The vial was initially stored in the refrigerator on 4-JUN-2023 and did not underwent any temperature excursions. No treatment medication was reported. This case was reported for patient 17 out of 50 patients. This case was linked to US-MODERNATX, INC.-MOD-2023-735331 (E2B Linked Report).; Sender's Comments: US-MODERNATX, INC.-MOD-2023-735331:Master case, Patient 1 out of 50 (Lot AS7143C was administered on 5Jun2023)

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2666927

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7143C

gering

Staat: -
Alter: -
Geschlecht: U
Eingang: 07.08.2023
Impfdatum: 05.06.2023
Beginn: 05.06.2023
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered No adverse event Product storage error

Symptomtext

the vial was initially stored in the refrigerator on 4-Jun-2023 and was administered on 5-Jun-2023; No adverse event; the dose the patient received on 5JUN2023 from vials of the Moderna COVID-19 bivalent vaccine that had expired; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (the dose the patient received on 5JUN2023 from vials of the Moderna COVID-19 bivalent vaccine that had expired), PRODUCT STORAGE ERROR (the vial was initially stored in the refrigerator on 4-Jun-2023 and was administered on 5-Jun-2023) and NO ADVERSE EVENT (No adverse event) in an adult patient of an unknown gender who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. AS7143C) for COVID-19 prophylaxis. No Medical History information was reported. On 05-Jun-2023, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On 05-Jun-2023, the patient experienced EXPIRED PRODUCT ADMINISTERED (the dose the patient received on 5JUN2023 from vials of the Moderna COVID-19 bivalent vaccine that had expired). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (the vial was initially stored in the refrigerator on 4-Jun-2023 and was administered on 5-Jun-2023) and NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (the dose the patient received on 5JUN2023 from vials of the Moderna COVID-19 bivalent vaccine that had expired), PRODUCT STORAGE ERROR (the vial was initially stored in the refrigerator on 4-Jun-2023 and was administered on 5-Jun-2023) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for EXPIRED PRODUCT ADMINISTERED (the dose the patient received on 5JUN2023 from vials of the Moderna COVID-19 bivalent vaccine that had expired) and PRODUCT STORAGE ERROR (the vial was initially stored in the refrigerator on 4-Jun-2023 and was administered on 5-Jun-2023). No concomitant medication was reported. The doses text of the suspect was reported as Unknown. It was reported that a facility administered 50 doses to patients on 5JUN2023 from vials of the Moderna COVID-19 bivalent vaccine that had expired. Lot AS7143C was administered on 5-JUN-2023 to 40 patients. Lot 019H22A was administered on 5-JUN-2023 to 10 patients. The HCP does not have any patient details at this time. No adverse reactions have been reported by any patients. The expiry date for Lot-AS7143C was reported as 11-MAY-2023 and Lot-019H22A was reported as 30-MAY-2023. The vial size was unknown. The vials did not undergo any temperature excursions. No treatment medication was reported. This case contains information about patient 26th out of 50 patients. This case was linked to US-MODERNATX, INC.-MOD-2023-735331 (E2B Linked Report).; Sender's Comments: US-MODERNATX, INC.-MOD-2023-735331:Master case, Patient 1 out of 50 (Lot AS7143C was administered on 5-JUN-2023)

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2666926

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7143C

gering

Staat: -
Alter: -
Geschlecht: U
Eingang: 07.08.2023
Impfdatum: 05.06.2023
Beginn: 05.06.2023
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered No adverse event Product storage error

Symptomtext

The vial was stored in the refrigerator on 04-JUN-2023 after expiration date 11-MAY-2023.; No adverse event; Dose administered to patient on 5-JUN-2023 from vials of the Moderna COVID-19 bivalent vaccine that was expired on 11-MAY-2023.; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Dose administered to patient on 5-JUN-2023 from vials of the Moderna COVID-19 bivalent vaccine that was expired on 11-MAY-2023.), PRODUCT STORAGE ERROR (The vial was stored in the refrigerator on 04-JUN-2023 after expiration date 11-MAY-2023.) and NO ADVERSE EVENT (No adverse event) in an adult patient of an unknown gender who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. AS7143C) for COVID-19 prophylaxis. No Medical History information was reported. On 05-Jun-2023, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On 05-Jun-2023, the patient experienced EXPIRED PRODUCT ADMINISTERED (Dose administered to patient on 5-JUN-2023 from vials of the Moderna COVID-19 bivalent vaccine that was expired on 11-MAY-2023.). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (The vial was stored in the refrigerator on 04-JUN-2023 after expiration date 11-MAY-2023.) and NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Dose administered to patient on 5-JUN-2023 from vials of the Moderna COVID-19 bivalent vaccine that was expired on 11-MAY-2023.), PRODUCT STORAGE ERROR (The vial was stored in the refrigerator on 04-JUN-2023 after expiration date 11-MAY-2023.) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for EXPIRED PRODUCT ADMINISTERED (Dose administered to patient on 5-JUN-2023 from vials of the Moderna COVID-19 bivalent vaccine that was expired on 11-MAY-2023.) and PRODUCT STORAGE ERROR (The vial was stored in the refrigerator on 04-JUN-2023 after expiration date 11-MAY-2023.). No concomitant medication was reported. Suspect product dosage text was reported as unknown. The vial did not undergo any temperature excursions. Suspect vaccine expiry date was 11-May-2023. It was reported that no adverse reactions have been reported by any patients. No treatment medication was reported. This case is reported for patient 16th out of 50 adult patients. This case was linked to US-MODERNATX, INC.-MOD-2023-735331 (E2B Linked Report).; Sender's Comments: US-MODERNATX, INC.-MOD-2023-735331:Master case, Patient 1 out of 50 (Lot AS7143C was administered on 5Jun2023)

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2666925

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7143C

gering

Staat: -
Alter: -
Geschlecht: U
Eingang: 07.08.2023
Impfdatum: 05.06.2023
Beginn: 05.06.2023
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered No adverse event Product storage error

Symptomtext

The vial was stored in the refrigerator on 04-JUN-2023 after expiration date 11-MAY-2023; No adverse event; Dose administered to patient on 5-JUN-2023 from vials of the Moderna COVID-19 bivalent vaccine that was expired on 11-MAY-2023; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Dose administered to patient on 5-JUN-2023 from vials of the Moderna COVID-19 bivalent vaccine that was expired on 11-MAY-2023), PRODUCT STORAGE ERROR (The vial was stored in the refrigerator on 04-JUN-2023 after expiration date 11-MAY-2023) and NO ADVERSE EVENT (No adverse event) in an adult patient of an unknown gender who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. AS7143C) for COVID-19 prophylaxis. No Medical History information was reported. On 05-Jun-2023, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On 05-Jun-2023, the patient experienced EXPIRED PRODUCT ADMINISTERED (Dose administered to patient on 5-JUN-2023 from vials of the Moderna COVID-19 bivalent vaccine that was expired on 11-MAY-2023). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (The vial was stored in the refrigerator on 04-JUN-2023 after expiration date 11-MAY-2023) and NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Dose administered to patient on 5-JUN-2023 from vials of the Moderna COVID-19 bivalent vaccine that was expired on 11-MAY-2023), PRODUCT STORAGE ERROR (The vial was stored in the refrigerator on 04-JUN-2023 after expiration date 11-MAY-2023) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for EXPIRED PRODUCT ADMINISTERED (Dose administered to patient on 5-JUN-2023 from vials of the Moderna COVID-19 bivalent vaccine that was expired on 11-MAY-2023) and PRODUCT STORAGE ERROR (The vial was stored in the refrigerator on 04-JUN-2023 after expiration date 11-MAY-2023). No concomitant medication was reported. Suspect product dosage text was reported as unknown. It was reported that no adverse reactions have been reported by any patients. The vial was initially stored in the refrigerator on 4-JUN-2023 and did not underwent any temperature excursions. No treatment medication was reported. This case is reported for patient 25 out of 50 patients This case was linked to US-MODERNATX, INC.-MOD-2023-735331 (E2B Linked Report).; Sender's Comments: US-MODERNATX, INC.-MOD-2023-735331:Master case

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2666924

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7143C

gering

Staat: -
Alter: -
Geschlecht: U
Eingang: 07.08.2023
Impfdatum: 05.06.2023
Beginn: 05.06.2023
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered No adverse event Product storage error

Symptomtext

the vial was initially stored in the refrigerator on 4-Jun-2023 and was administered on 5-Jun-2023; No adverse event; the dose the patient received on 5JUN2023 from vials of the Moderna COVID-19 bivalent vaccine that had expired; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (the dose the patient received on 5JUN2023 from vials of the Moderna COVID-19 bivalent vaccine that had expired), PRODUCT STORAGE ERROR (the vial was initially stored in the refrigerator on 4-Jun-2023 and was administered on 5-Jun-2023) and NO ADVERSE EVENT (No adverse event) in an adult patient of an unknown gender who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. AS7143C) for COVID-19 prophylaxis. No Medical History information was reported. On 05-Jun-2023, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On 05-Jun-2023, the patient experienced EXPIRED PRODUCT ADMINISTERED (the dose the patient received on 5JUN2023 from vials of the Moderna COVID-19 bivalent vaccine that had expired). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (the vial was initially stored in the refrigerator on 4-Jun-2023 and was administered on 5-Jun-2023) and NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (the dose the patient received on 5JUN2023 from vials of the Moderna COVID-19 bivalent vaccine that had expired), PRODUCT STORAGE ERROR (the vial was initially stored in the refrigerator on 4-Jun-2023 and was administered on 5-Jun-2023) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for EXPIRED PRODUCT ADMINISTERED (the dose the patient received on 5JUN2023 from vials of the Moderna COVID-19 bivalent vaccine that had expired) and PRODUCT STORAGE ERROR (the vial was initially stored in the refrigerator on 4-Jun-2023 and was administered on 5-Jun-2023). No concomitant medication was reported. The doses text of the suspect was reported as Unknown. It was reported that a facility administered 50 doses to patients on 5JUN2023 from vials of the Moderna COVID-19 bivalent vaccine that had expired. Lot AS7143C was administered on 5-JUN-2023 to 40 patients. Lot 019H22A was administered on 5-JUN-2023 to 10 patients. The HCP does not have any patient details at this time. No adverse reactions have been reported by any patients. The expiry date for Lot-AS7143C was reported as 11-MAY-2023 and Lot-019H22A was reported as 30-MAY-2023. The vial size was unknown. The vials did not undergo any temperature excursions. No treatment medication was reported. This case contains information about patient 15th out of 50 patients. This case was linked to US-MODERNATX, INC.-MOD-2023-735331 (E2B Linked Report).; Sender's Comments: US-MODERNATX, INC.-MOD-2023-735331:Master case, Patient 1 out of 50 (Lot AS7143C was administered on 5Jun2023)

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2666923

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7143C

gering

Staat: -
Alter: -
Geschlecht: U
Eingang: 07.08.2023
Impfdatum: 05.06.2023
Beginn: 05.06.2023
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered No adverse event Product storage error

Symptomtext

Vaccine was expired on 11-May-2023 and was stored in referigerator on 04-Jun-2023; No adverse event; Dose to patient on 5JUN2023 from vials of the Moderna COVID-19 bivalent vaccine that had expired; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Dose to patient on 5JUN2023 from vials of the Moderna COVID-19 bivalent vaccine that had expired), PRODUCT STORAGE ERROR (Vaccine was expired on 11-May-2023 and was stored in referigerator on 04-Jun-2023) and NO ADVERSE EVENT (No adverse event) in an adult patient of an unknown gender who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. AS7143C) for COVID-19 prophylaxis. No Medical History information was reported. On 05-Jun-2023, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On 05-Jun-2023, the patient experienced EXPIRED PRODUCT ADMINISTERED (Dose to patient on 5JUN2023 from vials of the Moderna COVID-19 bivalent vaccine that had expired). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Vaccine was expired on 11-May-2023 and was stored in referigerator on 04-Jun-2023) and NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Dose to patient on 5JUN2023 from vials of the Moderna COVID-19 bivalent vaccine that had expired), PRODUCT STORAGE ERROR (Vaccine was expired on 11-May-2023 and was stored in referigerator on 04-Jun-2023) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for EXPIRED PRODUCT ADMINISTERED (Dose to patient on 5JUN2023 from vials of the Moderna COVID-19 bivalent vaccine that had expired) and PRODUCT STORAGE ERROR (Vaccine was expired on 11-May-2023 and was stored in referigerator on 04-Jun-2023). No concomitant medication was reported. Suspect product dosage text was reported as unknown. It was reported that no adverse reactions have been reported by any patients. The vial was initially stored in the refrigerator on 4-JUN-2023 and did not underwent any temperature excursions. No treatment medication was reported. This case is reported for patient 24 out of 50 patients. This case was linked to US-MODERNATX, INC.-MOD-2023-735331 (E2B Linked Report).; Sender's Comments: US-MODERNATX, INC.-MOD-2023-735331:master case

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2666922

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7143C

gering

Staat: -
Alter: -
Geschlecht: U
Eingang: 07.08.2023
Impfdatum: 05.06.2023
Beginn: 05.06.2023
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered No adverse event Product storage error

Symptomtext

The vial was stored in the refrigerator on 04-JUN-2023 after expiration date 11-MAY-2023; No adverse event; Dose administered to patient on 5-JUN-2023 from vials of the Moderna COVID-19 bivalent vaccine that was expired on 11-MAY-2023; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Dose administered to patient on 5-JUN-2023 from vials of the Moderna COVID-19 bivalent vaccine that was expired on 11-MAY-2023), PRODUCT STORAGE ERROR (The vial was stored in the refrigerator on 04-JUN-2023 after expiration date 11-MAY-2023) and NO ADVERSE EVENT (No adverse event) in an adult patient of an unknown gender who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. AS7143C) for COVID-19 prophylaxis. No Medical History information was reported. On 05-Jun-2023, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On 05-Jun-2023, the patient experienced EXPIRED PRODUCT ADMINISTERED (Dose administered to patient on 5-JUN-2023 from vials of the Moderna COVID-19 bivalent vaccine that was expired on 11-MAY-2023). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (The vial was stored in the refrigerator on 04-JUN-2023 after expiration date 11-MAY-2023) and NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Dose administered to patient on 5-JUN-2023 from vials of the Moderna COVID-19 bivalent vaccine that was expired on 11-MAY-2023), PRODUCT STORAGE ERROR (The vial was stored in the refrigerator on 04-JUN-2023 after expiration date 11-MAY-2023) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for EXPIRED PRODUCT ADMINISTERED (Dose administered to patient on 5-JUN-2023 from vials of the Moderna COVID-19 bivalent vaccine that was expired on 11-MAY-2023) and PRODUCT STORAGE ERROR (The vial was stored in the refrigerator on 04-JUN-2023 after expiration date 11-MAY-2023). No concomitant medication was reported. Suspect product dosage text was reported as unknown. It was reported that no adverse reactions have been reported by any patients. The vial was initially stored in the refrigerator on 4-JUN-2023 and did not underwent any temperature excursions. No treatment medication was reported. This case is reported for patient 33 out of 50 patients This case was linked to US-MODERNATX, INC.-MOD-2023-735331 (E2B Linked Report).; Sender's Comments: US-MODERNATX, INC.-MOD-2023-735331:Master case

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2666921

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7143C

gering

Staat: -
Alter: -
Geschlecht: U
Eingang: 07.08.2023
Impfdatum: 05.06.2023
Beginn: 05.06.2023
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered No adverse event Product storage error

Symptomtext

Vaccine was expired on 11-May-2023 and was stored in referigerator on 04-Jun-2023; No adverse event; Dose to patient on 5JUN2023 from vials of the Moderna COVID-19 bivalent vaccine that had expired; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Dose to patient on 5JUN2023 from vials of the Moderna COVID-19 bivalent vaccine that had expired), PRODUCT STORAGE ERROR (Vaccine was expired on 11-May-2023 and was stored in referigerator on 04-Jun-2023) and NO ADVERSE EVENT (No adverse event) in an adult patient of an unknown gender who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. AS7143C) for COVID-19 prophylaxis. No Medical History information was reported. On 05-Jun-2023, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On 05-Jun-2023, the patient experienced EXPIRED PRODUCT ADMINISTERED (Dose to patient on 5JUN2023 from vials of the Moderna COVID-19 bivalent vaccine that had expired). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Vaccine was expired on 11-May-2023 and was stored in referigerator on 04-Jun-2023) and NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Dose to patient on 5JUN2023 from vials of the Moderna COVID-19 bivalent vaccine that had expired), PRODUCT STORAGE ERROR (Vaccine was expired on 11-May-2023 and was stored in referigerator on 04-Jun-2023) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for EXPIRED PRODUCT ADMINISTERED (Dose to patient on 5JUN2023 from vials of the Moderna COVID-19 bivalent vaccine that had expired) and PRODUCT STORAGE ERROR (Vaccine was expired on 11-May-2023 and was stored in referigerator on 04-Jun-2023). No concomitant medication was reported. Suspect product dosage text was reported as unknown. It was reported that no adverse reactions have been reported by any patients. The vial was initially stored in the refrigerator on 4-JUN-2023 and did not underwent any temperature excursions. No treatment medication was reported. This case is reported for patient 14 out of 50 patients. This case was linked to US-MODERNATX, INC.-MOD-2023-735331 (E2B Linked Report).; Sender's Comments: US-MODERNATX, INC.-MOD-2023-735331:Master case

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2666920

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7143C

gering

Staat: -
Alter: -
Geschlecht: U
Eingang: 07.08.2023
Impfdatum: 05.06.2023
Beginn: 05.06.2023
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered No adverse event Product storage error

Symptomtext

The vial was initially stored in the refrigerator on 4-JUN-2023 and expired on 11-MAY-2023.; She states that no adverse reactions have been reported by any patients; doses to patients on 5JUN2023 from vials of the Moderna COVID-19 bivalent vaccine that had expired; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (doses to patients on 5JUN2023 from vials of the Moderna COVID-19 bivalent vaccine that had expired), PRODUCT STORAGE ERROR (The vial was initially stored in the refrigerator on 4-JUN-2023 and expired on 11-MAY-2023.) and NO ADVERSE EVENT (She states that no adverse reactions have been reported by any patients) in an adult patient of an unknown gender who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. AS7143C) for COVID-19 prophylaxis. No Medical History information was reported. On 05-Jun-2023, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On 05-Jun-2023, the patient experienced EXPIRED PRODUCT ADMINISTERED (doses to patients on 5JUN2023 from vials of the Moderna COVID-19 bivalent vaccine that had expired). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (The vial was initially stored in the refrigerator on 4-JUN-2023 and expired on 11-MAY-2023.) and NO ADVERSE EVENT (She states that no adverse reactions have been reported by any patients). At the time of the report, EXPIRED PRODUCT ADMINISTERED (doses to patients on 5JUN2023 from vials of the Moderna COVID-19 bivalent vaccine that had expired), PRODUCT STORAGE ERROR (The vial was initially stored in the refrigerator on 4-JUN-2023 and expired on 11-MAY-2023.) and NO ADVERSE EVENT (She states that no adverse reactions have been reported by any patients) outcome was unknown. For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (She states that no adverse reactions have been reported by any patients) to be not related. No further causality assessments were provided for EXPIRED PRODUCT ADMINISTERED (doses to patients on 5JUN2023 from vials of the Moderna COVID-19 bivalent vaccine that had expired) and PRODUCT STORAGE ERROR (The vial was initially stored in the refrigerator on 4-JUN-2023 and expired on 11-MAY-2023.). No concomitant medication was reported. Suspect product dosage text was reported as unknown. It was reported that no adverse reactions have been reported by any patients. The vial was initially stored in the refrigerator on 4-JUN-2023 and did not underwent any temperature excursions. No treatment medication was reported. This case is reported for patient 13 out of 50 patients. This case was linked to US-MODERNATX, INC.-MOD-2023-735331 (E2B Linked Report).; Sender's Comments: US-MODERNATX, INC.-MOD-2023-735331:Master case, Patient 1 out of 50 (Lot AS7143C was administered on 5Jun2023)

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2666919

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7143C

gering

Staat: -
Alter: -
Geschlecht: U
Eingang: 07.08.2023
Impfdatum: 05.06.2023
Beginn: 05.06.2023
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered No adverse event Product storage error

Symptomtext

The vial was stored in the refrigerator on 04 JUN 2023 after expiration date 11 MAY 2023 and Dose administered to patient on 5 JUN 2023; No adverse event; Dose administered to patient on 5-JUN-2023 from vials of the Moderna COVID-19 bivalent vaccine that was expired on 11-MAY-2023; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Dose administered to patient on 5-JUN-2023 from vials of the Moderna COVID-19 bivalent vaccine that was expired on 11-MAY-2023), PRODUCT STORAGE ERROR (The vial was stored in the refrigerator on 04 JUN 2023 after expiration date 11 MAY 2023 and Dose administered to patient on 5 JUN 2023) and NO ADVERSE EVENT (No adverse event) in an adult patient of an unknown gender who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. AS7143C) for COVID-19 prophylaxis. No Medical History information was reported. On 05-Jun-2023, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On 05-Jun-2023, the patient experienced EXPIRED PRODUCT ADMINISTERED (Dose administered to patient on 5-JUN-2023 from vials of the Moderna COVID-19 bivalent vaccine that was expired on 11-MAY-2023). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (The vial was stored in the refrigerator on 04 JUN 2023 after expiration date 11 MAY 2023 and Dose administered to patient on 5 JUN 2023) and NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Dose administered to patient on 5-JUN-2023 from vials of the Moderna COVID-19 bivalent vaccine that was expired on 11-MAY-2023), PRODUCT STORAGE ERROR (The vial was stored in the refrigerator on 04 JUN 2023 after expiration date 11 MAY 2023 and Dose administered to patient on 5 JUN 2023) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for EXPIRED PRODUCT ADMINISTERED (Dose administered to patient on 5-JUN-2023 from vials of the Moderna COVID-19 bivalent vaccine that was expired on 11-MAY-2023) and PRODUCT STORAGE ERROR (The vial was stored in the refrigerator on 04 JUN 2023 after expiration date 11 MAY 2023 and Dose administered to patient on 5 JUN 2023). No concomitant medication was reported. Suspect product dosage text was reported as unknown. It was reported that no adverse reactions have been reported by any patients. The vial was initially stored in the refrigerator on 4-JUN-2023 and did not underwent any temperature excursions. No treatment medication was reported. This case was reported for patient 32 out of 50 patients. This case was linked to US-MODERNATX, INC.-MOD-2023-735331 (E2B Linked Report).; Sender's Comments: US-MODERNATX, INC.-MOD-2023-735331:Patient 1 out of 50 (Lot AS7143C was administered on 5Jun2023)

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2666918

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7143C

gering

Staat: -
Alter: -
Geschlecht: U
Eingang: 07.08.2023
Impfdatum: 05.06.2023
Beginn: 05.06.2023
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered No adverse event Product storage error

Symptomtext

The vial was stored in the refrigerator on 04-JUN-2023 after expiration date 11-MAY-2023.; No adverse event; Dose administered to patient on 5-JUN-2023 from vials of the Moderna COVID-19 bivalent vaccine that was expired on 11-MAY-2023.; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Dose administered to patient on 5-JUN-2023 from vials of the Moderna COVID-19 bivalent vaccine that was expired on 11-MAY-2023.), PRODUCT STORAGE ERROR (The vial was stored in the refrigerator on 04-JUN-2023 after expiration date 11-MAY-2023.) and NO ADVERSE EVENT (No adverse event) in an adult patient of an unknown gender who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. AS7143C) for COVID-19 prophylaxis. No Medical History information was reported. On 05-Jun-2023, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On 05-Jun-2023, the patient experienced EXPIRED PRODUCT ADMINISTERED (Dose administered to patient on 5-JUN-2023 from vials of the Moderna COVID-19 bivalent vaccine that was expired on 11-MAY-2023.). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (The vial was stored in the refrigerator on 04-JUN-2023 after expiration date 11-MAY-2023.) and NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Dose administered to patient on 5-JUN-2023 from vials of the Moderna COVID-19 bivalent vaccine that was expired on 11-MAY-2023.), PRODUCT STORAGE ERROR (The vial was stored in the refrigerator on 04-JUN-2023 after expiration date 11-MAY-2023.) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for EXPIRED PRODUCT ADMINISTERED (Dose administered to patient on 5-JUN-2023 from vials of the Moderna COVID-19 bivalent vaccine that was expired on 11-MAY-2023.) and PRODUCT STORAGE ERROR (The vial was stored in the refrigerator on 04-JUN-2023 after expiration date 11-MAY-2023.). No concomitant medication was reported. Suspect product dosage text was reported as unknown. The vial did not undergo any temperature excursions. Suspect vaccine expiry date was 11-May-2023. It was reported that no adverse reactions have been reported by any patients. No treatment medication was reported. This case is reported for patient 12th out of 50 adult patients. This case was linked to US-MODERNATX, INC.-MOD-2023-735331 (E2B Linked Report).; Sender's Comments: US-MODERNATX, INC.-MOD-2023-735331:Master case, Patient 1 out of 50 (Lot AS7143C was administered on 5Jun2023)

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2666917

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7143C

gering

Staat: -
Alter: -
Geschlecht: U
Eingang: 07.08.2023
Impfdatum: 05.06.2023
Beginn: 05.06.2023
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered No adverse event Product storage error

Symptomtext

The vial was initially stored in the refrigerator on 4-JUN-2023 and expired on 11-MAY-2023.; She states that no adverse reactions have been reported by any patients; doses to patients on 5JUN2023 from vials of the Moderna COVID-19 bivalent vaccine that had expired; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (doses to patients on 5JUN2023 from vials of the Moderna COVID-19 bivalent vaccine that had expired), PRODUCT STORAGE ERROR (The vial was initially stored in the refrigerator on 4-JUN-2023 and expired on 11-MAY-2023.) and NO ADVERSE EVENT (She states that no adverse reactions have been reported by any patients) in an adult patient of an unknown gender who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. AS7143C) for COVID-19 prophylaxis. No Medical History information was reported. On 05-Jun-2023, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On 05-Jun-2023, the patient experienced EXPIRED PRODUCT ADMINISTERED (doses to patients on 5JUN2023 from vials of the Moderna COVID-19 bivalent vaccine that had expired). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (The vial was initially stored in the refrigerator on 4-JUN-2023 and expired on 11-MAY-2023.) and NO ADVERSE EVENT (She states that no adverse reactions have been reported by any patients). At the time of the report, EXPIRED PRODUCT ADMINISTERED (doses to patients on 5JUN2023 from vials of the Moderna COVID-19 bivalent vaccine that had expired), PRODUCT STORAGE ERROR (The vial was initially stored in the refrigerator on 4-JUN-2023 and expired on 11-MAY-2023.) and NO ADVERSE EVENT (She states that no adverse reactions have been reported by any patients) outcome was unknown. For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (She states that no adverse reactions have been reported by any patients) to be not related. No further causality assessments were provided for EXPIRED PRODUCT ADMINISTERED (doses to patients on 5JUN2023 from vials of the Moderna COVID-19 bivalent vaccine that had expired) and PRODUCT STORAGE ERROR (The vial was initially stored in the refrigerator on 4-JUN-2023 and expired on 11-MAY-2023.). No concomitant medication was reported. Suspect product dosage text was reported as unknown. It was reported that no adverse reactions have been reported by any patients. The vial was initially stored in the refrigerator on 4-JUN-2023 and did not underwent any temperature excursions. No treatment medication was reported. This case is reported for patient 23 out of 50 patients. This case was linked to US-MODERNATX, INC.-MOD-2023-735331 (E2B Linked Report).; Sender's Comments: US-MODERNATX, INC.-MOD-2023-735331:Master case, Patient 1 out of 50 (Lot AS7143C was administered on 5-JUN-2023)

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2666916

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7143C

gering

Staat: -
Alter: -
Geschlecht: U
Eingang: 07.08.2023
Impfdatum: 05.06.2023
Beginn: 05.06.2023
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered No adverse event Product storage error

Symptomtext

The vial was stored in the refrigerator on 04 JUN 2023 after expiration date 11 MAY 2023 and Dose administered to patient on 5 JUN 2023; No adverse event; Dose administered to patient on 5-JUN-2023 from vials of the Moderna COVID-19 bivalent vaccine that was expired on 11-MAY-2023; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Dose administered to patient on 5-JUN-2023 from vials of the Moderna COVID-19 bivalent vaccine that was expired on 11-MAY-2023), PRODUCT STORAGE ERROR (The vial was stored in the refrigerator on 04 JUN 2023 after expiration date 11 MAY 2023 and Dose administered to patient on 5 JUN 2023) and NO ADVERSE EVENT (No adverse event) in an adult patient of an unknown gender who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. AS7143C) for COVID-19 prophylaxis. No Medical History information was reported. On 05-Jun-2023, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On 05-Jun-2023, the patient experienced EXPIRED PRODUCT ADMINISTERED (Dose administered to patient on 5-JUN-2023 from vials of the Moderna COVID-19 bivalent vaccine that was expired on 11-MAY-2023). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (The vial was stored in the refrigerator on 04 JUN 2023 after expiration date 11 MAY 2023 and Dose administered to patient on 5 JUN 2023) and NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Dose administered to patient on 5-JUN-2023 from vials of the Moderna COVID-19 bivalent vaccine that was expired on 11-MAY-2023), PRODUCT STORAGE ERROR (The vial was stored in the refrigerator on 04 JUN 2023 after expiration date 11 MAY 2023 and Dose administered to patient on 5 JUN 2023) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for EXPIRED PRODUCT ADMINISTERED (Dose administered to patient on 5-JUN-2023 from vials of the Moderna COVID-19 bivalent vaccine that was expired on 11-MAY-2023) and PRODUCT STORAGE ERROR (The vial was stored in the refrigerator on 04 JUN 2023 after expiration date 11 MAY 2023 and Dose administered to patient on 5 JUN 2023). No concomitant medication was reported. Suspect product dosage text was reported as unknown. It was reported that no adverse reactions have been reported by any patients. The vial was initially stored in the refrigerator on 4-JUN-2023 and did not underwent any temperature excursions. No treatment medication was reported. This case was reported for patient 22 out of 50 patients. This case was linked to US-MODERNATX, INC.-MOD-2023-735331 (E2B Linked Report).; Sender's Comments: US-MODERNATX, INC.-MOD-2023-735331:Master case, Patient 1 out of 50 (Lot AS7143C was administered on 5-JUN-2023)

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2666915

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7143C

gering

Staat: -
Alter: -
Geschlecht: U
Eingang: 07.08.2023
Impfdatum: 05.06.2023
Beginn: 05.06.2023
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered No adverse event Product storage error

Symptomtext

the vial was initially stored in the refrigerator on 4-Jun-2023 and was administered on 5-Jun-2023; She states that no adverse reactions have been reported by any patients; the dose the patient received on 5JUN2023 from vials of the Moderna COVID-19 bivalent vaccine that had expired; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (the dose the patient received on 5JUN2023 from vials of the Moderna COVID-19 bivalent vaccine that had expired), PRODUCT STORAGE ERROR (the vial was initially stored in the refrigerator on 4-Jun-2023 and was administered on 5-Jun-2023) and NO ADVERSE EVENT (She states that no adverse reactions have been reported by any patients) in an adult patient of an unknown gender who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. AS7143C) for COVID-19 prophylaxis. No Medical History information was reported. On 05-Jun-2023, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On 05-Jun-2023, the patient experienced EXPIRED PRODUCT ADMINISTERED (the dose the patient received on 5JUN2023 from vials of the Moderna COVID-19 bivalent vaccine that had expired). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (the vial was initially stored in the refrigerator on 4-Jun-2023 and was administered on 5-Jun-2023) and NO ADVERSE EVENT (She states that no adverse reactions have been reported by any patients). At the time of the report, EXPIRED PRODUCT ADMINISTERED (the dose the patient received on 5JUN2023 from vials of the Moderna COVID-19 bivalent vaccine that had expired), PRODUCT STORAGE ERROR (the vial was initially stored in the refrigerator on 4-Jun-2023 and was administered on 5-Jun-2023) and NO ADVERSE EVENT (She states that no adverse reactions have been reported by any patients) outcome was unknown. Not Provided For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (She states that no adverse reactions have been reported by any patients) to be not related. No further causality assessments were provided for EXPIRED PRODUCT ADMINISTERED (the dose the patient received on 5JUN2023 from vials of the Moderna COVID-19 bivalent vaccine that had expired) and PRODUCT STORAGE ERROR (the vial was initially stored in the refrigerator on 4-Jun-2023 and was administered on 5-Jun-2023). No concomitant medication was reported. The doses text of the suspect was reported as Unknown. It was reported that a facility administered 50 doses to patients on 5JUN2023 from vials of the Moderna COVID-19 bivalent vaccine that had expired. Lot AS7143C was administered on 5-JUN-2023 to 40 patients. Lot 019H22A was administered on 5-JUN-2023 to 10 patients. The HCP does not have any patient details at this time. No adverse reactions have been reported by any patients. The expiry date for Lot-AS7143C was reported as 11-MAY-2023 and Lot-019H22A was reported as 30-MAY-2023. The vial size was unknown. The vials did not undergo any temperature excursions. No treatment medication was reported. This case contains information about patient 11th out of 50 patients. This case was linked to US-MODERNATX, INC.-MOD-2023-735331 (E2B Linked Report).; Sender's Comments: US-MODERNATX, INC.-MOD-2023-735331:Master case, Patient 11 out of 50 (Lot AS7143C was administered on 5Jun2023)

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2666914

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7143C

gering

Staat: -
Alter: -
Geschlecht: U
Eingang: 07.08.2023
Impfdatum: 05.06.2023
Beginn: 05.06.2023
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered No adverse event Product storage error

Symptomtext

The vial was stored in the refrigerator on 04-JUN-2023 after expiration date 11-MAY-2023; No adverse event; Dose administered to patient on 5-JUN-2023 from vials of the Moderna COVID-19 bivalent vaccine that was expired on 11-MAY-2023; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Dose administered to patient on 5-JUN-2023 from vials of the Moderna COVID-19 bivalent vaccine that was expired on 11-MAY-2023), PRODUCT STORAGE ERROR (The vial was stored in the refrigerator on 04-JUN-2023 after expiration date 11-MAY-2023) and NO ADVERSE EVENT (No adverse event) in an adult patient of an unknown gender who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. AS7143C) for COVID-19 prophylaxis. No Medical History information was reported. On 05-Jun-2023, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On 05-Jun-2023, the patient experienced EXPIRED PRODUCT ADMINISTERED (Dose administered to patient on 5-JUN-2023 from vials of the Moderna COVID-19 bivalent vaccine that was expired on 11-MAY-2023). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (The vial was stored in the refrigerator on 04-JUN-2023 after expiration date 11-MAY-2023) and NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Dose administered to patient on 5-JUN-2023 from vials of the Moderna COVID-19 bivalent vaccine that was expired on 11-MAY-2023), PRODUCT STORAGE ERROR (The vial was stored in the refrigerator on 04-JUN-2023 after expiration date 11-MAY-2023) and NO ADVERSE EVENT (No adverse event) outcome was unknown. Not Provided For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for EXPIRED PRODUCT ADMINISTERED (Dose administered to patient on 5-JUN-2023 from vials of the Moderna COVID-19 bivalent vaccine that was expired on 11-MAY-2023) and PRODUCT STORAGE ERROR (The vial was stored in the refrigerator on 04-JUN-2023 after expiration date 11-MAY-2023). No concomitant medication was reported. Suspect product dosage text was reported as unknown. It was reported that no adverse reactions have been reported by any patients. The vial was initially stored in the refrigerator on 4-JUN-2023 and did not underwent any temperature excursions. No treatment medication was reported. This case is reported for patient 10 out of 50 patients.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2666913

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7143C

gering

Staat: -
Alter: -
Geschlecht: U
Eingang: 07.08.2023
Impfdatum: 05.06.2023
Beginn: 05.06.2023
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered No adverse event Product storage error

Symptomtext

Vaccine was expired on 11-May-2023 and was stored in referigerator on 04-Jun-2023; No adverse event; Dose to patient on 5JUN2023 from vials of the Moderna COVID-19 bivalent vaccine that had expired; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Dose to patient on 5JUN2023 from vials of the Moderna COVID-19 bivalent vaccine that had expired), PRODUCT STORAGE ERROR (Vaccine was expired on 11-May-2023 and was stored in referigerator on 04-Jun-2023) and NO ADVERSE EVENT (No adverse event) in an adult patient of an unknown gender who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. AS7143C) for COVID-19 prophylaxis. No Medical History information was reported. On 05-Jun-2023, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On 05-Jun-2023, the patient experienced EXPIRED PRODUCT ADMINISTERED (Dose to patient on 5JUN2023 from vials of the Moderna COVID-19 bivalent vaccine that had expired). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Vaccine was expired on 11-May-2023 and was stored in referigerator on 04-Jun-2023) and NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Dose to patient on 5JUN2023 from vials of the Moderna COVID-19 bivalent vaccine that had expired), PRODUCT STORAGE ERROR (Vaccine was expired on 11-May-2023 and was stored in referigerator on 04-Jun-2023) and NO ADVERSE EVENT (No adverse event) outcome was unknown. Not Provided For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for EXPIRED PRODUCT ADMINISTERED (Dose to patient on 5JUN2023 from vials of the Moderna COVID-19 bivalent vaccine that had expired) and PRODUCT STORAGE ERROR (Vaccine was expired on 11-May-2023 and was stored in referigerator on 04-Jun-2023). No concomitant medication was reported. Suspect product dosage text was reported as unknown. It was reported that no adverse reactions have been reported by any patients. The vial was initially stored in the refrigerator on 4-JUN-2023 and did not underwent any temperature excursions. No treatment medication was reported. This case is reported for patient 9 out of 50 patients. This case was linked to US-MODERNATX, INC.-MOD-2023-735331 (E2B Linked Report).; Sender's Comments: US-MODERNATX, INC.-MOD-2023-735331:master case

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2666912

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7143C

gering

Staat: -
Alter: -
Geschlecht: U
Eingang: 07.08.2023
Impfdatum: 05.06.2023
Beginn: 05.06.2023
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered No adverse event Product storage error

Symptomtext

The vial was initially stored in the refrigerator on 4-JUN-2023 and expired on 11-MAY-2023.; She states that no adverse reactions have been reported by any patients; doses to patients on 5JUN2023 from vials of the Moderna COVID-19 bivalent vaccine that had expired; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (doses to patients on 5JUN2023 from vials of the Moderna COVID-19 bivalent vaccine that had expired), PRODUCT STORAGE ERROR (The vial was initially stored in the refrigerator on 4-JUN-2023 and expired on 11-MAY-2023.) and NO ADVERSE EVENT (She states that no adverse reactions have been reported by any patients) in an adult patient of an unknown gender who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. AS7143C) for COVID-19 prophylaxis. No Medical History information was reported. On 05-Jun-2023, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On 05-Jun-2023, the patient experienced EXPIRED PRODUCT ADMINISTERED (doses to patients on 5JUN2023 from vials of the Moderna COVID-19 bivalent vaccine that had expired). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (The vial was initially stored in the refrigerator on 4-JUN-2023 and expired on 11-MAY-2023.) and NO ADVERSE EVENT (She states that no adverse reactions have been reported by any patients). At the time of the report, EXPIRED PRODUCT ADMINISTERED (doses to patients on 5JUN2023 from vials of the Moderna COVID-19 bivalent vaccine that had expired), PRODUCT STORAGE ERROR (The vial was initially stored in the refrigerator on 4-JUN-2023 and expired on 11-MAY-2023.) and NO ADVERSE EVENT (She states that no adverse reactions have been reported by any patients) outcome was unknown. Not Provided For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (She states that no adverse reactions have been reported by any patients) to be not related. No further causality assessments were provided for EXPIRED PRODUCT ADMINISTERED (doses to patients on 5JUN2023 from vials of the Moderna COVID-19 bivalent vaccine that had expired) and PRODUCT STORAGE ERROR (The vial was initially stored in the refrigerator on 4-JUN-2023 and expired on 11-MAY-2023.). No concomitant medication was reported. Suspect product dosage text was reported as unknown. It was reported that no adverse reactions have been reported by any patients. The vial was initially stored in the refrigerator on 4-JUN-2023 and did not underwent any temperature excursions. No treatment medication was reported. This case is reported for patient 8 out of 50 patients. This case was linked to US-MODERNATX, INC.-MOD-2023-735331 (E2B Linked Report).; Sender's Comments: US-MODERNATX, INC.-MOD-2023-735331:Master case, Patient 1 out of 50 (Lot AS7143C was administered on 5-JUN-2023)

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2666911

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7143C

gering

Staat: -
Alter: -
Geschlecht: U
Eingang: 07.08.2023
Impfdatum: 05.06.2023
Beginn: 05.06.2023
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered No adverse event Product storage error

Symptomtext

The vial was stored in the refrigerator on 04 JUN 2023 after expiration date 11 MAY 2023 and Dose administered to patient on 5 JUN 2023; No adverse event; Dose administered to patient on 5-JUN-2023 from vials of the Moderna COVID-19 bivalent vaccine that was expired on 11-MAY-2023; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Dose administered to patient on 5-JUN-2023 from vials of the Moderna COVID-19 bivalent vaccine that was expired on 11-MAY-2023), PRODUCT STORAGE ERROR (The vial was stored in the refrigerator on 04 JUN 2023 after expiration date 11 MAY 2023 and Dose administered to patient on 5 JUN 2023) and NO ADVERSE EVENT (No adverse event) in an adult patient of an unknown gender who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. AS7143C) for COVID-19 prophylaxis. No Medical History information was reported. On 05-Jun-2023, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On 05-Jun-2023, the patient experienced EXPIRED PRODUCT ADMINISTERED (Dose administered to patient on 5-JUN-2023 from vials of the Moderna COVID-19 bivalent vaccine that was expired on 11-MAY-2023). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (The vial was stored in the refrigerator on 04 JUN 2023 after expiration date 11 MAY 2023 and Dose administered to patient on 5 JUN 2023) and NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Dose administered to patient on 5-JUN-2023 from vials of the Moderna COVID-19 bivalent vaccine that was expired on 11-MAY-2023), PRODUCT STORAGE ERROR (The vial was stored in the refrigerator on 04 JUN 2023 after expiration date 11 MAY 2023 and Dose administered to patient on 5 JUN 2023) and NO ADVERSE EVENT (No adverse event) outcome was unknown. Not Provided For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for EXPIRED PRODUCT ADMINISTERED (Dose administered to patient on 5-JUN-2023 from vials of the Moderna COVID-19 bivalent vaccine that was expired on 11-MAY-2023) and PRODUCT STORAGE ERROR (The vial was stored in the refrigerator on 04 JUN 2023 after expiration date 11 MAY 2023 and Dose administered to patient on 5 JUN 2023). No concomitant medication was reported. Suspect product dosage text was reported as unknown. It was reported that no adverse reactions have been reported by any patients. The vial was initially stored in the refrigerator on 4-JUN-2023 and did not underwent any temperature excursions. No treatment medication was reported. This case was reported for patient 7 out of 50 patients. This case was linked to US-MODERNATX, INC.-MOD-2023-735331 (E2B Linked Report).; Sender's Comments: US-MODERNATX, INC.-MOD-2023-735331:Master case

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2666910

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7143C

gering

Staat: -
Alter: -
Geschlecht: U
Eingang: 07.08.2023
Impfdatum: 05.06.2023
Beginn: 05.06.2023
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered No adverse event Product storage error

Symptomtext

The vial was stored in the refrigerator on 04-JUN-2023 after expiration date 11-MAY-2023.; No adverse event; Dose administered to patient on 5-JUN-2023 from vials of the Moderna COVID-19 bivalent vaccine that was expired on 11-MAY-2023.; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Dose administered to patient on 5-JUN-2023 from vials of the Moderna COVID-19 bivalent vaccine that was expired on 11-MAY-2023.), PRODUCT STORAGE ERROR (The vial was stored in the refrigerator on 04-JUN-2023 after expiration date 11-MAY-2023.) and NO ADVERSE EVENT (No adverse event) in an adult patient of an unknown gender who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. AS7143C) for COVID-19 prophylaxis. No Medical History information was reported. On 05-Jun-2023, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On 05-Jun-2023, the patient experienced EXPIRED PRODUCT ADMINISTERED (Dose administered to patient on 5-JUN-2023 from vials of the Moderna COVID-19 bivalent vaccine that was expired on 11-MAY-2023.). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (The vial was stored in the refrigerator on 04-JUN-2023 after expiration date 11-MAY-2023.) and NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Dose administered to patient on 5-JUN-2023 from vials of the Moderna COVID-19 bivalent vaccine that was expired on 11-MAY-2023.), PRODUCT STORAGE ERROR (The vial was stored in the refrigerator on 04-JUN-2023 after expiration date 11-MAY-2023.) and NO ADVERSE EVENT (No adverse event) outcome was unknown. Not Provided For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for EXPIRED PRODUCT ADMINISTERED (Dose administered to patient on 5-JUN-2023 from vials of the Moderna COVID-19 bivalent vaccine that was expired on 11-MAY-2023.) and PRODUCT STORAGE ERROR (The vial was stored in the refrigerator on 04-JUN-2023 after expiration date 11-MAY-2023.). No concomitant medication was reported. Suspect product dosage text was reported as unknown. The vial did not undergo any temperature excursions. Suspect vaccine expiry date was 11-May-2023. It was reported that no adverse reactions have been reported by any patients. No treatment medication was reported. This case is reported for patient 6th out of 50 adult patients. This case was linked to US-MODERNATX, INC.-MOD-2023-735331 (E2B Linked Report).; Sender's Comments: US-MODERNATX, INC.-MOD-2023-735331:Master case, Patient 1 out of 50

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2666909

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7143C

gering

Staat: -
Alter: -
Geschlecht: U
Eingang: 07.08.2023
Impfdatum: 05.06.2023
Beginn: 05.06.2023
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered No adverse event Product storage error

Symptomtext

the vial was initially stored in the refrigerator on 4-Jun-2023 and was administered on 5-Jun-2023; She states that no adverse reactions have been reported by any patients; the dose the patient received on 5JUN2023 from vials of the Moderna COVID-19 bivalent vaccine that had expired; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (the dose the patient received on 5JUN2023 from vials of the Moderna COVID-19 bivalent vaccine that had expired), PRODUCT STORAGE ERROR (the vial was initially stored in the refrigerator on 4-Jun-2023 and was administered on 5-Jun-2023) and NO ADVERSE EVENT (She states that no adverse reactions have been reported by any patients) in an adult patient of an unknown gender who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. AS7143C) for COVID-19 prophylaxis. No Medical History information was reported. On 05-Jun-2023, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On 05-Jun-2023, the patient experienced EXPIRED PRODUCT ADMINISTERED (the dose the patient received on 5JUN2023 from vials of the Moderna COVID-19 bivalent vaccine that had expired). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (the vial was initially stored in the refrigerator on 4-Jun-2023 and was administered on 5-Jun-2023) and NO ADVERSE EVENT (She states that no adverse reactions have been reported by any patients). At the time of the report, EXPIRED PRODUCT ADMINISTERED (the dose the patient received on 5JUN2023 from vials of the Moderna COVID-19 bivalent vaccine that had expired), PRODUCT STORAGE ERROR (the vial was initially stored in the refrigerator on 4-Jun-2023 and was administered on 5-Jun-2023) and NO ADVERSE EVENT (She states that no adverse reactions have been reported by any patients) outcome was unknown. Not Provided For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (She states that no adverse reactions have been reported by any patients) to be not related. No further causality assessments were provided for EXPIRED PRODUCT ADMINISTERED (the dose the patient received on 5JUN2023 from vials of the Moderna COVID-19 bivalent vaccine that had expired) and PRODUCT STORAGE ERROR (the vial was initially stored in the refrigerator on 4-Jun-2023 and was administered on 5-Jun-2023). No concomitant medication was reported. The doses text of the suspect was reported as Unknown. It was reported that a facility administered 50 doses to patients on 5JUN2023 from vials of the Moderna COVID-19 bivalent vaccine that had expired. Lot AS7143C was administered on 5-JUN-2023 to 40 patients. Lot 019H22A was administered on 5-JUN-2023 to 10 patients. The HCP does not have any patient details at this time. No adverse reactions have been reported by any patients. The expiry date for Lot-AS7143C was reported as 11-MAY-2023 and Lot-019H22A was reported as 30-MAY-2023. The vial size was unknown. The vials did not undergo any temperature excursions. No treatment medication was reported. This case contains information about patient 5th out of 50 patients. This case was linked to US-MODERNATX, INC.-MOD-2023-735331 (E2B Linked Report).; Sender's Comments: US-MODERNATX, INC.-MOD-2023-735331:Master case, Patient 5 out of 50 (Lot AS7143C was administered on 5Jun2023)

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2666908

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7143C

gering

Staat: -
Alter: -
Geschlecht: U
Eingang: 07.08.2023
Impfdatum: 05.06.2023
Beginn: 05.06.2023
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered No adverse event Product storage error

Symptomtext

The vial was stored in the refrigerator on 04-JUN-2023 after expiration date 11-MAY-2023; No adverse event; Dose administered to patient on 5-JUN-2023 from vials of the Moderna COVID-19 bivalent vaccine that was expired on 11-MAY-2023; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Dose administered to patient on 5-JUN-2023 from vials of the Moderna COVID-19 bivalent vaccine that was expired on 11-MAY-2023), PRODUCT STORAGE ERROR (The vial was stored in the refrigerator on 04-JUN-2023 after expiration date 11-MAY-2023) and NO ADVERSE EVENT (No adverse event) in an adult patient of an unknown gender who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. AS7143C) for COVID-19 prophylaxis. No Medical History information was reported. On 05-Jun-2023, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On 05-Jun-2023, the patient experienced EXPIRED PRODUCT ADMINISTERED (Dose administered to patient on 5-JUN-2023 from vials of the Moderna COVID-19 bivalent vaccine that was expired on 11-MAY-2023). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (The vial was stored in the refrigerator on 04-JUN-2023 after expiration date 11-MAY-2023) and NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Dose administered to patient on 5-JUN-2023 from vials of the Moderna COVID-19 bivalent vaccine that was expired on 11-MAY-2023), PRODUCT STORAGE ERROR (The vial was stored in the refrigerator on 04-JUN-2023 after expiration date 11-MAY-2023) and NO ADVERSE EVENT (No adverse event) outcome was unknown. Not Provided For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for EXPIRED PRODUCT ADMINISTERED (Dose administered to patient on 5-JUN-2023 from vials of the Moderna COVID-19 bivalent vaccine that was expired on 11-MAY-2023) and PRODUCT STORAGE ERROR (The vial was stored in the refrigerator on 04-JUN-2023 after expiration date 11-MAY-2023). No concomitant medication was reported. Suspect product dosage text was reported as unknown. It was reported that no adverse reactions have been reported by any patients. The vial was initially stored in the refrigerator on 4-JUN-2023 and did not underwent any temperature excursions. No treatment medication was reported. This case is reported for patient 4 out of 50 patients This case was linked to US-MODERNATX, INC.-MOD-2023-735331 (E2B Linked Report).; Sender's Comments: US-MODERNATX, INC.-MOD-2023-735331:Master case

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2666907

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7143C

gering

Staat: -
Alter: -
Geschlecht: U
Eingang: 07.08.2023
Impfdatum: 05.06.2023
Beginn: 05.06.2023
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered No adverse event Product storage error

Symptomtext

The vial was initially stored in the refrigerator on 4-JUN-2023 and expired on 11-MAY-2023.; She states that no adverse reactions have been reported by any patients; doses to patients on 5JUN2023 from vials of the Moderna COVID-19 bivalent vaccine that had expired; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (doses to patients on 5JUN2023 from vials of the Moderna COVID-19 bivalent vaccine that had expired), PRODUCT STORAGE ERROR (The vial was initially stored in the refrigerator on 4-JUN-2023 and expired on 11-MAY-2023.) and NO ADVERSE EVENT (She states that no adverse reactions have been reported by any patients) in an adult patient of an unknown gender who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. AS7143C) for COVID-19 prophylaxis. No Medical History information was reported. On 05-Jun-2023, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On 05-Jun-2023, the patient experienced EXPIRED PRODUCT ADMINISTERED (doses to patients on 5JUN2023 from vials of the Moderna COVID-19 bivalent vaccine that had expired). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (The vial was initially stored in the refrigerator on 4-JUN-2023 and expired on 11-MAY-2023.) and NO ADVERSE EVENT (She states that no adverse reactions have been reported by any patients). At the time of the report, EXPIRED PRODUCT ADMINISTERED (doses to patients on 5JUN2023 from vials of the Moderna COVID-19 bivalent vaccine that had expired), PRODUCT STORAGE ERROR (The vial was initially stored in the refrigerator on 4-JUN-2023 and expired on 11-MAY-2023.) and NO ADVERSE EVENT (She states that no adverse reactions have been reported by any patients) outcome was unknown. Not Provided For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (She states that no adverse reactions have been reported by any patients) to be not related. No further causality assessments were provided for EXPIRED PRODUCT ADMINISTERED (doses to patients on 5JUN2023 from vials of the Moderna COVID-19 bivalent vaccine that had expired) and PRODUCT STORAGE ERROR (The vial was initially stored in the refrigerator on 4-JUN-2023 and expired on 11-MAY-2023.). No concomitant medication was reported. Suspect product dosage text was reported as unknown. It was reported that no adverse reactions have been reported by any patients. The vial was initially stored in the refrigerator on 4-JUN-2023 and did not underwent any temperature excursions. No treatment medication was reported. This case is reported for patient 2 out of 50 patients. This case was linked to US-MODERNATX, INC.-MOD-2023-735331 (E2B Linked Report).; Sender's Comments: US-MODERNATX, INC.-MOD-2023-735331:Master case, Patient 2 out of 50 (Lot AS7143C was administered on 5Jun2023)

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2666639

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7143C

gering

Staat: -
Alter: -
Geschlecht: U
Eingang: 07.08.2023
Impfdatum: 05.06.2023
Beginn: 05.06.2023
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered No adverse event

Symptomtext

No adverse event; doses to patients on 5JUN2023 from vials of the Moderna COVID-19 bivalent vaccine that had expired; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (doses to patients on 5JUN2023 from vials of the Moderna COVID-19 bivalent vaccine that had expired) and NO ADVERSE EVENT (No adverse event) in an adult patient of an unknown gender who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. AS7143C) for COVID-19 prophylaxis. No Medical History information was reported. On 05-Jun-2023, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On 05-Jun-2023, the patient experienced EXPIRED PRODUCT ADMINISTERED (doses to patients on 5JUN2023 from vials of the Moderna COVID-19 bivalent vaccine that had expired). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (doses to patients on 5JUN2023 from vials of the Moderna COVID-19 bivalent vaccine that had expired) and NO ADVERSE EVENT (No adverse event) outcome was unknown. Not Provided For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (doses to patients on 5JUN2023 from vials of the Moderna COVID-19 bivalent vaccine that had expired). No concomitant medication was reported. Suspect product dosage text was reported as unknown. It was reported that no adverse reactions have been reported by any patients. The vial was initially stored in the refrigerator on 4-JUN-2023 and did not underwent any temperature excursions. No treatment medication was reported. This case is reported for patient 3 out of 50 patients. This case was linked to US-MODERNATX, INC.-MOD-2023-735331 (Linked Report).; Sender's Comments: US-MODERNATX, INC.-MOD-2023-735331:master case

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2663455

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7143C

gering

Staat: -
Alter: 64,0
Geschlecht: F
Eingang: 31.07.2023
Impfdatum: 08.09.2022
Beginn: 24.07.2023
Tage bis Beginn: 319,0
Dosis: 4
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

COVID-19 Pharyngitis streptococcal Sinusitis

Symptomtext

Sinus infection; strep throat; Covid 19; This spontaneous case was reported by a consumer and describes the occurrence of SINUSITIS (Sinus infection), PHARYNGITIS STREPTOCOCCAL (strep throat) and COVID-19 (Covid 19) in a 64-year-old female patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. AS7143C) for COVID-19 prophylaxis. Concomitant products included PROCAINE BENZYLPENICILLIN (PENICILLIN PROCAIN) for an unknown indication. On 08-Sep-2022, the patient received fourth dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On 24-Jul-2023, after starting mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)), the patient experienced COVID-19 (Covid 19). On an unknown date, the patient experienced SINUSITIS (Sinus infection) and PHARYNGITIS STREPTOCOCCAL (strep throat). The patient was treated with NIRMATRELVIR, RITONAVIR (PAXLOVID) at an unspecified dose and frequency. At the time of the report, SINUSITIS (Sinus infection) outcome was unknown and PHARYNGITIS STREPTOCOCCAL (strep throat) and COVID-19 (Covid 19) had not resolved. For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter did not provide any causality assessments. The patient received 4 doses of the Moderna COVID-19 vaccines and now has COVID-19. The patient received first dose on 03-Mar-2021 (lot number 026A21A), second dose on 31-Mar-2021 (lot number 025B21A) and third dose on 25-Aug-2021 (lot number 028D21A). On an unknown date, the symptoms started with mostly fatigue, and feeling overall crappy and tired. She went to the doctor yesterday who diagnosed her with COVID after a test. She also had a sinus infection and was taking penicillin. The patient was so sick with COVID. HCP diagnosed her with COVID 4 days ago and prescribed her with Pfizer's Paxlovid and penicillin. Patient had throat and nasal swab 4 days ago and tested it and Doctor said she had COVID and strep throat. Taking Paxlovid and penicillin for 4 days. Feeling sicker than when she had chemo. This was patient's first time having COVID. Most recent FOLLOW-UP information incorporated above includes: On 27-Jul-2023: Live follow-up information received included updated narrative.

Weitere VAERSDATA-Felder

Praegender Schweregrund: COVID-19
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: PENICILLIN PROCAIN
Allergien: -
Vorherige Impfungen: -

VAERS 2661274

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7143C

gering

Staat: -
Alter: 61,0
Geschlecht: F
Eingang: 26.07.2023
Impfdatum: 08.09.2022
Beginn: 15.02.2023
Tage bis Beginn: 160,0
Dosis: 5
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt

Facial paresis

Symptomtext

RIGHT FACIAL MUSCLE WEAKNESS

Weitere VAERSDATA-Felder

Praegender Schweregrund: Facial paresis
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2651808

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7143C

gering

Staat: ND
Alter: -
Geschlecht: U
Eingang: 03.07.2023
Impfdatum: 12.05.2023
Beginn: 12.05.2023
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered No adverse event

Symptomtext

No adverse event; The vaccine was administered on 5/12/2023 and they stated that it had expired on 5/11/2023; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (The vaccine was administered on 5/12/2023 and they stated that it had expired on 5/11/2023) and NO ADVERSE EVENT (No adverse event) in a patient of an unknown age and gender who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. AS7143C) for COVID-19 prophylaxis. No Medical History information was reported. On 12-May-2023, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On 12-May-2023, the patient experienced EXPIRED PRODUCT ADMINISTERED (The vaccine was administered on 5/12/2023 and they stated that it had expired on 5/11/2023). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (The vaccine was administered on 5/12/2023 and they stated that it had expired on 5/11/2023) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (The vaccine was administered on 5/12/2023 and they stated that it had expired on 5/11/2023). Vaccine was administered to a resident. It was stored as specified per recommendations until administration. Concomitant medication was not provided. Treatment information was not reported.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2644766

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7143C

gering

Staat: ND
Alter: 74,0
Geschlecht: F
Eingang: 13.06.2023
Impfdatum: 12.05.2023
Beginn: 12.06.2023
Tage bis Beginn: 31,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Expired product administered

Symptomtext

According to phone call received vaccine expired 5/11/2023 and was administered on 5/12/2023. No email received with update regarding expiration of this vaccination. Vaccination was ordered for administration starting in September 2022 which is less than 1 year.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: NA
Aktuelle Erkrankungen: NA
Vorgeschichte: Alzheimer's Disease, Dementia, Hypertension, Hyperlipidemia
Andere Medikamente: Multivitamin, Calcium-Vit D, Vitamin B Complex, Lotrel Oral Capsule, Escitalopram, Donepezil, Aspirin, Quetiapine
Allergien: Bees, Latex
Vorherige Impfungen: -

VAERS 2642209

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7143C

gering

Staat: -
Alter: 76,0
Geschlecht: M
Eingang: 07.06.2023
Impfdatum: 15.09.2022
Beginn: 19.11.2022
Tage bis Beginn: 65,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt

Obstructive sleep apnoea syndrome

Symptomtext

OBSTRUCTIVE SLEEP APNEA

Weitere VAERSDATA-Felder

Praegender Schweregrund: Obstructive sleep apnoea syndrome
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2629166

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7143C

gering

Staat: VA
Alter: 40,0
Geschlecht: F
Eingang: 09.05.2023
Impfdatum: 10.09.2022
Beginn: 01.01.2023
Tage bis Beginn: 113,0
Dosis: 4
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: ja Hospital: unbekannt Disable: ja ER: unbekannt Erholt: nein

Colitis ulcerative Colonoscopy abnormal

Symptomtext

Diagnosed with Ulcerative Colitis, both sides mild to moderate.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Colitis ulcerative
Hospital-Tage: -
Labordaten: Colonoscopy 4 April 2023
Aktuelle Erkrankungen: -
Vorgeschichte: Diagnosed with Ulcerative Colitis (mild to moderate, both sides) in April 2023.
Andere Medikamente: Claritin, Singulair, Symbicort
Allergien: -
Vorherige Impfungen: -

VAERS 2619805

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge AS7143C

gering

Staat: VT
Alter: 64,0
Geschlecht: M
Eingang: 24.04.2023
Impfdatum: 12.09.2022
Beginn: 01.02.2023
Tage bis Beginn: 142,0
Dosis: 5
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Chest X-ray normal Cough Respiratory tract congestion Secretion discharge

Symptomtext

HAVE HAD A COUGH AND A GREAT DEAL OF CHEST CONGESTION/EXCESSIVE MUCOUS PRODUCTION FOR THE SINCE LATE JANUARY/EARLY FEBRUARY

Weitere VAERSDATA-Felder

Praegender Schweregrund: Chest X-ray normal
Hospital-Tage: -
Labordaten: CHEST XRAY, COUGH MEDICINE AND DECONGESTANT GIVEN. NEGATIVE XRAY FOR PNEUMONIA, COUGH MEDICINE AND DECONGESTANT MILDLY EFFECTIVE. TODAY, 4/23/2023 SYPTOMS ARE FINALLY SUBSIDING
Aktuelle Erkrankungen: NONE
Vorgeschichte: GOUT
Andere Medikamente: uloric/FEBUXOSTAT 40 MG DAILY
Allergien: QUINOLINE BASED ANTIBIOTICS
Vorherige Impfungen: -

VAERS 2617712

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7143C

gering

Staat: -
Alter: 67,0
Geschlecht: F
Eingang: 24.04.2023
Impfdatum: 09.09.2022
Beginn: 14.09.2022
Tage bis Beginn: 5,0
Dosis: 5
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Acoustic stimulation tests abnormal Deafness bilateral Tinnitus Acoustic stimulation tests Deafness

Symptomtext

hearing loss; tinnitus; This spontaneous case was reported by an other health care professional and describes the occurrence of DEAFNESS (hearing loss) in a 67-year-old female patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. AS7143B) for COVID-19 prophylaxis. The occurrence of additional non-serious events is detailed below. Patient did not received any other vaccines in the 4 weeks prior to COVID-19 vaccine. Concomitant products included TOZINAMERAN (PFIZER BIONTECH COVID-19 VACCINE) from 31-Mar-2022 to an unknown date for an unknown indication. On 09-Sep-2022, the patient received fifth dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On 14-Sep-2022, after starting mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)), the patient experienced TINNITUS (tinnitus). On an unknown date, the patient experienced DEAFNESS (hearing loss) (seriousness criterion medically significant). At the time of the report, TINNITUS (tinnitus) and DEAFNESS (hearing loss) had not resolved. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Acoustic stimulation tests: moderate hearing loss in both ears. For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter did not provide any causality assessments. Patient previously had 1st dose of Moderna vaccine on 21-Jan-2021, 2nd dose from Moderna on 15-Feb-2021 and 3rd dose from Moderna booster vaccine on 29-Oct-2021. No concomitant medications were reported. After 5 days of bivalent dose administration, in the evening, patient realized she had severe tinnitus, it was not there before, it came all of a sudden. Patient went to the doctor, took hearing test with ENT which showed moderate hearing loss in both ears. Patient had hearing aids which were not helpful. Patient never had COVID-19. No treatment details were reported. Company comment: This spontaneous case concerns a 67-year-old female patient, with no relevant medical history, who experienced the unexpected and serious (medically significant) event of DEAFNESS after the mRNA-1273.222 vaccine, considered as the fifth dose of the vaccine schedule. The exact onset of the event was not reported; hence, latency could not be properly assessed. Five days after vaccination, she experienced sudden severe tinnitus. She consulted with no abnormal findings in her ears. A hearing test showed moderate hearing loss in both ears and hearing aids did not improve it. Previously she received 3 doses of mRNA-1273 vaccine and a PFIZER BIONTECH COVID-19 VACCINE as a booster dose (Interchange of vaccine products & Revaccination with different COVID-19 vaccine). No further clinical information was available for medical review. Patient?s age could be a risk factor for deafness and concomitant Pfizer vaccine remains as a confounder.. The benefit-risk relationship of mRNA-1273.222 vaccine is not affected by this report.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acoustic stimulation tests abnormal
Hospital-Tage: -
Labordaten: Test Name: hearing test; Result Unstructured Data: moderate hearing loss in both ears
Aktuelle Erkrankungen: -
Vorgeschichte: Comments: Patient did not received any other vaccines in the 4 weeks prior to COVID-19 vaccine.
Andere Medikamente: PFIZER BIONTECH COVID-19 VACCINE
Allergien: -
Vorherige Impfungen: -

VAERS 2619128

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7143C

gering

Staat: MO
Alter: 77,0
Geschlecht: F
Eingang: 21.04.2023
Impfdatum: 16.09.2022
Beginn: 24.02.2023
Tage bis Beginn: 161,0
Dosis: 5
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

COVID-19 Rhinorrhoea SARS-CoV-2 test positive Sneezing

Symptomtext

My initial symptoms were sneezing and runny nose, which continued for probably two days. I didn't feel sick, though. I thought it was just allergies. On the third day, I took a COVID-19 test and got a positive result. On the fourth day, I called the doctor's office and asked if I should have PAXLOVID. They prescribed me PAXLOVID, which I took for five days. They had me stop taking simvastatin while I took the PAXLOVID on account of contraindications; I ceased taking the simvastatin for ten days. I felt fine, and I never had any other symptoms aside from the sneezing and runny nose.

Weitere VAERSDATA-Felder

Praegender Schweregrund: COVID-19
Hospital-Tage: -
Labordaten: FEB2023 home antigen test, positive result
Aktuelle Erkrankungen: None
Vorgeschichte: Hypertension; Acid Reflux Disease; High Cholesterol; Osteoarthritis; Potassium Deficiency; Hypothyroidism; Mild Depression
Andere Medikamente: Carvedilol; omeprazole; potassium chloride; levothyroxine; valsartan; bupropion; furosemide; simvastatin; tizanidine; vitamin D3; gabapentin; XYZAL; magnesium; multivitamin; biotin; vitamin C; calcium; NEURIVA; MOTRIN; TYLENOL; turmeric; vi
Allergien: Penicillin; KEFLEX; amlodipine; tramadol
Vorherige Impfungen: -

VAERS 2615784

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge as7143c

gering

Staat: IL
Alter: 76,0
Geschlecht: F
Eingang: 15.04.2023
Impfdatum: 07.09.2022
Beginn: 17.01.2023
Tage bis Beginn: 132,0
Dosis: 5
Route/Site: SYR / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: ja ER: unbekannt Erholt: nein

Acoustic stimulation tests abnormal Deafness bilateral Hearing aid user Magnetic resonance imaging head normal SARS-CoV-2 test negative Sudden hearing loss

Symptomtext

1/17/23-all of sudden i lost my hearing in left ear 2/3/23-primary doctor gave me Prednisone 20mg 3times daily/10 days 2/16/23-saw ENT. have lost of hearing in both ears (left ear 80%). Said i could live with it, get a shot in ear but don't really recommend or get a hearing aid. I went with a hearing aid ($860.00) Had Covid on 12/13/22. tested negative 10 days later

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acoustic stimulation tests abnormal
Hospital-Tage: -
Labordaten: 2/16/23-hearing test with ENT 2/24/23-hearing test at Privacy 2/27/23-MRIw/wo contrast of my Brain. No Tumors
Aktuelle Erkrankungen: None
Vorgeschichte: Arthritis Both Knees Bone on Bone
Andere Medikamente: Hydrochlorothiazide, Meloxicam, Fluticasone Nasal Spray as needed, Patanol as needed, Vitamin D3, Vitamin C, Tylenol, Aspirin 81mg
Allergien: None
Vorherige Impfungen: -

VAERS 2611455

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7143C

gering

Staat: MI
Alter: 62,0
Geschlecht: F
Eingang: 07.04.2023
Impfdatum: 14.09.2022
Beginn: 02.12.2022
Tage bis Beginn: 79,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Cough Nasal congestion Respiratory disorder

Symptomtext

I developed some upper respiratory issues, nasal congestion, cough.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Cough
Hospital-Tage: -
Labordaten: None
Aktuelle Erkrankungen: No
Vorgeschichte: Scleroderma; Raynaud's
Andere Medikamente: Nifedipine; sildenafil; methotrexate; PLAVIX; KEFLEX; folic acid
Allergien: Sulfa
Vorherige Impfungen: -

VAERS 2610640

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7143C

gering

Staat: IN
Alter: 63,0
Geschlecht: M
Eingang: 06.04.2023
Impfdatum: 01.09.2022
Beginn: 01.01.2023
Tage bis Beginn: 122,0
Dosis: 4
Route/Site: IM / AR

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

COVID-19 No adverse event SARS-CoV-2 test positive

Symptomtext

I did not have a reaction to the vaccine. I tested positive for COVID-19 in 01/2023. I contacted my doctor and was prescribed PAXLOVID. I tolerated the medication without any complications. As of today, I feel better with no lingering symptoms.

Weitere VAERSDATA-Felder

Praegender Schweregrund: COVID-19
Hospital-Tage: -
Labordaten: JAN2023 COVID-19 test positive
Aktuelle Erkrankungen: N/A
Vorgeschichte: Bladder Cancer
Andere Medikamente: N/A
Allergien: N/A
Vorherige Impfungen: -

VAERS 2610382

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7143C

gering

Staat: -
Alter: -
Geschlecht: F
Eingang: 06.04.2023
Impfdatum: -
Beginn: 01.12.2022
Tage bis Beginn: -
Dosis: 5
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

COVID-19

Symptomtext

COVID-19; COVID-19; This spontaneous case was reported by a patient family member or friend and describes the occurrence of the first episode of COVID-19 (COVID-19) and the second episode of COVID-19 (COVID-19) in an adult female patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. AS7143C) for COVID-19 prophylaxis. Previously administered products included for COVID-19 prophylaxis: Moderna COVID-19 Vaccine (Patient had 5 shots and and all were Moderna.). Past adverse reactions to the above products included No adverse event with Moderna COVID-19 Vaccine. On an unknown date, the patient received fifth dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. In December 2022, the patient experienced the first episode of COVID-19 (COVID-19). In January 2023, the patient experienced the second episode of COVID-19 (COVID-19). At the time of the report, last episode of COVID-19 (COVID-19) had resolved. For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter did not provide any causality assessments. No concomitant drug was reported. The patient said that they got COVID in December 2022 and January 2023. The symptoms were mild. No treatment drug was reported. This case was linked to US-MODERNATX, INC.-MOD-2023-717679 (Linked Report).; Sender's Comments: US-MODERNATX, INC.-MOD-2023-717679:Husband case

Weitere VAERSDATA-Felder

Praegender Schweregrund: COVID-19
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2609306

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7143C

gering

Staat: MI
Alter: 59,0
Geschlecht: M
Eingang: 04.04.2023
Impfdatum: 01.09.2022
Beginn: 02.10.2022
Tage bis Beginn: 31,0
Dosis: 5
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt

COVID-19 SARS-CoV-2 test positive Vaccine breakthrough infection

Symptomtext

Breakthrough case admission after 5 vaccines Moderna 3/19/21 Lot# 045A21A; Moderna 4/16/21 Lot# 038B21A; Moderna 8/8/21 Lot# 088D21A; Moderna 4/10/22 Lot# 001M21A; Moderna 9/1/22 Lot# AS7143C

Weitere VAERSDATA-Felder

Praegender Schweregrund: COVID-19
Hospital-Tage: -
Labordaten: COVID +
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2609087

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7143C

gering

Staat: FL
Alter: 71,0
Geschlecht: M
Eingang: 04.04.2023
Impfdatum: 08.09.2022
Beginn: 12.01.2023
Tage bis Beginn: 126,0
Dosis: 5
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

COVID-19 SARS-CoV-2 test positive Throat irritation

Symptomtext

The symptoms were just a scratchy throat. It lasted a day. I continued to test positive for 12 days. My doctor called in a prescription for PAXLOVID. It was primarily to keep any infection from spreading to my heart.

Weitere VAERSDATA-Felder

Praegender Schweregrund: COVID-19
Hospital-Tage: -
Labordaten: 12JAN2023 COVID-19 test positive; 24JAN2023 COVID-19 test negative; 26JAN2023 COVID-19 test negative
Aktuelle Erkrankungen: N/A
Vorgeschichte: COPD
Andere Medikamente: Amlodipine; aspirin; PLAVIX; LASIX; metoprolol succinate; pravastatin
Allergien: N/A
Vorherige Impfungen: -

VAERS 2607917

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7143C

gering

Staat: -
Alter: -
Geschlecht: U
Eingang: 01.04.2023
Impfdatum: 01.09.2022
Beginn: 01.12.2022
Tage bis Beginn: 91,0
Dosis: 5
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

COVID-19

Symptomtext

did get Covid in Dec 2022 after having the 5 shots; This spontaneous case was reported by a patient and describes the occurrence of COVID-19 (did get Covid in Dec 2022 after having the 5 shots) in a patient of an unknown age and gender who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. AS7143C) for COVID-19 prophylaxis. No Medical History information was reported. In September 2022, the patient received fifth dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Intramuscular) 1 dosage form. In December 2022, the patient experienced COVID-19 (did get Covid in Dec 2022 after having the 5 shots). At the time of the report, COVID-19 (did get Covid in Dec 2022 after having the 5 shots) outcome was unknown. For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Intramuscular), the reporter did not provide any causality assessments. No concomitant drug was reported. The patient said that they got Covid in Dec-2022 after having the 5 shots. It was a very mild infection. No treatment drug was reported. Most recent FOLLOW-UP information incorporated above includes: On 29-Mar-2023: Live non significant follow up

Weitere VAERSDATA-Felder

Praegender Schweregrund: COVID-19
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2599647

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7143C

gering

Staat: NC
Alter: 65,0
Geschlecht: M
Eingang: 20.03.2023
Impfdatum: 16.09.2022
Beginn: 25.01.2023
Tage bis Beginn: 131,0
Dosis: 4
Route/Site: SYR / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Atrial fibrillation Electrocardiogram ambulatory

Symptomtext

I experienced AFib in late January 2023. I went to see my PCP on 02/09/2023 and he diagnosed me with AFib and have been wearing a heart monitor since 03/15/2023.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Atrial fibrillation
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: None
Vorgeschichte: Obesity, High blood pressure
Andere Medikamente: Lisinopril, Pantoprazole, Metoprolol, Eliquis, Rosuvastatin, Multivitamin
Allergien: Shellfish
Vorherige Impfungen: -

VAERS 2598564

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge AS7143C

gering

Staat: WA
Alter: 58,0
Geschlecht: F
Eingang: 17.03.2023
Impfdatum: 07.09.2022
Beginn: 13.01.2023
Tage bis Beginn: 128,0
Dosis: 5
Route/Site: IM / AR

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Sinusitis

Symptomtext

I had a sinus infection. I had two rounds of antibiotics. I had two virtual visits.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Sinusitis
Hospital-Tage: -
Labordaten: None
Aktuelle Erkrankungen: None
Vorgeschichte: Yes; not listed
Andere Medikamente: Yes; not listed
Allergien: Yes; not listed
Vorherige Impfungen: -

VAERS 2597669

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7143C

gering

Staat: OH
Alter: 67,0
Geschlecht: M
Eingang: 16.03.2023
Impfdatum: 14.09.2022
Beginn: 27.09.2022
Tage bis Beginn: 13,0
Dosis: 5
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Anaemia Blood iron decreased Blood test abnormal Haemoglobin decreased

Symptomtext

I became anemic; my hemoglobin dropped pretty significantly. I give blood for every 6 weeks to a clinic, and my donation was declined due to low iron levels. I called my doctor the next day to call for an examination. They took blood work and noticed my low levels were low. I have been going to receive doses of IV iron; I had to receive 3 doses to have a follow-up examination of bloodwork to see if I need to receive any additional IVs in the future.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Anaemia
Hospital-Tage: -
Labordaten: 27SEP2022 Bloodwork, abnormal
Aktuelle Erkrankungen: N/A
Vorgeschichte: High Blood Pressure
Andere Medikamente: Hydrochlorothiazide; simvastatin; olmesartan; pantoprazole; gabapentin; fish oil; aspirin; multivitamin; zinc; vitamin D
Allergien: N/A
Vorherige Impfungen: -

VAERS 2597640

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7143C

gering

Staat: FL
Alter: 50,0
Geschlecht: F
Eingang: 16.03.2023
Impfdatum: 10.09.2022
Beginn: 26.02.2023
Tage bis Beginn: 169,0
Dosis: 5
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

COVID-19 Cough SARS-CoV-2 test positive

Symptomtext

I did not have an adverse reaction to the vaccine. I tested positive for COVID-19 on 02/26/2023. I contacted my doctor to notify them that, I was positive. I took TYLENOL to help with my symptoms. As of today, I still have a cough.

Weitere VAERSDATA-Felder

Praegender Schweregrund: COVID-19
Hospital-Tage: -
Labordaten: 26FEB2023 COVID-19 test positive
Aktuelle Erkrankungen: N/A
Vorgeschichte: High Blood Pressure
Andere Medikamente: Losartan; pantoprazole; fish oil
Allergien: Penicillin
Vorherige Impfungen: -

VAERS 2597063

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7143C

gering

Staat: CA
Alter: 58,0
Geschlecht: F
Eingang: 15.03.2023
Impfdatum: 09.09.2022
Beginn: 18.12.2022
Tage bis Beginn: 100,0
Dosis: 5
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: nein

Blood test Computerised tomogram Echocardiogram Heart rate increased Heart rate irregular

Symptomtext

I had an irregular heart beat and had a telehealth visit and was directed to urgent care and I was taken by ambulance to emergency room. It was over 166 bpm, I was given drugs to reduce it and the next day it went back up to over 180bpm. I went back to the hospital, I was given medication to reduce it again by a cardiologist. I have an appointment on March 24th for a 5 hour procedure I'll have to stay over night for and I've been told there isn't a cure but a progressive problem. The medications I'm currently on have huge side effects.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Blood test
Hospital-Tage: 3,0
Labordaten: 21FEB2023 - Echocardiogram 21FEB2023 - Blood Test 21FEB2023 - Cat Scan
Aktuelle Erkrankungen: None
Vorgeschichte: None
Andere Medikamente: Vitamin
Allergien: None
Vorherige Impfungen: -

VAERS 2596200

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7143C

gering

Staat: CA
Alter: 66,0
Geschlecht: M
Eingang: 14.03.2023
Impfdatum: 10.09.2022
Beginn: 20.01.2023
Tage bis Beginn: 132,0
Dosis: 5
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

COVID-19 Cough SARS-CoV-2 test positive

Symptomtext

Symptoms began with a slight cough on January 23, 2023. I still had the minor cough the following day and tested positive for COVID-19. I contacted the doctor on the same day and received prescription for Paxlovid and began taking it on the same day. I tested negative the following Sunday afternoon.

Weitere VAERSDATA-Felder

Praegender Schweregrund: COVID-19
Hospital-Tage: -
Labordaten: COVID-19 home test, positive, 012023
Aktuelle Erkrankungen: N/A
Vorgeschichte: Cardiovascular Disease; High Blood Pressure; Obesity
Andere Medikamente: Lipitor; Metoprolol; Diflucan; Baby Aspirin; Vitamin C; Zinc
Allergien: Nickel; Wool; Bee stings; Crab; Grasses
Vorherige Impfungen: -

VAERS 2595548

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7143C

gering

Staat: NC
Alter: 67,0
Geschlecht: M
Eingang: 13.03.2023
Impfdatum: 11.09.2022
Beginn: -
Tage bis Beginn: -
Dosis: 5
Route/Site: SYR / AR

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Anaemia Blood test abnormal Haemoglobin decreased

Symptomtext

December 22, 2022 I had no symptoms. I had a physical. I received the results of bloodwork I had the week before. The results showed Hemoglobin count was off at 10.2 which is low. I had more bloodwork to look at iron that day. I was diagnosed with anemia. I started taking iron supplements. I had an appointment with a GI on 1/10/22. I had an appointment with a Hematologist on 2/2/2023 who confirmed my diagnosis. He did more bloodwork and my iron had improved some after beginning iron. I am having more follow up tests to check for internal bleeding.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Anaemia
Hospital-Tage: -
Labordaten: Bloodwork, abnormal, diagnosed with anemia, Hemoglobin was 10.2. Follow up bloodwork, iron level had improved.
Aktuelle Erkrankungen: None
Vorgeschichte: Hypolipidemia; Diabetes Type 2; Chronic sinusitis; Kidney stones; Hypothyroidism
Andere Medikamente: TRICOR; LIPITOR; metformin ER; ramipril; OZEMPIC; TRESIBA FLEX TOUCH; lispro quick pen; allopurinol; UROCIT- K; FLOMAX; SYNTHROID; terbinafine hydrochloride; ALLEGRA; CENTRUM SILVER multivitamin for men; omega 3 oil; mega red krill oil; low
Allergien: Chronic sinusitis
Vorherige Impfungen: -

VAERS 2595511

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7143C

gering

Staat: IL
Alter: 68,0
Geschlecht: F
Eingang: 13.03.2023
Impfdatum: 09.09.2022
Beginn: 30.12.2022
Tage bis Beginn: 112,0
Dosis: 5
Route/Site: SYR / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

COVID-19 Influenza like illness Rhinorrhoea SARS-CoV-2 test positive

Symptomtext

I was positive for COVID-19 on 30DEC2022, I was out of state and had to call my doctors office. I spoke to the doctor over the phone, they prescribed PAXLOVID. I did not have a fever, really bad runny nose, achy feeling through my body just like the flu. I took PAXLOVID and started feeling better a while after not right away, I don't know if I had a rebound but I didn't retake the test.

Weitere VAERSDATA-Felder

Praegender Schweregrund: COVID-19
Hospital-Tage: -
Labordaten: 30DEC2022 COVID-19 test positive
Aktuelle Erkrankungen: N/A
Vorgeschichte: Diabetes; Thyroid
Andere Medikamente: JARDIANCE; triamterene; rosuvastatin; glipizide; vitamin D3; STABILIUM; L-theanine ashwagandha; elderberry; pregabalin; SYNTHROID
Allergien: Aspirin; ibuprofen; INAPSINE; ENTEX; latex; metformin; apples; peaches; jackfruit; cashews
Vorherige Impfungen: -

VAERS 2594829

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7143C

gering

Staat: NY
Alter: 78,0
Geschlecht: F
Eingang: 10.03.2023
Impfdatum: 08.09.2022
Beginn: 01.11.2022
Tage bis Beginn: 54,0
Dosis: 4
Route/Site: IM / AR

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Epidural injection Foreign travel Nasopharyngitis

Symptomtext

I did not have an adverse reaction to the vaccine. I have a history of back problems and received an epidural injection 11/2022. I recently went out of the country and on the way back, I developed a bad cold. I am taking Claritin and cough medicine to help with the symptoms.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Epidural injection
Hospital-Tage: -
Labordaten: N/A
Aktuelle Erkrankungen: N/A
Vorgeschichte: N/A
Andere Medikamente: Calcium; Vitamin D3
Allergien: N/A
Vorherige Impfungen: -

VAERS 2594727

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7143C

gering

Staat: WA
Alter: 37,0
Geschlecht: F
Eingang: 10.03.2023
Impfdatum: 08.09.2022
Beginn: 01.02.2023
Tage bis Beginn: 146,0
Dosis: 4
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Breast mass Magnetic resonance imaging breast abnormal

Symptomtext

A lump was found on my left breast in February 2023 (6x5x4mm). The only reason I got the breast MRI was because I was found to have the Braca1 gene found after I had my colonoscopy. At this time, I am not having a biopsy. I will be having a mastectomy soon.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Breast mass
Hospital-Tage: -
Labordaten: Breast MRI, abnormal, 02/2023
Aktuelle Erkrankungen: N/A
Vorgeschichte: Depression; Anxiety; PTSD; Pre Diabetic; Hypertension
Andere Medikamente: Escitalopram; WELLBUTRIN; ADVIL
Allergien: Benzyl alcohol
Vorherige Impfungen: -

VAERS 2593888

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7143C

gering

Staat: IA
Alter: 74,0
Geschlecht: M
Eingang: 09.03.2023
Impfdatum: 07.09.2022
Beginn: 18.02.2023
Tage bis Beginn: 164,0
Dosis: 5
Route/Site: IM / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

COVID-19 SARS-CoV-2 test positive

Symptomtext

NO REACTIONS

Weitere VAERSDATA-Felder

Praegender Schweregrund: COVID-19
Hospital-Tage: -
Labordaten: COVID 19 POSITIVE
Aktuelle Erkrankungen: none
Vorgeschichte: HTN, elevated Chlosteral
Andere Medikamente: Lisinopril, Atorvastatin, HCTZ, Lansoprazole 30mg, zyrtec, coq10, one a day silver, fish oil, zinc
Allergien: Nystatin, Whey Protein, Ocytocin, MSM
Vorherige Impfungen: -

VAERS 2593886

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7143C

gering

Staat: NC
Alter: 66,0
Geschlecht: F
Eingang: 09.03.2023
Impfdatum: 07.09.2022
Beginn: 08.02.2023
Tage bis Beginn: 154,0
Dosis: 4
Route/Site: IM / AR

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Computerised tomogram abdomen abnormal Nephrolithiasis Renal stone removal Urinary tract infection Urine analysis

Symptomtext

I been having recurring UTI's that would not go away. I was seeing my urologist had done a CAT Scan and we discovered that I had Kidney Stones. I had to have them surgically removed on 2/20/23. Because the treatment of the UTI had not been working we then went to looking for more of what could be happening and that is what led to finding the stones and having them removed. At this point I still have the UTI but the stones have gone away. I have graduated from oral antibiotics to an intramuscular injected antibiotic.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Computerised tomogram abdomen abnormal
Hospital-Tage: -
Labordaten: CAT Scan; Urinalysis
Aktuelle Erkrankungen: N/A
Vorgeschichte: Asthma
Andere Medikamente: Estradiol; meloxicam; atorvastatin; omeprazole
Allergien: Foods in the mustard family; sulfa antibiotics; erythromycin; ZOFRAN; tetracycline; DARVON COMPOUND
Vorherige Impfungen: -

VAERS 2593287

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7143C

gering

Staat: CA
Alter: 74,0
Geschlecht: M
Eingang: 08.03.2023
Impfdatum: 06.09.2022
Beginn: 26.12.2022
Tage bis Beginn: 111,0
Dosis: 5
Route/Site: IM / AR

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

COVID-19 SARS-CoV-2 test positive

Symptomtext

My wife and I tested positive for COVID-19 on December 26, 2022. I had a telehealth visit and was prescribed PAXLOVID but didn't take it. My symptoms were very mild thankfully because of the vaccine.

Weitere VAERSDATA-Felder

Praegender Schweregrund: COVID-19
Hospital-Tage: -
Labordaten: 26DEC22 COVID-19 home test positive
Aktuelle Erkrankungen: None
Vorgeschichte: None
Andere Medikamente: Antihistamine
Allergien: None
Vorherige Impfungen: -

VAERS 2591954

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge AS7143C

gering

Staat: WA
Alter: 74,0
Geschlecht: M
Eingang: 06.03.2023
Impfdatum: 03.09.2022
Beginn: 01.10.2022
Tage bis Beginn: 28,0
Dosis: 5
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: ja

Atrial fibrillation Chest X-ray Cough Electrocardiogram

Symptomtext

Persistent ongoing cough; peridural afibulation.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Atrial fibrillation
Hospital-Tage: -
Labordaten: EKG - 24Feb2023 Chest X-Ray- 24Feb2023
Aktuelle Erkrankungen: N/A
Vorgeschichte: Obstructive Sleep Apnea
Andere Medikamente: multivitamin; Fish oil; aspirin 81 mg once daily; celeiumfiber 3 tablets two tablets a day; Zetia 10mg; Losartin posaium 125 mg once a day; Itenoil 100 mg 1 per day; Testorpipione 200 mg once a month; Trezinodone as needed; Amlopin;
Allergien: N/A
Vorherige Impfungen: -

VAERS 2585304

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge AS7143C

gering

Staat: CA
Alter: -
Geschlecht: F
Eingang: 22.02.2023
Impfdatum: 01.09.2022
Beginn: 01.09.2022
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Circumstance or information capable of leading to medication error No adverse event Wrong product administered

Symptomtext

she should have received a Bivalent dose. When I asked her however, she states that she received a Monovalent dose; No adverse event; she should have received a Bivalent dose. When I asked her however, she states that she received a Monovalent dose; This spontaneous case was reported by a consumer and describes the occurrence of WRONG PRODUCT ADMINISTERED (she should have received a Bivalent dose. When I asked her however, she states that she received a Monovalent dose), CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR (she should have received a Bivalent dose. When I asked her however, she states that she received a Monovalent dose) and NO ADVERSE EVENT (No adverse event) in an adult female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. AS7143C) for COVID-19 prophylaxis. No Medical History information was reported. In September 2022, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In September 2022, the patient experienced WRONG PRODUCT ADMINISTERED (she should have received a Bivalent dose. When I asked her however, she states that she received a Monovalent dose). On an unknown date, the patient experienced CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR (she should have received a Bivalent dose. When I asked her however, she states that she received a Monovalent dose) and NO ADVERSE EVENT (No adverse event). At the time of the report, WRONG PRODUCT ADMINISTERED (she should have received a Bivalent dose. When I asked her however, she states that she received a Monovalent dose), CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR (she should have received a Bivalent dose. When I asked her however, she states that she received a Monovalent dose) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for WRONG PRODUCT ADMINISTERED (she should have received a Bivalent dose. When I asked her however, she states that she received a Monovalent dose) and CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR (she should have received a Bivalent dose. When I asked her however, she states that she received a Monovalent dose). No concomitant medications was reported. Dose of Suspect Moderna vaccine was reported as Initial Booster. No treatment medications was reported. Reporter did not allow further contact

Weitere VAERSDATA-Felder

Praegender Schweregrund: Circumstance or information capable of leading to medication error
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2575930

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge AS7143C

gering

Staat: CA
Alter: 54,0
Geschlecht: M
Eingang: 04.02.2023
Impfdatum: 14.12.2022
Beginn: 14.12.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

Expired product administered Product storage error

Symptomtext

Vaccination administered on 2/4/23 after being thawed on 11/5/2022. Per manufacturer, vaccine should be discarded after thawed for 30-days. Vaccine given outside of these parameters. Patient did not report any adverse reactions/symptoms at this time. Patient will be contacted to re-administer vaccination.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2575928

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7143C

gering

Staat: CA
Alter: 32,0
Geschlecht: M
Eingang: 04.02.2023
Impfdatum: 20.12.2022
Beginn: 20.12.2022
Tage bis Beginn: 0,0
Dosis: 3
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Expired product administered Product storage error

Symptomtext

Vaccine administered on 01/07/2023 after being thawed on 11/5/2022. Per manufacturer, vaccine should be discarded after thawed for 30 days. Vaccine given outside of these parameters. Patient did not report any adverse reactions/symptoms at this time. Patient will be contacted for re-administration of the vaccine.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2575927

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge AS7143C

gering

Staat: CA
Alter: 35,0
Geschlecht: F
Eingang: 04.02.2023
Impfdatum: 14.12.2022
Beginn: 14.12.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

Expired product administered Product storage error

Symptomtext

Vaccination administered on 2/4/23 after being thawed on 11/5/2022. Per manufacturer, vaccine should be discarded after thawed for 30-days. Vaccine given outside of these parameters. Patient did not report any adverse reactions/symptoms at this time. Patient will be contacted to re-administer vaccination.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2575926

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge AS7143C

gering

Staat: CA
Alter: 42,0
Geschlecht: M
Eingang: 04.02.2023
Impfdatum: 19.12.2022
Beginn: 19.12.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

Expired product administered Product storage error

Symptomtext

Vaccination administered on 2/4/23 after being thawed on 11/5/2022. Per manufacturer, vaccine should be discarded after thawed for 30-days. Vaccine given outside of these parameters. Patient did not report any adverse reactions/symptoms at this time. Patient will be contacted to re-administer vaccination.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2575925

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge AS7143C

gering

Staat: CA
Alter: 32,0
Geschlecht: M
Eingang: 04.02.2023
Impfdatum: 20.12.2022
Beginn: 20.12.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

Expired product administered Product storage error

Symptomtext

Vaccination administered on 2/4/23 after being thawed on 11/5/2022. Per manufacturer, vaccine should be discarded after thawed for 30-days. Vaccine given outside of these parameters. Patient did not report any adverse reactions/symptoms at this time. Patient will be contacted to re-administer vaccination.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2575924

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7143C

gering

Staat: CA
Alter: 43,0
Geschlecht: M
Eingang: 04.02.2023
Impfdatum: 20.12.2022
Beginn: 20.12.2022
Tage bis Beginn: 0,0
Dosis: 2
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Expired product administered Product storage error

Symptomtext

Vaccine administered on 01/07/2023 after being thawed on 11/5/2022. Per manufacturer, vaccine should be discarded after thawed for 30 days. Vaccine given outside of these parameters. Patient did not report any adverse reactions/symptoms at this time. Patient will be contacted for re-administration of the vaccine.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2575922

UNKNOWN MANUFACTURER · VACCINE NOT SPECIFIED (NO BRAND NAME) · Charge AS7143C

gering

Staat: -
Alter: 27,0
Geschlecht: M
Eingang: 04.02.2023
Impfdatum: 20.12.2022
Beginn: 20.12.2022
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

No adverse event Product storage error

Symptomtext

vaccination administered on 2/4/23 after being thawed on 11/5/2022. Per manufacturer, vaccine should be discarded after thawed for 30-days. Vaccine given outside of these parameters. Patient did not report any adverse reactions/symptoms at this time.

Weitere VAERSDATA-Felder

Praegender Schweregrund: No adverse event
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2575920

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge AS7143C

gering

Staat: CA
Alter: 32,0
Geschlecht: M
Eingang: 04.02.2023
Impfdatum: 20.12.2022
Beginn: 20.12.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

Expired product administered Product storage error

Symptomtext

Vaccination administered on 2/4/23 after being thawed on 11/5/2022. Per manufacturer, vaccine should be discarded after thawed for 30-days. Vaccine given outside of these parameters. Patient did not report any adverse reactions/symptoms at this time. Patient will be contacted to re-administer vaccination.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2575919

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge AS7143C

gering

Staat: CA
Alter: 35,0
Geschlecht: M
Eingang: 04.02.2023
Impfdatum: 20.12.2022
Beginn: 20.12.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

Expired product administered Product storage error

Symptomtext

Vaccination administered on 2/4/23 after being thawed on 11/5/2022. Per manufacturer, vaccine should be discarded after thawed for 30-days. Vaccine given outside of these parameters. Patient did not report any adverse reactions/symptoms at this time. Patient will be contacted to re-administer vaccination.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2575917

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge AS7143C

gering

Staat: CA
Alter: 49,0
Geschlecht: M
Eingang: 04.02.2023
Impfdatum: 20.12.2022
Beginn: 20.12.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

Expired product administered Product storage error

Symptomtext

Vaccination administered on 2/4/23 after being thawed on 11/5/2022. Per manufacturer, vaccine should be discarded after thawed for 30-days. Vaccine given outside of these parameters. Patient did not report any adverse reactions/symptoms at this time. Patient will be contacted to re-administer vaccination.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2575915

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge AS7143C

gering

Staat: CA
Alter: 38,0
Geschlecht: M
Eingang: 04.02.2023
Impfdatum: 04.02.2023
Beginn: 04.02.2023
Tage bis Beginn: 0,0
Dosis: 3
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

Expired product administered Product storage error

Symptomtext

Vaccination administered on 2/4/23 after being thawed on 11/5/2022. Per manufacturer, vaccine should be discarded after thawed for 30-days. Vaccine given outside of these parameters. Patient did not report any adverse reactions/symptoms at this time.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2568208

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge AS7143C

gering

Staat: ND
Alter: 47,0
Geschlecht: M
Eingang: 26.01.2023
Impfdatum: 02.12.2021
Beginn: 01.11.2022
Tage bis Beginn: 334,0
Dosis: 3
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

COVID-19 immunisation Suspected COVID-19

Symptomtext

REVACCINATION WITH DIFFERENT COVID-19 VACCINE; SUSPECTED COVID-19 INFECTION; This spontaneous report received from a patient via other manufacturer (Pfizer) concerned a 48 year old male. The patient's height, and weight were not reported. The patient's concurrent conditions included: oxicodone, trazidone, dextromethorphan hbr allergy, and chronic severe headaches (treated with botox injections, tylenol, and advil). The patient was previously treated with covid-19 vaccine ad26.cov2.s (Dose Number in Series 1) (suspension for injection, route of admin not reported, batch number: 1816022, expiry: UNKNOWN) dose was not reported, 1 total administered at left arm on 12-JUL-2021 for covid-19 prophylaxis. It was unknown whether patient had any adverse events following vaccination with first dose of covid-19 vaccine ad26.cov2.s (Dose Number in Series 1) The patient received additional covid-19 vaccine ad26.cov2.s (Dose number in series 2) (suspension for injection, route of admin not reported, batch number: 213D21A, expiry: UNKNOWN) dose was not reported, 1 total administered at left arm on 02-DEC-2021 for covid-19 prophylaxis. Age at time of vaccination 47 years old. It was unknown whether patient had any adverse events following vaccination with covid-19 vaccine ad26.cov2.s (Dose number in series 2) The patient additionally received non-company suspect drugs included: (Spikevax) Moderna bivalent booster (elasomeran) (Dose number in series 3) (form of admin, route of admin were not reported, batch number: AS7143C, expiry: UNKNOWN) dose was not reported, administered at right arm on 01-NOV-2022 for covid-19 prophylaxis which was revaccination with different covid-19 vaccine (Dose number in series 3). Concomitant medications included botox injections (botulinum toxin type A), Advil (ibuprofen), Tylenol (paracetamol) for chronic severe headaches, Cold Relief (acetylsalicylic acid/chlorphenamine maleate/phenylephrine bitartrate), (guaifenesin), and (pseudoephedrine hydrochloride). On unspecified date in 2022, the patient experienced suspected covid-19 infection (Dose number in series 3) and received non-company suspect drug Paxlovid for treatment of covid-19 (form of admin, route of admin were not reported, batch number: unknown expiry: UNKNOWN) dose was not reported, administered from 05-DEC-2022 to 10-DEC-2022. On 15-DEC-2022, the patient was sick (Dose number in series 3). Although he felt pretty good at the end of the Paxlovid treatment, a few days later he became extremely sick again and that lasted for over a week. He spoke with the physician and was told that this could happen for the next few months. Very slowly he began feeling better, but 2 days ago it started getting worse again. The action taken with covid-19 vaccine ad26.cov2.s, elasomeran was not applicable and with paxlovid was drug discontinued. The patient was recovering from suspected covid-19 infection, and the outcome of revaccination with different covid-19 vaccine was not reported. This report was non-serious.

Weitere VAERSDATA-Felder

Praegender Schweregrund: COVID-19 immunisation
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: Chronic headaches (treated with botox injections, tylenol, and advil); Drug allergy
Vorgeschichte: -
Andere Medikamente: SUDAFED [PSEUDOEPHEDRINE HYDROCHLORIDE]; TYLENOL; ADVIL [IBUPROFEN]; EQUATE COLD RELIEF; MUCINEX; BOTOX
Allergien: -
Vorherige Impfungen: -

VAERS 2564885

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7143C

gering

Staat: NV
Alter: -
Geschlecht: M
Eingang: 21.01.2023
Impfdatum: 29.12.2022
Beginn: 29.12.2022
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered No adverse event Product storage error

Symptomtext

No adverse event; A dose was given to a patient 26 hours after puncture on 29Dec2022; A dose was given to a patient 26 hours after puncture on 29Dec2022; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (A dose was given to a patient 26 hours after puncture on 29Dec2022), PRODUCT STORAGE ERROR (A dose was given to a patient 26 hours after puncture on 29Dec2022) and NO ADVERSE EVENT (No adverse event) in an adult male patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. AS7143C) for COVID-19 prophylaxis. No Medical History information was reported. On 29-Dec-2022, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On 29-Dec-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (A dose was given to a patient 26 hours after puncture on 29Dec2022) and PRODUCT STORAGE ERROR (A dose was given to a patient 26 hours after puncture on 29Dec2022). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (A dose was given to a patient 26 hours after puncture on 29Dec2022), PRODUCT STORAGE ERROR (A dose was given to a patient 26 hours after puncture on 29Dec2022) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for EXPIRED PRODUCT ADMINISTERED (A dose was given to a patient 26 hours after puncture on 29Dec2022) and PRODUCT STORAGE ERROR (A dose was given to a patient 26 hours after puncture on 29Dec2022). No concomitant medication was reported. It was unknown if patient received any other vaccines in the 4 weeks prior to COVID-19 vaccine. A dose was given to a patient 26 hours after puncture on 29Dec2022. It was his second booster. The patient did not report any issues or reactions after that. The lot number is AS7143C. Vial size was 2.5 mL The vial was initially stored in the refrigerator on 28Dec2022. The vial was first punctured was on 28Dec2022 at 3:30, almost 4 PM 7. Date and time of administration of vaccine was 29Dec2022 at 6:10 PM. The vial was stored in the fridge post puncture. No temperature excursions. Amount of time the vial was exposed to room temperature range (8? to 25?C= 46? to 77?F) was 30 seconds. No treatment medication was reported. Reporter did not allow further contact

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2537179

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge AS7143C

gering

Staat: VA
Alter: 73,0
Geschlecht: F
Eingang: 20.12.2022
Impfdatum: 07.10.2022
Beginn: -
Tage bis Beginn: -
Dosis: 5
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Alopecia Thyroid function test

Symptomtext

hair loss; This spontaneous case was reported by a patient and describes the occurrence of ALOPECIA (hair loss) in an elderly female patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. AS7143C) for COVID-19 prophylaxis. The patient's past medical history included Fever. Concomitant products included INFLUENZA VACCINE for an unknown indication. On 07-Oct-2022, the patient received fifth dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On an unknown date, the patient experienced ALOPECIA (hair loss). The patient was treated with MINOXIDIL (ROGAINE) at an unspecified dose and frequency. At the time of the report, ALOPECIA (hair loss) had not resolved. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Thyroid function test: Normal. For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter did not provide any causality assessments. It was reported that patient hair was very long at one point, but now it's very thin. She stated that it started after the Moderna vaccine. Then patient had her flu shot the next week. She wonders if she took them too close together. Patient states she didn't have a reaction before the Moderna. Patient felt it was overnight that she started losing hair. Patient did not have this issue with the other shots. Did not get any reaction. She did have a small fever last spring.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Alopecia
Hospital-Tage: -
Labordaten: Test Name: Thyroid level check; Result Unstructured Data: Normal
Aktuelle Erkrankungen: -
Vorgeschichte: Medical History/Concurrent Conditions: Fever
Andere Medikamente: INFLUENZA VACCINE
Allergien: -
Vorherige Impfungen: -

VAERS 2536566

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge AS7143C

gering

Staat: WV
Alter: 73,0
Geschlecht: M
Eingang: 19.12.2022
Impfdatum: 08.09.2022
Beginn: 04.12.2022
Tage bis Beginn: 87,0
Dosis: 5
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

COVID-19 SARS-CoV-2 test positive

Symptomtext

No reaction at all to the injection. 3 months later tested positive for covid.

Weitere VAERSDATA-Felder

Praegender Schweregrund: COVID-19
Hospital-Tage: -
Labordaten: Dec 4, 2022 tested positive at Urgent Care facility
Aktuelle Erkrankungen: none
Vorgeschichte: none
Andere Medikamente: atenolol 100mg atorvastatin 40mg olmesartan 20mg
Allergien: none
Vorherige Impfungen: -

VAERS 2536200

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7143C

gering

Staat: NV
Alter: 57,0
Geschlecht: M
Eingang: 18.12.2022
Impfdatum: 04.11.2022
Beginn: 07.11.2022
Tage bis Beginn: 3,0
Dosis: 4
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Tinnitus

Symptomtext

Severe Tinitis

Weitere VAERSDATA-Felder

Praegender Schweregrund: Tinnitus
Hospital-Tage: -
Labordaten: N/A
Aktuelle Erkrankungen: N/A
Vorgeschichte: N/A
Andere Medikamente: None
Allergien: NKDA
Vorherige Impfungen: -

VAERS 2533420

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7143C

gering

Staat: PA
Alter: 79,0
Geschlecht: F
Eingang: 15.12.2022
Impfdatum: 14.09.2022
Beginn: 10.12.2022
Tage bis Beginn: 87,0
Dosis: 5
Route/Site: SYR / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

COVID-19 SARS-CoV-2 test positive

Symptomtext

Tested positive for COVID-19, 3 months aver receiving 5th dose. Called doctor and was given the option to take PAXLOVID, but decided not to.

Weitere VAERSDATA-Felder

Praegender Schweregrund: COVID-19
Hospital-Tage: -
Labordaten: Home COVID-19 test, yes.
Aktuelle Erkrankungen: N/A
Vorgeschichte: High Blood Pressure; Lyme Disease; Psoriasis; Liken Planus Oral Autoimmune
Andere Medikamente: Simvastatin; tyrosine; amlodipine; glucosamine; vitamin D.
Allergien: Sulfa
Vorherige Impfungen: -

VAERS 2530145

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7143C

gering

Staat: RI
Alter: 72,0
Geschlecht: F
Eingang: 13.12.2022
Impfdatum: 12.09.2022
Beginn: 11.11.2022
Tage bis Beginn: 60,0
Dosis: 5
Route/Site: SYR / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

COVID-19 Exposure to SARS-CoV-2 Rhinorrhoea SARS-CoV-2 test negative SARS-CoV-2 test positive Throat irritation

Symptomtext

11/11/2022 I had been exposed to COVID. I started with a tickle in my throat on November 11, 2022. I tested negative for COVID on 11/11/22 and 11/12/22. I tested on 11/13/22 and tested positive. On 11/13/22 I did a telehealth with a doctor. I then texted with my PCP to ask what she felt about me taking PAXLOVID. She ordered it and I started taking it that evening. I had no symptoms. On day 10 after the positive test, I tested for COVID, and I was negative. I was negative for three days. Then I tested again on Day 14 and, I was positive. It was 10 days after that before I tested negative again. I did have a slight runny nose for one day. I have totally recovered.

Weitere VAERSDATA-Felder

Praegender Schweregrund: COVID-19
Hospital-Tage: -
Labordaten: Home COVID tests, positive and negative
Aktuelle Erkrankungen: None
Vorgeschichte: Bladder cancer in remission
Andere Medikamente: Atorvastatin; lisinopril; vitamin D3; calcium
Allergien: Penicillin; BACTRIM; ZITHROMAX; COMPAZINE
Vorherige Impfungen: Flu shot, my arm became swollen, sore, red and hot for a couple of days.

VAERS 2528227

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7143C

gering

Staat: LA
Alter: 74,0
Geschlecht: F
Eingang: 09.12.2022
Impfdatum: 08.09.2022
Beginn: 28.11.2022
Tage bis Beginn: 81,0
Dosis: 5
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

COVID-19 Cough Nasal congestion SARS-CoV-2 test positive Sinus disorder

Symptomtext

I had nasal congestion and a cough. I took a COVID-19 test at home and it was positive. I talked to my doctor and because my symptoms were so mild, he did not prescribe me anything. My doctor checked on me everyday to log my symptoms. I checked my fever for 6 days, but I did not have fever. My doctor told me to try to stay away from people for a couple of weeks because I still may have COVID-19 particles. I am still having sinus issues.

Weitere VAERSDATA-Felder

Praegender Schweregrund: COVID-19
Hospital-Tage: -
Labordaten: COVID-19 test, positive, 11/28/2022
Aktuelle Erkrankungen: N/A
Vorgeschichte: Heart Patient; Crohn's Disease
Andere Medikamente: Vitamin D3; aspirin; ZYRTEC; LIPITOR; TOPROL; NORVASC; PROTONIX; calcium; ZETIA; alendronate
Allergien: Codeine
Vorherige Impfungen: -

VAERS 2528170

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge AS7143C

gering

Staat: -
Alter: 76,0
Geschlecht: U
Eingang: 09.12.2022
Impfdatum: 06.09.2022
Beginn: -
Tage bis Beginn: -
Dosis: UNK
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Extra dose administered No adverse event

Symptomtext

Moderna Covid-19 vaccine, bivalent received; No Adverse event; This spontaneous case was reported by a patient and describes the occurrence of EXTRA DOSE ADMINISTERED (Moderna Covid-19 vaccine, bivalent received) and NO ADVERSE EVENT (No Adverse event) in a 76-year-old patient of an unknown gender who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch nos. 059S22A and AS7143C) for COVID-19 prophylaxis. No Medical History information was reported. On 06-Sep-2022, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On 03-Dec-2022, received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) dosage was changed to .5 milliliter. On an unknown date, the patient experienced EXTRA DOSE ADMINISTERED (Moderna Covid-19 vaccine, bivalent received) and NO ADVERSE EVENT (No Adverse event). At the time of the report, EXTRA DOSE ADMINISTERED (Moderna Covid-19 vaccine, bivalent received) was resolving and NO ADVERSE EVENT (No Adverse event) outcome was unknown. For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No Adverse event) to be not related. No further causality assessment was provided for EXTRA DOSE ADMINISTERED (Moderna Covid-19 vaccine, bivalent received). No relevant concomitant medications were reported. No treatment information was provided.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Extra dose administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2527869

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7143C

gering

Staat: GA
Alter: 72,0
Geschlecht: F
Eingang: 09.12.2022
Impfdatum: 08.09.2022
Beginn: 09.11.2022
Tage bis Beginn: 62,0
Dosis: 4
Route/Site: SYR / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Cough Nasal discomfort Productive cough Pulmonary function test normal Sinusitis Throat irritation

Symptomtext

I have had a cough that has gotten deeper that has a lot of phlegm that causes nasal irritation and throat irritation my doctor thinks I have a sinus infection and prescribed prednisone and an amoxiclav.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Cough
Hospital-Tage: -
Labordaten: Lung function test result normal.
Aktuelle Erkrankungen: None
Vorgeschichte: Lupus anti coagulant; Sarcoidosis; Cervical Myelopathy; High Blood Pressure; Obesity; Elevated liver enzymes
Andere Medikamente: Pregabalin; atorvastatin; amlodipine; phentermine; levothyroxine; XARELTO; OZEMPIC; melatonin; ZYRTEC; probiotic
Allergien: NEOSPORIN; POLYSPORIN
Vorherige Impfungen: -

VAERS 2527436

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7143C

gering

Staat: CO
Alter: 11,0
Geschlecht: M
Eingang: 08.12.2022
Impfdatum: 14.11.2022
Beginn: 14.11.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Incorrect dose administered

Symptomtext

Pt received 0.5 ml instead of 0.25 ml based on age

Weitere VAERSDATA-Felder

Praegender Schweregrund: Incorrect dose administered
Hospital-Tage: -
Labordaten: na
Aktuelle Erkrankungen: na
Vorgeschichte: na
Andere Medikamente: na
Allergien: na
Vorherige Impfungen: -

VAERS 2519872

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7143C

gering

Staat: AR
Alter: 58,0
Geschlecht: M
Eingang: 30.11.2022
Impfdatum: 09.09.2022
Beginn: 28.11.2022
Tage bis Beginn: 80,0
Dosis: 5
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein

COVID-19 SARS-CoV-2 test positive

Symptomtext

hospitalized with covid; fully vaccinated with 3 boosters

Weitere VAERSDATA-Felder

Praegender Schweregrund: COVID-19
Hospital-Tage: -
Labordaten: positive covid pcr 11/27/22
Aktuelle Erkrankungen: unkown
Vorgeschichte: DM2, CHF, Obesity
Andere Medikamente: unknown
Allergien: codeine
Vorherige Impfungen: -

VAERS 2519571

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge AS7143C

gering

Staat: MN
Alter: 4,0
Geschlecht: F
Eingang: 30.11.2022
Impfdatum: 25.11.2022
Beginn: 25.11.2022
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

No adverse event Product administered to patient of inappropriate age Wrong product administered

Symptomtext

No adverse event; A toddler received as a first dose a 0.25ml adult formula bivalent vaccine; A toddler received as a first dose a 0.25ml adult formula bivalent vaccine; This spontaneous case was reported by a pharmacist and describes the occurrence of WRONG PRODUCT ADMINISTERED (A toddler received as a first dose a 0.25ml adult formula bivalent vaccine), PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (A toddler received as a first dose a 0.25ml adult formula bivalent vaccine) and NO ADVERSE EVENT (No adverse event) in a 4-year-old female patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. AS7143C) for COVID-19 prophylaxis. No Medical History information was reported. On 25-Nov-2022, the patient received first dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) .25 milliliter. On 25-Nov-2022, the patient experienced WRONG PRODUCT ADMINISTERED (A toddler received as a first dose a 0.25ml adult formula bivalent vaccine) and PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (A toddler received as a first dose a 0.25ml adult formula bivalent vaccine). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, WRONG PRODUCT ADMINISTERED (A toddler received as a first dose a 0.25ml adult formula bivalent vaccine), PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (A toddler received as a first dose a 0.25ml adult formula bivalent vaccine) and NO ADVERSE EVENT (No adverse event) outcome was unknown. The action taken with mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown) was unknown. For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for WRONG PRODUCT ADMINISTERED (A toddler received as a first dose a 0.25ml adult formula bivalent vaccine) and PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (A toddler received as a first dose a 0.25ml adult formula bivalent vaccine). No concomitant medications were reported. No treatment medications were reported.

Weitere VAERSDATA-Felder

Praegender Schweregrund: No adverse event
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2513866

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7143C

gering

Staat: AR
Alter: 82,0
Geschlecht: F
Eingang: 22.11.2022
Impfdatum: 14.09.2022
Beginn: 18.11.2022
Tage bis Beginn: 65,0
Dosis: 5
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: ja

COVID-19 SARS-CoV-2 test positive

Symptomtext

hospitalized with covid; fully vaccinated with 3 boosters

Weitere VAERSDATA-Felder

Praegender Schweregrund: COVID-19
Hospital-Tage: 2,0
Labordaten: positive covid pcr 11/18/22
Aktuelle Erkrankungen: unknown
Vorgeschichte: Coronary Artery Disease, Hyperlipidemia, Thyroid (hypothyroidism) and Other (pacemaker )
Andere Medikamente: unknown
Allergien: Sulfa, Demerol, Morphine, Pneumococcal vaccine
Vorherige Impfungen: -

VAERS 2509175

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge AS7143C

gering

Staat: PA
Alter: 84,0
Geschlecht: M
Eingang: 16.11.2022
Impfdatum: 16.09.2022
Beginn: 08.11.2022
Tage bis Beginn: 53,0
Dosis: 5
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

COVID-19 SARS-CoV-2 test

Symptomtext

COVID-19/sore throat and coughing a lot in bed and so forth; This spontaneous case was reported by a patient family member or friend and describes the occurrence of COVID-19 (COVID-19/sore throat and coughing a lot in bed and so forth) in an 84-year-old male patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. AS7143C) for COVID-19 vaccination. Patient had no Allergies. Previously administered products included for Product used for unknown indication: Flu vaccine (Flu yearly around the same time as with the reporter). Past adverse reactions to the above products included No adverse event with Flu vaccine. Concurrent medical conditions included Hypertension and AFib. Concomitant products included APIXABAN (ELIQUIS) for an unknown indication. On 16-Sep-2022, the patient received fifth dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On 08-Nov-2022, the patient experienced COVID-19 (COVID-19/sore throat and coughing a lot in bed and so forth). The patient was treated with NIRMATRELVIR, RITONAVIR (PAXLOVID) at an unspecified dose and frequency. At the time of the report, COVID-19 (COVID-19/sore throat and coughing a lot in bed and so forth) had not resolved. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 09-Nov-2022, SARS-CoV-2 test: Positive. Concomitant medications also includes high blood medications and other medications for male stuff. The patient received first dose on 26-Jan-2021 with lot number 030L20A, second dose on 23-Feb-2021 with lot number 031L20A, 1st booster dose on 3-Nov-2021 with lot number 032F21 and 2nd booster dose on 8-Apr-2022 with lot number 002M21A. It was reported that initially, patient had sore throat then on (08-Nov-2022) coughing a lot in bed and so forth and did a home test on 09-Nov-2022 and it came out positive. The AE did not cause patient to seek medical care. The patient does not experienced a similar event in the past. The symptoms were getting better. Patient was prescribed with Paxlovid. This case was linked to US-MODERNATX, INC.-MOD-2022-672556, US-MODERNATX, INC.-MOD-2022-672560 (E2B Linked Report).; Sender's Comments: US-MODERNATX, INC.-MOD-2022-672556:Wife's bivalent dose US-MODERNATX, INC.-MOD-2022-672560:Wife's second booster

Weitere VAERSDATA-Felder

Praegender Schweregrund: COVID-19
Hospital-Tage: -
Labordaten: Test Date: 20221109; Test Name: COVID-19 Test; Test Result: Positive
Aktuelle Erkrankungen: AFib; Hypertension
Vorgeschichte: Comments: Patient had no Allergies.
Andere Medikamente: ELIQUIS
Allergien: -
Vorherige Impfungen: -

VAERS 2493011

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge AS7143C

gering

Staat: OK
Alter: 65,0
Geschlecht: M
Eingang: 28.10.2022
Impfdatum: -
Beginn: -
Tage bis Beginn: -
Dosis: UNK
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Accidental underdose No adverse event

Symptomtext

No adverse event; Received 0.25 ml of bivalent dose; This spontaneous case was reported by a nurse and describes the occurrence of ACCIDENTAL UNDERDOSE (Received 0.25 ml of bivalent dose) and NO ADVERSE EVENT (No adverse event) in a 65-year-old male patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. AS7143C) for COVID-19 prophylaxis. No Medical History information was reported. In 2022, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) .25 milliliter. In 2022, the patient experienced ACCIDENTAL UNDERDOSE (Received 0.25 ml of bivalent dose). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, ACCIDENTAL UNDERDOSE (Received 0.25 ml of bivalent dose) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for ACCIDENTAL UNDERDOSE (Received 0.25 ml of bivalent dose). No concomitant medications were provided. Reporter saw that the dosage was changed to 0.5 ml. For the past month, reporter had been giving 0.25 ml. 19 patients received the half doses on 15-Sep-2022, 22-Sep-2022, 29-Sep-2022 and 06-Oct-2022. No treatment medication was provided. This case was linked to US-MODERNATX, INC.-MOD-2022-662961, US-MODERNATX, INC.-MOD-2022-662973, US-MODERNATX, INC.-MOD-2022-662974, US-MODERNATX, INC.-MOD-2022-663147 (E2B Linked Report).; Sender's Comments: US-MODERNATX, INC.-MOD-2022-662973:Same reporter US-MODERNATX, INC.-MOD-2022-662961:Same reporter US-MODERNATX, INC.-MOD-2022-663147:Same reporter US-MODERNATX, INC.-MOD-2022-662974:Same reporter

Weitere VAERSDATA-Felder

Praegender Schweregrund: Accidental underdose
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2492010

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge AS7143C

gering

Staat: OK
Alter: 31,0
Geschlecht: F
Eingang: 28.10.2022
Impfdatum: -
Beginn: -
Tage bis Beginn: -
Dosis: UNK
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Accidental underdose No adverse event

Symptomtext

No Adverse event; received 0.25 ml of bivalent dose; This spontaneous case was reported by a nurse and describes the occurrence of ACCIDENTAL UNDERDOSE (received 0.25 ml of bivalent dose) and NO ADVERSE EVENT (No Adverse event) in a 31-year-old female patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. AS7143C) for COVID-19 prophylaxis. No Medical History information was reported. In 2022, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) .25 milliliter. In 2022, the patient experienced ACCIDENTAL UNDERDOSE (received 0.25 ml of bivalent dose). On an unknown date, the patient experienced NO ADVERSE EVENT (No Adverse event). At the time of the report, ACCIDENTAL UNDERDOSE (received 0.25 ml of bivalent dose) and NO ADVERSE EVENT (No Adverse event) outcome was unknown. For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No Adverse event) to be not related. No further causality assessment was provided for ACCIDENTAL UNDERDOSE (received 0.25 ml of bivalent dose). No relevant concomitant medications were reported. Treatment medication was not provided by the reporter. This case was linked to MODERNATX, INC.-MOD-2022-662961, MODERNATX, INC.-MOD-2022-662973, MODERNATX, INC.-MOD-2022-662974 (E2B Linked Report).; Sender's Comments: MODERNATX, INC.-MOD-2022-662961:Same reporter MODERNATX, INC.-MOD-2022-662973:Same reporter MODERNATX, INC.-MOD-2022-662974:Same reporter

Weitere VAERSDATA-Felder

Praegender Schweregrund: Accidental underdose
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2492003

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge AS7143C

gering

Staat: OK
Alter: 49,0
Geschlecht: M
Eingang: 28.10.2022
Impfdatum: -
Beginn: -
Tage bis Beginn: -
Dosis: UNK
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Accidental underdose No adverse event

Symptomtext

No Adverse event; received 0.25 ml of bivalent dose; This spontaneous case was reported by a nurse and describes the occurrence of ACCIDENTAL UNDERDOSE (received 0.25 ml of bivalent dose) and NO ADVERSE EVENT (No Adverse event) in a 49-year-old male patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. AS7143C) for COVID-19 prophylaxis. No Medical History information was reported. In 2022, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) .25 milliliter. In 2022, the patient experienced ACCIDENTAL UNDERDOSE (received 0.25 ml of bivalent dose). On an unknown date, the patient experienced NO ADVERSE EVENT (No Adverse event). At the time of the report, ACCIDENTAL UNDERDOSE (received 0.25 ml of bivalent dose) and NO ADVERSE EVENT (No Adverse event) outcome was unknown. For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No Adverse event) to be not related. No further causality assessment was provided for ACCIDENTAL UNDERDOSE (received 0.25 ml of bivalent dose). No concomitant information was reported. It was reported that the dosage was changed to 0.5 ml. For the past month, nurse had been given 0.25 ml to 19 patients who received the half doses on 15-Sep-2022, 22-Sep-2022, 29-Sep-2022, and 06-Oct-2022. No treatment information was provided. This case was linked to US-MODERNATX, INC.-MOD-2022-662961, US-MODERNATX, INC.-MOD-2022-662973, US-MODERNATX, INC.-MOD-2022-662974 (E2B Linked Report).; Sender's Comments: US-MODERNATX, INC.-MOD-2022-662974:Same reporter US-MODERNATX, INC.-MOD-2022-662973:Same reporter US-MODERNATX, INC.-MOD-2022-662961:Same reporter

Weitere VAERSDATA-Felder

Praegender Schweregrund: Accidental underdose
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2491982

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge AS7143C

gering

Staat: OK
Alter: 33,0
Geschlecht: F
Eingang: 28.10.2022
Impfdatum: -
Beginn: -
Tage bis Beginn: -
Dosis: UNK
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Accidental underdose No adverse event

Symptomtext

No adverse event; received 0.25 ml of bivalent dose; This spontaneous case was reported by a nurse and describes the occurrence of ACCIDENTAL UNDERDOSE (received 0.25 ml of bivalent dose) and NO ADVERSE EVENT (No adverse event) in a 33-year-old female patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. AS7143C) for COVID-19 prophylaxis. No Medical History information was reported. In 2022, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) .25 milliliter. In 2022, the patient experienced ACCIDENTAL UNDERDOSE (received 0.25 ml of bivalent dose). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, ACCIDENTAL UNDERDOSE (received 0.25 ml of bivalent dose) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for ACCIDENTAL UNDERDOSE (received 0.25 ml of bivalent dose). Concomitant medications were not reported. It was reported that 19 patients received half doses on 15-Sep-2022, 22-Sep-2022, 29-Sep-2022 and 06-Oct-2022. For the past month, the reporter had been giving 0.25 ml dose instead of 0.5 ml dose of bivalent vaccine. Treatment information was not reported.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Accidental underdose
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2491981

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge AS7143C

gering

Staat: OK
Alter: 71,0
Geschlecht: F
Eingang: 28.10.2022
Impfdatum: -
Beginn: -
Tage bis Beginn: -
Dosis: UNK
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Accidental underdose No adverse event

Symptomtext

No adverse event; Received 0.25 ml of bivalent dose; This spontaneous case was reported by a nurse and describes the occurrence of ACCIDENTAL UNDERDOSE (Received 0.25 ml of bivalent dose) and NO ADVERSE EVENT (No adverse event) in a 71-year-old female patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. AS7143C) for COVID-19 prophylaxis. No Medical History information was reported. In 2022, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) .25 milliliter. In 2022, the patient experienced ACCIDENTAL UNDERDOSE (Received 0.25 ml of bivalent dose). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, ACCIDENTAL UNDERDOSE (Received 0.25 ml of bivalent dose) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for ACCIDENTAL UNDERDOSE (Received 0.25 ml of bivalent dose). No concomitant medications were provided. 19 patients who received the half doses on 15Sep2022, 22Sep2022, 29Sep2022, and 06Oct2022. This case was created for one of the 19 patients. No treatment medications were reported. This case was linked to US-MODERNATX, INC.-MOD-2022-662961, US-MODERNATX, INC.-MOD-2022-662973, US-MODERNATX, INC.-MOD-2022-662887, US-MODERNATX, INC.-MOD-2022-662970, US-MODERNATX, INC.-MOD-2022-662974, US-MODERNATX, INC.-MOD-2022-662991, US-MODERNATX, INC.-MOD-2022-663001, US-MODERNATX, INC.-MOD-2022-663009, US-MODERNATX, INC.-MOD-2022-663012, US-MODERNATX, INC.-MOD-2022-663015, US-MODERNATX, INC.-MOD-2022-663040, US-MODERNATX, INC.-MOD-2022-663041, US-MODERNATX, INC.-MOD-2022-663044, US-MODERNATX, INC.-MOD-2022-663045, US-MODERNATX, INC.-MOD-2022-663047, US-MODERNATX, INC.-MOD-2022-663091, US-MODERNATX, INC.-MOD-2022-663128, US-MODERNATX, INC.-MOD-2022-663137, US-MODERNATX, INC.-MOD-2022-663147, US-MODERNATX, INC.-MOD-2022-662974 (E2B Linked Report).; Sender's Comments: US-MODERNATX, INC.-MOD-2022-662973:Same reporter US-MODERNATX, INC.-MOD-2022-662961:Same reporter US-MODERNATX, INC.-MOD-2022-662887:Same reporter US-MODERNATX, INC.-MOD-2022-662970:Same reporter US-MODERNATX, INC.-MOD-2022-662974:Same reporter US-MODERNATX, INC.-MOD-2022-662991:Same reporter US-MODERNATX, INC.-MOD-2022-663001:Same reporter US-MODERNATX, INC.-MOD-2022-663009:Same reporter US-MODERNATX, INC.-MOD-2022-663012:Same reporter US-MODERNATX, INC.-MOD-2022-663015:Same reporter US-MODERNATX, INC.-MOD-2022-663040:Same reporter US-MODERNATX, INC.-MOD-2022-663041:Same reporter US-MODERNATX, INC.-MOD-2022-663044:Same reporter US-MODERNATX, INC.-MOD-2022-663045:Same reporter US-MODERNATX, INC.-MOD-2022-663047:Same reporter US-MODERNATX, INC.-MOD-2022-663091:Same reporter US-MODERNATX, INC.-MOD-2022-663128:Same reporter US-MODERNATX, INC.-MOD-2022-663137:Same reporter US-MODERNATX, INC.-MOD-2022-663147:Same reporter US-MODERNATX, INC.-MOD-2022-662974:Same reporter

Weitere VAERSDATA-Felder

Praegender Schweregrund: Accidental underdose
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2491700

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge AS7143C

gering

Staat: OK
Alter: 50,0
Geschlecht: F
Eingang: 27.10.2022
Impfdatum: -
Beginn: -
Tage bis Beginn: -
Dosis: UNK
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Accidental underdose No adverse event

Symptomtext

No Adverse event; Received 0.25 ml of bivalent dose instead of 0.5 ml; This spontaneous case was reported by an other health care professional and describes the occurrence of ACCIDENTAL UNDERDOSE (Received 0.25 ml of bivalent dose instead of 0.5 ml) and NO ADVERSE EVENT (No Adverse event) in a 50-year-old female patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. AS7143C) for COVID-19 prophylaxis. No Medical History information was reported. In 2022, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) .25 milliliter. In 2022, the patient experienced ACCIDENTAL UNDERDOSE (Received 0.25 ml of bivalent dose instead of 0.5 ml). On an unknown date, the patient experienced NO ADVERSE EVENT (No Adverse event). At the time of the report, ACCIDENTAL UNDERDOSE (Received 0.25 ml of bivalent dose instead of 0.5 ml) and NO ADVERSE EVENT (No Adverse event) outcome was unknown. For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No Adverse event) to be not related. No further causality assessment was provided for ACCIDENTAL UNDERDOSE (Received 0.25 ml of bivalent dose instead of 0.5 ml). No concomitant medications were provided. Reporter saw that the dosage was changed to 0.5 ml. For the past month, reporter had been giving 0.25 ml. 19 patients received the half doses on 15-Sep-2022, 22-Sep-2022, 29-Sep-2022 and 06-Oct-2022. No treatment medication was provided. This case was linked to US-MODERNATX, INC.-MOD-2022-662961, US-MODERNATX, INC.-MOD-2022-662973, US-MODERNATX, INC.-MOD-2022-662974, US-MODERNATX, INC.-MOD-2022-662887, US-MODERNATX, INC.-MOD-2022-662970, US-MODERNATX, INC.-MOD-2022-662991, US-MODERNATX, INC.-MOD-2022-663001, US-MODERNATX, INC.-MOD-2022-663009, US-MODERNATX, INC.-MOD-2022-663012, US-MODERNATX, INC.-MOD-2022-663015, US-MODERNATX, INC.-MOD-2022-663040, US-MODERNATX, INC.-MOD-2022-663041, US-MODERNATX, INC.-MOD-2022-663044, US-MODERNATX, INC.-MOD-2022-663045, US-MODERNATX, INC.-MOD-2022-663047, US-MODERNATX, INC.-MOD-2022-663091, US-MODERNATX, INC.-MOD-2022-663128, US-MODERNATX, INC.-MOD-2022-663137 (E2B Linked Report).; Sender's Comments: US-MODERNATX, INC.-MOD-2022-662974:Same reporter US-MODERNATX, INC.-MOD-2022-662973:Same reporter US-MODERNATX, INC.-MOD-2022-662961:Same reporter US-MODERNATX, INC.-MOD-2022-662887:Same reporter US-MODERNATX, INC.-MOD-2022-662970:Same reporter US-MODERNATX, INC.-MOD-2022-662991:Same reporter US-MODERNATX, INC.-MOD-2022-663001:Same reporter US-MODERNATX, INC.-MOD-2022-663009:Same reporter US-MODERNATX, INC.-MOD-2022-663012:Same reporter US-MODERNATX, INC.-MOD-2022-663015:Same reporter US-MODERNATX, INC.-MOD-2022-663040:Same reporter US-MODERNATX, INC.-MOD-2022-663041:Same reporter US-MODERNATX, INC.-MOD-2022-663044:Same reporter US-MODERNATX, INC.-MOD-2022-663045:Same reporter US-MODERNATX, INC.-MOD-2022-663047:Same reporter US-MODERNATX, INC.-MOD-2022-663091:Same reporter US-MODERNATX, INC.-MOD-2022-663128:Same reporter US-MODERNATX, INC.-MOD-2022-663137:Same reporter

Weitere VAERSDATA-Felder

Praegender Schweregrund: Accidental underdose
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2490799

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge AS7143C

gering

Staat: OK
Alter: 31,0
Geschlecht: M
Eingang: 27.10.2022
Impfdatum: -
Beginn: -
Tage bis Beginn: -
Dosis: UNK
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Accidental underdose No adverse event

Symptomtext

received 0.25 ml of bivalent dose; No Adverse event; This spontaneous case was reported by a nurse and describes the occurrence of ACCIDENTAL UNDERDOSE (received 0.25 ml of bivalent dose) and NO ADVERSE EVENT (No Adverse event) in a 31-year-old male patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. AS7143C) for COVID-19 prophylaxis. No Medical History information was reported. On an unknown date, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) .25 milliliter. On an unknown date, the patient experienced ACCIDENTAL UNDERDOSE (received 0.25 ml of bivalent dose) and NO ADVERSE EVENT (No Adverse event). At the time of the report, ACCIDENTAL UNDERDOSE (received 0.25 ml of bivalent dose) and NO ADVERSE EVENT (No Adverse event) outcome was unknown. For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No Adverse event) to be not related. No further causality assessment was provided for ACCIDENTAL UNDERDOSE (received 0.25 ml of bivalent dose). Concomitant medication was not provided. Nurse reported that 19 patients received the half doses on 15-Sep-2022, 22-Sep-2022, 29-Sep-2022, and 06-Oct-2022. Treatment information was not provided. This case was linked to US-MODERNATX, INC.-MOD-2022-662961, US-MODERNATX, INC.-MOD-2022-662973 (E2B Linked Report).; Sender's Comments: US-MODERNATX, INC.-MOD-2022-662973:Same reporter US-MODERNATX, INC.-MOD-2022-662961:Same reporter

Weitere VAERSDATA-Felder

Praegender Schweregrund: Accidental underdose
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2490798

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge AS7143C

gering

Staat: OK
Alter: 60,0
Geschlecht: M
Eingang: 27.10.2022
Impfdatum: -
Beginn: -
Tage bis Beginn: -
Dosis: UNK
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Accidental underdose No adverse event

Symptomtext

No Adverse event; received 0.25 ml of bivalent dose; This spontaneous case was reported by a nurse and describes the occurrence of ACCIDENTAL UNDERDOSE (received 0.25 ml of bivalent dose) and NO ADVERSE EVENT (No Adverse event) in a 60-year-old male patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. AS7143C) for COVID-19 prophylaxis. No Medical History information was reported. In 2022, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) .25 milliliter. In 2022, the patient experienced ACCIDENTAL UNDERDOSE (received 0.25 ml of bivalent dose). On an unknown date, the patient experienced NO ADVERSE EVENT (No Adverse event). At the time of the report, ACCIDENTAL UNDERDOSE (received 0.25 ml of bivalent dose) and NO ADVERSE EVENT (No Adverse event) outcome was unknown. For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No Adverse event) to be not related. No further causality assessment was provided for ACCIDENTAL UNDERDOSE (received 0.25 ml of bivalent dose). No concomitant medication were reported. The nurse reported that for the past month, a total of 19 patients received the half doses of Bivalent on 15-Sep-2022, 22-Sep-2022, 29-Sep-2022 and 06-Oct-2022, instead of 0.5 ml. No treatment information was provided by the reporter.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Accidental underdose
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2490797

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge AS7143C

gering

Staat: OK
Alter: 41,0
Geschlecht: M
Eingang: 27.10.2022
Impfdatum: -
Beginn: -
Tage bis Beginn: -
Dosis: UNK
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Accidental underdose No adverse event

Symptomtext

No Adverse event; received 0.25 ml of bivalent dose; This spontaneous case was reported by a nurse and describes the occurrence of ACCIDENTAL UNDERDOSE (received 0.25 ml of bivalent dose) and NO ADVERSE EVENT (No Adverse event) in a 41-year-old male patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. AS7143C) for COVID-19 prophylaxis. No Medical History information was reported. In 2022, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) .25 milliliter. In 2022, the patient experienced ACCIDENTAL UNDERDOSE (received 0.25 ml of bivalent dose). On an unknown date, the patient experienced NO ADVERSE EVENT (No Adverse event). At the time of the report, ACCIDENTAL UNDERDOSE (received 0.25 ml of bivalent dose) and NO ADVERSE EVENT (No Adverse event) outcome was unknown. For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No Adverse event) to be not related. No further causality assessment was provided for ACCIDENTAL UNDERDOSE (received 0.25 ml of bivalent dose). No concomitant medications were reported. It was reported that reporter was giving 0.25 ml instead of 0.5 ml of Moderna bivalent vaccine. Reported that 19 patients received the half doses on 15 Sep 2022, 22 Sep 2022, 29 Sep 2022, and 06 Oct 2022. No treatment medications were reported. This case was linked to MODERNATX, INC.-MOD-2022-662961, MODERNATX, INC.-MOD-2022-662973 (E2B Linked Report).; Sender's Comments: MODERNATX, INC.-MOD-2022-662961:Same reporter MODERNATX, INC.-MOD-2022-662973:Same reporter

Weitere VAERSDATA-Felder

Praegender Schweregrund: Accidental underdose
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2490796

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge AS7143C

gering

Staat: OK
Alter: 61,0
Geschlecht: M
Eingang: 27.10.2022
Impfdatum: -
Beginn: -
Tage bis Beginn: -
Dosis: UNK
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Accidental underdose No adverse event

Symptomtext

No Adverse event; Patient received 0.25 ml of bivalent dose; This spontaneous case was reported by a nurse and describes the occurrence of ACCIDENTAL UNDERDOSE (Patient received 0.25 ml of bivalent dose) and NO ADVERSE EVENT (No Adverse event) in a 61-year-old male patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. AS7143C) for COVID-19 prophylaxis. No Medical History information was reported. In 2022, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) .25 milliliter. In 2022, the patient experienced ACCIDENTAL UNDERDOSE (Patient received 0.25 ml of bivalent dose). On an unknown date, the patient experienced NO ADVERSE EVENT (No Adverse event). At the time of the report, ACCIDENTAL UNDERDOSE (Patient received 0.25 ml of bivalent dose) and NO ADVERSE EVENT (No Adverse event) outcome was unknown. For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No Adverse event) to be not related. No further causality assessment was provided for ACCIDENTAL UNDERDOSE (Patient received 0.25 ml of bivalent dose). No concomitant medications were reported. Reporter saw that the dosage was changed to 0.5 ml. For the past month, reporter had been giving 0.25 ml. 19 patients received the half doses on 15-Sep-2022, 22-Sep-2022, 29-Sep-2022 and 06-Oct-2022. No treatment information was provided.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Accidental underdose
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2490795

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge AS7143C

gering

Staat: OK
Alter: 64,0
Geschlecht: F
Eingang: 27.10.2022
Impfdatum: -
Beginn: -
Tage bis Beginn: -
Dosis: UNK
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Accidental underdose No adverse event

Symptomtext

No Adverse event; received 0.25 ml of bivalent dose; This spontaneous case was reported by a nurse and describes the occurrence of ACCIDENTAL UNDERDOSE (received 0.25 ml of bivalent dose) and NO ADVERSE EVENT (No Adverse event) in a 64-year-old female patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. AS7143C) for COVID-19 prophylaxis. No Medical History information was reported. In 2022, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) .25 milliliter. In 2022, the patient experienced ACCIDENTAL UNDERDOSE (received 0.25 ml of bivalent dose). On an unknown date, the patient experienced NO ADVERSE EVENT (No Adverse event). At the time of the report, ACCIDENTAL UNDERDOSE (received 0.25 ml of bivalent dose) and NO ADVERSE EVENT (No Adverse event) outcome was unknown. For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No Adverse event) to be not related. No further causality assessment was provided for ACCIDENTAL UNDERDOSE (received 0.25 ml of bivalent dose). Concomitant medication was not reported. Nurse reported that 19 patients received the half doses on 15-Sep-2022, 22-Sep-2022, 29-Sep-2022, and 06-Oct-2022. Treatment information was not reported. This case was linked to US-MODERNATX, INC.-MOD-2022-662961, US-MODERNATX, INC.-MOD-2022-662973 (E2B Linked Report).; Sender's Comments: US-MODERNATX, INC.-MOD-2022-662973:Same reporter US-MODERNATX, INC.-MOD-2022-662961:Same reporter

Weitere VAERSDATA-Felder

Praegender Schweregrund: Accidental underdose
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2490794

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge AS7143C

gering

Staat: OK
Alter: 59,0
Geschlecht: F
Eingang: 27.10.2022
Impfdatum: -
Beginn: -
Tage bis Beginn: -
Dosis: UNK
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Accidental underdose No adverse event

Symptomtext

received 0.25 ml of bivalent dose; No Adverse event; This spontaneous case was reported by a nurse and describes the occurrence of ACCIDENTAL UNDERDOSE (received 0.25 ml of bivalent dose) and NO ADVERSE EVENT (No Adverse event) in a 59-year-old female patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. AS7143C) for COVID-19 prophylaxis. No Medical History information was reported. On an unknown date, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) .25 milliliter. On an unknown date, the patient experienced ACCIDENTAL UNDERDOSE (received 0.25 ml of bivalent dose) and NO ADVERSE EVENT (No Adverse event). At the time of the report, ACCIDENTAL UNDERDOSE (received 0.25 ml of bivalent dose) and NO ADVERSE EVENT (No Adverse event) outcome was unknown. For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No Adverse event) to be not related. No further causality assessment was provided for ACCIDENTAL UNDERDOSE (received 0.25 ml of bivalent dose). No concomitant medications were reported. Reported that reporter was giving 0.25 ml instead of 0.5 ml of Moderna bivalent vaccine. Reported that 19 patients received the half doses on 15Sep2022, 22Sep2022, 29Sep2022, and 06Oct2022. No treatment medications were reported. This case was linked to US-MODERNATX, INC.-MOD-2022-662961 (E2B Linked Report).; Sender's Comments: US-MODERNATX, INC.-MOD-2022-662961:Same reporter

Weitere VAERSDATA-Felder

Praegender Schweregrund: Accidental underdose
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2490792

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge AS7143C

gering

Staat: OK
Alter: 22,0
Geschlecht: M
Eingang: 27.10.2022
Impfdatum: -
Beginn: -
Tage bis Beginn: -
Dosis: UNK
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Accidental underdose No adverse event

Symptomtext

No Adverse event; received 0.25 ml of bivalent dose; This spontaneous case was reported by a nurse and describes the occurrence of ACCIDENTAL UNDERDOSE (received 0.25 ml of bivalent dose) and NO ADVERSE EVENT (No Adverse event) in a 22-year-old male patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. AS7143C) for COVID-19 prophylaxis. No Medical History information was reported. In 2022, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) .25 milliliter. In 2022, the patient experienced ACCIDENTAL UNDERDOSE (received 0.25 ml of bivalent dose). On an unknown date, the patient experienced NO ADVERSE EVENT (No Adverse event). At the time of the report, ACCIDENTAL UNDERDOSE (received 0.25 ml of bivalent dose) and NO ADVERSE EVENT (No Adverse event) outcome was unknown. For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No Adverse event) to be not related. No further causality assessment was provided for ACCIDENTAL UNDERDOSE (received 0.25 ml of bivalent dose). Concomitant drugs were not reported. It was reported that 19 patients received the half doses on 15-Sep-2022, 22-Sep-2022, 29-Sep-2022 and 06-Oct-2022. For the past month, reporter had been giving 0.25 ml instead of 0.5 ml. Treatment medications were not provided. This case was linked to US-MODERNATX, INC.-MOD-2022-662961, US-MODERNATX, INC.-MOD-2022-662973 (Linked Report).; Sender's Comments: US-MODERNATX, INC.-MOD-2022-662973:Same reporter US-MODERNATX, INC.-MOD-2022-662961:Same reporter

Weitere VAERSDATA-Felder

Praegender Schweregrund: Accidental underdose
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2490790

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge AS7143C

gering

Staat: OK
Alter: -
Geschlecht: F
Eingang: 27.10.2022
Impfdatum: -
Beginn: -
Tage bis Beginn: -
Dosis: UNK
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Accidental underdose No adverse event

Symptomtext

No Adverse event; received 0.25 ml of bivalent dose; This spontaneous case was reported by a nurse and describes the occurrence of ACCIDENTAL UNDERDOSE (received 0.25 ml of bivalent dose) and NO ADVERSE EVENT (No Adverse event) in an adult female patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. AS7143C) for COVID-19 prophylaxis. No Medical History information was reported. In 2022, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) .25 milliliter. In 2022, the patient experienced ACCIDENTAL UNDERDOSE (received 0.25 ml of bivalent dose). On an unknown date, the patient experienced NO ADVERSE EVENT (No Adverse event). At the time of the report, ACCIDENTAL UNDERDOSE (received 0.25 ml of bivalent dose) and NO ADVERSE EVENT (No Adverse event) outcome was unknown. For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No Adverse event) to be not related. No further causality assessment was provided for ACCIDENTAL UNDERDOSE (received 0.25 ml of bivalent dose). No concomitant medications were reported. Reporter saw that the dosage was changed to 0.5 ml. For the past month, reporter had been giving 0.25 ml. 19 patients received the half doses on 15-Sep-2022, 22-Sep-2022, 29-Sep-2022 and 06-Oct-2022. No treatment information was provided. This case was linked to US-MODERNATX, INC.-MOD-2022-662961, US-MODERNATX, INC.-MOD-2022-662973 (E2B Linked Report).; Sender's Comments: US-MODERNATX, INC.-MOD-2022-662973:Same reporter US-MODERNATX, INC.-MOD-2022-662961:Same reporter

Weitere VAERSDATA-Felder

Praegender Schweregrund: Accidental underdose
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2490787

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge AS7143C

gering

Staat: OK
Alter: 36,0
Geschlecht: F
Eingang: 27.10.2022
Impfdatum: -
Beginn: -
Tage bis Beginn: -
Dosis: UNK
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Accidental underdose No adverse event

Symptomtext

No Adverse event; received 0.25 ml of bivalent dose; This spontaneous case was reported by a nurse and describes the occurrence of ACCIDENTAL UNDERDOSE (received 0.25 ml of bivalent dose) and NO ADVERSE EVENT (No Adverse event) in a 36-year-old female patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. AS7143C) for COVID-19 prophylaxis. No Medical History information was reported. In 2022, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) .25 milliliter. In 2022, the patient experienced ACCIDENTAL UNDERDOSE (received 0.25 ml of bivalent dose). On an unknown date, the patient experienced NO ADVERSE EVENT (No Adverse event). At the time of the report, ACCIDENTAL UNDERDOSE (received 0.25 ml of bivalent dose) and NO ADVERSE EVENT (No Adverse event) outcome was unknown. For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No Adverse event) to be not related. No further causality assessment was provided for ACCIDENTAL UNDERDOSE (received 0.25 ml of bivalent dose). No concomitant information was reported. It was reported that the dosage was changed to 0.5 ml. For the past month, nurse had been given 0.25 ml to 19 patients who received the half doses on 15-Sep-2022, 22-Sep-2022, 29-Sep-2022, and 06-Oct-2022. No treatment information was provided. This case was linked to MODERNATX, INC.-MOD-2022-662961, MODERNATX, INC.-MOD-2022-662973 (E2B Linked Report).; Sender's Comments: MODERNATX, INC.-MOD-2022-662973:Same reporter MODERNATX, INC.-MOD-2022-662961:Same reporter

Weitere VAERSDATA-Felder

Praegender Schweregrund: Accidental underdose
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2490786

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge AS7143C

gering

Staat: OK
Alter: 35,0
Geschlecht: F
Eingang: 27.10.2022
Impfdatum: -
Beginn: -
Tage bis Beginn: -
Dosis: UNK
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Accidental underdose No adverse event

Symptomtext

No Adverse event; Received 0.25 ml of bivalent dose; This spontaneous case was reported by a nurse and describes the occurrence of ACCIDENTAL UNDERDOSE (Received 0.25 ml of bivalent dose) and NO ADVERSE EVENT (No Adverse event) in a 35-year-old female patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. AS7143C) for COVID-19 prophylaxis. No Medical History information was reported. In 2022, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) .25 milliliter. In 2022, the patient experienced ACCIDENTAL UNDERDOSE (Received 0.25 ml of bivalent dose). On an unknown date, the patient experienced NO ADVERSE EVENT (No Adverse event). At the time of the report, ACCIDENTAL UNDERDOSE (Received 0.25 ml of bivalent dose) and NO ADVERSE EVENT (No Adverse event) outcome was unknown. For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No Adverse event) to be not related. No further causality assessment was provided for ACCIDENTAL UNDERDOSE (Received 0.25 ml of bivalent dose). No concomitant medications were provided. Reporter saw that the dosage was changed to 0.5 ml. For the past month, reporter had been giving 0.25 ml. 19 patients received the half doses on 15-Sep-2022, 22-Sep-2022, 29-Sep-2022 and 06-Oct-2022. No treatment medication was provided. This case was linked to US-MODERNATX, INC.-MOD-2022-662961, US-MODERNATX, INC.-MOD-2022-662887, US-MODERNATX, INC.-MOD-2022-662970, US-MODERNATX, INC.-MOD-2022-662974, US-MODERNATX, INC.-MOD-2022-662991, US-MODERNATX, INC.-MOD-2022-663001, US-MODERNATX, INC.-MOD-2022-663009, US-MODERNATX, INC.-MOD-2022-663012, US-MODERNATX, INC.-MOD-2022-663015, US-MODERNATX, INC.-MOD-2022-663040, US-MODERNATX, INC.-MOD-2022-663041, US-MODERNATX, INC.-MOD-2022-663044, US-MODERNATX, INC.-MOD-2022-663045, US-MODERNATX, INC.-MOD-2022-663091, US-MODERNATX, INC.-MOD-2022-663128, US-MODERNATX, INC.-MOD-2022-663137, US-MODERNATX, INC.-MOD-2022-663147 (E2B Linked Report).; Sender's Comments: US-MODERNATX, INC.-MOD-2022-662961:Same reporter US-MODERNATX, INC.-MOD-2022-662887:Same reporter US-MODERNATX, INC.-MOD-2022-662970:Same reporter US-MODERNATX, INC.-MOD-2022-662974:Same reporter US-MODERNATX, INC.-MOD-2022-662991:Same reporter US-MODERNATX, INC.-MOD-2022-663001:Same reporter US-MODERNATX, INC.-MOD-2022-663009:Same reporter US-MODERNATX, INC.-MOD-2022-663012:Same reporter US-MODERNATX, INC.-MOD-2022-663015:Same reporter US-MODERNATX, INC.-MOD-2022-663040:Same reporter US-MODERNATX, INC.-MOD-2022-663041:Same reporter US-MODERNATX, INC.-MOD-2022-663044:Same reporter US-MODERNATX, INC.-MOD-2022-663045:Same reporter US-MODERNATX, INC.-MOD-2022-663091:Same reporter US-MODERNATX, INC.-MOD-2022-663128:Same reporter US-MODERNATX, INC.-MOD-2022-663137:Same reporter US-MODERNATX, INC.-MOD-2022-663147:Same reporter

Weitere VAERSDATA-Felder

Praegender Schweregrund: Accidental underdose
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2490785

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge AS7143C

gering

Staat: OK
Alter: 29,0
Geschlecht: M
Eingang: 27.10.2022
Impfdatum: -
Beginn: -
Tage bis Beginn: -
Dosis: UNK
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Accidental underdose No adverse event

Symptomtext

No Adverse event; Received 0.25 ml of bivalent dose; This spontaneous case was reported by a nurse and describes the occurrence of ACCIDENTAL UNDERDOSE (Received 0.25 ml of bivalent dose) and NO ADVERSE EVENT (No Adverse event) in a 29-year-old male patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. AS7143C) for COVID-19 prophylaxis. No Medical History information was reported. In 2022, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) .25 milliliter. In 2022, the patient experienced ACCIDENTAL UNDERDOSE (Received 0.25 ml of bivalent dose). On an unknown date, the patient experienced NO ADVERSE EVENT (No Adverse event). At the time of the report, ACCIDENTAL UNDERDOSE (Received 0.25 ml of bivalent dose) and NO ADVERSE EVENT (No Adverse event) outcome was unknown. For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No Adverse event) to be not related. No further causality assessment was provided for ACCIDENTAL UNDERDOSE (Received 0.25 ml of bivalent dose). No concomitant medications were provided. Reporter saw that the dosage was changed to 0.5 ml. For the past month, reporter had been giving 0.25 ml. 19 patients received the half doses on 15-Sep-2022, 22-Sep-2022, 29-Sep-2022 and 06-Oct-2022. No treatment medication was provided. This case was linked to US-MODERNATX, INC.-MOD-2022-662887, US-MODERNATX, INC.-MOD-2022-662970, US-MODERNATX, INC.-MOD-2022-662973, US-MODERNATX, INC.-MOD-2022-662974, US-MODERNATX, INC.-MOD-2022-662991, US-MODERNATX, INC.-MOD-2022-663001, US-MODERNATX, INC.-MOD-2022-663009, US-MODERNATX, INC.-MOD-2022-663012, US-MODERNATX, INC.-MOD-2022-663015, US-MODERNATX, INC.-MOD-2022-663040, US-MODERNATX, INC.-MOD-2022-663041, US-MODERNATX, INC.-MOD-2022-663044, US-MODERNATX, INC.-MOD-2022-663045, US-MODERNATX, INC.-MOD-2022-663047, US-MODERNATX, INC.-MOD-2022-663091, US-MODERNATX, INC.-MOD-2022-663128, US-MODERNATX, INC.-MOD-2022-663137, US-MODERNATX, INC.-MOD-2022-663147 (E2B Linked Report).; Sender's Comments: US-MODERNATX, INC.-MOD-2022-662887:Same reporter US-MODERNATX, INC.-MOD-2022-662970:Same reporter US-MODERNATX, INC.-MOD-2022-662973:Same reporter US-MODERNATX, INC.-MOD-2022-662974:Same reporter US-MODERNATX, INC.-MOD-2022-662991:Same reporter US-MODERNATX, INC.-MOD-2022-663001:Same reporter US-MODERNATX, INC.-MOD-2022-663009:Same reporter US-MODERNATX, INC.-MOD-2022-663012:Same reporter US-MODERNATX, INC.-MOD-2022-663015:Same reporter US-MODERNATX, INC.-MOD-2022-663040:Same reporter US-MODERNATX, INC.-MOD-2022-663041:Same reporter US-MODERNATX, INC.-MOD-2022-663044:Same reporter US-MODERNATX, INC.-MOD-2022-663045:Same reporter US-MODERNATX, INC.-MOD-2022-663091:Same reporter US-MODERNATX, INC.-MOD-2022-663128:Same reporter US-MODERNATX, INC.-MOD-2022-663137:Same reporter US-MODERNATX, INC.-MOD-2022-663147:Same reporter

Weitere VAERSDATA-Felder

Praegender Schweregrund: Accidental underdose
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2490781

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge AS7143C

gering

Staat: OK
Alter: 37,0
Geschlecht: M
Eingang: 27.10.2022
Impfdatum: -
Beginn: -
Tage bis Beginn: -
Dosis: UNK
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Accidental underdose No adverse event

Symptomtext

No Adverse event; received 0.25 ml of bivalent dose; This spontaneous case was reported by a nurse and describes the occurrence of ACCIDENTAL UNDERDOSE (received 0.25 ml of bivalent dose) and NO ADVERSE EVENT (No Adverse event) in a 37-year-old male patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. AS7143C) for COVID-19 prophylaxis. No Medical History information was reported. In 2022, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) .25 milliliter. In 2022, the patient experienced ACCIDENTAL UNDERDOSE (received 0.25 ml of bivalent dose). On an unknown date, the patient experienced NO ADVERSE EVENT (No Adverse event). At the time of the report, ACCIDENTAL UNDERDOSE (received 0.25 ml of bivalent dose) and NO ADVERSE EVENT (No Adverse event) outcome was unknown. For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No Adverse event) to be not related. No further causality assessment was provided for ACCIDENTAL UNDERDOSE (received 0.25 ml of bivalent dose). No concomitant information was reported. It was reported that the dosage was changed to 0.5 ml. For the past month, nurse had been given 0.25 ml to 19 patients who received the half doses on 15-Sep-2022, 22-Sep-2022, 29-Sep-2022, and 06-Oct-2022. No treatment information was provided. This case was linked to US-MODERNATX, INC.-MOD-2022-662961, US-MODERNATX, INC.-MOD-2022-662973 (E2B Linked Report).; Sender's Comments: US-MODERNATX, INC.-MOD-2022-662973:Same reporter US-MODERNATX, INC.-MOD-2022-662961:Same reporter

Weitere VAERSDATA-Felder

Praegender Schweregrund: Accidental underdose
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2490080

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7143C

gering

Staat: CA
Alter: 61,0
Geschlecht: M
Eingang: 26.10.2022
Impfdatum: 19.09.2022
Beginn: 27.09.2022
Tage bis Beginn: 8,0
Dosis: 5
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Dry eye Ophthalmological examination Scan Vision blurred

Symptomtext

Very Dry Eyes, predominantly the right eye. Blurry vision in right eye that hasn't fully come back into focus although seems to be better each day.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Dry eye
Hospital-Tage: -
Labordaten: Eye Doctor did retinal scan and did a visual exam of my eyes. Recommended artificial tears and gel eye drops at night.
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: Penicillin
Vorherige Impfungen: -

VAERS 2489572

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge AS7143C

gering

Staat: -
Alter: -
Geschlecht: U
Eingang: 26.10.2022
Impfdatum: 18.09.2022
Beginn: 22.10.2022
Tage bis Beginn: 34,0
Dosis: 5
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

COVID-19 SARS-CoV-2 test

Symptomtext

tested positive for Covid yesterday; This spontaneous case was reported by a patient and describes the occurrence of COVID-19 (tested positive for Covid yesterday) in a patient of an unknown age and gender who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. AS7143C) for COVID-19 prophylaxis. The patient's past medical history included COVID-19 and COVID-19. On 18-Sep-2022, the patient received fifth dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On 22-Oct-2022, the patient experienced COVID-19 (tested positive for Covid yesterday). At the time of the report, COVID-19 (tested positive for Covid yesterday) outcome was unknown. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 22-Oct-2022, SARS-CoV-2 test: (Positive) Positive and (Positive) Positive. On 23-Oct-2022, SARS-CoV-2 test: (Positive) Positive. Concomitant drugs were not reported. It was reported that patient had total 5 doses and all was of Moderna. It was also reported that for patient it was the third time of COVID infection, most recent being the second time in 5 months. Patient was isolating at home with chest tightness, sneezing, congestion, runny nose, headache, fatigue and dull sense of taste. Patient had two rapid tests and a PCR test on 22-Oct-2022. Treatment medications were not provided.

Weitere VAERSDATA-Felder

Praegender Schweregrund: COVID-19
Hospital-Tage: -
Labordaten: Test Date: 20221022; Test Name: COVID-19 test; Test Result: Positive ; Result Unstructured Data: Positive; Test Date: 20221022; Test Name: COVID-19 test; Test Result: Positive ; Result Unstructured Data: Positive; Test Date: 20221023; Test Name: COVID-19 test; Test Result: Positive ; Result Unstructured Data: Positive
Aktuelle Erkrankungen: -
Vorgeschichte: Medical History/Concurrent Conditions: COVID-19
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2486039

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge AS7143C

gering

Staat: IL
Alter: 66,0
Geschlecht: F
Eingang: 22.10.2022
Impfdatum: 12.09.2022
Beginn: 06.10.2022
Tage bis Beginn: 24,0
Dosis: 5
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

COVID-19 SARS-CoV-2 test

Symptomtext

she traveled to 2 other places. She came down with mild COVID Disease with Positive PCR test; This spontaneous case was reported by a patient and describes the occurrence of COVID-19 (she traveled to 2 other places. She came down with mild COVID Disease with Positive PCR test) in a 66-year-old female patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. AS7143C) for COVID-19 vaccination. No Medical History information was reported. On 12-Sep-2022, the patient received fifth dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On 06-Oct-2022, the patient experienced COVID-19 (she traveled to 2 other places. She came down with mild COVID Disease with Positive PCR test). At the time of the report, COVID-19 (she traveled to 2 other places. She came down with mild COVID Disease with Positive PCR test) outcome was unknown. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 06-Oct-2022, SARS-CoV-2 test: Positive. No concomitant information provided On 08-Mar-2021, The patient received first dose of moderna COVID-19 vaccine (Lot: 036A21A). On 05-Apr-2021, The patient received second dose of moderna COVID-19 vaccine (Lot: 025B21A). On 01-Nov-2021, The patient received 1st booster of moderna COVID-19 vaccine (Lot: 004 F21A). On 02-May-2022, The patient received 2nd booster of moderna COVID-19 vaccine (Lot: 002M21A). It was reported that she traveled to 2 other places and came down with mild COVID disease with positive PCR test on 06-Oct-2022, less than a month after bivalent Booster. No treatment information provided

Weitere VAERSDATA-Felder

Praegender Schweregrund: COVID-19
Hospital-Tage: -
Labordaten: Test Date: 20221006; Test Name: PCR test; Test Result: Positive
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2478014

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge AS7143C

gering

Staat: MO
Alter: -
Geschlecht: U
Eingang: 14.10.2022
Impfdatum: 12.10.2022
Beginn: 12.10.2022
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered No adverse event Product storage error

Symptomtext

Dose administered after more than 12 hours post puncture/Dose administered after exposure to room temperature for more than 24 hours; No adverse event; Dose administered after more than 12 hours post puncture/Dose administered after exposure to room temperature for more than 24 hours; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Dose administered after more than 12 hours post puncture/Dose administered after exposure to room temperature for more than 24 hours), PRODUCT STORAGE ERROR (Dose administered after more than 12 hours post puncture/Dose administered after exposure to room temperature for more than 24 hours) and NO ADVERSE EVENT (No adverse event) in a patient of an unknown age and gender who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. AS7143C) for COVID-19 prophylaxis. No Medical History information was reported. On 12-Oct-2022 at 1:00 PM, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On 12-Oct-2022 at 1:00 PM, the patient experienced EXPIRED PRODUCT ADMINISTERED (Dose administered after more than 12 hours post puncture/Dose administered after exposure to room temperature for more than 24 hours). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Dose administered after more than 12 hours post puncture/Dose administered after exposure to room temperature for more than 24 hours) and NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Dose administered after more than 12 hours post puncture/Dose administered after exposure to room temperature for more than 24 hours), PRODUCT STORAGE ERROR (Dose administered after more than 12 hours post puncture/Dose administered after exposure to room temperature for more than 24 hours) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for EXPIRED PRODUCT ADMINISTERED (Dose administered after more than 12 hours post puncture/Dose administered after exposure to room temperature for more than 24 hours) and PRODUCT STORAGE ERROR (Dose administered after more than 12 hours post puncture/Dose administered after exposure to room temperature for more than 24 hours). No concomitant medications were reported. The vial size was reported as 2.5 mL and was an individual vial. The vial was first punctured on 15-Sep-2022 at an unknown time. The vial was initially stored in refrigerator post puncture on 15-Sep-2022. The vial did not undergo any temperature excursions. The total amount of time during the vial was exposed to room temperature range (8 degree Celsius to 25 degree Celsius/46 degree Fahrenheit to 77 degree Fahrenheit) was 27 days. No treatment medications were reported. Reporter did not allow further contact

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2477572

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7143C

gering

Staat: CA
Alter: 50,0
Geschlecht: F
Eingang: 13.10.2022
Impfdatum: 07.09.2022
Beginn: 07.09.2022
Tage bis Beginn: 0,0
Dosis: 5
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Injury associated with device

Symptomtext

While technician was getting ready to inject the vaccine to patient, she accidently pricked her finger with the vaccine needle. The technician wasn't sure if she pricked her finger and so went on to inject the patient with the same needle. Once the technician completed the vaccination she realized she had forsure pricked her finger because she saw blood on the glove.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Injury associated with device
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2476788

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge AS7143C

gering

Staat: NM
Alter: 23,0
Geschlecht: M
Eingang: 13.10.2022
Impfdatum: 10.10.2022
Beginn: 10.10.2022
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

No adverse event Wrong product administered

Symptomtext

No adverse event; Patient inadvertently administered bivalent vaccine as first dose instead of the monovalent vaccine; This spontaneous case was reported by a pharmacist and describes the occurrence of WRONG PRODUCT ADMINISTERED (Patient inadvertently administered bivalent vaccine as first dose instead of the monovalent vaccine) and NO ADVERSE EVENT (No adverse event) in a 23-year-old male patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. AS7143C) for COVID-19 vaccination. No Medical History information was reported. On 10-Oct-2022, the patient received first dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Intramuscular) .5 milliliter. On 10-Oct-2022, the patient experienced WRONG PRODUCT ADMINISTERED (Patient inadvertently administered bivalent vaccine as first dose instead of the monovalent vaccine). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, WRONG PRODUCT ADMINISTERED (Patient inadvertently administered bivalent vaccine as first dose instead of the monovalent vaccine) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Intramuscular), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for WRONG PRODUCT ADMINISTERED (Patient inadvertently administered bivalent vaccine as first dose instead of the monovalent vaccine). No concomitant medications were reported. No treatment medications were reported.

Weitere VAERSDATA-Felder

Praegender Schweregrund: No adverse event
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2476765

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge AS7143C

gering

Staat: GA
Alter: 72,0
Geschlecht: M
Eingang: 13.10.2022
Impfdatum: 03.10.2022
Beginn: 03.10.2022
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

No adverse event Underdose

Symptomtext

No adverse event; A dose of the Moderna COVID-19 vaccine bivalent was given at 0.25mL by intramuscular injection; This spontaneous case was reported by a pharmacist and describes the occurrence of UNDERDOSE (A dose of the Moderna COVID-19 vaccine bivalent was given at 0.25mL by intramuscular injection) and NO ADVERSE EVENT (No adverse event) in a 72-year-old male patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. AS7143C) for COVID-19 prophylaxis. No Medical History information was reported. On 03-Oct-2022, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Intramuscular) .25 milliliter. On 03-Oct-2022, the patient experienced UNDERDOSE (A dose of the Moderna COVID-19 vaccine bivalent was given at 0.25mL by intramuscular injection). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, UNDERDOSE (A dose of the Moderna COVID-19 vaccine bivalent was given at 0.25mL by intramuscular injection) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Intramuscular), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for UNDERDOSE (A dose of the Moderna COVID-19 vaccine bivalent was given at 0.25mL by intramuscular injection). No concomitant medications were reported. A dose of the Moderna COVID-19 vaccine bivalent was given at 0.25mL by intramuscular injection. The patient has not reported any symptoms. No additional doses, medications or treatments have been administered at this time.

Weitere VAERSDATA-Felder

Praegender Schweregrund: No adverse event
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2472266

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge AS7143C

gering

Staat: OR
Alter: 75,0
Geschlecht: M
Eingang: 07.10.2022
Impfdatum: 29.09.2022
Beginn: 29.09.2022
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

No adverse event Underdose

Symptomtext

No adverse event; Patient administered with 0.25 instead of 0.5 mL dose of bivalent vaccine; This spontaneous case was reported by a pharmacist and describes the occurrence of UNDERDOSE (Patient administered with 0.25 instead of 0.5 mL dose of bivalent vaccine) and NO ADVERSE EVENT (No adverse event) in a 75-year-old male patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. AS7143C) for COVID-19 prophylaxis. No Medical History information was reported. On 29-Sep-2022, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) .25 milliliter. On 29-Sep-2022, the patient experienced UNDERDOSE (Patient administered with 0.25 instead of 0.5 mL dose of bivalent vaccine). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, UNDERDOSE (Patient administered with 0.25 instead of 0.5 mL dose of bivalent vaccine) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for UNDERDOSE (Patient administered with 0.25 instead of 0.5 mL dose of bivalent vaccine). No concomitant medication details was reported. It was reported that patient did not had any adverse events. No treatment medication details was reported. This case was linked to US-MODERNATX, INC.-MOD-2022-654894, US-MODERNATX, INC.-MOD-2022-654906, US-MODERNATX, INC.-MOD-2022-654905 (E2B Linked Report).; Sender's Comments: US-MODERNATX, INC.-MOD-2022-654906:Patient No. 3 US-MODERNATX, INC.-MOD-2022-654894:Patient No. 1 US-MODERNATX, INC.-MOD-2022-654905:Patient No. 2

Weitere VAERSDATA-Felder

Praegender Schweregrund: No adverse event
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2471544

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge AS7143C

gering

Staat: OR
Alter: 73,0
Geschlecht: F
Eingang: 07.10.2022
Impfdatum: 29.09.2022
Beginn: 29.09.2022
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

No adverse event Underdose

Symptomtext

No adverse event; patient administered with 0.25 instead of 0.5 mL dose of bivalent vaccine; This spontaneous case was reported by a pharmacist and describes the occurrence of UNDERDOSE (patient administered with 0.25 instead of 0.5 mL dose of bivalent vaccine) and NO ADVERSE EVENT (No adverse event) in a 73-year-old female patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. AS7143C) for COVID-19 vaccination. No Medical History information was reported. On 29-Sep-2022, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) .25 milliliter. On 29-Sep-2022, the patient experienced UNDERDOSE (patient administered with 0.25 instead of 0.5 mL dose of bivalent vaccine). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, UNDERDOSE (patient administered with 0.25 instead of 0.5 mL dose of bivalent vaccine) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for UNDERDOSE (patient administered with 0.25 instead of 0.5 mL dose of bivalent vaccine). Concomitant medications were not reported. It was reported that patient did not report any adverse events. No treatment information was provided by the reporter. This case was linked to US-MODERNATX, INC.-MOD-2022-654894, US-MODERNATX, INC.-MOD-2022-654906, US-MODERNATX, INC.-MOD-2022-654910 (E2B Linked Report).; Sender's Comments: US-MODERNATX, INC.-MOD-2022-654894:Patient No-1 US-MODERNATX, INC.-MOD-2022-654906:Patient No -3 US-MODERNATX, INC.-MOD-2022-654910:Patient No-4

Weitere VAERSDATA-Felder

Praegender Schweregrund: No adverse event
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2471316

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge AS7143C

gering

Staat: OR
Alter: 76,0
Geschlecht: F
Eingang: 07.10.2022
Impfdatum: 29.09.2022
Beginn: 29.09.2022
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

No adverse event Underdose

Symptomtext

No adverse event; patient administered with 0.25 instead of 0.5 mL dose of bivalent vaccine; This spontaneous case was reported by a pharmacist and describes the occurrence of UNDERDOSE (patient administered with 0.25 instead of 0.5 mL dose of bivalent vaccine) and NO ADVERSE EVENT (No adverse event) in a 76-year-old female patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. AS7143C) for COVID-19 vaccination. No Medical History information was reported. On 29-Sep-2022, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) .25 milliliter. On 29-Sep-2022, the patient experienced UNDERDOSE (patient administered with 0.25 instead of 0.5 mL dose of bivalent vaccine). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, UNDERDOSE (patient administered with 0.25 instead of 0.5 mL dose of bivalent vaccine) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for UNDERDOSE (patient administered with 0.25 instead of 0.5 mL dose of bivalent vaccine). No concomitant medications was reported. It was reported that patient did not had any adverse events. No treatment drug details was reported. This case was linked to US-MODERNATX, INC.-MOD-2022-654905, US-MODERNATX, INC.-MOD-2022-654910, US-MODERNATX, INC.-MOD-2022-654894 (E2B Linked Report).; Sender's Comments: US-MODERNATX, INC.-MOD-2022-654905:Patient No -2 US-MODERNATX, INC.-MOD-2022-654910:Patient No -4 US-MODERNATX, INC.-MOD-2022-654894:Patient No-1

Weitere VAERSDATA-Felder

Praegender Schweregrund: No adverse event
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2471311

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge AS7143C

gering

Staat: OR
Alter: 73,0
Geschlecht: F
Eingang: 07.10.2022
Impfdatum: 29.09.2022
Beginn: 29.09.2022
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

No adverse event Underdose

Symptomtext

No adverse event; patient administered with 0.25 instead of 0.5 mL dose of bivalent vaccine; This spontaneous case was reported by a pharmacist and describes the occurrence of UNDERDOSE (patient administered with 0.25 instead of 0.5 mL dose of bivalent vaccine) and NO ADVERSE EVENT (No adverse event) in a 73-year-old female patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. AS7143C) for COVID-19 vaccination. No Medical History information was reported. On 29-Sep-2022, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) .25 milliliter. On 29-Sep-2022, the patient experienced UNDERDOSE (patient administered with 0.25 instead of 0.5 mL dose of bivalent vaccine). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, UNDERDOSE (patient administered with 0.25 instead of 0.5 mL dose of bivalent vaccine) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for UNDERDOSE (patient administered with 0.25 instead of 0.5 mL dose of bivalent vaccine). Concomitant drugs were not reported. It was reported that patients did not report any AEs. Treatment medications were not reported. This case was linked to US-MODERNATX, INC.-MOD-2022-654905, US-MODERNATX, INC.-MOD-2022-654906, US-MODERNATX, INC.-MOD-2022-654910 (E2B Linked Report).; Sender's Comments: US-MODERNATX, INC.-MOD-2022-654905:Patient 2 US-MODERNATX, INC.-MOD-2022-654906:Patient 3 US-MODERNATX, INC.-MOD-2022-654910:Patient 4

Weitere VAERSDATA-Felder

Praegender Schweregrund: No adverse event
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2470266

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge as7143c

gering

Staat: TN
Alter: 56,0
Geschlecht: M
Eingang: 05.10.2022
Impfdatum: 01.10.2022
Beginn: 01.10.2022
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Expired product administered

Symptomtext

Out of date vaccine given. Provider on site was notified that patient received out of date vaccine. Was told to let patient know. Patient was made aware, and is in the medical field and started he did not want to get revaccinated as long as we kept our supply in the refrigerator it will be fine. Patient has not had any adverse reaction to the vaccine. All conversations were documented in the patients chart.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: none
Aktuelle Erkrankungen: none
Vorgeschichte: hypertensive disorder hypothyroidism male hypogonadism
Andere Medikamente: albuterol sulfate HFA 90 mcg/actuation aerosol inhaler INHALE INHALE TWO PUFFS BY MOUTH EVERY 4 TO 6 HOURS AS NEEDED clindamycin phosphate 1 % topical solution APPLY TO AFFECTED AREA(S) A THIN LAYER TWO TIMES A DAY cyclobenzaprine 5 mg
Allergien: nkda nkfa
Vorherige Impfungen: -

VAERS 2466748

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7143C

gering

Staat: WA
Alter: 35,0
Geschlecht: M
Eingang: 02.10.2022
Impfdatum: 26.09.2022
Beginn: 30.09.2022
Tage bis Beginn: 4,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Sensitive skin

Symptomtext

Skin hypersensitivity over the right (opposite) site of the body, on fingers, hand, back, hip areas. Symptoms started ~84 hours after injection. Symptoms have lasted 36 hours and have not subsided. Severity does not vary during the day.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Sensitive skin
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: none
Vorgeschichte: None
Andere Medikamente: None
Allergien: Penicillin
Vorherige Impfungen: -

VAERS 2465432

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7143C

gering

Staat: AL
Alter: 55,0
Geschlecht: F
Eingang: 30.09.2022
Impfdatum: 26.09.2022
Beginn: 26.09.2022
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Product storage error

Symptomtext

Patient received a dose from a vial that had been used on a previous day. The vial used was actually pulled from the fridge and doses were withdrawn on 9/24/22. The vial was not appropriately disposed of at that time. The technician then thought the vial was pulled for doses to be given on 9/26/22, but it was the vial from 9/24/22. Once this was discovered the patient received a dose from a new vial in her opposite arm's deltoid.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Product storage error
Hospital-Tage: -
Labordaten: Unknown
Aktuelle Erkrankungen: Unknown
Vorgeschichte: Unknown
Andere Medikamente: Unknown
Allergien: No known allergies
Vorherige Impfungen: -

VAERS 2465411

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge as7143c

gering

Staat: AL
Alter: 57,0
Geschlecht: M
Eingang: 30.09.2022
Impfdatum: 26.09.2022
Beginn: 26.09.2022
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Product storage error

Symptomtext

Patient received a dose from a vial that had been used on a previous day. The vial used was actually pulled from the fridge and doses were withdrawn on 9/24/22. The vial was not appropriately disposed of at that time. The technician then thought the vial was pulled for doses to be given on 9/26/22, but it was the vial from 9/24/22. Once this was discovered the patient received a dose from a new vial in his opposite arm's deltoid.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Product storage error
Hospital-Tage: -
Labordaten: Unknown
Aktuelle Erkrankungen: Unknown
Vorgeschichte: -
Andere Medikamente: Unknown
Allergien: No known allergies
Vorherige Impfungen: -

VAERS 2464011

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge AS7143C.

gering

Staat: AZ
Alter: 55,0
Geschlecht: U
Eingang: 29.09.2022
Impfdatum: 22.09.2022
Beginn: 22.09.2022
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Accidental underdose No adverse event

Symptomtext

No adverse event; adult individual was only given 0.25ml dose of the new updated booster for Covid rather than the full 0.5ml dose; This spontaneous case was reported by a pharmacist and describes the occurrence of ACCIDENTAL UNDERDOSE (adult individual was only given 0.25ml dose of the new updated booster for Covid rather than the full 0.5ml dose) and NO ADVERSE EVENT (No adverse event) in a 55-year-old patient of an unknown gender who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. AS7143C.) for COVID-19 prophylaxis. No Medical History information was reported. On 22-Sep-2022, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) .25 milliliter. On 22-Sep-2022, the patient experienced ACCIDENTAL UNDERDOSE (adult individual was only given 0.25ml dose of the new updated booster for Covid rather than the full 0.5ml dose). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, ACCIDENTAL UNDERDOSE (adult individual was only given 0.25ml dose of the new updated booster for Covid rather than the full 0.5ml dose) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for ACCIDENTAL UNDERDOSE (adult individual was only given 0.25ml dose of the new updated booster for Covid rather than the full 0.5ml dose). No Concomitant medication was reported. No treatment information was provided.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Accidental underdose
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2464000

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge AS7143C

gering

Staat: AZ
Alter: 21,0
Geschlecht: F
Eingang: 29.09.2022
Impfdatum: 23.09.2022
Beginn: 23.09.2022
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

No adverse event Wrong product administered

Symptomtext

No adverse event; First dose was Bivalent booster; This spontaneous case was reported by a pharmacist and describes the occurrence of WRONG PRODUCT ADMINISTERED (First dose was Bivalent booster) and NO ADVERSE EVENT (No adverse event) in a 21-year-old female patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. AS7143C) for COVID-19 vaccination. No Medical History information was reported. On 23-Sep-2022, the patient received first dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On 23-Sep-2022, the patient experienced WRONG PRODUCT ADMINISTERED (First dose was Bivalent booster). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, WRONG PRODUCT ADMINISTERED (First dose was Bivalent booster) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for WRONG PRODUCT ADMINISTERED (First dose was Bivalent booster). Concomitant medication information was not provided by the reporter. Patient came in to get the COVID booster. Patient did not bring the COVID card, so patient was given a Bivalent vaccine, but then the patient revealed that never received a COVID shot. Treatment information was not provided by the reporter.

Weitere VAERSDATA-Felder

Praegender Schweregrund: No adverse event
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2463987

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge AS7143C

gering

Staat: SD
Alter: 60,0
Geschlecht: M
Eingang: 29.09.2022
Impfdatum: 26.09.2022
Beginn: 26.09.2022
Tage bis Beginn: 0,0
Dosis: 5
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Accidental underdose No adverse event

Symptomtext

No adverse Event; Received 0.25ml dose of Bivalent Booster instead of 0.5 ml; This spontaneous case was reported by a patient and describes the occurrence of ACCIDENTAL UNDERDOSE (Received 0.25ml dose of Bivalent Booster instead of 0.5 ml) and NO ADVERSE EVENT (No adverse Event) in a 60-year-old male patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. AS7143C) for COVID-19 prophylaxis. No Medical History information was reported. On 26-Sep-2022, the patient received fifth dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) .25 milliliter. On 26-Sep-2022, the patient experienced ACCIDENTAL UNDERDOSE (Received 0.25ml dose of Bivalent Booster instead of 0.5 ml). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse Event). At the time of the report, ACCIDENTAL UNDERDOSE (Received 0.25ml dose of Bivalent Booster instead of 0.5 ml) and NO ADVERSE EVENT (No adverse Event) outcome was unknown. For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse Event) to be not related. No further causality assessment was provided for ACCIDENTAL UNDERDOSE (Received 0.25ml dose of Bivalent Booster instead of 0.5 ml). No concomitant drug were reported. The pharmacist was talking to the patient, who told him to call this number. The patient was told that the pharmacist was supposed to call. The pharmacist states that he will give the patient the other half of the booster dose. Patient received First dose on 23-MAR-2021, Lot# 045A21A and Expiration date was reported as unknown. On unknown date patient received second shot of vaccine, Lot number and Expiration date was reported as unknown. On unknown dates patient received 2 Monovalent Booster doses, Lot number and Expiration date was reported as unknown. No treatment drug were reported. Most recent FOLLOW-UP information incorporated above includes: On 26-Sep-2022: Follow up document contain secondary reporter was added.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Accidental underdose
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2463402

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7143C

gering

Staat: PA
Alter: 58,0
Geschlecht: M
Eingang: 28.09.2022
Impfdatum: 16.09.2022
Beginn: 16.09.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Incorrect dose administered Syringe issue Underdose

Symptomtext

The BD syringe was faulty and vaccine came out of the barrel of the syringe. Unknown how much vaccine was administered to patient. Patient came back 9/19/22 and received the vaccine again.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Incorrect dose administered
Hospital-Tage: -
Labordaten: none
Aktuelle Erkrankungen: unknown
Vorgeschichte: unknown
Andere Medikamente: unknown
Allergien: NKDA
Vorherige Impfungen: -

VAERS 2463072

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7143C

gering

Staat: MI
Alter: 39,0
Geschlecht: M
Eingang: 28.09.2022
Impfdatum: 22.09.2022
Beginn: 01.09.2022
Tage bis Beginn: -
Dosis: 4
Route/Site: IM / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

Syringe issue Underdose

Symptomtext

Dose leakage from syringe pt given approximately half of dose

Weitere VAERSDATA-Felder

Praegender Schweregrund: Syringe issue
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2461881

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge AS7143C

gering

Staat: OH
Alter: 38,0
Geschlecht: M
Eingang: 27.09.2022
Impfdatum: 09.09.2022
Beginn: 20.09.2022
Tage bis Beginn: 11,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Herpes zoster Varicella virus test positive

Symptomtext

Tested positive for shingles 9/20/2022

Weitere VAERSDATA-Felder

Praegender Schweregrund: Herpes zoster
Hospital-Tage: -
Labordaten: None
Aktuelle Erkrankungen: None
Vorgeschichte: Psoriasis
Andere Medikamente: Valacyclovir 9/20 -9/24/2022
Allergien: None
Vorherige Impfungen: -

VAERS 2460732

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7143C

gering

Staat: VA
Alter: 52,0
Geschlecht: F
Eingang: 26.09.2022
Impfdatum: 06.09.2022
Beginn: 08.09.2022
Tage bis Beginn: 2,0
Dosis: 5
Route/Site: SYR / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Atrial fibrillation Electrocardiogram abnormal Heart rate increased

Symptomtext

Thursday 9/8 may have started around 2 p.m., ended 4 p.m. Atrial fibrillation with very high heart rate. No prior history of either. Symptoms validated with multiple ECGs taken by Watch. Symptoms lasted for about 2 hours and then resolved suddenly with no intervention. ECG validated the return to sinus rhythm and normal heart rate.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Atrial fibrillation
Hospital-Tage: -
Labordaten: None yet (cardiology appointment scheduled but first available was a month away)
Aktuelle Erkrankungen: None
Vorgeschichte: None
Andere Medikamente: escitalopram, levothyroxine, vitamin D, B vitamin combination
Allergien: hydroxychloroquine
Vorherige Impfungen: -

VAERS 2456326

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge as7143c

gering

Staat: AR
Alter: 71,0
Geschlecht: F
Eingang: 23.09.2022
Impfdatum: 15.09.2022
Beginn: 15.09.2022
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Incorrect dose administered Product label confusion

Symptomtext

Incorrect dose administered. A half dose (0.25ml) of the moderna bivalent booster was administered. The mistake was discovered a 7 days after administration. The patient was notified and scheduled to receive the other half dose (0.25ml) as soon as possible based on CDC guidelines. The package labeling on the Bivalent vaccine is confusing and most likely to blame for this error.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Incorrect dose administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2456316

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge as7143c

gering

Staat: AR
Alter: 79,0
Geschlecht: M
Eingang: 23.09.2022
Impfdatum: 15.09.2022
Beginn: 15.09.2022
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

Incorrect dose administered Incorrect product formulation administered

Symptomtext

Incorrect dose administered. A half dose (0.25ml) of the moderna bivalent booster was administered. The mistake was discovered a 7 days after administration. The patient was notified and scheduled to receive the other half dose (0.25ml) as soon as possible based on CDC guidelines. The package labeling on the Bivalent vaccine is confusing and most likely to blame for this error.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Incorrect dose administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2456309

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge as7143c

gering

Staat: AR
Alter: 77,0
Geschlecht: F
Eingang: 23.09.2022
Impfdatum: 15.09.2022
Beginn: 15.09.2022
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Incorrect dose administered Incorrect product formulation administered

Symptomtext

Incorrect dose administered. A half dose (0.25ml) of the moderna bivalent booster was administered. The mistake was discovered a 7 days after administration. The patient was notified and scheduled to receive the other half dose (0.25ml) as soon as possible based on CDC guidelines. The package labeling on the Bivalent vaccine is confusing and most likely to blame for this error.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Incorrect dose administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2456306

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge as7143c

gering

Staat: AR
Alter: 69,0
Geschlecht: M
Eingang: 23.09.2022
Impfdatum: 15.09.2022
Beginn: 15.09.2022
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

Incorrect dose administered Incorrect product formulation administered

Symptomtext

Incorrect dose administered. A half dose (0.25ml) of the moderna bivalent booster was administered. The mistake was discovered a 7 days after administration. The patient was notified and scheduled to receive the other half dose (0.25ml) as soon as possible based on CDC guidelines. The package labeling on the Bivalent vaccine is confusing and most likely to blame for this error.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Incorrect dose administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2456303

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge as7143c

gering

Staat: AR
Alter: 78,0
Geschlecht: F
Eingang: 23.09.2022
Impfdatum: 15.09.2022
Beginn: 01.09.2022
Tage bis Beginn: -
Dosis: UNK
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Incorrect dose administered Incorrect product formulation administered

Symptomtext

Incorrect dose administered. A half dose (0.25ml) of the moderna bivalent booster was administered. The mistake was discovered a 7 days after administration. The patient was notified and scheduled to receive the other half dose (0.25ml) as soon as possible based on CDC guidelines. The package labeling on the Bivalent vaccine is confusing and most likely to blame for this error.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Incorrect dose administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2456301

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge as7143c

gering

Staat: AR
Alter: 75,0
Geschlecht: F
Eingang: 23.09.2022
Impfdatum: 15.09.2022
Beginn: 15.09.2022
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Incorrect dose administered Incorrect product formulation administered

Symptomtext

Incorrect dose administered. A half dose (0.25ml) of the moderna bivalent booster was administered. The mistake was discovered a 7 days after administration. The patient was notified and scheduled to receive the other half dose (0.25ml) as soon as possible based on CDC guidelines. The package labeling on the Bivalent vaccine is confusing and most likely to blame for this error.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Incorrect dose administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2456205

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge as7143c

gering

Staat: AR
Alter: 73,0
Geschlecht: M
Eingang: 23.09.2022
Impfdatum: 15.09.2022
Beginn: 15.09.2022
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

Incorrect dose administered Incorrect product formulation administered

Symptomtext

Incorrect dose administered. A half dose (0.25ml) of the moderna bivalent booster was administered. The mistake was discovered a 7 days after administration. The patient was notified and scheduled to receive the other half dose (0.25ml) as soon as possible based on CDC guidelines. The package labeling on the Bivalent vaccine is confusing and most likely to blame for this error.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Incorrect dose administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2454625

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7143C

gering

Staat: -
Alter: 88,0
Geschlecht: M
Eingang: 22.09.2022
Impfdatum: 20.09.2022
Beginn: 21.09.2022
Tage bis Beginn: 1,0
Dosis: 5
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Pupillary light reflex tests abnormal Sitting disability Unresponsive to stimuli

Symptomtext

Change in condition: Resident was observed leaning forward in his W/C after supper (1830). Resident was unresponsive to staff and could not hold himself in an upright sitting position. Resident's pupils PERRLA, resident unable to grasp hands, talk, smile etc. Resident's vital signs: BP: 101/69 mmHg; O2: 96% RA; P: 107/min; R: 26/min (shallow); T: 96.5 deg. F. Upon auscultation of the lungs, no adventitious lung sounds noted. Hospitalist at medical facility notified via telephone and telephone order received to send resident non-urgently to ER for evaluation per Dr. Sent to ER and admitted under observation status.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Pupillary light reflex tests abnormal
Hospital-Tage: -
Labordaten: unknown.
Aktuelle Erkrankungen: none
Vorgeschichte: Dementia; Iron deficiency anemia, chronic kidney disease; Hyperglycemia; Benign prostatic hyperplasia; Hypertension; Heart failure; Benign neoplasm of colon.
Andere Medikamente: Calcium w/ vit D; Donepezil; Ferrous sulfate; Furosemide; Memantine; Miralax; Senna s; Tamsulosin; Vitamin C; Vitamin D
Allergien: NKA
Vorherige Impfungen: -

VAERS 2453494

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7143C

gering

Staat: MD
Alter: 80,0
Geschlecht: M
Eingang: 21.09.2022
Impfdatum: 07.09.2022
Beginn: 07.09.2022
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Incorrect dose administered No adverse event

Symptomtext

The patient was administered a volume of 0.25mL instead on 9-7-22 of the intended volume of 0.5mL. The error was recognized the next day and action was immediately taken to reach out to Moderna and CDC for clinical recommendations on the appropriate steps forward. On 9-16-22 responses were received, with the direction to have the patient come back as soon as possible to repeat the dose to receive the full dose of 0.5mL. No adverse effects were reported. The patient returned and received the full dose on 9-19-22.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Incorrect dose administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2453486

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7143C

gering

Staat: MD
Alter: 63,0
Geschlecht: M
Eingang: 21.09.2022
Impfdatum: 07.09.2022
Beginn: 07.09.2022
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Incorrect dose administered No adverse event

Symptomtext

The patient was administered a volume of 0.25mL instead on 9-7-22 of the intended volume of 0.5mL. The error was recognized the next day and action was immediately taken to reach out to Moderna and CDC for clinical recommendations on the appropriate steps forward. On 9-16-22 responses were received, with the direction to have the patient come back as soon as possible to repeat the dose to receive the full dose of 0.5mL. No adverse effects were reported. The patient returned and received the full dose on 9-17-22.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Incorrect dose administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2453474

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7143C

gering

Staat: MD
Alter: 61,0
Geschlecht: F
Eingang: 21.09.2022
Impfdatum: 07.09.2022
Beginn: 07.09.2022
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Underdose

Symptomtext

The patient was administered a volume of 0.25mL instead on 9-7-22 of the intended volume of 0.5mL. The error was recognized the next day and action was immediately taken to reach out to Moderna and CDC for clinical recommendations on the appropriate steps forward. On 9-16-22 responses were received, with the direction to have the patient come back as soon as possible to repeat the dose to receive the full dose of 0.5mL. No adverse effects were reported. The patient returned and received the full dose on 9-16-22.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Underdose
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2452784

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7143C

gering

Staat: MD
Alter: 79,0
Geschlecht: F
Eingang: 20.09.2022
Impfdatum: 07.09.2022
Beginn: 07.09.2022
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

No adverse event Product preparation error

Symptomtext

The patient was administered a volume of 0.25mL instead of the appropriate volume of 0.5mL. The error was recognized the following day and outreach was made to Moderna and CDC for clinical recommendations for the next step. Upon response from the clinical team 9 days later the patient was informed of the error and was given the direction to return to the pharmacy at as soon as possible to receive a complete dose of 0.5mL. No adverse events had been reported. Patient received full dose 9-19-22.

Weitere VAERSDATA-Felder

Praegender Schweregrund: No adverse event
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2452782

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7143C

gering

Staat: MD
Alter: 69,0
Geschlecht: F
Eingang: 20.09.2022
Impfdatum: 07.09.2022
Beginn: 07.09.2022
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Incorrect dose administered No adverse event Underdose

Symptomtext

The patient was administered a volume of 0.25mL instead of the appropriate volume of 0.5mL. The error was recognized the following day and outreach was made to Moderna and CDC for clinical recommendations for the next step. Upon response from the clinical team 9 days later the patient was informed of the error and was given the direction to return to the pharmacy at as soon as possible to receive a complete dose of 0.5mL. No adverse events had been reported. Patient has not yet returned for full dose.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Incorrect dose administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: DM
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2452781

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7143C

gering

Staat: MD
Alter: 73,0
Geschlecht: M
Eingang: 20.09.2022
Impfdatum: 07.09.2022
Beginn: 07.09.2022
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

No adverse event Underdose

Symptomtext

The patient was administered a volume of 0.25mL instead of the appropriate volume of 0.5mL. The error was recognized the following day and outreach was made to Moderna and CDC for clinical recommendations for the next step. Upon response from the clinical team 9 days later the patient was informed of the error and was given the direction to return to the pharmacy at as soon as possible to receive a complete dose of 0.5mL. No adverse events had been reported. Patient has not yet returned for full dose.

Weitere VAERSDATA-Felder

Praegender Schweregrund: No adverse event
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: CHF, CKD, prostate cancer
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2452778

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7143C

gering

Staat: MD
Alter: 62,0
Geschlecht: F
Eingang: 20.09.2022
Impfdatum: 07.09.2022
Beginn: 07.09.2022
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Incorrect dose administered No adverse event

Symptomtext

The patient was administered a volume of 0.25mL instead of the appropriate volume of 0.5mL. The error was recognized the following day and outreach was made to Moderna and CDC for clinical recommendations for the next step. Upon response from the clinical team 9 days later the patient was informed of the error and was given the direction to return to the pharmacy at as soon as possible to receive a complete dose of 0.5mL. No adverse events had been reported. Patient has not yet returned for full dose.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Incorrect dose administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2452777

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7143C

gering

Staat: MD
Alter: 49,0
Geschlecht: F
Eingang: 20.09.2022
Impfdatum: 07.09.2022
Beginn: 07.09.2022
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Incorrect dose administered No adverse event

Symptomtext

The patient was administered a volume of 0.25mL instead of the appropriate volume of 0.5mL. The error was recognized the following day and outreach was made to Moderna and CDC for clinical recommendations for the next step. Upon response from the clinical team 9 days later the patient was informed of the error and was given the direction to return to the pharmacy at as soon as possible to receive a complete dose of 0.5mL. No adverse events had been reported. Patient has not yet returned for the full dose.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Incorrect dose administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2452775

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7143C

gering

Staat: MD
Alter: 71,0
Geschlecht: F
Eingang: 20.09.2022
Impfdatum: 07.09.2022
Beginn: 07.09.2022
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

No adverse event Underdose

Symptomtext

The patient was administered a volume of 0.25mL instead of the appropriate volume of 0.5mL. The error was recognized the following day and outreach was made to Moderna and CDC for clinical recommendations for the next step. Upon response from the clinical team 9 days later the patient was informed of the error and was given the direction to return to the pharmacy at as soon as possible to receive a complete dose of 0.5mL. No adverse events had been reported. Patient received full dose on 9-17-22

Weitere VAERSDATA-Felder

Praegender Schweregrund: No adverse event
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2452774

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7143C

gering

Staat: MD
Alter: 62,0
Geschlecht: F
Eingang: 20.09.2022
Impfdatum: 07.09.2022
Beginn: 07.09.2022
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

No adverse event Underdose

Symptomtext

The patient was administered a volume of 0.25mL instead of the appropriate volume of 0.5mL. The error was recognized the following day and outreach was made to Moderna and CDC for clinical recommendations for the next step. Upon response from the clinical team 9 days later the patient was informed of the error and was given the direction to return to the pharmacy at as soon as possible to receive a complete dose of 0.5mL. No adverse events had been reported. Full dose was administered on 9-20-22

Weitere VAERSDATA-Felder

Praegender Schweregrund: No adverse event
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: Beta Thalassemia Minor
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2452773

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7143C

gering

Staat: MD
Alter: 70,0
Geschlecht: M
Eingang: 20.09.2022
Impfdatum: 07.09.2022
Beginn: 07.09.2022
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

No adverse event Underdose

Symptomtext

The patient was administered a volume of 0.25mL instead of the appropriate volume of 0.5mL. The error was recognized the following day and outreach was made to Moderna and CDC for clinical recommendations for the next step. Upon response from the clinical team 9 days later the patient was informed of the error and was given the direction to return to the pharmacy at as soon as possible to receive a complete dose of 0.5mL. No adverse events had been reported. Patient has not yet returned for full dose

Weitere VAERSDATA-Felder

Praegender Schweregrund: No adverse event
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: CLL
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2452771

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7143C

gering

Staat: MD
Alter: 59,0
Geschlecht: F
Eingang: 20.09.2022
Impfdatum: 07.09.2022
Beginn: 07.09.2022
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

No adverse event Underdose

Symptomtext

The patient was administered a volume of 0.25mL instead of the appropriate volume of 0.5mL. The error was recognized the following day and outreach was made to Moderna and CDC for clinical recommendations for the next step. Upon response from the clinical team 9 days later the patient was informed of the error and was given the direction to return to the pharmacy at as soon as possible to receive a complete dose of 0.5mL. No adverse event had been reported and correct dose was administered on 09-17-22.

Weitere VAERSDATA-Felder

Praegender Schweregrund: No adverse event
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: RA
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2452770

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7143C

gering

Staat: MD
Alter: 76,0
Geschlecht: F
Eingang: 20.09.2022
Impfdatum: 07.09.2022
Beginn: 07.09.2022
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Incorrect dose administered No adverse event Underdose

Symptomtext

The patient was administered a volume of 0.25mL instead of the appropriate volume of 0.5mL. The error was recognized the following day and outreach was made to Moderna and CDC for clinical recommendations for the next step. Upon response from the clinical team 9 days later the patient was informed of the error and was given the direction to return to the pharmacy at as soon as possible to receive a complete dose of 0.5mL. No adverse event had been reported. Correct dose was administered on 09-18-22

Weitere VAERSDATA-Felder

Praegender Schweregrund: Incorrect dose administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2452769

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7143C

gering

Staat: MD
Alter: 70,0
Geschlecht: M
Eingang: 20.09.2022
Impfdatum: 07.09.2022
Beginn: 07.09.2022
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

Incorrect dose administered No adverse event Underdose

Symptomtext

The patient was administered a volume of 0.25mL instead of the appropriate volume of 0.5mL. The error was recognized the following day and outreach was made to Moderna and CDC for clinical recommendations for the next step. Upon response from the clinical team 9 days later the patient was informed of the error and was given the direction to return to the pharmacy at as soon as possible to receive a complete dose of 0.5mL. No adverse events had been reported. Complete dose was administered on 9-19-22

Weitere VAERSDATA-Felder

Praegender Schweregrund: Incorrect dose administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2452293

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7143C

gering

Staat: -
Alter: 63,0
Geschlecht: M
Eingang: 20.09.2022
Impfdatum: 13.09.2022
Beginn: 01.09.2022
Tage bis Beginn: -
Dosis: UNK
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

Incorrect dose administered No adverse event

Symptomtext

0.25 ml was given instead of 0.5 ml No adverse reactions reported

Weitere VAERSDATA-Felder

Praegender Schweregrund: Incorrect dose administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2452269

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7143C

gering

Staat: WA
Alter: 77,0
Geschlecht: F
Eingang: 20.09.2022
Impfdatum: 13.09.2022
Beginn: 01.09.2022
Tage bis Beginn: -
Dosis: UNK
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

Incorrect dose administered No adverse event Underdose

Symptomtext

0.25 ml was admininstred instead of 0.5 ml. No adverse reaction reported

Weitere VAERSDATA-Felder

Praegender Schweregrund: Incorrect dose administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2452254

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7143C

gering

Staat: WA
Alter: 70,0
Geschlecht: M
Eingang: 20.09.2022
Impfdatum: 13.09.2022
Beginn: 01.09.2022
Tage bis Beginn: -
Dosis: UNK
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

Incorrect dose administered No adverse event

Symptomtext

0.25 was administered instead of 0.5 No adverse reaction reported

Weitere VAERSDATA-Felder

Praegender Schweregrund: Incorrect dose administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2452241

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7143C

gering

Staat: WA
Alter: 41,0
Geschlecht: M
Eingang: 20.09.2022
Impfdatum: 15.09.2022
Beginn: 01.09.2022
Tage bis Beginn: -
Dosis: UNK
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

Incorrect dose administered No adverse event

Symptomtext

0.25 ml was administered instead of 0.5 ml. No adverse reactions reported

Weitere VAERSDATA-Felder

Praegender Schweregrund: Incorrect dose administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2452235

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7143C

gering

Staat: -
Alter: 86,0
Geschlecht: M
Eingang: 20.09.2022
Impfdatum: 15.09.2022
Beginn: 01.09.2022
Tage bis Beginn: -
Dosis: UNK
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

Incorrect dose administered No adverse event

Symptomtext

0.25 ml was administered instead of 0.5 ml No adverse reactions reported

Weitere VAERSDATA-Felder

Praegender Schweregrund: Incorrect dose administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2452231

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7143C

gering

Staat: WA
Alter: 86,0
Geschlecht: F
Eingang: 20.09.2022
Impfdatum: 15.09.2022
Beginn: 01.09.2022
Tage bis Beginn: -
Dosis: UNK
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

No adverse event Underdose

Symptomtext

0.25 ml instead of 0.5 ml. No adverse reactions

Weitere VAERSDATA-Felder

Praegender Schweregrund: No adverse event
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2450906

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge AS7143C

gering

Staat: MI
Alter: 75,0
Geschlecht: M
Eingang: 19.09.2022
Impfdatum: 08.09.2022
Beginn: 19.09.2022
Tage bis Beginn: 11,0
Dosis: 4
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt

COVID-19 SARS-CoV-2 test positive Vaccine breakthrough infection

Symptomtext

Breakthrough case admission after 4 vaccines Moderna 2/4/21 Lot# 013M20A; Moderna 3/4/21 Lot# 030A21A; Moderna 10/20/21 Lot# 076C21A; Moderna 9/8/22 Lot# AS7143C

Weitere VAERSDATA-Felder

Praegender Schweregrund: COVID-19
Hospital-Tage: -
Labordaten: COVID +
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2450499

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge as7143c

gering

Staat: ID
Alter: 16,0
Geschlecht: F
Eingang: 17.09.2022
Impfdatum: 14.09.2022
Beginn: 14.09.2022
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

No adverse event Product administered to patient of inappropriate age

Symptomtext

Moderna bivalent given to patient under age 18. No adverse reactions from patient.

Weitere VAERSDATA-Felder

Praegender Schweregrund: No adverse event
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2449888

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7143C

gering

Staat: CA
Alter: -
Geschlecht: F
Eingang: 17.09.2022
Impfdatum: 13.09.2022
Beginn: 13.09.2022
Tage bis Beginn: 0,0
Dosis: 6
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Device connection issue Extra dose administered No adverse event

Symptomtext

This spontaneous case was reported by a patient family member or friend and describes the occurrence of DEVICE CONNECTION ISSUE (Syringe leaked upon administration), EXTRA DOSE ADMINISTERED (Administered an additional dose of the Bivalent moderna covid-19 vaccine from the same lot number and expiration date/ This was her 5th dose of the vaccine) and NO ADVERSE EVENT (No adverse event) in a female patient of an unknown age who received mRNA-1273 BIVALENT (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch nos. AS7143C and AS7143C) for COVID-19 prophylaxis. No Medical History information was reported. On 13-Sep-2022, the patient received fifth dose of mRNA-1273 BIVALENT (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Intramuscular) 1 dosage form. On 13-Sep-2022, received sixth dose of mRNA-1273 BIVALENT (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Intramuscular) dosage was changed to 1 dosage form. On 13-Sep-2022, the patient experienced DEVICE CONNECTION ISSUE (Syringe leaked upon administration) and EXTRA DOSE ADMINISTERED (Administered an additional dose of the Bivalent moderna covid-19 vaccine from the same lot number and expiration date/ This was her 5th dose of the vaccine). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, DEVICE CONNECTION ISSUE (Syringe leaked upon administration), EXTRA DOSE ADMINISTERED (Administered an additional dose of the Bivalent moderna covid-19 vaccine from the same lot number and expiration date/ This was her 5th dose of the vaccine) and NO ADVERSE EVENT (No adverse event) outcome was unknown. No concomitant medications were provided. Patient received her dose of the Moderna COVID-19 bivalent vaccine by intramuscular injection as the syringe leaked upon administration. This was give on 13-SEP-2022. This was her 5th dose of the vaccine. During the call the pharmacist administered an additional dose of the Bivalent moderna covid-19 vaccine from the same lot number and expiration date. Patient has not experienced any symptoms. No treatment medications were reported.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Device connection issue
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2449710

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge AS7143C

gering

Staat: VA
Alter: 69,0
Geschlecht: M
Eingang: 17.09.2022
Impfdatum: 04.09.2022
Beginn: 04.09.2022
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

No adverse event Underdose

Symptomtext

No adverse event; administered with 0.25ml of the bivalent booster dose instead of the 0.5ml dose; This spontaneous case was reported by a nurse and describes the occurrence of UNDERDOSE (administered with 0.25ml of the bivalent booster dose instead of the 0.5ml dose) and NO ADVERSE EVENT (No adverse event) in a 69-year-old male patient who received mRNA-1273 BIVALENT (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. AS7143C) for COVID-19 vaccination. No Medical History information was reported. On 04-Sep-2022, the patient received dose of mRNA-1273 BIVALENT (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) .25 milliliter. On 04-Sep-2022, the patient experienced UNDERDOSE (administered with 0.25ml of the bivalent booster dose instead of the 0.5ml dose). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, UNDERDOSE (administered with 0.25ml of the bivalent booster dose instead of the 0.5ml dose) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 BIVALENT (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for UNDERDOSE (administered with 0.25ml of the bivalent booster dose instead of the 0.5ml dose). Concomitant medication details were not reported by the reporter. On 02-Mar-2021, patient received First dose of Moderna COVID-19 vaccine with batch number 002A21A. On 30-Mar2021, patient received second dose of Moderna COVID-19 vaccine with batch number 028A21A. On 25-Oct-2021, patient received First booster of Moderna COVID-19 vaccine dose with batch number 076C21A. On 18-Apr-2022, patient received Second booster of Moderna COVID-19 vaccine dose with batch number 001M21A. The patient received the bivalent booster dose of the Moderna Covid-19 vaccine on 04-Sep-2022 and received 0.25ml instead of the 0.5ml dose. Vaccine provider called and informed patients that CDC recommended giving a full 0.5ml of the vaccine again instead of just 0.25. Treatment details was not reported by the reporter.

Weitere VAERSDATA-Felder

Praegender Schweregrund: No adverse event
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2449616

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge AS7143C

gering

Staat: VA
Alter: 66,0
Geschlecht: M
Eingang: 17.09.2022
Impfdatum: 07.09.2022
Beginn: 09.09.2022
Tage bis Beginn: 2,0
Dosis: 5
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Tension Throat tightness

Symptomtext

About two days after receiving the new Moderna Omicron booster, I began experiencing periodic mild tightening/tension of the lower throat, primarily in the subglottis region. Ten days have elapsed since receiving the shot, and some mild tightening is still periodically noticeable when swallowing or performing aerobic exercise (light jogging or fast walking).

Weitere VAERSDATA-Felder

Praegender Schweregrund: Tension
Hospital-Tage: -
Labordaten: None have been performed.
Aktuelle Erkrankungen: None
Vorgeschichte: None
Andere Medikamente: None
Allergien: Wheat, lactose, amoxicillin
Vorherige Impfungen: Moderna vaccine, typical soreness and fatigue, age 66

VAERS 2448969

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge AS7143C

gering

Staat: PR
Alter: 52,0
Geschlecht: F
Eingang: 17.09.2022
Impfdatum: 06.09.2022
Beginn: 06.09.2022
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Inappropriate schedule of product administration Limb discomfort

Symptomtext

little of discomfort in her left arm during 1 day after the vaccine was given; bivalent booster administered instead of 1st dose of primary series; This spontaneous case was reported by a pharmacist and describes the occurrence of LIMB DISCOMFORT (little of discomfort in her left arm during 1 day after the vaccine was given) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (bivalent booster administered instead of 1st dose of primary series) in a 52-year-old female patient who received mRNA-1273 BIVALENT (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. AS7143C) for COVID-19 vaccination. The patient had never been diagnosed with/ tested positive for COVID-19. Patient had no acute and chronic illness at the time of vaccination. No AE cause patient to seek medical care. Concurrent medical conditions included Penicillin allergy. Concomitant products included INFLUENZA VACCINE INACT SPLIT 3V (AFLURIA) for an unknown indication. On 06-Sep-2022, the patient received first dose of mRNA-1273 BIVALENT (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Intramuscular) 1 dosage form. On 06-Sep-2022, the patient experienced LIMB DISCOMFORT (little of discomfort in her left arm during 1 day after the vaccine was given) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (bivalent booster administered instead of 1st dose of primary series). On 06-Sep-2022, LIMB DISCOMFORT (little of discomfort in her left arm during 1 day after the vaccine was given) had resolved and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (bivalent booster administered instead of 1st dose of primary series) outcome was unknown. The action taken with mRNA-1273 BIVALENT (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Intramuscular) was unknown. For mRNA-1273 BIVALENT (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Intramuscular), the reporter did not provide any causality assessments. No concomitant and treatment information was provided.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Inappropriate schedule of product administration
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: Penicillin allergy
Vorgeschichte: Comments: The patient had never been diagnosed with/ tested positive for COVID-19. Patient had no acute and chronic illness at the time of vaccination. No AE cause patient to seek medical care.
Andere Medikamente: AFLURIA
Allergien: -
Vorherige Impfungen: -

VAERS 2447924

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH BIVALENT)) · Charge as7143c

gering

Staat: MS
Alter: 58,0
Geschlecht: M
Eingang: 16.09.2022
Impfdatum: 16.09.2022
Beginn: -
Tage bis Beginn: -
Dosis: UNK
Route/Site: IM / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

Product storage error

Symptomtext

Vaccine administered 24 hours after being moved from refrigerator to room temperature

Weitere VAERSDATA-Felder

Praegender Schweregrund: Product storage error
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2447918

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge as7143c

gering

Staat: MS
Alter: 45,0
Geschlecht: F
Eingang: 16.09.2022
Impfdatum: 16.09.2022
Beginn: -
Tage bis Beginn: -
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Product storage error

Symptomtext

Patient received injection 24 hours after the vial was taken out of refrigerator. Maximum, per guidelines, is 12 hours

Weitere VAERSDATA-Felder

Praegender Schweregrund: Product storage error
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2447902

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7143C

gering

Staat: -
Alter: 33,0
Geschlecht: M
Eingang: 16.09.2022
Impfdatum: 15.09.2022
Beginn: 15.09.2022
Tage bis Beginn: 0,0
Dosis: 3
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

Inappropriate schedule of product administration

Symptomtext

PATIENT WAS INADVERTINLY GIVEN A MODERNA BIVALENT BOOSTER SHOT TOO EARLY. DUE TO THE VACCINE RECORD. HAVING POORLY WRITTEN VACCINATION DATES. PATIENT WAS NOTIFED ABOUT ERROR. PATIENT WAS UNAFFECTED BY ADDITIONAL DOSE. PATIENT HAD NO COMPLAINTS OR CONCERNS AS A RESULT OF THE ADDITIONAL DOSE.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Inappropriate schedule of product administration
Hospital-Tage: -
Labordaten: N/A
Aktuelle Erkrankungen: NONE
Vorgeschichte: NONE
Andere Medikamente: UKNOWN
Allergien: NONE
Vorherige Impfungen: -

VAERS 2447828

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge AS7143C

gering

Staat: CA
Alter: 57,0
Geschlecht: F
Eingang: 16.09.2022
Impfdatum: 16.09.2022
Beginn: 16.09.2022
Tage bis Beginn: 0,0
Dosis: 5
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Incorrect product formulation administered

Symptomtext

Patient got Monovalent Moderna instead of Bivalent

Weitere VAERSDATA-Felder

Praegender Schweregrund: Incorrect product formulation administered
Hospital-Tage: -
Labordaten: none
Aktuelle Erkrankungen: not known
Vorgeschichte: not known
Andere Medikamente: not known
Allergien: no known
Vorherige Impfungen: -

VAERS 2447818

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge AS7143C

gering

Staat: CA
Alter: 61,0
Geschlecht: M
Eingang: 16.09.2022
Impfdatum: 16.09.2022
Beginn: 16.09.2022
Tage bis Beginn: 0,0
Dosis: 5
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Incorrect product formulation administered

Symptomtext

Patient was given the MOnovalent moderna instead of Bivalent

Weitere VAERSDATA-Felder

Praegender Schweregrund: Incorrect product formulation administered
Hospital-Tage: -
Labordaten: not known
Aktuelle Erkrankungen: none known
Vorgeschichte: not known
Andere Medikamente: none known
Allergien: no known
Vorherige Impfungen: -

VAERS 2447808

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge AS7143C

gering

Staat: CA
Alter: 67,0
Geschlecht: M
Eingang: 16.09.2022
Impfdatum: 16.09.2022
Beginn: 16.09.2022
Tage bis Beginn: 0,0
Dosis: 5
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Incorrect product formulation administered

Symptomtext

Patient was given Monovalent instead of Bivalent.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Incorrect product formulation administered
Hospital-Tage: -
Labordaten: None.
Aktuelle Erkrankungen: none known
Vorgeschichte: not known
Andere Medikamente: none known
Allergien: none known
Vorherige Impfungen: -

VAERS 2446603

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7143C

gering

Staat: MT
Alter: 9,0
Geschlecht: M
Eingang: 15.09.2022
Impfdatum: 15.09.2022
Beginn: 15.09.2022
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Nervousness No adverse event Product administered to patient of inappropriate age Wrong product administered

Symptomtext

Mom brought her two kids in for their Pfizer vaccines and she was to receive the bivalent Moderna booster. Tech went to give the 9 year old his vaccine and he started getting nervous and she ended up giving him the Moderna vaccine. No adverse reactions were noted while the patient was in the pharmacy.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Nervousness
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2445030

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge As7143c

gering

Staat: LA
Alter: 43,0
Geschlecht: F
Eingang: 14.09.2022
Impfdatum: 12.09.2022
Beginn: 14.09.2022
Tage bis Beginn: 2,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Herpes zoster

Symptomtext

Shingles

Weitere VAERSDATA-Felder

Praegender Schweregrund: Herpes zoster
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: None
Vorgeschichte: Fibromyalgia Spinal stenosis Failed L5s1 fusion Herniated l4l5 disc Arthritis
Andere Medikamente: Multi vitamin patch Clonazepam Celexa Gabapentin Tramadol Tizanidine
Allergien: Penicillin, Cipro, ambien, metformin, pineapple
Vorherige Impfungen: -

VAERS 2442835

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7143C

gering

Staat: KY
Alter: 47,0
Geschlecht: M
Eingang: 13.09.2022
Impfdatum: 07.09.2022
Beginn: 10.09.2022
Tage bis Beginn: 3,0
Dosis: UNK
Route/Site: SYR / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

COVID-19 SARS-CoV-2 test positive

Symptomtext

Positive for COVID - home test 9/11/2022. Physician confirmed 9/12/2022.

Weitere VAERSDATA-Felder

Praegender Schweregrund: COVID-19
Hospital-Tage: -
Labordaten: COVID test.
Aktuelle Erkrankungen: None
Vorgeschichte: High blood pressure. High cholesterol.
Andere Medikamente: Azor 10/40. Zyrtec. Vitamin D. Magnesium Glyconate.
Allergien: Penicillin
Vorherige Impfungen: -

VAERS 2441104

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7143C

gering

Staat: -
Alter: 15,0
Geschlecht: F
Eingang: 13.09.2022
Impfdatum: 09.09.2022
Beginn: 09.09.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

Incorrect product formulation administered

Symptomtext

administered Moderna bivalent booster to 15 year old

Weitere VAERSDATA-Felder

Praegender Schweregrund: Incorrect product formulation administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2440981

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge as7143c

gering

Staat: IN
Alter: 31,0
Geschlecht: F
Eingang: 12.09.2022
Impfdatum: 07.09.2022
Beginn: 07.09.2022
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Incorrect product formulation administered

Symptomtext

The patient was registered for the new bivalent moderna booster and received the new booster however she never received her primary series

Weitere VAERSDATA-Felder

Praegender Schweregrund: Incorrect product formulation administered
Hospital-Tage: -
Labordaten: not applicable
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2440829

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge as7143c

gering

Staat: UT
Alter: 13,0
Geschlecht: F
Eingang: 12.09.2022
Impfdatum: 06.09.2022
Beginn: 06.09.2022
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

No adverse event Product administered to patient of inappropriate age

Symptomtext

The patient is under the age of 18 years old and received the bi-valent version of Moderna. After speaking with the mother the patient has not shown any signs of adverse effects or symptoms.

Weitere VAERSDATA-Felder

Praegender Schweregrund: No adverse event
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2440825

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge as7143c

gering

Staat: UT
Alter: 16,0
Geschlecht: M
Eingang: 12.09.2022
Impfdatum: 12.09.2022
Beginn: 12.09.2022
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

No adverse event Product administered to patient of inappropriate age

Symptomtext

Patient is under the age of 18 years old and was given this bi-valent. After speaking with the mother of the child there were no adverse events to be reported.

Weitere VAERSDATA-Felder

Praegender Schweregrund: No adverse event
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2440130

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7143C

gering

Staat: NH
Alter: 82,0
Geschlecht: M
Eingang: 11.09.2022
Impfdatum: 09.09.2022
Beginn: 09.09.2022
Tage bis Beginn: 0,0
Dosis: 5
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Incorrect dose administered

Symptomtext

Patient was mistakenly give 0.25ml dose instead of the indicated 0.5ml dose. Patient returned to the pharmacy the next day to receive the remainder of the dose.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Incorrect dose administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2440129

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7143C

gering

Staat: NH
Alter: 75,0
Geschlecht: F
Eingang: 11.09.2022
Impfdatum: 09.09.2022
Beginn: 09.09.2022
Tage bis Beginn: 0,0
Dosis: 5
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Incorrect dose administered

Symptomtext

Patient was mistakenly given a 0.25ml dose instead of the indicated 0.5ml dose. Patient returned to the pharmacy the next day to receive the remainder of the dose.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Incorrect dose administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2440127

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7143C

gering

Staat: NH
Alter: 45,0
Geschlecht: F
Eingang: 11.09.2022
Impfdatum: 09.09.2022
Beginn: 09.09.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

Underdose

Symptomtext

Patient was mistakenly given 0.25ml dose instead of the indicated 0.5ml. Patient returned to the pharmacy the next day and received the remainder of the dose.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Underdose
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2440125

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7143C

gering

Staat: NH
Alter: 64,0
Geschlecht: M
Eingang: 11.09.2022
Impfdatum: 09.09.2022
Beginn: 09.09.2022
Tage bis Beginn: 0,0
Dosis: 5
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

Wrong technique in product usage process

Symptomtext

Patient was mistakenly given a 0.25ml dose instead of the indicated 0.5ml dose. Patient returned to the pharmacy the next day and was administered the remaining dose.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Wrong technique in product usage process
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2440121

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7143C

gering

Staat: NH
Alter: 69,0
Geschlecht: M
Eingang: 11.09.2022
Impfdatum: 09.09.2022
Beginn: 09.09.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Incorrect dose administered

Symptomtext

Patient was mistakenly given a 0.25ml dose instead of the 0.5ml dose indicated.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Incorrect dose administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2439934

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge as7143c

gering

Staat: MD
Alter: 53,0
Geschlecht: F
Eingang: 10.09.2022
Impfdatum: 08.09.2022
Beginn: -
Tage bis Beginn: -
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Incorrect product formulation administered

Symptomtext

so patient has no any symptoms

Weitere VAERSDATA-Felder

Praegender Schweregrund: Incorrect product formulation administered
Hospital-Tage: -
Labordaten: no tests no problem so far
Aktuelle Erkrankungen: not known
Vorgeschichte: not known
Andere Medikamente: n/a
Allergien: n/a
Vorherige Impfungen: -

VAERS 2439675

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge AS7143C

gering

Staat: VA
Alter: 68,0
Geschlecht: F
Eingang: 10.09.2022
Impfdatum: 04.09.2022
Beginn: 04.09.2022
Tage bis Beginn: 0,0
Dosis: 5
Route/Site: OT / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

No adverse event Underdose

Symptomtext

No adverse event; administered with 0.25ml of the bivalent booster dose instead of the 0.5ml dose; This spontaneous case was reported by a nurse and describes the occurrence of UNDERDOSE (administered with 0.25ml of the bivalent booster dose instead of the 0.5ml dose) and NO ADVERSE EVENT (No adverse event) in a 68-year-old female patient who received mRNA-1273 BIVALENT (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. AS7143C) for COVID-19 vaccination. No Medical History information was reported. On 04-Sep-2022, the patient received fifth dose of mRNA-1273 BIVALENT (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) .25 milliliter. On 04-Sep-2022, the patient experienced UNDERDOSE (administered with 0.25ml of the bivalent booster dose instead of the 0.5ml dose). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, UNDERDOSE (administered with 0.25ml of the bivalent booster dose instead of the 0.5ml dose) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 BIVALENT (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for UNDERDOSE (administered with 0.25ml of the bivalent booster dose instead of the 0.5ml dose). Concomitant medication details were not reported by the reporter. On 02-Mar-2021, patient received First dose of Moderna COVID-19 vaccine with batch number 002A21A. On 30-Mar2021, patient received second dose of Moderna COVID-19 vaccine with batch number 028A21A. On 25-Oct-2021, patient received First booster of Moderna COVID-19 vaccine dose with batch number 076C21A. On 18-Apr-2022, patient received Second booster of Moderna COVID-19 vaccine dose with batch number 001M21A. A retired pediatric nurse practitioner reported that she got the bivalent booster dose of the Moderna Covid-19 vaccine last 04Sep2022. Patients were given 0.25ml instead of the 0.5ml dose. Vaccine provider called and informed patients that CDC recommended giving a full 0.5ml of the vaccine again instead of just 0.25. Treatment details was not reported by the reporter.

Weitere VAERSDATA-Felder

Praegender Schweregrund: No adverse event
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2439604

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge AS7143C

gering

Staat: IN
Alter: 66,0
Geschlecht: M
Eingang: 10.09.2022
Impfdatum: 02.09.2022
Beginn: 02.09.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: OT / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Extra dose administered No adverse event

Symptomtext

This spontaneous case was reported by a patient and describes the occurrence of EXTRA DOSE ADMINISTERED (The patient was given two 0.25 ml doses of the Bivalent Moderna COVID-19 vaccine) and NO ADVERSE EVENT (No adverse event) in a 66-year-old male patient who received mRNA-1273 BIVALENT (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch nos. AS7143C and AS7143C) for COVID-19 prophylaxis. Previously administered products included for Product used for unknown indication: Pfizer (Dose 1), Pfizer (Dose 3 (first booster dose)) and Pfizer (Dose 2). Past adverse reactions to the above products included No adverse event with Pfizer, Pfizer and Pfizer. On 02-Sep-2022 at 1:20 PM, the patient received fourth dose of mRNA-1273 BIVALENT (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Intramuscular) .25 milliliter. On 02-Sep-2022 at 2:42 PM, received fifth dose of mRNA-1273 BIVALENT (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Intramuscular) dosage was changed to .25 milliliter. On 02-Sep-2022, the patient experienced EXTRA DOSE ADMINISTERED (The patient was given two 0.25 ml doses of the Bivalent Moderna COVID-19 vaccine). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, EXTRA DOSE ADMINISTERED (The patient was given two 0.25 ml doses of the Bivalent Moderna COVID-19 vaccine) and NO ADVERSE EVENT (No adverse event) outcome was unknown. No past illness information for the patient was not provided. The patient had not experienced symptoms with any previous doses of any vaccines. No concomitant medications were reported. The patient had not experienced any symptoms since having the two doses of 0.25 ml. Treatment information was provided as none.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Extra dose administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2439007

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7143C

gering

Staat: CO
Alter: 77,0
Geschlecht: F
Eingang: 10.09.2022
Impfdatum: 10.09.2022
Beginn: 10.09.2022
Tage bis Beginn: 0,0
Dosis: 5
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Erythema Peripheral swelling

Symptomtext

Patient reported that her whole arms were swollen and red starting a few hours after getting the shots

Weitere VAERSDATA-Felder

Praegender Schweregrund: Erythema
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: unknown
Vorgeschichte: osteoporosis
Andere Medikamente: N/A
Allergien: Aspirin
Vorherige Impfungen: -

VAERS 2437485

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge As7143c

gering

Staat: NM
Alter: 70,0
Geschlecht: F
Eingang: 09.09.2022
Impfdatum: 09.09.2022
Beginn: 09.09.2022
Tage bis Beginn: 0,0
Dosis: 5
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Exposure via skin contact Syringe issue

Symptomtext

inserted vaccine with a vanish point syringe. pushed the plunger to inject vaccine vanish point make a load popping sound all vaccine came out the backend at the plunger on to vaccinators hand patent was revaccinated without failure of syringe system

Weitere VAERSDATA-Felder

Praegender Schweregrund: Exposure via skin contact
Hospital-Tage: -
Labordaten: none
Aktuelle Erkrankungen: none
Vorgeschichte: none
Andere Medikamente: Not known
Allergien: none
Vorherige Impfungen: -

VAERS 2437481

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7143C

gering

Staat: CA
Alter: 75,0
Geschlecht: F
Eingang: 09.09.2022
Impfdatum: 06.09.2022
Beginn: 06.09.2022
Tage bis Beginn: 0,0
Dosis: 5
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Underdose

Symptomtext

THE PATIENT RECEIVED 0.25 ML OF THE MODERNA BIVALENT VACCINE INSTEAD OF 0.5 ML ON 9-6-2022.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Underdose
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2437479

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7143C

gering

Staat: CA
Alter: 52,0
Geschlecht: M
Eingang: 09.09.2022
Impfdatum: 06.09.2022
Beginn: 06.09.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Underdose

Symptomtext

THE PATIENT RECEIVED 0.25 ML OF THE MODERNA BIVALENT VACCINE INSTEAD OF 0.5 ML ON 9-6-2022.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Underdose
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2437454

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7143C

gering

Staat: CA
Alter: 63,0
Geschlecht: F
Eingang: 09.09.2022
Impfdatum: 06.09.2022
Beginn: 06.09.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Incorrect dose administered

Symptomtext

THE PATIENT RECEIVED 0.25 ML OF THE MODERNA BIVALENT VACCINE INSTEAD OF 0.5 ML ON 9-6-2022. THE PATIENT CAME BACK ON 9-7-2022 TO RECEIVE THE SECOND 0.25ML.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Incorrect dose administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2437451

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7143C

gering

Staat: CA
Alter: 74,0
Geschlecht: F
Eingang: 09.09.2022
Impfdatum: 06.09.2022
Beginn: 06.09.2022
Tage bis Beginn: 0,0
Dosis: 5
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Incorrect dose administered

Symptomtext

THE PATIENT RECEIVED 0.25 ML OF THE MODERNA BIVALENT VACCINE INSTEAD OF 0.5 ML ON 9-6-2022. THE PATIENT CAME BACK ON 9-7-2022 TO RECEIVE THE SECOND 0.25ML.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Incorrect dose administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2437448

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7143C

gering

Staat: CA
Alter: 69,0
Geschlecht: M
Eingang: 09.09.2022
Impfdatum: 06.09.2022
Beginn: 06.09.2022
Tage bis Beginn: 0,0
Dosis: 5
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Underdose

Symptomtext

The patient received 0.25mL of the Moderna bivalent vaccine instead of 0.5mL on 9/6/2022. The patient came back on 9/7/2022 to receive the second 0.25mL.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Underdose
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2436948

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7143C

gering

Staat: CA
Alter: 70,0
Geschlecht: M
Eingang: 09.09.2022
Impfdatum: 06.09.2022
Beginn: 06.09.2022
Tage bis Beginn: 0,0
Dosis: 5
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Incorrect dose administered

Symptomtext

THE PATIENT RECEIVED 0.25 ML OF THE MODERNA BIVALENT VACCINE INSTEAD OF 0.5 ML ON 9-6-2022. THE PATIENT CAME BACK ON 9-7-2022 TO RECEIVE THE SECOND 0.25ML.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Incorrect dose administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2436945

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7143C

gering

Staat: CA
Alter: 73,0
Geschlecht: F
Eingang: 09.09.2022
Impfdatum: 06.09.2022
Beginn: 06.09.2022
Tage bis Beginn: 0,0
Dosis: 5
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Product administered to patient of inappropriate age

Symptomtext

THE PATIENT RECEIVED 0.25 ML OF THE MODERNA BIVALENT VACCINE INSTEAD OF 0.5 ML ON 9-6-2022. THE PATIENT CAME BACK ON 9-7-2022 TO RECEIVE THE SECOND 0.25ML.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Product administered to patient of inappropriate age
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2436938

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7143C

gering

Staat: CA
Alter: 52,0
Geschlecht: F
Eingang: 09.09.2022
Impfdatum: 06.09.2022
Beginn: 06.09.2022
Tage bis Beginn: 0,0
Dosis: 4
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Wrong technique in product usage process

Symptomtext

THE PATIENT RECEIVED 0.25 ML OF THE MODERNA BIVALENT VACCINE INSTEAD OF 0.5 ML ON 9-6-2022. THE PATIENT CAME BACK ON 9-7-2022 TO RECEIVE THE SECOND 0.25ML.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Wrong technique in product usage process
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2436937

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7143C

gering

Staat: CA
Alter: 81,0
Geschlecht: F
Eingang: 09.09.2022
Impfdatum: 06.09.2022
Beginn: 06.09.2022
Tage bis Beginn: 0,0
Dosis: 5
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Underdose

Symptomtext

THE PATIENT RECEIVED 0.25 ML OF THE MODERNA BIVALENT VACCINE INSTEAD OF 0.5 ML ON 9-6-2022. THE PATIENT CAME BACK ON 9-7-2022 TO RECEIVE THE SECOND 0.25ML.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Underdose
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2436934

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7143C

gering

Staat: CA
Alter: 74,0
Geschlecht: M
Eingang: 09.09.2022
Impfdatum: 06.09.2022
Beginn: 06.09.2022
Tage bis Beginn: 0,0
Dosis: 5
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Underdose

Symptomtext

THE PATIENT RECEIVED 0.25 ML OF THE MODERNA BIVALENT VACCINE INSTEAD OF 0.5 ML ON 9-6-2022. THE PATIENT CAME BACK ON 9-7-2022 TO RECEIVE THE SECOND 0.25ML.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Underdose
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2436928

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7143C

gering

Staat: CA
Alter: 95,0
Geschlecht: F
Eingang: 09.09.2022
Impfdatum: 06.09.2022
Beginn: 06.09.2022
Tage bis Beginn: 0,0
Dosis: 5
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Wrong technique in product usage process

Symptomtext

THE PATIENT RECEIVED 0.25 ML OF THE MODERNA BIVALENT VACCINE INSTEAD OF 0.5 ML ON 9-6-2022. THE PATIENT CAME BACK ON 9-7-2022 TO RECEIVE THE SECOND 0.25ML.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Wrong technique in product usage process
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2436927

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7143C

gering

Staat: CA
Alter: 55,0
Geschlecht: F
Eingang: 09.09.2022
Impfdatum: 06.09.2022
Beginn: 06.09.2022
Tage bis Beginn: 0,0
Dosis: 5
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Wrong technique in product usage process

Symptomtext

THE PATIENT RECEIVED 0.25 ML OF THE MODERNA BIVALENT VACCINE INSTEAD OF 0.5 ML ON 9-6-2022. THE PATIENT CAME BACK ON 9-7-2022 TO RECEIVE THE SECOND 0.25ML.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Wrong technique in product usage process
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2436725

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7143C

gering

Staat: CA
Alter: 60,0
Geschlecht: M
Eingang: 09.09.2022
Impfdatum: 06.09.2022
Beginn: 06.09.2022
Tage bis Beginn: 0,0
Dosis: 5
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Wrong technique in product usage process

Symptomtext

THE PATIENT RECEIVED 0.25 ML OF THE MODERNA BIVALENT VACCINE INSTEAD OF 0.5 ML ON 9-6-2022. THE PATIENT CAME BACK ON 9-7-2022 TO RECEIVE THE SECOND 0.25ML.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Wrong technique in product usage process
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2436723

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7143C

gering

Staat: CA
Alter: 77,0
Geschlecht: M
Eingang: 09.09.2022
Impfdatum: 06.09.2022
Beginn: 06.09.2022
Tage bis Beginn: 0,0
Dosis: 5
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Underdose

Symptomtext

THE PATIENT RECEIVED 0.25 ML OF THE MODERNA BIVALENT VACCINE INSTEAD OF 0.5 ML ON 9-6-2022. THE PATIENT CAME BACK ON 9-7-2022 TO RECEIVE THE SECOND 0.25ML.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Underdose
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2436720

MODERNA · COVID19 (COVID19 (MODERNA BIVALENT)) · Charge AS7143C

gering

Staat: TX
Alter: 70,0
Geschlecht: M
Eingang: 09.09.2022
Impfdatum: 06.09.2022
Beginn: 06.09.2022
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Wrong technique in product usage process

Symptomtext

THE PATIENT RECEIVED 0.25 ML OF THE MODERNA BIVALENT VACCINE INSTEAD OF 0.5 ML ON 9-6-2022. THE PATIENT CAME BACK ON 9-7-2022 TO RECEIVE THE SECOND 0.25ML.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Wrong technique in product usage process
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -